UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________

FORM 10-Q

(Mark One)


☒			☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
			For the quarterly period ended ~~June~~September 30, 2020
			OR
☐			☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
			For the transition period from__________________ to _______________

Commission File Number

Registrant; State of Incorporation; Address and Telephone Number

IRS Employer Identification No.

1-11178

Revlon, Inc.

13-3662955

Delaware

One New York Plaza

New York, New York 10004

212-527-4000

33-59650

Revlon Consumer Products Corporation

13-3662953

Delaware

One New York Plaza

New York, New York 10004

212-527-4000

Securities registered pursuant to Section 12(b) or 12(g) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Revlon, Inc.

Class A Common Stock

REV

New York Stock Exchange

Revlon Consumer Products Corporation

None

N/A

Indicate by check mark whether the registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.


Revlon, Inc.	Yes ☒	No ☐
Revlon Consumer Products Corporation	Yes ☐	No ☒

Indicate by check mark whether the registrants have submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ¨

Indicate by check mark whether each registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller Reporting Company

Emerging Growth Company

Revlon, Inc.

Yes ☐ No ☒

Yes ☒ No ☐

Yes ☐ No ☒

Yes

☒

No ☐

Yes

☐

No ☒

Revlon Consumer Products Corporation

Yes ☐ No ☒

Yes ☒ No ☐

Yes

☒

No ☐

Yes

☐

No ☒

If an emerging growth company, indicate by check mark if the registrants have elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether each registrant is a shell company (as defined in Rule 12b-2 of the Act).


Revlon, Inc.	Yes	☐	No ☒
Revlon Consumer Products Corporation	Yes	☐	No ☒

Number of shares of common stock outstanding as of ~~June~~September 30, 2020:


Revlon, Inc. Class A Common Stock:			~~53,326,315~~53,330,303
Revlon Consumer Products Corporation Common Stock:			5,260

At such date, (i) 46,223,321 shares of Revlon, Inc. Class A Common Stock were beneficially owned by MacAndrews & Forbes Incorporated and certain of its affiliates; and (ii) all shares of Revlon Consumer Products Corporation ("Products Corporation") Common Stock were held by Revlon, Inc.

Products Corporation meets the conditions set forth in General Instructions H(1)(a) and (b) of Form 10-Q as, among other things, all of Products Corporation's equity securities are owned directly by Revlon, Inc., which is a reporting company under the Securities Exchange Act of 1934, as amended, and which filed with the SEC on ~~August 6,~~November 13, 2020 all of the material required to be filed pursuant to Section 13, 14 or 15(d) thereof. Products Corporation is therefore filing this Form 10-Q with a reduced disclosure format applicable to Products Corporation.

REVLON, INC. AND SUBSIDIARIES

INDEX

PART I - Financial Information

Item 1.

Financial Statements of Revlon, Inc. and Subsidiaries

Consolidated Balance Sheets as of ~~June~~September 30, 2020 (Unaudited) and December 31, 2019

Unaudited Consolidated Statements of Operations and Comprehensive Loss for the Three and ~~Six~~Nine Months Ended ~~June~~September 30, 2020 and 2019

Unaudited Consolidated Statement of Stockholders' Deficiency for the Three and ~~Six~~Nine Months Ended ~~June~~September 30, 2020 and 2019

Unaudited Consolidated Statements of Cash Flows for the ~~Six~~Nine Months Ended ~~June~~September 30, 2020 and 2019

Financial Statements of Revlon Consumer Products Corporation and Subsidiaries

Consolidated Balance Sheets as of ~~June~~September 30, 2020 (Unaudited) and December 31, 2019

Unaudited Consolidated Statements of Operations and Comprehensive Loss for the Three and ~~Six~~Nine Months Ended ~~June~~September 30, 2020 and 2019

Unaudited Consolidated Statement of Stockholders' Deficiency for the Three and ~~Six~~Nine Months Ended ~~June~~September 30, 2020 and 2019

910

Unaudited Consolidated Statements of Cash Flows for the ~~Six~~Nine Months Ended ~~June~~September 30, 2020 and 2019

1011

Combined Notes to Unaudited Consolidated Financial Statements

1213

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

5255

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

8596

Item 4.

Controls and Procedures

8697

PART II - Other Information

Item 1.

Item 1A.

Item 5.

~~103~~114

Item 6.

Exhibits

~~104~~114

Signatures

Table of Contents

REVLON, INC. AND SUBSIDIARIES

PART I - FINANCIAL INFORMATION

REVLON, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(dollars in millions, except share and per share amounts)

June 30, 2020 December 31, 2019
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents $ 338.5 $ 104.3
Trade receivables, less allowance for doubtful accounts of $12.6 and $11.4 as of June 30, 2020 and December 31, 2019, respectively 288.3 423.4
Inventories 511.2 448.4
Prepaid expenses and other assets 144.9 135.3
Total current assets 1,282.9 1,111.4
Property, plant and equipment, net of accumulated depreciation of $508.8 and $488.1 as of June 30, 2020 and December 31, 2019, respectively 365.5 408.6
Deferred income taxes 229.2 175.1
Goodwill 562.7 673.7
Intangible assets, net of accumulated amortization and impairment of $276.3 and $226.4 as of June 30, 2020 and December 31, 2019, respectively 441.6 490.7
Other assets 117.4 121.1
Total assets $ 2,999.3 $ 2,980.6
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Current liabilities:
Short-term borrowings $ 2.6 $ 2.2
Current portion of long-term debt 648.3 288.0
Accounts payable 224.6 251.8
Accrued expenses and other current liabilities 378.5 414.9
Total current liabilities 1,254.0 956.9
Long-term debt 2,975.8 2,906.2
Long-term pension and other post-retirement plan liabilities 170.6 181.2
Other long-term liabilities 147.4 157.5
Stockholders’ deficiency:
Class A Common Stock, par value $0.01 per share: 900,000,000 shares authorized; 57,696,143 and 56,470,490 shares issued as of June 30, 2020 and December 31, 2019, respectively 0.5 0.5
Additional paid-in capital 1,075.4 1,071.9
Treasury stock, at cost: 1,769,665 and 1,625,580 shares of Class A Common Stock as of June 30, 2020 and December 31, 2019, respectively (35.2) (33.5)
Accumulated deficit (2,353.4) (2,012.7)
Accumulated other comprehensive loss (235.8) (247.4)
Total stockholders’ deficiency (1,548.5) (1,221.2)
Total liabilities and stockholders’ deficiency $ 2,999.3 $ 2,980.6


	September 30, 2020		December 31, 2019
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	268.3	$	104.3
Trade receivables, less allowance for doubtful accounts of $12.4 and $11.4 as of September 30, 2020 and December 31, 2019, respectively	340.8		423.4
Inventories, net	525.5		448.4
Prepaid expenses and other assets	140.8		135.3
Total current assets	1,275.4		1,111.4
Property, plant and equipment, net of accumulated depreciation of $530.3 and $488.1 as of September 30, 2020 and December 31, 2019, respectively	355.8		408.6
Deferred income taxes	230.5		175.1
Goodwill	563.2		673.7
Intangible assets, net of accumulated amortization and impairment of $286.7 and $226.4 as of September 30, 2020 and December 31, 2019, respectively	435.9		490.7
Other assets	112.5		121.1
Total assets	$	2,973.3	$	2,980.6

LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Current liabilities:
Short-term borrowings	$	2.0	$	2.2
Current portion of long-term debt	704.5		288.0
Accounts payable	219.9		251.8
Accrued expenses and other current liabilities	387.9		414.9

Total current liabilities	1,314.3		956.9
Long-term debt	2,926.5		2,906.2
Long-term pension and other post-retirement plan liabilities	166.7		181.2
Other long-term liabilities	148.7		157.5

Stockholders’ deficiency:
Class A Common Stock, par value $0.01 per share: 900,000,000 shares authorized; 57,674,817 and 56,470,490 shares issued as of September 30, 2020 and December 31, 2019, respectively	0.5		0.5
Additional paid-in capital	1,080.5		1,071.9
Treasury stock, at cost: 1,771,032 and 1,625,580 shares of Class A Common Stock as of September 30, 2020 and December 31, 2019, respectively	(35.2)		(33.5)
Accumulated deficit	(2,397.9)		(2,012.7)
Accumulated other comprehensive loss	(230.8)		(247.4)
Total stockholders’ deficiency	(1,582.9)		(1,221.2)
Total liabilities and stockholders’ deficiency	$	2,973.3	$	2,980.6

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(dollars in millions, except share and per share amounts)


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended September 30,				Nine Months Ended September 30,

		2020		2019		2020		2019			2020		2019		2020		2019

Net sales	Net sales	$	347.6	$	570.2	$	800.6	$	1,123.4	Net sales	$	477.1	$	596.8	$	1,277.7	$	1,720.2
Cost of sales	Cost of sales	168.6		243.9		366.4		481.7		Cost of sales	234.3		269.0		600.7		750.7
Gross profit	Gross profit	179.0		326.3		434.2		641.7		Gross profit	242.8		327.8		677.0		969.5
Selling, general and administrative expenses	Selling, general and administrative expenses	196.3		332.5		485.7		665.1		Selling, general and administrative expenses	253.4		308.1		739.1		973.2
Acquisition, integration and divestiture costs	Acquisition, integration and divestiture costs	1.2		—		3.3		0.6		Acquisition, integration and divestiture costs	0.9		0.1		4.2		0.7
Restructuring charges and other, net	Restructuring charges and other, net	20.7		3.2		45.5		8.7		Restructuring charges and other, net	(0.7)		2.9		44.8		11.6
Impairment charges	Impairment charges	19.8		—		144.1		—		Impairment charges	0		0		144.1		0
(Gain) loss on divested assets		(0.2)		—		0.6		—
Operating loss		(58.8)		(9.4)		(245.0)		(32.7)
Gain on divested assets										Gain on divested assets	(1.1)		0		(0.5)		0
Operating (loss) income										Operating (loss) income	(9.7)		16.7		(254.7)		(16.0)
Other expenses:	Other expenses:									Other expenses:
Interest expense, net	Interest expense, net	60.9		47.8		109.3		95.5		Interest expense, net	68.7		50.2		178.0		145.7

Amortization of debt issuance costs	Amortization of debt issuance costs	6.0		3.5		10.0		6.7		Amortization of debt issuance costs	7.8		3.7		17.8		10.4
(Gain) loss on early extinguishment of debt, net		(11.9)		—		(11.9)		—
Foreign currency losses, net		2.3		1.2		18.9		1.4
Gain on early extinguishment of debt										Gain on early extinguishment of debt	(31.2)		0		(43.1)		0
Foreign currency (gains) losses, net										Foreign currency (gains) losses, net	(9.8)		7.6		9.1		9.0
Miscellaneous, net	Miscellaneous, net	20.6		4.6		16.5		5.9		Miscellaneous, net	(2.6)		1.7		13.9		7.6
Other expenses	Other expenses	77.9		57.1		142.8		109.5		Other expenses	32.9		63.2		175.7		172.7
Loss from continuing operations before income taxes	Loss from continuing operations before income taxes	(136.7)		(66.5)		(387.8)		(142.2)		Loss from continuing operations before income taxes	(42.6)		(46.5)		(430.4)		(188.7)
Benefit from income taxes		(9.9)		(1.2)		(47.1)		(1.1)
Provision for (benefit from) income taxes										Provision for (benefit from) income taxes	1.9		(2.1)		(45.2)		(3.2)
Loss from continuing operations, net of taxes	Loss from continuing operations, net of taxes	(126.8)		(65.3)		(340.7)		(141.1)		Loss from continuing operations, net of taxes	(44.5)		(44.4)		(385.2)		(185.5)
Income from discontinued operations, net of taxes		—		1.6		—		2.3
(Loss) income from discontinued operations, net of taxes										(Loss) income from discontinued operations, net of taxes	0		(0.3)		0		2.0
Net loss	Net loss	$	(126.8)	$	(63.7)	$	(340.7)	$	(138.8)	Net loss	$	(44.5)	$	(44.7)	$	(385.2)	$	(183.5)
Other comprehensive (loss) income:
Other comprehensive income (loss):										Other comprehensive income (loss):
Foreign currency translation adjustments	Foreign currency translation adjustments	10.3		2.6		5.1		1.3		Foreign currency translation adjustments	2.2		(1.8)		7.3		(0.5)
Amortization of pension related costs, net of tax^(a)(b)	Amortization of pension related costs, net of tax^(a)(b)	4.0		2.7		6.5		4.9		Amortization of pension related costs, net of tax(a)(b)	2.8		2.3		9.3		7.2

Other comprehensive (loss) income, net		14.3		5.3		11.6		6.2
Other comprehensive income, net										Other comprehensive income, net	5.0		0.5		16.6		6.7
Total comprehensive loss	Total comprehensive loss	$	(112.5)	$	(58.4)	$	(329.1)	$	(132.6)	Total comprehensive loss	$	(39.5)	$	(44.2)	$	(368.6)	$	(176.8)

Basic and Diluted (loss) earnings per common share:	Basic and Diluted (loss) earnings per common share:									Basic and Diluted (loss) earnings per common share:
Continuing operations	Continuing operations	$	(2.37)	$	(1.23)	$	(6.39)	$	(2.66)	Continuing operations	$	(0.83)	$	(0.84)	$	(7.22)	$	(3.50)
Discontinued operations	Discontinued operations	—		0.03		—		0.04		Discontinued operations	0		0		0		0.04
Net loss	Net loss	$	(2.37)	$	(1.20)	$	(6.39)	$	(2.62)	Net loss	$	(0.83)	$	(0.84)	$	(7.22)	$	(3.46)

Weighted average number of common shares outstanding:	Weighted average number of common shares outstanding:									Weighted average number of common shares outstanding:
Basic	Basic	53,471,004		53,126,700		53,319,228		53,020,633		Basic	53,476,354		53,129,004		53,371,986		53,057,154
Diluted	Diluted	53,471,004		53,126,700		53,319,228		53,020,633		Diluted	53,476,354		53,129,004		53,371,986		53,057,154

^(a) Net of a ~~$1.5~~$0.5 million tax ~~benefit~~expense and $0.3 million of tax expense for the three months ended ~~June~~September 30, 2020 and 2019, respectively, and net of a ~~$1.2~~$0.7 million tax benefit and ~~$0.6~~$0.9 million of tax expense for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

^(b) This amount is included in the computation of net periodic benefit costs (income). See Note 10, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIENCY

(dollars in millions, except share and per share amounts)


		Common Stock		Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholders’ Deficiency			Common Stock		Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholders’ Deficiency

Balance, January 1, 2020	Balance, January 1, 2020	$	0.5	$	1,071.9	$	(33.5)	$	(2,012.7)	$	(247.4)	$	(1,221.2)	Balance, January 1, 2020	$	0.5	$	1,071.9	$	(33.5)	$	(2,012.7)	$	(247.4)	$	(1,221.2)
Treasury stock acquired, at cost ^(a)	Treasury stock acquired, at cost ^(a)	—		—		(0.4)		—		—		(0.4)		Treasury stock acquired, at cost (a)	—		—		(0.4)		—		—		(0.4)
Stock-based compensation amortization	Stock-based compensation amortization	—		2.4		—		—		—		2.4		Stock-based compensation amortization	—		2.4		—		—		—		2.4
Net loss	Net loss	—		—		—		(213.9)		—		(213.9)		Net loss	—		—		—		(213.9)		—		(213.9)
Other comprehensive (loss) income, net ^(b)	Other comprehensive (loss) income, net ^(b)	—		—		—		—		(2.7)		(2.7)		Other comprehensive (loss) income, net (b)	—		—		—		—		(2.7)		(2.7)
Balance, March 31, 2020	Balance, March 31, 2020	0.5		1,074.3		(33.9)		(2,226.6)		(250.1)		(1,435.8)		Balance, March 31, 2020	0.5		1,074.3		(33.9)		(2,226.6)		(250.1)		(1,435.8)

Treasury stock acquired, at cost (a)														Treasury stock acquired, at cost (a)	—		—		(1.3)		—		—		(1.3)
Stock-based compensation amortization														Stock-based compensation amortization	—		1.1		—		—		—		1.1
Net loss														Net loss	—		—		—		(126.8)		—		(126.8)
Other comprehensive (loss) income, net (b)														Other comprehensive (loss) income, net (b)	—		—		—		—		14.3		14.3
Balance, June 30, 2020														Balance, June 30, 2020	0.5		1,075.4		(35.2)		(2,353.4)		(235.8)		(1,548.5)

Treasury stock acquired, at cost ^(a)	Treasury stock acquired, at cost ^(a)	—		—		(1.3)		—		—		(1.3)		Treasury stock acquired, at cost (a)	—		—		—		—		—		—
Stock-based compensation amortization	Stock-based compensation amortization	—		1.1		—		—		—		1.1		Stock-based compensation amortization	—		5.1		—		—		—		5.1
Net loss	Net loss	—		—		—		(126.8)		—		(126.8)		Net loss	—		—		—		(44.5)		—		(44.5)
Other comprehensive (loss) income, net ^(b)	Other comprehensive (loss) income, net ^(b)	—		—		—		—		14.3		14.3		Other comprehensive (loss) income, net (b)	—		—		—		—		5.0		5.0
Balance, June 30, 2020		$	0.5	$	1,075.4	$	(35.2)	$	(2,353.4)	$	(235.8)	$	(1,548.5)
Balance, September 30, 2020														Balance, September 30, 2020	$	0.5	$	1,080.5	$	(35.2)	$	(2,397.9)	$	(230.8)	$	(1,582.9)


		Common Stock		Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholders’ Deficiency			Common Stock		Additional Paid-In Capital		Treasury Stock		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholders’ Deficiency
Balance, January 1, 2019	Balance, January 1, 2019	$	0.5	$	1,063.8	$	(31.9)	$	(1,855.0)	$	(234.2)	$	(1,056.8)	Balance, January 1, 2019	$	0.5	$	1,063.8	$	(31.9)	$	(1,855.0)	$	(234.2)	$	(1,056.8)
Treasury stock acquired, at cost ^(a)	Treasury stock acquired, at cost ^(a)	—		—		(1.6)		—		—		(1.6)		Treasury stock acquired, at cost (a)	—		—		(1.6)		—		—		(1.6)
Stock-based compensation amortization	Stock-based compensation amortization	—		0.4		—		—		—		0.4		Stock-based compensation amortization	—		0.4		—		—		—		0.4
Net loss	Net loss	—		—		—		(75.1)		—		(75.1)		Net loss	—		—		—		(75.1)		—		(75.1)
Other comprehensive (loss) income, net ^(b)	Other comprehensive (loss) income, net ^(b)	—		—		—		—		0.9		0.9		Other comprehensive (loss) income, net (b)	—		—		—		—		0.9		0.9
Balance, March 31, 2019	Balance, March 31, 2019	0.5		1,064.2		(33.5)		(1,930.1)		(233.3)		(1,132.2)		Balance, March 31, 2019	0.5		1,064.2		(33.5)		(1,930.1)		(233.3)		(1,132.2)
Treasury stock acquired, at cost ^(a)	Treasury stock acquired, at cost ^(a)	—		—		—		—		—		0.0		Treasury stock acquired, at cost (a)	—		—		0		—		—		0
Stock-based compensation amortization	Stock-based compensation amortization	—		3.4		—		—		—		3.4		Stock-based compensation amortization	—		3.4		—		—		—		3.4
Net loss	Net loss	—		—		—		(63.7)		—		(63.7)		Net loss	—		—		—		(63.7)		—		(63.7)
Other comprehensive (loss) income, net ^(b)	Other comprehensive (loss) income, net ^(b)	—		—		—		—		5.3		5.3		Other comprehensive (loss) income, net (b)	—		—		—		—		5.3		5.3
Balance, June 30, 2019	Balance, June 30, 2019	$	0.5	$	1,067.6	$	(33.5)	$	(1,993.8)	$	(228.0)	$	(1,187.2)	Balance, June 30, 2019	$	0.5	$	1,067.6	$	(33.5)	$	(1,993.8)	$	(228.0)	$	(1,187.2)

Treasury stock acquired, at cost (a)														Treasury stock acquired, at cost (a)	—		—		—		—		—		—
Stock-based compensation amortization														Stock-based compensation amortization	—		3.9		—		—		—		3.9
Net loss														Net loss	—		—		—		(44.7)		—		(44.7)
Other comprehensive (loss) income, net (b)														Other comprehensive (loss) income, net (b)	—		—		—		—		0.5		0.5
Balance, September 30, 2019														Balance, September 30, 2019	$	0.5	$	1,071.5	$	(33.5)	$	(2,038.5)	$	(227.5)	$	(1,227.5)

^(a) Pursuant to the share withholding provisions of the Fourth Amended and Restated Revlon, Inc. Stock Plan (as amended, the "Stock Plan"), the Company withheld an aggregate of ~~79,554~~756 and NaN shares of Revlon Class A Common Stock during the three months ended ~~June~~September 30, 2020 and 2019, and ~~94,531~~127,725 and 85,607 shares of Revlon Class A Common Stock during the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively, to satisfy certain minimum statutory tax withholding requirements related to the vesting of restricted shares and restricted stock units ("RSUs") for certain senior executives and employees. These withheld shares were recorded as treasury stock using the cost method, at a weighted-average price per share of ~~$11.76~~$8.50 and NaN during the

Table of Contents

three months ended ~~June~~September 30, 2020 and 2019, and ~~$13.62~~$12.99 and $18.86 during the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively, based on the closing price of Revlon Class A Common Stock as reported on the New York Stock Exchange (the "NYSE") consolidated tape on each respective vesting date, for a total of ~~$1.2 million~~approximately $6,400 and NaN during the three months ended ~~June~~September 30, 2020 and 2019, $1.6 million and $1.6 million during the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, See Note 11, "Stock Compensation Plan," for details regarding restricted stock awards and RSUs under the Stock Plan.

^(b) See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in millions)


		Six Months Ended June 30,							Nine Months Ended September 30,
		2020		2019			2020		2019
CASH FLOWS FROM OPERATING ACTIVITIES:	CASH FLOWS FROM OPERATING ACTIVITIES:					CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	Net loss	$	(340.7)	$	(138.8)	Net loss	$	(385.2)	$	(183.5)
Adjustments to reconcile net loss to net cash used in operating activities:	Adjustments to reconcile net loss to net cash used in operating activities:					Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	Depreciation and amortization	73.2		85.7		Depreciation and amortization	108.3		124.6
Foreign currency losses from re-measurement	Foreign currency losses from re-measurement	18.9		1.4		Foreign currency losses from re-measurement	9.1		9.0
Amortization of debt discount	Amortization of debt discount	0.8		0.8		Amortization of debt discount	1.3		1.2
Stock-based compensation amortization	Stock-based compensation amortization	3.5		3.8		Stock-based compensation amortization	8.6		7.7
Impairment charges	Impairment charges	144.1		—		Impairment charges	144.1		0
Benefit from deferred income taxes	Benefit from deferred income taxes	(56.6)		(12.4)		Benefit from deferred income taxes	(54.4)		(19.0)

Amortization of debt issuance costs	Amortization of debt issuance costs	10.0		6.7		Amortization of debt issuance costs	17.8		10.4

Loss on divested assets		0.6		—
Gain on divested assets						Gain on divested assets	(0.5)		0
Pension and other post-retirement cost	Pension and other post-retirement cost	2.7		4.1		Pension and other post-retirement cost	4.2		6.3
(Gain) loss on early extinguishment of debt, net		(11.9)		—
Gain on early extinguishment of debt						Gain on early extinguishment of debt	(43.1)		0
Paid-in-kind interest accrued on the 2020 BrandCo Facilities	Paid-in-kind interest accrued on the 2020 BrandCo Facilities	1.5		—		Paid-in-kind interest accrued on the 2020 BrandCo Facilities	6.2		0
Change in assets and liabilities:	Change in assets and liabilities:					Change in assets and liabilities:
Decrease in trade receivables		126.3		42.8
Decrease (increase) in trade receivables						Decrease (increase) in trade receivables	78.0		(30.5)
Increase in inventories	Increase in inventories	(70.6)		(36.7)		Increase in inventories	(79.4)		(4.9)
Increase in prepaid expenses and other current assets	Increase in prepaid expenses and other current assets	(7.4)		(11.5)		Increase in prepaid expenses and other current assets	(1.7)		(5.5)
(Decrease) increase in accounts payable	(Decrease) increase in accounts payable	(13.3)		73.3		(Decrease) increase in accounts payable	(27.8)		9.1
Decrease in accrued expenses and other current liabilities	Decrease in accrued expenses and other current liabilities	(23.5)		(55.4)		Decrease in accrued expenses and other current liabilities	(25.2)		(81.0)
Pension and other post-retirement plan contributions	Pension and other post-retirement plan contributions	(5.5)		(4.5)		Pension and other post-retirement plan contributions	(7.5)		(7.8)
Purchases of permanent displays	Purchases of permanent displays	(12.7)		(20.1)		Purchases of permanent displays	(16.5)		(28.4)
Other, net	Other, net	(3.6)		19.6		Other, net	6.8		25.5
Net cash used in operating activities	Net cash used in operating activities	(164.2)		(41.2)		Net cash used in operating activities	(256.9)		(166.8)
CASH FLOWS FROM INVESTING ACTIVITIES:	CASH FLOWS FROM INVESTING ACTIVITIES:					CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	Capital expenditures	(2.7)		(12.2)		Capital expenditures	(7.4)		(20.0)

Net cash used in investing activities	Net cash used in investing activities	(2.7)		(12.2)		Net cash used in investing activities	(7.4)		(20.0)
CASH FLOWS FROM FINANCING ACTIVITIES:	CASH FLOWS FROM FINANCING ACTIVITIES:					CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	Net decrease in short-term borrowings and overdraft	(7.0)		(18.8)		Net decrease in short-term borrowings and overdraft	(0.7)		(22.4)
Borrowings under the 2020 BrandCo Facilities	Borrowings under the 2020 BrandCo Facilities	880.0		—		Borrowings under the 2020 BrandCo Facilities	880.0		0
Repurchases of the 5.75% Senior Notes	Repurchases of the 5.75% Senior Notes	(99.6)		—		Repurchases of the 5.75% Senior Notes	(114.1)		0
Net borrowings under the Amended 2016 Revolving Credit Facility	Net borrowings under the Amended 2016 Revolving Credit Facility	(22.9)		59.9		Net borrowings under the Amended 2016 Revolving Credit Facility	19.5		13.4
Repayment of the 2019 Term Loan Facility		(200.0)		—
Net borrowings under the 2019 Term Loan Facility (a)						Net borrowings under the 2019 Term Loan Facility (a)	(200.0)		200.0
Repayments under the 2018 Foreign Asset-Based Term Loan	Repayments under the 2018 Foreign Asset-Based Term Loan	(31.4)		—		Repayments under the 2018 Foreign Asset-Based Term Loan	(31.4)		0
Repayments under the 2016 Term Loan Facility	Repayments under the 2016 Term Loan Facility	(6.9)		(9.0)		Repayments under the 2016 Term Loan Facility	(9.2)		(13.5)
Payment of financing costs	Payment of financing costs	(101.2)		(1.4)		Payment of financing costs	(108.3)		(13.4)
Tax withholdings related to net share settlements of restricted stock and RSUs	Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		(1.6)		Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		(1.6)

Other financing activities	Other financing activities	(1.0)		(0.5)		Other financing activities	(0.3)		(0.9)
Net cash provided by financing activities	Net cash provided by financing activities	408.4		28.6		Net cash provided by financing activities	433.9		161.6
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2.1)		0.5		Effect of exchange rate changes on cash, cash equivalents and restricted cash	(0.4)		(1.4)
Net increase (decrease) in cash, cash equivalents and restricted cash	Net increase (decrease) in cash, cash equivalents and restricted cash	239.4		(24.3)		Net increase (decrease) in cash, cash equivalents and restricted cash	169.2		(26.6)
Cash, cash equivalents and restricted cash at beginning of period ^(a)(b)	Cash, cash equivalents and restricted cash at beginning of period ^(a)(b)	104.5		87.5		Cash, cash equivalents and restricted cash at beginning of period ^(a)(b)	104.5		87.5
Cash, cash equivalents and restricted cash at end of period ^(a)(b)	Cash, cash equivalents and restricted cash at end of period ^(a)(b)	$	343.9	$	63.2	Cash, cash equivalents and restricted cash at end of period ^(a)(b)	$	273.7	$	60.9
Supplemental schedule of cash flow information:^(b)	Supplemental schedule of cash flow information:^(b)					Supplemental schedule of cash flow information:^(b)
Cash paid during the period for:	Cash paid during the period for:					Cash paid during the period for:
Interest	Interest	$	105.9	$	94.8	Interest	$	182.2	$	157.9
Income taxes, net of refunds	Income taxes, net of refunds	8.0		0.6		Income taxes, net of refunds	12.6		6.9

Supplemental schedule of non-cash investing and financing activities:	Supplemental schedule of non-cash investing and financing activities:					Supplemental schedule of non-cash investing and financing activities:

Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities	Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities	$	809.8	$	—	Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities	$	846.0	$	0
Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities	Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities	29.1		—		Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities	29.1		0

^(a) The Company fully repaid the 2019 Term Loan Facility in May 2020.

(b)These amounts include restricted cash of $5.4 million and $0.2 million as of ~~June~~September 30, 2020 and 2019, respectively. The balance as of ~~June~~September 30, 2020 represents: (i) cash on deposit in lieu of a mandatory prepayment under the 2018 Foreign Asset-Based Term Facility; and (ii) cash on deposit to support

Table of Contents

~~Table of Contents~~

expenses and other current assets and other assets in the Company's Unaudited Consolidated Balance Sheets as of ~~June~~September 30, 2020 and ~~June~~September 30, 2019, respectively.

^(b) See Note 4, "Leases," for supplemental disclosure of non-cash financing and investing activities in relation to the lease liabilities arising from obtaining right-of-use assets following the implementation of the Financial Accounting Standards Board ("FASB"), Accounting Standard Codification ("ASC") Topic 842, ~~Leases~~.

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON CONSUMER PRODUCTS CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(dollars in millions, except share and per share amounts)


		June 30, 2020		December 31, 2019			September 30, 2020		December 31, 2019
		(Unaudited)					(Unaudited)
ASSETS	ASSETS					ASSETS
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	338.5	$	104.3	Cash and cash equivalents	$	268.3	$	104.3
Trade receivables, less allowance for doubtful accounts of $12.6 and $11.4 as of June 30, 2020 and December 31, 2019, respectively		288.3		423.4
Inventories		511.2		448.4
Trade receivables, less allowance for doubtful accounts of $12.4 and $11.4 as of September 30, 2020 and December 31, 2019, respectively						Trade receivables, less allowance for doubtful accounts of $12.4 and $11.4 as of September 30, 2020 and December 31, 2019, respectively	340.8		423.4
Inventories, net						Inventories, net	525.5		448.4
Prepaid expenses and other assets	Prepaid expenses and other assets	141.0		131.4		Prepaid expenses and other assets	136.9		131.4
Receivable from Revlon, Inc.	Receivable from Revlon, Inc.	166.8		161.2		Receivable from Revlon, Inc.	168.7		161.2
Total current assets	Total current assets	1,445.8		1,268.7		Total current assets	1,440.2		1,268.7
Property, plant and equipment, net of accumulated depreciation of $508.8 and $488.1 as of June 30, 2020 and December 31, 2019, respectively		365.5		408.6
Property, plant and equipment, net of accumulated depreciation of $530.3 and $488.1 as of September 30, 2020 and December 31, 2019, respectively						Property, plant and equipment, net of accumulated depreciation of $530.3 and $488.1 as of September 30, 2020 and December 31, 2019, respectively	355.8		408.6
Deferred income taxes	Deferred income taxes	211.1		158.1		Deferred income taxes	211.9		158.1
Goodwill	Goodwill	562.7		673.7		Goodwill	563.2		673.7
Intangible assets, net of accumulated amortization and impairment of $276.3 and $226.4 as of June 30, 2020 and December 31, 2019, respectively		441.6		490.7
Intangible assets, net of accumulated amortization and impairment of $286.7 and $226.4 as of September 30, 2020 and December 31, 2019, respectively						Intangible assets, net of accumulated amortization and impairment of $286.7 and $226.4 as of September 30, 2020 and December 31, 2019, respectively	435.9		490.7
Other assets	Other assets	117.4		121.1		Other assets	112.5		121.1
Total assets	Total assets	$	3,144.1	$	3,120.9	Total assets	$	3,119.5	$	3,120.9

LIABILITIES AND STOCKHOLDER'S DEFICIENCY	LIABILITIES AND STOCKHOLDER'S DEFICIENCY					LIABILITIES AND STOCKHOLDER'S DEFICIENCY
Current liabilities:	Current liabilities:					Current liabilities:
Short-term borrowings	Short-term borrowings	$	2.6	$	2.2	Short-term borrowings	$	2.0	$	2.2
Current portion of long-term debt	Current portion of long-term debt	648.3		288.0		Current portion of long-term debt	704.5		288.0
Accounts payable	Accounts payable	224.6		251.8		Accounts payable	219.9		251.8
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	381.6		418.2		Accrued expenses and other current liabilities	390.8		418.2

Total current liabilities	Total current liabilities	1,257.1		960.2		Total current liabilities	1,317.2		960.2
Long-term debt	Long-term debt	2,975.8		2,906.2		Long-term debt	2,926.5		2,906.2
Long-term pension and other post-retirement plan liabilities	Long-term pension and other post-retirement plan liabilities	170.6		181.2		Long-term pension and other post-retirement plan liabilities	166.7		181.2
Other long-term liabilities	Other long-term liabilities	152.3		162.7		Other long-term liabilities	153.6		162.7

Stockholder's deficiency:	Stockholder's deficiency:					Stockholder's deficiency:
Products Corporation Preferred stock, par value $1.00 per share; 1,000 shares authorized; 546 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively		54.6		54.6
Products Corporation Common Stock, par value $1.00 per share; 10,000 shares authorized; 5,260 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively		—		—
Products Corporation Preferred stock, par value $1.00 per share; 1,000 shares authorized; 546 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively						Products Corporation Preferred stock, par value $1.00 per share; 1,000 shares authorized; 546 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	54.6		54.6
Products Corporation Common Stock, par value $1.00 per share; 10,000 shares authorized; 5,260 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively						Products Corporation Common Stock, par value $1.00 per share; 10,000 shares authorized; 5,260 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	0		0
Additional paid-in capital	Additional paid-in capital	1,000.0		996.5		Additional paid-in capital	1,005.1		996.5
Accumulated deficit	Accumulated deficit	(2,230.5)		(1,893.1)		Accumulated deficit	(2,273.4)		(1,893.1)
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(235.8)		(247.4)		Accumulated other comprehensive loss	(230.8)		(247.4)
Total stockholder's deficiency	Total stockholder's deficiency	(1,411.7)		(1,089.4)		Total stockholder's deficiency	(1,444.5)		(1,089.4)
Total liabilities and stockholder's deficiency	Total liabilities and stockholder's deficiency	$	3,144.1	$	3,120.9	Total liabilities and stockholder's deficiency	$	3,119.5	$	3,120.9

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON CONSUMER PRODUCTS CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(dollars in millions)


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended September 30,				Nine Months Ended September 30,

		2020		2019		2020		2019			2020		2019		2020		2019

Net sales	Net sales	$	347.6	$	570.2	$	800.6	$	1,123.4	Net sales	$	477.1	$	596.8	$	1,277.7	$	1,720.2
Cost of sales	Cost of sales	168.6		243.9		366.4		481.7		Cost of sales	234.3		269.0		600.7		750.7
Gross profit	Gross profit	179.0		326.3		434.2		641.7		Gross profit	242.8		327.8		677.0		969.5
Selling, general and administrative expenses	Selling, general and administrative expenses	194.4		331.0		481.8		661.8		Selling, general and administrative expenses	251.4		306.3		733.2		968.1
Acquisition, integration and divestiture costs	Acquisition, integration and divestiture costs	1.2		—		3.3		0.6		Acquisition, integration and divestiture costs	0.9		0.1		4.2		0.7
Restructuring charges and other, net	Restructuring charges and other, net	20.7		3.2		45.5		8.7		Restructuring charges and other, net	(0.7)		2.9		44.8		11.6
Impairment charges	Impairment charges	19.8		—		144.1		—		Impairment charges	0		0		144.1		0
(Gain) loss on divested assets		(0.2)		—		0.6		—
Operating income (loss)		(56.9)		(7.9)		(241.1)		(29.4)
Gain on divested assets										Gain on divested assets	(1.1)		0		(0.5)		0
Operating (loss) income										Operating (loss) income	(7.7)		18.5		(248.8)		(10.9)
Other expenses:	Other expenses:									Other expenses:
Interest expense, net	Interest expense, net	60.9		47.8		109.3		95.5		Interest expense, net	68.7		50.2		178.0		145.7

Amortization of debt issuance costs	Amortization of debt issuance costs	6.0		3.5		10.0		6.7		Amortization of debt issuance costs	7.8		3.7		17.8		10.4
(Gain) loss on early extinguishment of debt, net		(11.9)		—		(11.9)		—
Foreign currency losses, net		2.3		1.2		18.9		1.4
Gain on early extinguishment of debt										Gain on early extinguishment of debt	(31.2)		0		(43.1)		0
Foreign currency (gains) losses, net										Foreign currency (gains) losses, net	(9.8)		7.6		9.1		9.0
Miscellaneous, net	Miscellaneous, net	20.6		4.6		16.5		5.9		Miscellaneous, net	(2.6)		1.7		13.9		7.6
Other expenses	Other expenses	77.9		57.1		142.8		109.5		Other expenses	32.9		63.2		175.7		172.7
Loss from continuing operations before income taxes	Loss from continuing operations before income taxes	(134.8)		(65.0)		(383.9)		(138.9)		Loss from continuing operations before income taxes	(40.6)		(44.7)		(424.5)		(183.6)
Benefit from income taxes		(9.6)		(0.9)		(46.5)		(0.6)
Provision for (benefit from) income taxes										Provision for (benefit from) income taxes	2.3		(1.8)		(44.2)		(2.4)
Loss from continuing operations, net of taxes	Loss from continuing operations, net of taxes	(125.2)		(64.1)		(337.4)		(138.3)		Loss from continuing operations, net of taxes	(42.9)		(42.9)		(380.3)		(181.2)
Income (loss) from discontinued operations, net of taxes		—		1.6		—		2.3
(Loss) income from discontinued operations, net of taxes										(Loss) income from discontinued operations, net of taxes	0		(0.3)		0		2.0
Net loss	Net loss	$	(125.2)	$	(62.5)	$	(337.4)	$	(136.0)	Net loss	$	(42.9)	$	(43.2)	$	(380.3)	$	(179.2)
Other comprehensive (loss) income:
Other comprehensive income (loss):										Other comprehensive income (loss):
Foreign currency translation adjustments	Foreign currency translation adjustments	10.3		2.6		5.1		1.3		Foreign currency translation adjustments	2.2		(1.8)		7.3		(0.5)
Amortization of pension related costs, net of tax^(a)(b)	Amortization of pension related costs, net of tax^(a)(b)	4.0		2.7		6.5		4.9		Amortization of pension related costs, net of tax(a)(b)	2.8		2.3		9.3		7.2

Other comprehensive (loss) income, net		14.3		5.3		11.6		6.2
Other comprehensive income, net										Other comprehensive income, net	5.0		0.5		16.6		6.7
Total comprehensive loss	Total comprehensive loss	$	(110.9)	$	(57.2)	$	(325.8)	$	(129.8)	Total comprehensive loss	$	(37.9)	$	(42.7)	$	(363.7)	$	(172.5)

^(b)This amount is included in the computation of net periodic benefit costs (income). See Note 10, "Pension and Post-Retirement Benefits," for additional information regarding net periodic benefit costs (income).

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON CONSUMER PRODUCTS CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENT OF STOCKHOLDER'S DEFICIENCY

(dollars in millions)


		Preferred Stock		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholder's Deficiency			Preferred Stock		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholder's Deficiency

Balance, January 1, 2020	Balance, January 1, 2020	$	54.6	$	996.5	$	(1,893.1)	$	(247.4)	$	(1,089.4)	Balance, January 1, 2020	$	54.6	$	996.5	$	(1,893.1)	$	(247.4)	$	(1,089.4)
Stock-based compensation amortization	Stock-based compensation amortization	—		2.4		—		—		2.4		Stock-based compensation amortization	—		2.4		—		—		2.4
Net loss	Net loss	—		—		(212.2)		—		(212.2)		Net loss	—		—		(212.2)		—		(212.2)
Other comprehensive (loss) income, net ^(a)	Other comprehensive (loss) income, net ^(a)	—		—		—		(2.7)		(2.7)		Other comprehensive (loss) income, net (a)	—		—		—		(2.7)		(2.7)
Balance, March 31, 2020	Balance, March 31, 2020	54.6		998.9		(2,105.3)		(250.1)		(1,301.9)		Balance, March 31, 2020	54.6		998.9		(2,105.3)		(250.1)		(1,301.9)

Stock-based compensation amortization												Stock-based compensation amortization	—		1.1		—		—		1.1
Net loss												Net loss	—		—		(125.2)		—		(125.2)
Other comprehensive (loss) income, net (a)												Other comprehensive (loss) income, net (a)	—		—		—		14.3		14.3
Balance, June 30, 2020												Balance, June 30, 2020	54.6		1,000.0		(2,230.5)		(235.8)		(1,411.7)

Stock-based compensation amortization	Stock-based compensation amortization	—		1.1		—		—		1.1		Stock-based compensation amortization	—		5.1		—		—		5.1
Net loss	Net loss	—		—		(125.2)		—		(125.2)		Net loss	—		—		(42.9)		—		(42.9)
Other comprehensive (loss) income, net ^(a)	Other comprehensive (loss) income, net ^(a)	—		—		—		14.3		14.3		Other comprehensive (loss) income, net (a)	—		—		—		5.0		5.0
Balance, June 30, 2020		$	54.6	$	1,000.0	$	(2,230.5)	$	(235.8)	$	(1,411.7)
Balance, September 30, 2020												Balance, September 30, 2020	$	54.6	$	1,005.1	$	(2,273.4)	$	(230.8)	$	(1,444.5)


		Preferred Stock		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholder's Deficiency			Preferred Stock		Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive (Loss) Income		Total Stockholder's Deficiency

Balance, January 1, 2019	Balance, January 1, 2019	$	54.6	$	988.4	$	(1,741.9)	$	(234.2)	$	(933.1)	Balance, January 1, 2019	$	54.6	$	988.4	$	(1,741.9)	$	(234.2)	$	(933.1)
Stock-based compensation amortization	Stock-based compensation amortization	—		0.4		—		—		0.4		Stock-based compensation amortization	—		0.4		—		—		0.4
Net loss	Net loss	—		—		(73.5)		—		(73.5)		Net loss	—		—		(73.5)		—		(73.5)
Other comprehensive (loss) income, net ^(a)	Other comprehensive (loss) income, net ^(a)	—		—		—		0.9		0.9		Other comprehensive (loss) income, net (a)	—		—		—		0.9		0.9
Balance, March 31, 2019	Balance, March 31, 2019	54.6		988.8		(1,815.4)		(233.3)		(1,005.3)		Balance, March 31, 2019	54.6		988.8		(1,815.4)		(233.3)		(1,005.3)
Stock-based compensation amortization	Stock-based compensation amortization	—		3.4		—		—		3.4		Stock-based compensation amortization	—		3.4		—		—		3.4
Net loss	Net loss	—		—		(62.5)		—		(62.5)		Net loss	—		—		(62.5)		—		(62.5)
Other comprehensive (loss) income, net ^(a)	Other comprehensive (loss) income, net ^(a)	—		—		—		5.3		5.3		Other comprehensive (loss) income, net (a)	—		—		—		5.3		5.3
Balance, June 30, 2019	Balance, June 30, 2019	$	54.6	$	992.2	$	(1,877.9)	$	(228.0)	$	(1,059.1)	Balance, June 30, 2019	$	54.6	$	992.2	$	(1,877.9)	$	(228.0)	$	(1,059.1)
Stock-based compensation amortization												Stock-based compensation amortization	—		3.8		—		—		3.8
Net loss												Net loss	—		—		(43.2)		—		(43.2)
Other comprehensive (loss) income, net (a)												Other comprehensive (loss) income, net (a)	—		—		—		0.5		0.5
Balance, September 30, 2019												Balance, September 30, 2019	$	54.6	$	996.0	$	(1,921.1)	$	(227.5)	$	(1,098.0)

^(a)See Note 13, "Accumulated Other Comprehensive Loss," regarding the changes in the accumulated balances for each component of other comprehensive loss during the three months ended ~~June~~September 30, 2020 and 2019, respectively.

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

REVLON CONSUMER PRODUCTS CORPORATION AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in millions)


		Six Months Ended June 30,							Nine Months Ended September 30,
		2020		2019			2020		2019
CASH FLOWS FROM OPERATING ACTIVITIES:	CASH FLOWS FROM OPERATING ACTIVITIES:					CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	Net loss	$	(337.4)	$	(136.0)	Net loss	$	(380.3)	$	(179.2)
Adjustments to reconcile net loss to net cash used in operating activities:	Adjustments to reconcile net loss to net cash used in operating activities:					Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	Depreciation and amortization	73.2		85.7		Depreciation and amortization	108.3		124.6
Foreign currency losses from re-measurement	Foreign currency losses from re-measurement	18.9		1.4		Foreign currency losses from re-measurement	9.1		9.0
Amortization of debt discount	Amortization of debt discount	0.8		0.8		Amortization of debt discount	1.3		1.2
Stock-based compensation amortization	Stock-based compensation amortization	3.5		3.8		Stock-based compensation amortization	8.6		7.7
Impairment charges	Impairment charges	144.1		—		Impairment charges	144.1		0
Benefit from deferred income taxes	Benefit from deferred income taxes	(55.7)		(11.6)		Benefit from deferred income taxes	(53.1)		(17.8)

Amortization of debt issuance costs	Amortization of debt issuance costs	10.0		6.7		Amortization of debt issuance costs	17.8		10.4

Loss on divested assets		0.6		—
Gain on divested assets						Gain on divested assets	(0.5)		0
Pension and other post-retirement cost	Pension and other post-retirement cost	2.7		4.1		Pension and other post-retirement cost	4.2		6.3
(Gain) loss on early extinguishment of debt, net		(11.9)		—
Gain on early extinguishment of debt						Gain on early extinguishment of debt	(43.1)		0
Paid-in-kind interest accrued on the 2020 BrandCo Facilities	Paid-in-kind interest accrued on the 2020 BrandCo Facilities	1.5		—		Paid-in-kind interest accrued on the 2020 BrandCo Facilities	6.2		0
Change in assets and liabilities:	Change in assets and liabilities:					Change in assets and liabilities:
Decrease in trade receivables		126.3		42.8
Decrease (increase) in trade receivables						Decrease (increase) in trade receivables	78.0		(30.5)
Increase in inventories	Increase in inventories	(70.6)		(36.7)		Increase in inventories	(79.4)		(4.9)
Increase in prepaid expenses and other current assets	Increase in prepaid expenses and other current assets	(13.0)		(16.4)		Increase in prepaid expenses and other current assets	(9.3)		(12.2)
(Decrease) increase in accounts payable	(Decrease) increase in accounts payable	(13.3)		73.3		(Decrease) increase in accounts payable	(27.8)		9.1
Decrease in accrued expenses and other current liabilities	Decrease in accrued expenses and other current liabilities	(22.1)		(54.1)		Decrease in accrued expenses and other current liabilities	(24.3)		(79.8)
Pension and other post-retirement plan contributions	Pension and other post-retirement plan contributions	(5.5)		(4.5)		Pension and other post-retirement plan contributions	(7.5)		(7.8)
Purchases of permanent displays	Purchases of permanent displays	(12.7)		(20.1)		Purchases of permanent displays	(16.5)		(28.4)
Other, net	Other, net	(3.6)		19.6		Other, net	7.3		25.5
Net cash used in operating activities	Net cash used in operating activities	(164.2)		(41.2)		Net cash used in operating activities	(256.9)		(166.8)
CASH FLOWS FROM INVESTING ACTIVITIES:	CASH FLOWS FROM INVESTING ACTIVITIES:					CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	Capital expenditures	(2.7)		(12.2)		Capital expenditures	(7.4)		(20.0)

Net cash used in investing activities	Net cash used in investing activities	(2.7)		(12.2)		Net cash used in investing activities	(7.4)		(20.0)
CASH FLOWS FROM FINANCING ACTIVITIES:	CASH FLOWS FROM FINANCING ACTIVITIES:					CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	Net decrease in short-term borrowings and overdraft	(7.0)		(18.8)		Net decrease in short-term borrowings and overdraft	(0.7)		(22.4)
Borrowings under the 2020 BrandCo Facilities	Borrowings under the 2020 BrandCo Facilities	880.0		—		Borrowings under the 2020 BrandCo Facilities	880.0		0
Repurchases of the 5.75% Senior Notes	Repurchases of the 5.75% Senior Notes	(99.6)		—		Repurchases of the 5.75% Senior Notes	(114.1)		0
Net borrowings under the Amended 2016 Revolving Credit Facility	Net borrowings under the Amended 2016 Revolving Credit Facility	(22.9)		59.9		Net borrowings under the Amended 2016 Revolving Credit Facility	19.5		13.4
Repayment of the 2019 Term Loan Facility		(200.0)		—
Net borrowings under the 2019 Term Loan Facility (a)						Net borrowings under the 2019 Term Loan Facility (a)	(200.0)		200.0
Repayments under the 2018 Foreign Asset-Based Term Loan	Repayments under the 2018 Foreign Asset-Based Term Loan	(31.4)		—		Repayments under the 2018 Foreign Asset-Based Term Loan	(31.4)		0
Repayments under the 2016 Term Loan Facility	Repayments under the 2016 Term Loan Facility	(6.9)		(9.0)		Repayments under the 2016 Term Loan Facility	(9.2)		(13.5)
Payment of financing costs	Payment of financing costs	(101.2)		(1.4)		Payment of financing costs	(108.3)		(13.4)
Tax withholdings related to net share settlements of restricted stock and RSUs	Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		(1.6)		Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		(1.6)

Other financing activities	Other financing activities	(1.0)		(0.5)		Other financing activities	(0.3)		(0.9)
Net cash provided by financing activities	Net cash provided by financing activities	408.4		28.6		Net cash provided by financing activities	433.9		161.6
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2.1)		0.5		Effect of exchange rate changes on cash, cash equivalents and restricted cash	(0.4)		(1.4)
Net increase (decrease) in cash, cash equivalents and restricted cash	Net increase (decrease) in cash, cash equivalents and restricted cash	239.4		(24.3)		Net increase (decrease) in cash, cash equivalents and restricted cash	169.2		(26.6)
Cash, cash equivalents and restricted cash at beginning of period^(a)(b)	Cash, cash equivalents and restricted cash at beginning of period^(a)(b)	104.5		87.5		Cash, cash equivalents and restricted cash at beginning of period^(a)(b)	104.5		87.5
Cash, cash equivalents and restricted cash at end of period ^(a)(b)	Cash, cash equivalents and restricted cash at end of period ^(a)(b)	$	343.9	$	63.2	Cash, cash equivalents and restricted cash at end of period ^(a)(b)	$	273.7	$	60.9
Supplemental schedule of cash flow information:^(b)	Supplemental schedule of cash flow information:^(b)					Supplemental schedule of cash flow information:^(b)
Cash paid during the period for:	Cash paid during the period for:					Cash paid during the period for:
Interest	Interest	$	105.9	$	94.8	Interest	$	182.2	$	157.9
Income taxes, net of refunds	Income taxes, net of refunds	8.0		0.6		Income taxes, net of refunds	12.6		6.9

Supplemental schedule of non-cash investing and financing activities:	Supplemental schedule of non-cash investing and financing activities:					Supplemental schedule of non-cash investing and financing activities:

Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities	Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities	$	809.8	$	—	Non-cash roll-up of participating lenders from the 2016 Term Loan Facility to the 2020 BrandCo Facilities	$	846.0	$	0
Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities	Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities	29.1		—		Paid-in-kind debt issuance costs capitalized to the 2020 BrandCo Facilities	29.1		0

(a) The Company fully repaid the 2019 Term Loan Facility in May 2020.

^(a)

Table of Contents

(b)These amounts include restricted cash of $5.4 million and $0.2 million as of ~~June~~September 30, 2020 and 2019, respectively, The balance as of ~~June~~September 30, 2020 represents: (i) cash on deposit in lieu of a mandatory prepayment under the 2018 Foreign Asset-Based Term Facility; and (ii) cash on deposit to support

~~Table of Contents~~

outstanding undrawn letters of credit. The balance as of ~~June~~September 30, 2019 represents: (i) cash on deposit in lieu of a mandatory prepayment under the 2018 Foreign Asset-Based Term Facility; and (ii) cash on deposit to support outstanding undrawn letters of credit. These balances were included within prepaid expenses and other current assets and other assets in the Company's Unaudited Consolidated Balance Sheets as of ~~June~~September 30, 2020 and ~~June~~September 30, 2019, respectively.

See Accompanying Notes to Unaudited Consolidated Financial Statements

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Revlon, Inc. ("Revlon" and together with its subsidiaries, the "Company") conducts its business exclusively through its direct wholly-owned operating subsidiary, Revlon Consumer Products Corporation ("Products Corporation") and its subsidiaries. Revlon is an indirect majority-owned subsidiary of MacAndrews & Forbes Incorporated (together with certain of its affiliates other than the Company, "MacAndrews & Forbes"), a corporation beneficially owned by Ronald O. Perelman. Mr. Perelman is Chairman of Revlon's and Products Corporation's Board of Directors.

The Company is a leading global beauty company with an iconic portfolio of brands that develops, manufactures, markets, distributes and sells an extensive array of color cosmetics; hair color, hair care and hair treatments; fragrances; skin care; beauty tools; men’s grooming products; anti-perspirant deodorants; and other beauty care products across a variety of distribution channels.

The Company operates in 4 brand-centric reporting units that are aligned with its organizational structure based on 4 global brand teams: Revlon; Elizabeth Arden; Portfolio; and Fragrances, which represent the Company's 4 reporting segments. For further information, refer to Note 14, "Segment Data and Related Information."

The accompanying Consolidated Financial Statements are unaudited. In management's opinion, all adjustments necessary for a fair presentation of the Company's financial information have been made. The Unaudited Consolidated Financial Statements include the Company's accounts after the elimination of all material intercompany balances and transactions.

Certain prior year amounts have been reclassified to conform to the current year presentation.

The preparation of the Company's Unaudited Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles ("U.S. GAAP") requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the Unaudited Consolidated Financial Statements in the period they are determined to be necessary. Significant estimates made in the accompanying Unaudited Consolidated Financial Statements include, but are not limited to: expected sales returns; certain assumptions related to the valuation of acquired intangible and long-lived assets and the recoverability of goodwill, intangible and long-lived assets; income taxes, including deferred tax valuation allowances and reserves for estimated tax liabilities; and certain estimates and assumptions used in the calculation of the net periodic benefit (income) costs and the projected benefit obligations for the Company’s pension and other post-retirement plans, including the expected long-term return on pension plan assets and the discount rate used to value the Company’s pension benefit obligations. The Unaudited Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements and related notes contained in Revlon's Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the "2019 Form 10-K").

The Company's results of operations and financial position for interim periods are not necessarily indicative of those to be expected for the full year.

Liquidity and Ability to Continue as a Going Concern

The ongoing and prolonged COVID-19 pandemic has continued to adversely impact the Company’s business in the third quarter of 2020 and beyond, as social-distancing restrictions and related actions designed to curb the spread of the virus have remained in place or have been reinstated as the COVID-19 pandemic spikes across the globe. These adverse economic conditions have resulted in the general slowdown of the global economy, in turn contributing to a significant decline in net sales within each of the Company’s reporting segments and regions.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

2020 ABL FILO Term Loans, the “New Loans”), if the holder is: (a)(i) a qualified institutional buyer as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”); (ii) an institutional accredited investor within the meaning of Rule 501(a)(1), (a)(2), (a)(3) or (a)(7) of the Securities Act; or (iii) a person that is not a “U.S. person” within the meaning of Regulation S under the Securities Act, (b) not a natural person and (c) not a “Disqualified Institution” (as defined under the Amended 2016 Revolving Credit Facility and related security documents and intercreditor agreements or the 2020 BrandCo Term Loan Facility and related security documents and intercreditor agreements) (an “Eligible Holder”). The “Per $1,000 Pro Rata Share” is (1) $1,000, divided by (2) the aggregate principal amount of 5.75% Senior Notes tendered for Mixed Consideration by all Eligible Holders and accepted for payment by Products Corporation.

On November 13, 2020, the Company announced that the Exchange Offer was successfully consummated and that Products Corporation had accepted $236 million in aggregate principal amount of 5.75% Senior Notes tendered in the Exchange Offer. Products Corporation used cash on hand to redeem, effective as of November 13, 2020, the remaining $106.8 million in aggregate principal amount of 5.75% Senior Notes pursuant to the terms of the indenture governing the 5.75% Senior Notes. Following the consummation of the Exchange Offer and the satisfaction and discharge of the remaining 5.75% Senior Notes, 0 5.75% Senior Notes remained outstanding.

In addition, the Company’s Amended 2016 Revolving Credit Facility matures on September 7, 2021, and the Company is currently in discussions with various lenders to extend such maturity or refinance such facility.

The uncertainty as to Products Corporation’s ability to extend or refinance the Amended 2016 Revolving Credit Facility raises substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of these uncertainties, nor do they include adjustments to reflect the possible future effects of the recoverability and classification of recorded asset amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

For more information, please see the risk factors discussed in Part II, Item 1A. “Risk Factors” of this Quarterly Report on Form 10-Q.

Recently Evaluated and/or Adopted Accounting Pronouncements

In August 2018, the FASB issued Accounting Standard Update ("ASU") No. 2018-15, "Internal Use Software (Subtopic 350-40) - Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract," which requires a customer in a cloud computing hosting arrangement that is a service contract to follow the existing guidance in ASC 350-40 on internal-use software to determine which implementation costs are to be deferred and recognized as an asset and which costs are to be expensed as incurred. This guidance is effective for annual periods beginning after December 15, 2019, with early adoption permitted, and may be applied either retrospectively or prospectively to all software implementation costs incurred after adoption. The Company adopted ASU No. 2018-15 prospectively, beginning as of January 1, 2020. The Company completed its assessment and determined that this new guidance does not have a material impact on the Company’s results of operations, financial condition and/or financial statement disclosures.

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

Recently Issued Accounting Pronouncements

In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The new guidance under ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. These amendments are effective immediately and may be applied prospectively to contract modifications made and hedging relationships entered into or evaluated on or before December 31, 2022. The Company is in the process of assessing the impact, if any, that ASU No. 2020-04 is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

In December 2019, the FASB issued ASU No. 2019-12, "Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes," which removes certain exceptions for recognizing deferred taxes for investments, performing intra-period allocations, ~~and~~ calculating income taxes in interim ~~periods.~~periods and how a company accounts for future events. This ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. This guidance is effective for annual periods beginning after December 15, 2020, with early adoption permitted, including adoption in any interim period. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The amendments in this ASU that are related to separate financial statements of legal entities that are not subject to tax should be applied on a retrospective basis for all periods presented. The amendments in this ASU that are related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments in this ASU that are related to franchise taxes that are partially based on income should be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments under this ASU should be applied on a prospective basis. After reviewing this ASU, the Company decided that it will adopt this guidance beginning as of January 1, 2021. The Company ~~is in~~completed its assessment of the ~~process~~possible effects of ~~assessing the impact, if any, that~~ this ASU upon its implementation and determined that it is not expected to have significant impacts on the Company’s results of operations, financial condition and/or financial statement disclosures.

In August 2018, the FASB issued ASU No. 2018-14, "Compensation-Retirement Benefits-Defined Benefit Plans-General (Subtopic 715): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans.” This new guidance removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. This guidance is effective for annual periods beginning after December 15, 2020, with early adoption permitted. The Company will adopt this guidance (on a retrospective basis for certain new additional disclosures), beginning as of January 1, 2021. This new pronouncement only affects disclosure items and it is not expected to have a material impact on the Company’s results of operations, financial condition and/or financial statement disclosures.

In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which was subsequently amended in November 2018 through ASU No. 2018-19, "Codification Improvements to Topic 326, Financial Instruments - Credit Losses." ASU No. 2016-13 will require entities to estimate lifetime expected credit losses for trade and other receivables, net investments in leases, financing receivables, debt securities and other instruments, which will result in earlier recognition of credit losses. Further, the new credit loss model will affect how entities in all industries estimate their allowance for losses for receivables that are current with respect to their payment terms. ASU No. 2018-19 further clarifies that receivables arising from operating leases are not within the scope of Topic 326. Instead, impairment from receivables of operating leases should be accounted for in accordance with Topic 842, Leases. In November 2019, the FASB issued ASU No. 2019-10, which, among other things, deferred the application of the new guidance on credit losses for smaller reporting companies ("SRC") to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. This guidance will be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (i.e., a modified-retrospective approach). Under the above-mentioned deferral, the Company expects to adopt ASU No. 2016-03, and the related ASU No. 2018-19 amendments, beginning as of January 1, 2023 and is in the process of assessing the impact, if any, that this new guidance is expected to have on the Company’s results of operations, financial condition and/or financial statement disclosures.

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

2. RESTRUCTURING CHARGES

Revlon 2020 Restructuring Program

Building upon its previously-announced 2018 Optimization Program, in March 2020 the Company announced that it is implementing a worldwide organizational restructuring (the “Revlon 2020 Restructuring Program”) designed to reduce the Company’s selling, general and administrative expenses, as well as cost of goods sold, improve the Company’s gross profit and Adjusted EBITDA and maximize productivity, cash flow and liquidity. The Revlon 2020 Restructuring Program includes rightsizing the organization and operating with more efficient workflows and processes. The leaner organizational structure is also expected to improve communication flow and cross-functional collaboration, leveraging the more efficient business processes.

As a result of the Revlon 2020 Restructuring Program, the Company expects to eliminate approximately 1,000 positions worldwide, including approximately 650 current employees and approximately 350 open positions of which approximately ~~700~~785 were eliminated by ~~June~~September 30, 2020. In March 2020, the Company began informing certain employees that were affected by the Revlon 2020 Restructuring Program. While certain aspects of the Revlon 2020 Restructuring Program may be subject to consultations with employees, works councils, unions and/or governmental authorities, the Company currently expects to substantially complete the employee-related actions by the end of 2020 and the other consolidation and outsourcing actions during 2021 and 2022.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

addition, the Company expects restructuring charges in the range of $75 million to $85 million to be charged and paid during 2021 and 2022. The Company expects that substantially all of these restructuring charges will be paid in cash, with approximately $55 million to $65 million of the total charges expected to be paid in 2020, approximately $40 million to $45 million expected to be paid in 2021, with the balance expected to be paid in 2022.

A summary of the 2020 Restructuring Charges incurred since its inception in March 2020 and through ~~June~~September 30, 2020 is presented in the following table:

Restructuring Charges and Other, Net
Employee Severance and Other Personnel Benefits Other Costs Total Restructuring Charges Leases (a) Other Related Charges(b) Total Restructuring and Related Charges
Cumulative charges incurred through June 30, 2020 $ 46.3 $ 0.3 $ 46.6 $ 9.8 $ 0.7 $ 57.1



	Restructuring Charges and Other, Net
	Employee Severance and Other Personnel Benefits		Other Costs		Total Restructuring Charges		Leases (a)		Other Related Charges (b)		Total Restructuring and Related Charges

Cumulative charges incurred through September 30, 2020	$	44.4	$	1.2	$	45.6	$	11.3	$	4.3	$	61.2

^(a) Lease-related charges are recorded within SG&A in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss. These lease-related charges include: (i) $3.5 million for accelerated recognition of rent expense related to certain abandoned leases; (ii) $3.0 million for the disposal of leasehold improvements and other equipment in connection with certain leases; (iii) ~~$2.4~~$3.9 million of rent expense related to the Revlon 2020 Restructuring Program; and (iv) $0.9 million of disposal of leasehold improvements and other equipment in connection with the abandoned leases identified in clause (i) of this footnote (a).

^(b)Other related charges are recorded within SG&A and cost of sales in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss.

A summary of the 2020 Restructuring Charges incurred since its inception in March 2020 and through ~~June~~September 30, 2020 by reportable segment is presented in the following table:



	Cumulative charges incurred through ~~June~~September 30, 2020
Revlon	$	~~18.0~~17.9
Elizabeth Arden	~~10.3~~10.0
Portfolio	~~11.1~~10.6
Fragrances	~~7.2~~7.1
Total	$	~~46.6~~45.6

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

2018 Optimization Restructuring Program

In November 2018, the Company announced that it was implementing the 2018 Optimization Restructuring Program (the "2018 Optimization Program") designed to streamline the Company’s operations, reporting structures and business processes, with the objective of maximizing productivity and improving profitability, cash flows and liquidity. The 2018 Optimization Program was substantially completed by December 31, 2019.

As of ~~June~~September 30, 2020, restructuring and related charges under the 2018 Optimization Program expected to be paid in cash are approximately $32 million of the total ~~$39.5~~$39.6 million of recorded charges, of which ~~$29.8~~$30.3 million were already paid through ~~June~~September 30, 2020, with any residual balance expected to be paid during the remainder of 2020.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

A summary of the 2018 Optimization Restructuring Charges incurred since its inception in November 2018 and through ~~June~~September 30, 2020 is presented in the following table:

Restructuring Charges and Other, Net
Employee Severance and Other Personnel Benefits^(a)
Other Costs Total Restructuring Charges
Inventory Adjustments^(b)
Other Related Charges^(c)
Total Restructuring and Related Charges
Charges incurred through December 31, 2019 $ 20.3 $ 0.3 $ 20.6 $ 4.9 $ 14.0 $ 39.5
Charges incurred during the six months ended June 30, 2020
(0.7) — (0.7) — 0.7 —
Cumulative charges incurred through June 30, 2020 $ 19.6 $ 0.3 $ 19.9 $ 4.9 $ 14.7 $ 39.5



	Restructuring Charges and Other, Net
	Employee Severance and Other Personnel Benefits(a)		Other Costs		Total Restructuring Charges		Inventory Adjustments(b)		Other Related Charges(c)		Total Restructuring and Related Charges
Charges incurred through December 31, 2019	$	20.3	$	0.3	$	20.6	$	4.9	$	14.0	$	39.5
Charges incurred during the nine months ended September 30, 2020	(0.6)		0		(0.6)		0		0.7		0.1
Cumulative charges incurred through September 30, 2020	$	19.7	$	0.3	$	20.0	$	4.9	$	14.7	$	39.6

^(a) Includes reversal due to true-up of previously-accrued restructuring charges.

^(b) Inventory adjustments are recorded within cost of sales in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss.

^(c)Other related charges are recorded within SG&A in the Company’s Unaudited Consolidated Statement of Operations and Comprehensive Loss.

A summary of the 2018 Optimization Restructuring Charges incurred since its inception in November 2018 and through ~~June~~September 30, 2020 by reportable segment is presented in the following table:


		Charges incurred during the six months ended June 30, 2020		Cumulative charges incurred through June 30, 2020			Charges incurred during the nine months ended September 30, 2020		Cumulative charges incurred through September 30, 2020
Revlon	Revlon	$	(0.4)	$	8.4	Revlon	$	(0.3)	$	8.5
Elizabeth Arden	Elizabeth Arden	(0.1)		4.2		Elizabeth Arden	(0.1)		4.2
Portfolio	Portfolio	(0.1)		3.9		Portfolio	(0.1)		3.9
Fragrances	Fragrances	(0.1)		3.4		Fragrances	(0.1)		3.4
Total	Total	$	(0.7)	$	19.9	Total	$	(0.6)	$	20.0

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

Restructuring Reserve

The liability balance and related activity for each of the Company's restructuring programs are presented in the following table:


											Utilized, Net																					Utilized, Net
				Liability Balance at January 1, 2020			Expense, Net			Foreign Currency Translation			Cash			Non-cash			Liability Balance at June 30, 2020			Liability Balance at January 1, 2020			Expense, Net			Foreign Currency Translation			Cash			Non-cash			Liability Balance at September 30, 2020
Revlon 2020 Restructuring Program:	Revlon 2020 Restructuring Program:																		Revlon 2020 Restructuring Program:
Employee severance and other personnel benefits	Employee severance and other personnel benefits	$	—		$	46.3		$	—		$	(9.0)		$	—		$	37.3	Employee severance and other personnel benefits	$	0		$	44.4		$	0		$	(20.3)		$	0		$	24.1
Other	Other	—			0.3			—			(0.3)			—			—		Other	0			1.2			0			(1.2)			0			0
Total Revlon 2020 Restructuring Program	Total Revlon 2020 Restructuring Program	—			46.6			—			(9.3)			—			37.3		Total Revlon 2020 Restructuring Program	0			45.6			0			(21.5)			0			24.1

2018 Optimization Program:	2018 Optimization Program:																		2018 Optimization Program:
Employee severance and other personnel benefits	Employee severance and other personnel benefits	5.7			(0.7)			—			(3.2)			—			1.8		Employee severance and other personnel benefits	5.7			(0.6)			0			(3.7)			0			1.4

Other immaterial actions:^(a)	Other immaterial actions:^(a)																		Other immaterial actions:(a)
Employee severance and other personnel benefits	Employee severance and other personnel benefits	4.3			(0.4)			—			(0.4)			—			3.5		Employee severance and other personnel benefits	4.3			(0.2)			0.2			(0.4)			0			3.9

Total restructuring reserve	Total restructuring reserve	$	10.0		$	45.5		$	—		$	(12.9)		$	—		$	42.6	Total restructuring reserve	$	10.0		$	44.8		$	0.2		$	(25.6)		$	0		$	29.4

^(a) The balance of other immaterial restructuring initiatives primarily consists of balances outstanding under the EA Integration Restructuring Program implemented by the Company in December 2016, which was completed by December 2018. The reversal of charges and payments made during the ~~six~~nine months ended ~~June~~September 30, 2020 primarily related to other individually and collectively immaterial restructuring initiatives.

As of ~~June~~September 30, 2020 and 2019, all of the restructuring reserve balances were included within accrued expenses and other current liabilities in the Company's Consolidated Balance Sheets.

~~3. INVENTORIES~~

~~As of June 30, 2020 and December 31, 2019, the Company's inventory balances consisted of the following:~~

June 30, December 31,
2020 2019
Finished goods $ 384.9 $ 326.5
Raw materials and supplies 109.8 110.4
Work-in-process 16.5 11.5
$ 511.2 $ 448.4

~~4. LEASES AND PROPERTY, PLANT AND EQUIPMENT~~

The Company leases facilities for executive offices, warehousing, research and development and sales operations and leases various types of equipment under operating and finance lease agreements. The majority of the Company’s real estate leases, in terms of total undiscounted payments, are located in the U.S.

At the effective date of January 1, 2019, the Company adopted ASU No. 2016-02 using a modified retrospective approach applying the standard’s transition provisions provided by such ASU. Refer to Note 1, "Description of Business and Summary of Significant Accounting Policies," in the 2019 Form 10-K for additional information regarding the Company's adoption of ASU No. 2016-02.

During the first and second quarter of 2020, as a result of COVID-19’s impact on the Company’s operations, the Company considered whether indicators of impairment existed for its Property, Plant and Equipment ("PP&E"), including its Right-of-Use ("ROU") assets consisting of the Company's leases as described above. In accordance with ASC Topic 360, "Property, Plant and Equipment," for purposes of recognition and measurement of an impairment loss, long-lived assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. An impairment loss is recognized only if the carrying amount of a long-lived asset and/or asset group is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset and/or asset group is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

and/or asset group and the impairment loss is measured as the amount by which the carrying amount of a long-lived asset and/or asset group exceeds its fair value. In performing such review, the Company considers several indicators of impairment, including, among other factors, the following: (i) whether there exists any significant adverse change in the extent or manner in which a long-lived asset and/or asset group is being used; (ii) whether there exists any projection or forecast demonstrating losses associated with the use of a long-lived asset and/or asset group; and (iii) whether there exists a current expectation that, more likely than not, a long-lived asset and/or asset group will be sold or otherwise disposed of significantly before the end of its previously-estimated useful life. Following these interim assessments, the Company concluded that the carrying amounts of its PP&E, including its lease ROU assets, were not impaired during the six months ended June 30, 2020.

~~The following table includes disclosure related to the ASC 842 lease standard for the periods presented,~~ ~~after application of the applicable practical expedients and short-term lease considerations:~~

Six Months Ended
June 30, 2020 June 30, 2019
Lease Cost:
Finance Lease Cost:
    Amortization of ROU assets $ 0.2 $ 0.1
    Interest on lease liabilities 0.1 0.0
Operating Lease Cost 21.8 21.3
Total Lease Cost $ 22.1 $ 21.4
Other Information:
Cash paid for amounts included in the measurement of lease liabilities:
    Operating cash flows from finance leases 0.1 0.0
    Operating cash flows from operating leases 19.2 21.0
    Financing cash flows from finance leases 0.1 0.4
June 30, 2020 December 31, 2019
ROU assets for finance leases 0.8 1.0
ROU assets for operating leases 88.4 91.4
Accumulated amortization on ROU assets for finance leases 0.5 0.3
Accumulated amortization on ROU assets for operating leases 29.7 23.2
Weighted-average remaining lease term - finance leases 2.4 years 2.8 years
Weighted-average remaining lease term - operating leases 5.8 years 6.2 years
Weighted-average discount rate - finance leases 15.0 % 15.6 %
Weighted-average discount rate - operating leases 15.7 % 15.8 %
3. INVENTORIES

~~Table~~As of ~~Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share~~September 30, 2020 and ~~per share amounts)~~December 31, 2019, the Company's net inventory balances consisted of the following:


	September 30,		December 31,
	2020		2019
Finished goods	$	402.2	$	326.5
Raw materials and supplies	106.8		110.4
Work-in-process	16.5		11.5
	$	525.5	$	448.4

~~Maturities~~

4. PROPERTY, PLANT AND EQUIPMENT

As of ~~lease liabilities as of June~~September 30, 2020 ~~were as follows:~~and December 31, 2019, the Company's property, plant and equipment balances consisted of the following:

Operating Leases Finance Leases
July 2020 through December 2020 $ 18.0 $ 0.3
2021 33.6 0.5
2022 26.4 0.3
2023 21.9 0.0
2024 16.5 —
Thereafter 47.8 —
Total undiscounted cash flows $ 164.2 $ 1.1
Present value:
Short-term lease liability $ 19.3 $ 0.4
Long-term lease liability 85.5 0.4
Total lease liability $ 104.8 $ 0.8
Difference between undiscounted cash flows and discounted cash flows $ 59.4 $ 0.3



	September 30,		December 31,
	2020		2019
Land and improvements	$	11.2	$	11.0
Building and improvements	112.6		113.0
Machinery and equipment	295.9		296.0
Office furniture, fixtures and capitalized software	240.2		241.5
Counters and trade fixtures	51.9		52.9
Leasehold improvements	43.8		50.1
Construction-in-progress	7.0		14.0
Right-of-Use assets	123.5		118.2
Property, plant and equipment and Right-of-Use assets, gross	886.1		896.7
Accumulated depreciation and amortization	(530.3)		(488.1)
Property, plant and equipment and Right-of-Use assets, net	$	355.8	$	408.6

Depreciation and amortization expense on property, plant and equipment and right-of-use assets was $18.3 million and $59.3 million during the three and nine months ended September 30, 2020, respectively, and $19.2 million and $65.2 million during the three and nine months ended September 30, 2019, respectively.

5. GOODWILL AND INTANGIBLE ASSETS, NET

Goodwill

In accordance with ASC Topic 350, “Intangibles – Goodwill and Other,” the Company performs its annual impairment test during the fourth quarter of each year. The Company also reviews goodwill for impairment whenever events or changes in circumstances indicate that the carrying value of its goodwill may not be recoverable. After the close of each interim quarter, management assesses whether there exists any indicators of impairment requiring the Company to perform an interim goodwill impairment analysis.

~~During~~In performing its goodwill impairment assessments the ~~first quarter~~Company uses the simplified approach allowed under ASU No. 2017-04, "Simplifying the Test for Goodwill Impairment." Following the results of such assessments, the Company records non-cash impairment charges in the amount by which the carrying value of each reporting unit exceeded its respective fair value, limited to the amount of each reporting unit's goodwill. Impairment charges are included as a separate component of operating income within the "Impairment charges" caption on the face of the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the applicable quarter-to-date and year-to-date periods.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

First and Second Quarter of 2020 Interim Goodwill Assessments

As of March 31, 2020 and June 30, 2020, as a result of COVID-19’s impact on the Company’s operations, the Company determined that indicators of potential impairment existed requiring the Company to perform an interim goodwill impairment ~~analysis.~~analyses. These indicators included a deterioration in the general economic conditions, adverse developments in equity and credit markets, deterioration in some of the economic channels in which the Company's operates (especially in the mass retail channel), the recent trading values of the Company's capital stock and the corresponding decline in the Company’s market capitalization and the revision of the Company's internal forecasts as a result of ~~COVID-19.~~

~~As a result, for~~ the ongoing and prolonged COVID-19 pandemic. For its first and second quarter of 2020 interim assessments, the Company examined and performed quantitative interim goodwill impairment assessments for all its reporting units, namely: (i) Revlon; (ii) Elizabeth Arden Skin and Color; (iii) Elizabeth Arden Fragrances; (iv) Fragrances; (v) Mass Portfolio; and (vi) Professional Portfolio. ~~In performing these assessments the Company used the simplified approach allowed under ASU No. 2017-04, "Simplifying the Test for Goodwill Impairment."~~

~~Based upon such assessments,~~For the first quarter of 2020, as of March 31, 2020:

•The Company determined that it was more likely than not that the fair values of each of ~~its Revlon,~~its: (i) Revlon; (ii) Elizabeth Arden ~~Skin~~Skin; and (iii) Color and Fragrances reporting units exceeded their respective carrying amounts for the first quarter of 2020. As of March 31, 2020, prior to the recording of any impairment charges, the Revlon, Elizabeth Arden Skin and Color and Fragrances reporting units had goodwill balances of $264.7 million, $67.4 million and $120.8 million, ~~respectively.~~respectively; and

•

~~Additionally, based on its first quarter of 2020 quantitative interim assessment, the~~The Company also determined that indicators of impairment existed for ~~the~~each of its: (i) Elizabeth Arden Fragrances; (ii) Mass Portfolio; and (iii) Professional Portfolio reporting units. Following the results of such assessments, the Company recorded non-cash impairment charges in the amount by which the carrying value of each reporting unit exceeded its respective fair value, limited to the amount of each reporting unit's goodwill. ForAccordingly, for the three months ended March 31, 2020, the Company recognized a total of $99.8 million of non-cash goodwill impairment charges consisting of: $54.3 million and $19.6 million for the Mass Portfolio and Professional Portfolio reporting units, respectively, within the Company's Portfolio segment and $25.9 million for the Elizabeth Arden Fragrances reporting unit within the Company's Elizabeth Arden segment. ~~These impairment charges were included as a separate component of operating income within the "Impairment charges" caption on the face of the Company's Unaudited Consolidated Statement of Operations~~

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

~~and Comprehensive Loss for the six months ended June 30, 2020.~~ Following the recognition of these non-cash goodwill impairment charges, as of March 31, 2020, the Elizabeth Arden Fragrances, Mass Portfolio and Professional Portfolio reporting units had approximately $23.5 million, NaN and $97.2 million, respectively, in remaining goodwill.

~~Primarily as a result of COVID-19 still affecting multiple countries around the world, the Company considered whether newer and/or additional indicators of impairment existed during~~For the second quarter of 2020, ~~that would warrant another interim assessment of goodwill for impairment purposes. The Company concluded that additional indicators of impairment existed~~ as of June 30, ~~2020, primarily in connection with further revisions to the Company's expected future cash flows as a result of COVID-19.~~2020:

~~Based upon such assessments for its second quarter of 2020, the~~•The Company determined that it was more likely than not that the fair values of each of ~~its Revlon,~~its: (i) Revlon; (ii) Elizabeth Arden Skin and ~~Color~~Color; and (iii) Fragrances reporting units exceeded their respective carrying amounts for the second quarter of 2020. As of June 30, 2020, prior to the recording of any impairment charges, the Revlon, Elizabeth Arden Skin and Color and Fragrances reporting units had goodwill balances of $264.9 million, $67.4 million and $120.8 million, ~~respectively.~~respectively; and

•

~~Additionally, based on its second quarter~~Primarily due to the continued worldwide effects of ~~2020 quantitative interim assessment,~~the ongoing and prolonged COVID-19 pandemic, the Company also determined that indicators of impairment existed for ~~the~~each of its: (i) Elizabeth Arden Fragrances; and (ii) Professional Portfolio reporting units. Following the results of such assessments, the Company recorded non-cash impairment charges in the amount by which the carrying value of each reporting unit exceeded its respective fair value, limited to the amount of each reporting unit's goodwill. ForAccordingly, for the three months ended June 30, 2020, the Company recognized a total of $11.2 million of non-cash goodwill impairment charges consisting of: $9.6 million for the Professional Portfolio reporting unit within the Company's Portfolio segment and $1.6 million for the Elizabeth Arden Fragrances reporting unit within the Company's Elizabeth Arden segment. These impairment charges were included as a separate component of operating income within the "Impairment charges" caption on the face of the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and six months ended June 30, 2020. Following the recognition of these non-cash goodwill impairment charges, as of June 30, 2020, the Elizabeth Arden Fragrances and Professional Portfolio reporting units had approximately $22.0 million and $87.6 million, respectively, in remaining goodwill.

Third Quarter 2020 Interim Goodwill Assessment

As of September 30, 2020, primarily due to the continued worldwide effects of the ongoing and prolonged COVID-19 pandemic, the Company re-assessed whether further indicators of impairment arose during the third quarter of 2020 that might result in additional goodwill impairment charges. For the third quarter of 2020 interim assessment, the Company, in accordance with ASC 350, performed qualitative analyses for its (i) Revlon; (ii) Elizabeth Arden Skin and Color; (iii) Elizabeth Arden Fragrances; (iv) Professional Portfolio; and (v) Fragrances reporting units. As discussed above, the Mass Portfolio reporting unit's goodwill was written down to NaN during the first quarter of 2020. In performing its third quarter of 2020 qualitative interim goodwill assessment, the Company considered, among other factors, the financial performance of each of its reporting

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

units, the Company's revised expected future cash flows as affected by the ongoing and prolonged COVID-19 pandemic, as well as the results of the second quarter of 2020 quantitative interim analysis.

For the third quarter of 2020, as of September 30, 2020:

•The Company, in accordance with ASC 350, performed qualitative analyses for its: (i) Revlon; (ii) Elizabeth Arden Skin and Color; (iii) Elizabeth Arden Fragrances; (iv) Professional Portfolio; and (v) Fragrances reporting units; and

•Based upon such assessment, the Company determined that it was more likely than not that the fair value of each of its previously mentioned reporting units exceeded their respective carrying amounts as of September 30, 2020. Consequently, 0 impairment changes were recognized during the three months ended September 30, 2020.

Total non-cash impairment charges recorded on the Company's goodwill were NaN and $111.0 million for the three and nine months ended September 30, 2020. NaN impairment charges were recognized during the nine months ended September 30, 2019.

Inputs and Assumptions Considerations

The above-mentioned fair values for the ~~two quarterly~~first and second quarter of 2020 quantitative interim assessments were primarily determined using a weighted average market and income approach. The income approach requires several assumptions including those regarding future sales growth, EBITDA (earnings before interest, taxes, depreciation and amortization) margins, and capital expenditures, which are the basis for the information used in the discounted cash flow model. The weighted-average cost of capital used in the income approach for the ~~two quarterly~~first and second quarter of 2020 quantitative interim assessments ranged from 10.5% to 12.0%, with a perpetual growth rate of 2%. For the market approach, for the first and second quarter of 2020 quantitative interim assessments, the Company considered the market comparable method based upon total enterprise value multiples of other comparable publicly-traded companies.

The key assumptions used to determine the estimated fair value of the reporting units for the ~~two quarterly~~first and second quarter of 2020 quantitative interim assessments, as well as for the third quarter of 2020 qualitative interim assessment, included the expected success of the Company's future new product launches, the Company's achievement of its expansion plans, the Company's realization of its cost reduction initiatives and other efficiency efforts, as well as certain assumptions regarding COVID-19's expected impact on the Company. If such plans and assumptions do not materialize as anticipated, or if there are further challenges in the business environment in which the Company's reporting units operate, a resulting change in actual results from the Company's key assumptions could have a negative impact on the estimated fair values of the reporting units, which could require the Company to recognize additional impairment charges in future reporting periods.

The inputs and assumptions utilized in the ~~two~~ quarterly interim impairment analyses are classified as Level 3 inputs in the fair value hierarchy as defined in ASC Topic 820, “Fair Value Measurements.”

The following table presents the changes in goodwill by segment for thenine months ended September 30,2020:



	Revlon		Portfolio		Elizabeth Arden		Fragrances		Total




Balance at January 1, 2020	$	264.9	$	171.1	$	116.9	$	120.8	$	673.7
Foreign currency translation adjustment	0.3		0.2		0		0		0.5

Goodwill impairment charge	0		(83.5)		(27.5)		0		(111.0)
Balance at September 30, 2020	$	265.2	$	87.8	$	89.4	$	120.8	$	563.2

Cumulative goodwill impairment charges(a)									$	(166.2)

(a) Amount refers to cumulative goodwill impairment charges related to impairments recognized in 2015, 2017, 2018 and 2020; NaN and $111.0 million of such impairment charges were recognized during the three and nine months ended September 30, 2020, respectively.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

~~The following table presents the changes in goodwill by segment for thesix months ended June 30,2020:~~

Revlon Portfolio Elizabeth Arden Fragrances Total
Balance at January 1, 2020 $ 264.9 $ 171.1 $ 116.9 $ 120.8 $ 673.7
Foreign currency translation adjustment — — — — —
Goodwill impairment charge — (83.5) (27.5) — (111.0)
Balance at June 30, 2020 $ 264.9 $ 87.6 $ 89.4 $ 120.8 $ 562.7
Cumulative goodwill impairment charges^(a)
$ (166.2)

^(a)~~Amount refers to cumulative goodwill impairment charges related to impairments recognized in 2015, 2017, 2018 and 2020;~~ ~~$11.2~~ ~~million and $111.0 million of such impairment charges were recognized during the three and six months ended June 30, 2020, respectively.~~

In connection with recognizing these goodwill impairment charges for the three and ~~six~~nine months ended ~~June~~September 30, 2020, the Company recognized a tax benefit of approximately NaN and $8.3 million, respectively, during such periods.

Intangible Assets, Net

Finite-Lived Intangibles

In accordance with ASC Topic 360, and in conjunction with the Company's performance of its interim impairment testing of goodwill for the first, second and ~~second~~third quarters of 2020, the Company reviewed its finite-lived intangible assets for impairment. In performing such review, the Company makes judgments about the recoverability of its purchased finite-lived intangible assets whenever events or changes in circumstances indicate that an impairment to its finite-lived intangible assets may exist. The Company also considers several indicators of impairment, including, among other factors, the following: (i) whether there exists any significant adverse change in the extent or manner in which a long-lived asset and/or asset group is being used; (ii) whether there exists any projection or forecast demonstrating losses associated with the use of a long-lived asset and/or asset group; and (iii) whether there exists a current expectation that, more likely than not, a long-lived asset and/or asset group will be sold or otherwise disposed of significantly before the end of its previously-estimated useful life. The carrying amount of a finite-lived intangible asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the finite-lived intangible asset and/or asset group and the impairment loss is measured as the amount by which the carrying amount of the finite-lived intangible asset exceeds its fair value. NaN impairment charges were recognized related to the carrying value of any of the Company's finite-lived intangible assets as a result of the first, second and third quarters of 2020 impairment assessments.

Indefinite-Lived Intangibles

In connection with the interim impairment assessment for the first and second quarters of 2020, the Company also quantitatively reviewed indefinite-lived intangible assets, consisting of certain trade names, using March 31, 2020 and June 30, 2020 carrying values, respectively, similar to goodwill, in accordance with ASC Topic 350.

As a result of COVID-19’s impact on the Company’s operations and on the expected future cash flows of certain asset groups, in connection with the Company's ~~first quarter of 2020~~quantitative interim assessment of ~~finite-lived~~goodwill in the first and second quarters of 2020, the Company performed quantitative interim assessments for its indefinite-lived intangible assets ~~as of March 31, 2020~~for the ~~Company recognized~~ same periods, which resulted in the recognition of:

•$24.5 million of total non-cash impairment charges related to certain indefinite-lived intangible assets within the Company's Mass Portfolio, Elizabeth Arden Fragrances and Elizabeth Arden Skin and Color reporting ~~units.~~units in the first quarter of 2020; and

As a result of COVID-19’s continued and additional impact on the Company’s operations and on the expected future cash flows of certain asset groups, in connection with the Company's interim assessment of indefinite-lived intangible assets for the second quarter of 2020, as of June 30, 2020 the Company recognized $8.6 million•$8.6 million of total non-cash impairment charges related to certain indefinite-lived intangible assets within the Company's Elizabeth Arden Fragrances and Elizabeth Arden Skin and Color reporting ~~units.~~units in the second quarter of 2020.

As of September 30, 2020, in accordance with the approach followed for the third quarter interim assessment of goodwill, the Company performed a qualitative assessment of its indefinite-lived intangible assets considering, among other factors, the financial performance of certain asset groups within its reporting units, the Company's revised, expected future cash flows (also as affected by COVID-19), as well as the results of the second quarter of 2020 quantitative interim analysis of indefinite-lived intangibles. NaN impairment charges were recognized related to the carrying value of any of the Company's indefinite-lived intangible assets as a result of the third quarter of 2020 qualitative interim impairment assessment. Consequently, total non-cash impairment charges recorded on the Company's indefinite-lived intangible assets were NaN and $33.1 million for the three and nine months ended September 30, 2020.

Inputs and Assumptions Considerations

The fair values of the Company's intangible assets ~~for the two quarterly interim assessments~~ were determined based on the undiscounted cash flows method for its finite-lived intangibles and based on the relief from royalty method for its indefinite-lived intangibles, respectively. The inputs and assumptions utilized in the impairment analyses are classified as Level 3 inputs in the fair value hierarchy as defined in ASC Topic 820, “Fair Value Measurements.” These impairment charges were included as a separate component of operating income within the "Impairment charges" caption on the face of the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and ~~six~~nine months ended ~~June~~September 30, 2020. A summary of such impairment charges by segments is included in the following table:

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)


		Three Months Ended																			Three Months Ended
		June 30, 2020																			September 30, 2020
		Revlon		Portfolio		Elizabeth Arden		Fragrances		Total			Revlon		Portfolio		Elizabeth Arden		Fragrances		Total

Indefinite-lived intangible assets	Indefinite-lived intangible assets	$	0.0	$	0.0	$	(8.6)	$	0.0	$	(8.6)	Indefinite-lived intangible assets	$	0	$	0	$	0	$	0	$	0
Total Intangibles Impairment	Total Intangibles Impairment	$	0.0	$	0.0	$	(8.6)	$	0.0	$	(8.6)	Total Intangibles Impairment	$	0	$	0	$	0	$	0	$	0


		Six Months Ended																			Nine Months Ended
		June 30, 2020																			September 30, 2020
		Revlon		Portfolio		Elizabeth Arden		Fragrances		Total			Revlon		Portfolio		Elizabeth Arden		Fragrances		Total

Indefinite-lived intangible assets	Indefinite-lived intangible assets	$	—	$	(2.5)	$	(30.6)	$	—	$	(33.1)	Indefinite-lived intangible assets	$	0	$	(2.5)	$	(30.6)	$	0	$	(33.1)
Total Intangibles Impairment	Total Intangibles Impairment	$	—	$	(2.5)	$	(30.6)	$	—	$	(33.1)	Total Intangibles Impairment	$	0	$	(2.5)	$	(30.6)	$	0	$	(33.1)

In connection with recognizing these intangible assets impairment charges for the three and ~~six~~nine months ended ~~June~~September 30, 2020, the Company recognized a tax benefit of approximately ~~$1.8 million~~NaN and $6.9 million, respectively, during such periods.

The following tables present details of the Company's total intangible assets as of ~~June~~September 30, 2020 and December 31, 2019:


		June 30, 2020																		September 30, 2020
		Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)		Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:	Finite-lived intangible assets:										Finite-lived intangible assets:
Trademarks and licenses	Trademarks and licenses	$	271.7	$	(119.3)	$	—	$	152.4	13	Trademarks and licenses	$	271.3	$	(122.7)	$	0	$	148.6	12
Customer relationships	Customer relationships	248.0		(103.1)		—		144.9		11	Customer relationships	248.8		(107.4)		0		141.4		11
Patents and internally-developed intellectual property	Patents and internally-developed intellectual property	21.9		(12.9)		—		9.0		5	Patents and internally-developed intellectual property	23.7		(15.2)		0		8.5		5
Distribution rights	Distribution rights	31.0		(6.6)		—		24.4		14	Distribution rights	31.0		(7.0)		0		24.0		14
Other	Other	1.3		(1.3)		—		—		0	Other	1.3		(1.3)		0		0		0
Total finite-lived intangible assets	Total finite-lived intangible assets	$	573.9	$	(243.2)	$	—	$	330.7		Total finite-lived intangible assets	$	576.1	$	(253.6)	$	0	$	322.5

Indefinite-lived intangible assets:	Indefinite-lived intangible assets:										Indefinite-lived intangible assets:
Trade names	Trade names	$	144.0	N/A		$	(33.1)	$	110.9		Trade names	$	146.5	N/A		$	(33.1)	$	113.4
Total indefinite-lived intangible assets	Total indefinite-lived intangible assets	$	144.0	N/A		$	(33.1)	$	110.9		Total indefinite-lived intangible assets	$	146.5	N/A		$	(33.1)	$	113.4

Total intangible assets	Total intangible assets	$	717.9	$	(243.2)	$	(33.1)	$	441.6		Total intangible assets	$	722.6	$	(253.6)	$	(33.1)	$	435.9

		December 31, 2019																		December 31, 2019
		Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)		Gross Carrying Amount		Accumulated Amortization		Impairment		Net Carrying Amount		Weighted-Average Useful Life (in Years)
Finite-lived intangible assets:	Finite-lived intangible assets:										Finite-lived intangible assets:
Trademarks and licenses	Trademarks and licenses	$	271.2	$	(110.9)	$	—	$	160.3	13	Trademarks and licenses	$	271.2	$	(110.9)	$	0	$	160.3	13
Customer relationships	Customer relationships	248.3		(96.5)		—		151.8		11	Customer relationships	248.3		(96.5)		0		151.8		11
Patents and internally-developed intellectual property	Patents and internally-developed intellectual property	21.5		(12.1)		—		9.4		5	Patents and internally-developed intellectual property	21.5		(12.1)		0		9.4		5
Distribution rights	Distribution rights	31.0		(5.6)		—		25.4		15	Distribution rights	31.0		(5.6)		0		25.4		15
Other	Other	1.3		(1.3)		—		—		0	Other	1.3		(1.3)		0		0		0
Total finite-lived intangible assets	Total finite-lived intangible assets	$	573.3	$	(226.4)	$	—	$	346.9		Total finite-lived intangible assets	$	573.3	$	(226.4)	$	0	$	346.9

Indefinite-lived intangible assets:	Indefinite-lived intangible assets:										Indefinite-lived intangible assets:
Trade names	Trade names	$	143.8	N/A		$	—	$	143.8		Trade names	$	143.8	N/A		$	0	$	143.8
Total indefinite-lived intangible assets	Total indefinite-lived intangible assets	$	143.8	N/A		$	—	$	143.8		Total indefinite-lived intangible assets	$	143.8	N/A		$	0	$	143.8

Total intangible assets	Total intangible assets	$	717.1	$	(226.4)	$	—	$	490.7		Total intangible assets	$	717.1	$	(226.4)	$	0	$	490.7

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Amortization expense for finite-lived intangible assets was ~~$8.2~~$8.3 million ~~and $8.8 million for~~in each of the three months ended ~~June~~September 30, 2020 and 2019, ~~respectively,~~ and ~~$16.7~~$25.0 million and ~~$23.6~~$31.9 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively. The variance with the previous comparable ~~six-month~~nine-month period was attributable primarily to the accelerated amortization of the Pure Ice intangible assets during the quarter ended March 31, 2019 as a result of the revision of the brand’s intangible assets useful lives following the termination of a business relationship with the brand's principal customer.

The following table reflects the estimated future amortization expense for each period presented, a portion of which is subject to exchange rate fluctuations, for the Company's finite-lived intangible assets as of ~~June~~September 30, 2020:


		Estimated Amortization Expense			Estimated Amortization Expense
2020	2020	$	17.3	2020	$	8.7
2021	2021	33.3		2021	33.4
2022	2022	32.4		2022	32.4
2023	2023	30.9		2023	30.9
2024	2024	27.5		2024	27.6
Thereafter	Thereafter	189.3		Thereafter	189.5
Total	Total	$	330.7	Total	$	322.5

6. ACCRUED EXPENSES AND OTHER

As of ~~June~~September 30, 2020 and December 31, 2019, the Company's accrued expenses and other current liabilities consisted of the following:


		June 30,		December 31,			September 30,		December 31,
		2020		2019			2020		2019
Sales returns and allowances	Sales returns and allowances	$	64.6	$	89.7	Sales returns and allowances	$	73.9	$	89.7
Advertising, marketing and promotional costs	Advertising, marketing and promotional costs	69.2		82.8		Advertising, marketing and promotional costs	72.9		82.8
Taxes ^(a)	Taxes ^(a)	46.9		54.3		Taxes (a)	48.1		54.3
Compensation and related benefits	Compensation and related benefits	31.3		42.1		Compensation and related benefits	40.1		42.1
Interest	Interest	34.8		34.0		Interest	22.0		34.0
Professional services and insurance	Professional services and insurance	19.8		16.3		Professional services and insurance	15.0		16.3
Short-term lease liability	Short-term lease liability	19.7		14.5		Short-term lease liability	19.0		14.5
Freight and distribution costs	Freight and distribution costs	7.4		13.2		Freight and distribution costs	3.1		13.2
Restructuring reserve	Restructuring reserve	42.6		10.0		Restructuring reserve	29.4		10.0
Software	Software	3.1		4.0		Software	3.1		4.0
Other ^(b)	Other ^(b)	39.1		54.0		Other (b)	61.3		54.0
Total	Total	$	378.5	$	414.9	Total	$	387.9	$	414.9

^(a) Accrued Taxes for Products Corporation as of ~~June~~September 30, 2020 and December 31, 2019 were ~~$49.9~~$51.1 million and $57.6 million, respectively.

^(b)Accrued Other as of December 31, 2019 includes approximately $2.3 million of severance to Mr. Fabian Garcia, the Company's former President and Chief Executive Officer, which was paid in 2020.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

7. DEBT

AsThe table below details the Company's debt balances as of ~~June~~September 30, 2020 and December 31, ~~2019, the Company's~~2019. See also Note 19, "Subsequent Events," for recent debt ~~balances consisted of the following:~~activity updates.


		June 30,		December 31,			September 30,		December 31,
		2020		2019			2020		2019
2020 BrandCo Term Loan Facility due 2025, net of debt issuance costs (see (a) below)	2020 BrandCo Term Loan Facility due 2025, net of debt issuance costs (see (a) below)	1,582.5		$	—	2020 BrandCo Term Loan Facility due 2025, net of debt issuance costs (see (a) below)	$	1,625.2	$	0
2019 Term Loan Facility due 2023, net of discounts and debt issuance costs (see (b) below)	2019 Term Loan Facility due 2023, net of discounts and debt issuance costs (see (b) below)	—		187.1		2019 Term Loan Facility due 2023, net of discounts and debt issuance costs (see (b) below)	0		187.1
2018 Foreign Asset-Based Term Facility due 2021, net of discounts and debt issuance costs (see (c) below)	2018 Foreign Asset-Based Term Facility due 2021, net of discounts and debt issuance costs (see (c) below)	51.6		82.3		2018 Foreign Asset-Based Term Facility due 2021, net of discounts and debt issuance costs (see (c) below)	54.6		82.3
Amended 2016 Revolving Credit Facility due 2021, net of debt issuance costs (see (d) below)	Amended 2016 Revolving Credit Facility due 2021, net of debt issuance costs (see (d) below)	247.2		269.9		Amended 2016 Revolving Credit Facility due 2021, net of debt issuance costs (see (d) below)	290.2		269.9
2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025, net of discounts and debt issuance costs (see (e) below)	2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025, net of discounts and debt issuance costs (see (e) below)	911.8		1,713.6		2016 Term Loan Facility: 2016 Term Loan due 2023 and 2025, net of discounts and debt issuance costs (see (e) below)	875.2		1,713.6
5.75% Senior Notes due 2021, net of debt issuance costs (see (f) below)	5.75% Senior Notes due 2021, net of debt issuance costs (see (f) below)	387.2		498.1		5.75% Senior Notes due 2021, net of debt issuance costs (see (f) below)	341.7		498.1
6.25% Senior Notes due 2024, net of debt issuance costs (see (g) below)	6.25% Senior Notes due 2024, net of debt issuance costs (see (g) below)	443.5		442.8		6.25% Senior Notes due 2024, net of debt issuance costs (see (g) below)	443.8		442.8

Spanish Government Loan due 2025	Spanish Government Loan due 2025	0.3		0.4		Spanish Government Loan due 2025	0.3		0.4
Debt	Debt	$	3,624.1	$	3,194.2	Debt	$	3,631.0	$	3,194.2
Less current portion^(*)	Less current portion^(*)	(648.3)		(288.0)		Less current portion(*)	(704.5)		(288.0)
Long-term debt	Long-term debt	$	2,975.8	$	2,906.2	Long-term debt	$	2,926.5	$	2,906.2

Short-term borrowings (see (h) below)	Short-term borrowings (see (h) below)	$	2.6	$	2.2	Short-term borrowings (see (h) below)	$	2.0	$	2.2

^(*) At ~~June~~September 30, 2020, the Company classified ~~$648.3~~$704.5 million as its current portion of long-term debt, comprised primarily of ~~$387.2~~$341.7 million of Products Corporation's 5.75% Senior Notes due February 15, 2021 (the "5.75% Senior Notes"), net of debt issuance costs, ~~$247.2~~$290.2 million of net borrowings under the Amended 2016 Revolving Credit Facility, net of debt issuance costs, ~~$9.6~~$54.6 million of the 2018 Foreign Asset-Based Term Facility due July 9, 2021, net of debt issuance costs and debt discount, $9.2 million of amortization payments on the 2016 Term Loan Facility scheduled to be paid over the next four calendar quarters, and ~~$4.2~~$8.6 million of amortization payments under the 2020 BrandCo Term Loan Facility due within one year. At December 31, 2019, the Company classified $288.0 million as its current portion of long-term debt, comprised primarily of $269.9 million of net borrowings under the Amended 2016 Revolving Credit Facility, net of debt issuance costs, and $18.0 million of amortization payments on the 2016 Term Loan Facility. See below in this Note 7, "Debt," and Note 19, "Subsequent Events," for details regarding the Company's recent debt-related transactions.

^(a)The aggregate principal amount outstanding under the 2020 BrandCo Term Loan Facility at ~~June~~September 30, 2020 was ~~$1,720.4~~$1,761.3 million, including ~~$809.8~~$846.0 million of principal rolled-up from the 2016 Term Loan Facility to the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility. See further details below, within this Note 7, ~~"Debt.~~"Debt," and Note 19, “Subsequent Events.”

^(b) On May 7, 2020, in connection with closing the 2020 BrandCo Facilities, ~~the Company~~Products Corporation fully repaid the 2019 Term Loan Facility pursuant to that Term Credit Agreement, dated as of August 6, 2019 (the “2019 Term Loan Facility”). See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding the 2019 Term Loan Facility, which prior to its repayment was scheduled to mature on the earliest of: (x) August 6, ~~2023;~~2023 and (y) the 180th day prior to the stated maturity of Products Corporation’s existing 2016 Term Loan Facility, if any loans under the 2016 Term Loan Facility remained outstanding and had not been replaced or refinanced by such date; and (z) the date of any springing maturity of the 2016 Term Loan Facility (i.e., the 91st day prior to the maturity of the 5.75% Senior Notes due February 15, 2021 if any 5.75% Senior Notes remained outstanding by such date and certain liquidity thresholds were not met).date. The lenders under the 2019 Term Loan Facility participated in the 2020 BrandCo Term Loan Facility and, as a result, the Company determined that the full repayment of the 2019 Term Loan Facility represented a debt modification under U.S. GAAP. Accordingly, the Company recorded approximately $33.5 million in connection with fees paid to the lenders for the prepayment of the 2019 Term Loan Facility, as well as approximately $10.3 million in other lenders' fees, which were capitalized as part of the total debt issuance costs for the 2020 BrandCo Term Loan Facility. See further details below, within this Note 7, ~~"Debt.~~"Debt,"and Note 19, “Subsequent Events.”

^(c) The aggregate principal amount outstanding under the 2018 Foreign Asset-Based Term Facility at ~~June~~September 30, 2020 was ~~U.S. Dollar~~the Euro equivalent ~~$54.5~~of $56.8 million. In connection with the amendment described below, the Company repaid €5 million of the original aggregate principal amount of €77 million. See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding the euro-denominated senior secured asset-based term loan facility that various foreign subsidiaries of Products Corporation entered into on July 9, 2018 and which is scheduled to mature on July 9, 2021 ~~subject to a springing maturity on November 16, 2020 if any of the 5.75% Senior Notes remain outstanding on such date~~ (the “2018 Foreign Asset-Based Term Facility”). In May, 2020 the Company entered into an amendment to the 2018 Foreign Asset Based Term Facility to, among other things, increase the margin applicable to the interest rate from EURIBOR (with a floor of 0.50%) plus a margin of 6.50% to EURIBOR (with a floor 0.50%) plus a margin of 7.00%. See further details below, within this Note 7, "Debt."

^(d) Total borrowings at face amount under Tranche A of the Amended 2016 Revolving Credit Facility at ~~June~~September 30, 2020 were ~~$249.5~~$291.9 million (excluding ~~$7.7~~$1.4 million of outstanding undrawn letters of credit). See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding Products Corporation's Amended 2016 Revolving Credit Facility. In April 2018, Products Corporation amended the Amended 2016 Revolving Credit Facility Agreement, as detailed below, to, among other things, add a ~~new~~ $41.5 million senior secured first in, last out "Tranche B," while the original $400 million tranche under such facility became a senior secured last in, first out "Tranche A." Tranche A matures on the earlier of: (x) September 7, 2021; and (y) the 91^st day prior to the maturity of Products Corporation’s 5.75% Senior Notes, if, on that date (and solely for so long as), (i) any of Products Corporation’s 5.75% Senior Notes remain outstanding and (ii) Products Corporation’s available liquidity does not exceed the aggregate principal amount of the then outstanding 5.75% Senior Notes by at least $200 million. On April 17, 2020, the maturity date of the 2018 Tranche B was extended from April 17, 2020 to May 17, 2020 and was fully repaid on such extended maturity date.

^(e) The aggregate principal amount outstanding under the 2016 Term Loan Facility at ~~June~~September 30, 2020 was ~~$924.8~~$886.3 million. See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding Products Corporation's 2016 Term Loan Facility that was originally scheduled to mature on the earlier of: (x) September 7, 2023; and (y) the 91^st day prior to the maturity of Products Corporation’s ~~5.75% Senior Notes due 2021 if, on that date (and solely for so long as), (i) any of Products Corporation's 5.75% Senior Notes remain outstanding and (ii) Products~~

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

5.75% Senior Notes if, on that date (and solely for so long as), (i) any of Products Corporation's 5.75% Senior Notes remain outstanding and (ii) Products Corporation’s available liquidity does not exceed the aggregate principal amount of the then outstanding 5.75% Senior Notes by at least $200 million (the “Original Maturity Date”). On May 7, 2020, in connection with closing the 2020 BrandCo Facilities, ~~the Company~~Products Corporation amended the 2016 Term Loan Facility to, among other things, extend the maturity of a portion of the 2016 Term Loan Facility to June 30, 2025, subject to certain springing maturities ~~the~~(the “Extended Maturity Date”). See further details below within this Note 7, ~~"Debt.~~"Debt," and Note 19, “Subsequent Events.” As a result of such transaction, as of ~~June~~September 30, 2020, ~~$894.0~~$855.6 million of the 2016 Term Loan Facility is scheduled to mature on the Original Maturity Date and ~~$30.8~~$30.7 million is scheduled to mature on the Extended Maturity Date.

^(f) The aggregate principal amount outstanding under the 5.75% Senior Notes at ~~June~~September 30, 2020 was ~~$387.2~~$342.8 million. See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding Products Corporation's 5.75% Senior Notes that are scheduled to mature on February 15, 2021. During the ~~three~~nine months ended ~~June~~September 30, 2020, ~~the Company~~Products Corporation repurchased $~~112.8~~157.2 million in aggregate principal face amount of the 5.75% Senior Notes, recording a ~~net~~ gain on extinguishment of debt of approximately $~~11.9~~43.1 million, which is included in ~~"(Gain) loss~~"Gain on early extinguishment of ~~debt, net"~~debt" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and ~~six~~nine months ended ~~June~~September 30, 2020. See further details below within this Note 7, ~~"Debt.~~"Debt," and Note 19, “Subsequent Events.”

^(g) The aggregate principal amount outstanding under the 6.25% Senior Notes at ~~June~~September 30, 2020 was $450 million. See Note 9, "Long-Term Debt," to the Consolidated Financial Statements in the Company's 2019 Form 10-K for certain details regarding Products Corporation's 6.25% Senior Notes that are scheduled to mature on August 1, 2024 (the "6.25% Senior Notes").

^(h)There were 0 borrowings at ~~June~~September 30, 2020 under the Second Amended and Restated Unsecured 2019 Senior Line of Credit Facility between Products Corporation and MacAndrews & Forbes Group, LLC (“M&F”), dated as of September 28, 2020 (the “2020 Restated Line of Credit Facility”), which was amended and restated in anticipation of a ~~related party, discussed below.~~Future Refinanced European ABL Facility (as hereinafter defined) and will provide Products Corporation with up to a $30 million tranche of a new facility of the 2018 Foreign Asset-Based Term Facility (the “New European ABL FILO Facility”) that would be secured on a “last-out” basis by the same collateral as the 2018 Foreign Asset-Based Term Facility or, if no Future Refinanced European ABL Facility is obtained, a stand-alone $30.0 million credit facility secured by the same collateral as the 2018 Foreign Asset-Based Term Facility when that facility is terminated, in each case, subject to a borrowing base.

Current Year Debt Transactions

5.75% Senior Notes Exchange Offer

See Note 19, “Subsequent Events” for important information regarding the Company’s debt-related transactions occurring after September 30, 2020. On September 29, 2020, Products Corporation commenced the “Exchange Offer” to exchange any and all of the then-outstanding 5.75% Senior Notes (the “Existing 5.75% Senior Notes”). As described in Note 19, the Exchange Offer was amended on October 23, 2020 and on November 13, 2020, the Company announced that the Exchange Offer was successfully consummated and that Products Corporation had accepted $236 million in aggregate principal amount of 5.75% Senior Notes tendered in the Exchange Offer. Products Corporation used cash on hand to redeem, effective as of November 13, 2020, the remaining $106.8 million in aggregate principal amount of 5.75% Senior Notes pursuant to the terms of the 5.75% Senior Notes Indenture. Following the consummation of the Exchange Offer and the satisfaction and discharge of the remaining 5.75% Senior Notes, 0 5.75% Senior Notes remained outstanding as of the closing on November 13, 2020.

Amendments to the 2020 BrandCo Term Loan Facility

Prior to consummating the Exchange Offer, on September 28, 2020, Products Corporation and certain lenders under the 2020 BrandCo Term Loan Facility, representing more than a majority in aggregate principal amount of loans thereunder (the “Supporting BrandCo Lenders”), entered into a Transaction Support Agreement (the “BrandCo TSA”) under which the Supporting BrandCo Lenders agreed to take certain actions to facilitate the Exchange Offer and Consent Solicitation, including, among other things:

•Relinquishing certain rights of such Supporting BrandCo Lenders to “roll-up” loans held by such Supporting BrandCo Lenders under the 2016 Term Loan Facility into New BrandCo Second-Lien Term Loans under the 2020 BrandCo Term Loan Facility (the “Roll-up Rights”);

•Tendering any Existing 5.75% Senior Notes held by such Supporting BrandCo Lenders into the Exchange Offer and Consent Solicitation;

•Consenting to amendments to the 2020 BrandCo Term Loan Facility to permit the exchange of Existing 5.75% Senior Notes for the New BrandCo Second-Lien Term Loans under the 2020 BrandCo Term Loan Facility as contemplated by the Offering Memorandum and the payment of the BrandCo Support and Consent Consideration;

•Consenting to other amendments to the 2020 BrandCo Term Loan Facility and the Amended 2016 Revolving Credit Facility to permit the Exchange Offer and Consent Solicitation to be completed as contemplated by the Offering Memorandum; and

•Supporting and cooperating with Products Corporation to consummate the transactions contemplated by the BrandCo TSA and the Offering Memorandum, including the Exchange Offer and Consent Solicitation.

In connection with such amendments, Products Corporation agreed to provide the following consideration (collectively, the “BrandCo Support and Consent Consideration”) upon the successful consummation of the Exchange Offer:

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

•$12.5 million aggregate principal amount of New BrandCo Second-Lien Term Loans as a fee to the Supporting BrandCo Lenders under the BrandCo TSA in connection with such Supporting BrandCo Lenders’ relinquishment of their Roll-up Rights;

•$10.0 million aggregate principal amount of New BrandCo Second-Lien Term Loans to one of the Supporting BrandCo Lenders in exchange for $18.7 million aggregate principal amount of Products Corporation’s 6.25% Senior Notes due 2024 held by such Supporting BrandCo Lender; and

•to all lenders under the 2020 BrandCo Term Loan Facility (including the Supporting BrandCo Lenders), an amendment fee that was payable pro rata based on principal amount of loans consenting, consisting of, at Products Corporation's option, either (x) an aggregate of $2.5 million of cash or (y) $5.0 million aggregate principal amount of New BrandCo Second-Lien Term Loans. Pursuant to the BrandCo Amendment, Products Corporation elected to pay this fee in-kind in the form of $5.0 million aggregate principal amount of New BrandCo Second-Lien Term Loans.

On November 13, 2020, Products Corporation entered into that certain Amendment No. 1 (the “BrandCo Amendment”) to the 2020 BrandCo Credit Agreement in connection with the Exchange Offer in order to, among other things, provide for the incurrence of $75 million in aggregate principal amount of New BrandCo Second-Lien Term Loans. The New BrandCo Second Lien Term Loans are a separate tranche of “Term B-2 Loans” (ranking junior to the Term B-1 Loans and senior to the Term B-3 Loans with respect to liens on certain specified collateral) under the BrandCo Credit Agreement. Except as to the use of proceeds, the terms of the New BrandCo Second-Lien Term Loans are substantially consistent with the other Term B-2 Loans. In connection with the BrandCo Amendment, Products Corporation paid certain fees to the lenders in-kind in the form of New BrandCo Second-Lien Term Loans in accordance with the BrandCo TSA.

MacAndrews & Forbes 2020 Restated Line of Credit Facility

In light of the upcoming maturity on July 9, 2021 of the 2018 Foreign Asset-Based Term Facility and the upcoming expiration on December 31, 2020 of the Amended 2019 Senior Line of Credit Facility, the Company sought to refinance or extend both the 2018 Foreign Asset-Based Term Facility and the Amended 2019 Senior Line of Credit Facility. Products Corporation sought to do so in order to reinforce its liquidity position to be better able to address the current business and economic environment and prepare for any further potential disruptions to its business and operations as may be brought on by the ongoing COVID-19 pandemic or other events.

As a result, and anticipating a future refinancing of the 2018 Foreign Asset-Based Term Facility (a “Future Refinanced European ABL Facility”), on September 28, 2020, Products Corporation and M&F entered into the Second Amended and Restated 2019 Senior Unsecured Line of Credit Facility (the “2020 Restated Line of Credit Facility”), which amended and restated the Amended 2019 Senior Line of Credit Facility and will provide Products Corporation with up to a $30 million tranche of a new facility of the 2018 Foreign Asset-Based Term Facility (the “New European ABL FILO Facility”) that would be secured on a “last-out” basis by the same collateral as the 2018 Foreign Asset-Based Term Facility or, if no Future Refinanced European ABL Facility is obtained, a stand-alone $30 million credit facility secured by the same collateral as the 2018 Foreign Asset-Based Term Facility when that facility is terminated, in each case, subject to a borrowing base. Upon the earlier of (x) the incurrence of a New European ABL FILO Facility and (y) December 31, 2020, the 2020 Restated Line of Credit Facility will terminate, such that M&F’s maximum committed amount under the 2020 Restated Line of Credit Facility will never exceed $30.0 million. As of September 30, 2020, there were 0 borrowings outstanding under the 2020 Restated Line of Credit Facility.

The New European ABL FILO Facility would mature on (x) the maturity date of any such Future Refinanced European ABL Facility or (y) if there is no Future Refinanced European ABL Facility, July 9, 2022. To the extent the Future Refinanced European ABL Facility exceeds $35.0 million in principal amount, the amount available under the New European ABL FILO Facility would decrease on a dollar-for-dollar basis, such that, if Products Corporation were able to obtain a Future Refinanced ABL Facility of $65.0 million from third parties, there would be no amounts available under the New European ABL FILO Facility. The interest rate for the New European ABL FILO Facility will be LIBOR + 10.00%. The covenants for the New European ABL FILO Facility would be substantially the same as those applicable to the 2018 European ABL Facility.

Consummation of 2020 BrandCo Refinancing Transactions

On May 7, 2020 (the “BrandCo 2020 Facilities Closing Date”), ~~the Company,~~Products Corporation entered into a term credit agreement (the “2020 BrandCo Credit Agreement”) with Jefferies Finance LLC, as administrative agent and collateral agent, and certain financial institutions (the “2020 Facilities Lenders”) that are lenders or the affiliates of lenders under Products Corporation’s Term Loan Credit Agreement, dated as of September 7, 2016 and amended on April 30, 2020 and as amended on the BrandCo 2020 Facilities Closing Date, as further described below (as amended to date, the “2016 Term Loan Facility”). Pursuant to the 2020 BrandCo Credit Agreement, the 2020 Facilities Lenders provided ~~the Company~~Products Corporation with new and roll-up senior

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

secured term loan facilities (the “2020 BrandCo Facilities” and, collectively, the "2020 BrandCo Term Loan Facility" and, together with the use of proceeds thereof and the Extension Amendment, ~~(as defined below),~~ the “2020 BrandCo Refinancing Transactions”).

Principal and Maturity: The 2020 BrandCo Facilities consist of: (i) a senior secured term loan facility in an aggregate principal amount outstanding on the BrandCo 2020 Facilities Closing Date of $815 million, plus the amount of certain fees and accrued interest that have been capitalized (the “2020 BrandCo Facility”); (ii) commitments in respect of a senior secured term loan facility in an aggregate principal amount of $950 million (the “Roll-up BrandCo Facility”); and (iii) a senior secured term loan facility in an aggregate principal amount outstanding on the BrandCo 2020 Facilities Closing Date of $3 million (the “Junior Roll-up BrandCo Facility”). Additionally, on May 28, 2020, Products Corporation borrowed from the 2020 Facilities Lenders an additional $65 million of term loans under the 2020 BrandCo Facility to repay in full the 2020 Incremental Facility ~~(as defined below)~~ under the 2016 Term Loan Facility, as a result of which the 2020 BrandCo Facility at June 30, 2020 had an aggregate principal amount outstanding of $910.6 million (including paid-in-kind closing fees of $29.1 million and paid-in-kind interest of $1.5 million that ~~have been~~were capitalized). Additionally, during the three months ended June 30, 2020 and the three months ended September 30, 2020, certain lenders under the 2016 Term Loan Facility due June 2023, representing ~~$809.8~~$846.0 million in aggregate principal outstanding, rolled-up to the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility due June 2025, as a result of which the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility at ~~June~~September 30, 2020 ~~have~~had an aggregate principal amount outstanding of ~~$809.8~~$846.0 million. The Company determined that the roll-up of such 2016 Term Loan Facility lenders into the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility represented a debt modification under U.S. GAAP, as the cash flow effect between the amount that Products Corporation owed to the participating lenders under the old debt instrument (i.e., the 2016 Term Loan Facility) and the amount that Products Corporation owed to such lenders after the consummation of the roll-up into the new debt instrument (i.e., the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility) on a present value basis was less than 10% and, thus, the debt instruments were not considered to be substantially different within the meaning of ASC 470, Debt, under U.S. GAAP.

The proceeds of the 2020 BrandCo Facility were used: (i) to repay in full approximately $200 million of indebtedness outstanding under Products Corporation’s 2019 Term Loan Facility; (ii) to repay in full and terminate commitments under the 2020 Incremental Facility; and (iii) to pay fees and expenses in connection with the 2020 BrandCo Facilities and the 2020 BrandCo Refinancing Transactions. The Company will use the remaining net proceeds for general corporate purposes, including repurchasing, repaying or refinancing Products Corporation’s outstanding 5.75% Senior Notes. The proceeds of the Roll-up BrandCo Facility are available prior to the third anniversary of the BrandCo 2020 Facilities Closing Date to purchase at par an equivalent amount of any remaining term loans under the 2016 Term Loan Facility held by the lenders participating in the 2020 BrandCo Facility or their transferees. During the three months ended June 30, 2020 and the three months ended September 30, 2020, certain lenders under the 2016 Term Loan Facility due June 2023, representing ~~$809.8~~$846.0 million in aggregate principal outstanding, rolled-up to the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility due June 2025, as a result of which the Roll-up BrandCo Facility and the

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

Junior Roll-up BrandCo Facility at ~~June~~September 30, 2020 have an aggregate principal amount outstanding of ~~$809.8~~$846.0 million, with a remaining capacity for the roll-up of loans under the 2016 Term Loan Facility of ~~$143.2~~$107.0 million. See “Amendments to the 2020 BrandCo Term Loan Facility” regarding the Supporting BrandCo Lenders relinquishing certain Roll-up Rights and Products Corporation’s issuance of the BrandCo Support and Consent Consideration.

The 2020 BrandCo Facilities will mature on June 30, 2025, subject to a springing maturity 91 days prior to the August 1, 2024 maturity date of Products Corporation’s 6.25% Senior Notes if, on such date, $100 million or more in aggregate principal amount of the 6.25% Senior Notes remain outstanding.

The Company incurred approximately ~~$116.7~~$119.3 million of new debt issuance costs in connection with closing the 2020 BrandCo Facility, which include paid-in kind amounts that are recorded as an adjustment to the carrying amount of the related liability and amortized to interest expense in accordance with the effective interest method over the term of the 2020 BrandCo Facilities.

Borrower, Guarantees and Security: Products Corporation is the borrower under the 2020 BrandCo Facilities and the 2020 BrandCo Facilities are guaranteed by certain of Products Corporation's indirect subsidiaries (the “BrandCos”) that hold certain intellectual property assets related to the Elizabeth Arden and American Crew brands, certain other Portfolio segment brands and certain owned Fragrance segment brands (the “Specified Brand Assets”). While the BrandCos do not guarantee the 2016 Term Loan Facility, all guarantors of the 2016 Term Loan Facility guarantee the 2020 BrandCo Facilities. All of the assets of the BrandCos (including all capital stock issued by the BrandCos) have been pledged to secure the 2020 BrandCo Facility on a first-priority basis, the Roll-up BrandCo Facility on a second-priority basis and the Junior Roll-up BrandCo Facility on a third-priority basis and while such assets do not secure the 2016 Term Loan Facility, the 2020 BrandCo Facilities are secured on a pari passu basis by the assets securing the 2016 Term Loan Facility.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Contribution and License Agreements: In connection with the pledge of the Specified Brand Assets, Products Corporation and certain of its subsidiaries contributed the Specified Brand Assets to the BrandCos. Products Corporation entered into license and royalty arrangements on arm’s length terms with the relevant BrandCos to provide for the continued use of the Specified Brand Assets by Products Corporation and its subsidiaries during the term of the 2020 BrandCo Facilities.

Interest and Fees: Loans under the 2020 BrandCo Facility bear interest at a rate equal to LIBOR (with a LIBOR floor of 1.50%) plus (x) 10.50% per annum, payable not less than quarterly in arrears in cash and (y) 2.00% per annum payable not less than quarterly in-kind by adding such amount to the principal amount of outstanding loans under the 2020 BrandCo Facility. Loans under the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility bear interest at a rate equal to LIBOR (with a LIBOR floor of 0.75%) plus 3.50% per annum, payable not less than quarterly in arrears in cash.

Affirmative and Negative Covenants: The 2020 BrandCo Facilities contain certain affirmative and negative covenants that, among other things, limit Products Corporation’s and its restricted subsidiaries’ ability to: (i) incur additional debt; (ii) incur liens; (iii) sell, transfer or dispose of assets; (iv) make investments; (v) make dividends and distributions on, or repurchases of, equity; (vi) make prepayments of contractually subordinated, unsecured or junior lien debt; (vii) enter into certain transactions with their affiliates; (viii) enter into sale-leaseback transactions; (ix) change their lines of business; (x) restrict dividends from their subsidiaries or restrict liens; (xi) change their fiscal year; and (xii) modify the terms of certain debt. The 2020 BrandCo Facilities also restrict distributions and other payments from the BrandCos based on certain minimum thresholds of net sales with respect to the Specified Brand Assets. The 2020 BrandCo Facilities also contain certain customary representations, warranties and events of default, including a cross default provision making it an event of default under the 2020 BrandCo Credit Agreement if there is an event of default under Products Corporation’s existing 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement or the indentures governing each of Products Corporation’s 5.75% Senior Notes ~~Indentures. The~~due 2021 and its 6.25% Senior Notes due 2024 (the “Senior Notes Indentures”). The lenders under the 2020 BrandCo Credit Agreement may declare all outstanding loans under the 2020 BrandCo Facilities to be due and payable immediately upon an event of default. Under such circumstances, the lenders under the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, and the holders under the Senior Notes Indentures may also declare all outstanding amounts under such instruments to be due and payable immediately as a result of similar cross default or cross acceleration provisions, subject to certain exceptions and limitations described in the relevant instruments.

Prepayments: The 2020 BrandCo Facilities are subject to certain mandatory prepayments, including from the net proceeds from the issuance of certain additional debt and asset sale proceeds of certain non-ordinary course asset sales or other dispositions of property, subject to certain exceptions. The 2020 BrandCo Facilities may be repaid at any time, subject to customary prepayment premiums.

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

Loan Facility (the “Extension Amendment”) that, among other things, made certain modifications to the covenants thereof and extended the maturity date of their term loans (“Extended Term Loans”) to June 30, 2025, subject to (i) the same September 7, 2023 springing maturity date of the non-extended term loans under the 2016 Term Loan Facility if, on such date, $75 million or more in aggregate principal amount of the non-extended term loans under the 2016 Term Loan Facility remains outstanding, and (ii) a springing maturity of 91 days prior to the August 1, 2024 maturity date of the 6.25% Senior Notes if, on such date, $100 million or more in aggregate principal amount of the 6.25% Senior Notes remains outstanding. The Extension Amendment became effective on the BrandCo 2020 Facilities Closing Date. As of ~~June~~September 30, 2020, approximately ~~$30.8~~$30.7 million in aggregate principal amount of Extended Term Loans were outstanding after giving effect to the 2020 BrandCo Refinancing Transactions. The Extended Term Loans bear interest at a rate of LIBOR (with a LIBOR floor of 0.75%) plus 3.50% per annum, payable not less than quarterly in arrears in cash, consistent with the interest rate applicable to the non-extended term loans. Approximately $17.0 million of accrued interest outstanding on the 2016 Term Loan Facility was paid on the BrandCo 2020 Facilities Closing Date. The aggregate principal amount of non-extended term loans under the 2016 Term Loan Facility as of ~~June~~September 30, 2020 was ~~$894.0~~approximately $855.6 million.

Repurchases of 5.75% Senior Notes due 2021

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Products Corporation repurchased and subsequently canceled an additional $44.4 million in aggregate principal face amount of its 5.75% Senior Notes. Accordingly, as of ~~June~~September 30, 2020, ~~the Company~~Products Corporation had repurchased and subsequently cancelled a total of approximately ~~$112.8~~$157.2 million in aggregate principal face amount of its 5.75% Senior Notes, resulting in a ~~net~~ gain on extinguishment of debt of approximately ~~$11.9~~$31.2 million and $43.1 million for the three and nine months ended September 30, 2020, respectively, which ~~was~~were recorded within ~~"(Gain) loss~~"Gain on early extinguishment of ~~debt, net"~~debt" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and ~~six~~nine months ended ~~June~~September 30, 2020. See Note 7, "Debt," and Note 19, ~~"Subsequent Events,"~~“Subsequent Events” for more information regarding ~~the Exchange Offer that the Company commenced in July 2020 with respect to the~~Products Corporation's 5.75% Senior ~~Notes.~~Notes and the related Exchange Offer.

Prepayment of the 2019 Term Loan Facility due 2023

On the BrandCo 2020 Facilities Closing Date, ~~the Company~~Products Corporation used a portion of the proceeds from the 2020 BrandCo Facility to fully prepay the entire principal amount outstanding under its 2019 Term Loan Facility, totaling $200 million, plus approximately $1.3 million of accrued interest outstanding thereon, as well as approximately $33.5 million in prepayment premiums, $10.3 million in lenders' fees, $0.3 million in legal fees and approximately $2.0 million in other third party fees. As the lenders under the 2019 Term Loan Facility participated in the 2020 BrandCo Term Loan Facility, the Company determined that the full repayment of the 2019 Term Loan Facility represented a debt modification under U.S. GAAP as the cash flow effect between the old debt instrument (i.e., the 2019 Term Loan Facility) and the new debt instrument (i.e., the 2020 BrandCo Facility) on a present value basis was less than 10% and, thus, the debt instruments were not considered to be substantially different within the meaning of ASC 470, Debt, under U.S. GAAP. Accordingly, the $33.5 million of prepayment premiums, as well as the $10.3 million in other lenders' fees were capitalized as part of the aforementioned ~~$116.7~~$119.3 million of total new debt issuance costs for the 2020 BrandCo Term Loan Facility, while the aforementioned $0.3 million of legal fees and $2.0 million in other third party fees were expensed as incurred in the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the ~~three and six~~nine months ended ~~June~~September 30, 2020.

Amendment to the 2018 Foreign Asset-Based Term Facility

On May 4, 2020, the Company entered into an amendment to the 2018 Foreign Asset Based Term Facility, which had an original outstanding principal amount of €77 million. Such amendment provided for the following:

•increasing the interest rate on the loan from EURIBOR (with a floor 0.50%) plus a margin of 6.50% to EURIBOR (with a floor 0.50%) plus a margin of 7.00%;

•adding a springing maturity date of 91 days prior to the February 15, 2021 maturity of the 5.75% Senior Notes if any of ~~the~~Products Corporation's 5.75% Senior Notes remain outstanding on such date;

•requiring a mandatory prepayment of €5.0 million; and

•clarifying certain terms and waiving certain provisions in connection with the 2020 BrandCo Refinancing Transactions.

Approximately $0.4 million of amendment fees paid to the lenders under 2018 Foreign Asset-Based Term Facility were capitalized and are amortized to interest expense, together with any unamortized debt issuance costs outstanding prior to the amendment. As of ~~June~~September 30, 2020, there was ~~€48.5~~the Euro equivalent of $56.8 million outstanding under the 2018 Foreign Asset-Based Term Facility, reflecting a repayment of €28.5 million made during the quarter ended June 30, 2020.

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

Incremental Revolving Credit Facility under the 2016 Term Loan Agreement

On April 30, 2020, Products Corporation entered into a Joinder Agreement (the “2020 Joinder Agreement”), with Revlon, certain of their subsidiaries and certain existing lenders (the “Incremental Lenders”) under Products Corporation’s 2016 Term Loan Agreement to provide for a $65 million incremental revolving credit facility (the “2020 Incremental Facility”). On the closing of the 2020 Incremental Facility, Products Corporation borrowed $63.5 million of revolving loans for working capital purposes and subsequently on May 11, 2020 Products Corporation also borrowed the additional $1.5 million of delayed ~~funding. After the BrandCo 2020 Facilities Closing Date, Products Corporation borrowed the remaining $1.5 million of~~funding revolving loans for working capital purposes. The commitments in respect of the 2020 Incremental Facility would have terminated on September 7, 2021, subject to a springing maturity date of 91 days prior to the February 15, 2021 maturity date of Products Corporation's 5.75% Senior Notes if any such notes remain outstanding on such date, and certain liquidity requirements are not satisfied.loans. Prior to its full repayment on May 28, 2020, amounts outstanding under the 2020 Incremental Facility bore interest at a rate of (x) LIBOR plus 16% or (y) an Alternate Base Rate plus 15%, at Products Corporation’s option. Except as to pricing, maturity and differences due to its revolving nature, the terms of the 2020 Incremental Facility were otherwise substantially consistent with the existing term loans under the 2016 Term Loan Facility. The 2020 Incremental Facility was repaid in full, and the commitments thereunder terminated, on May 28, 2020. Upon such repayment, approximately $2.9 million of upfront commitment fees that ~~the Company~~Products Corporation incurred in connection with consummating the 2020 Incremental Facility were entirely expensed within "Miscellaneous, net" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the ~~three and six~~nine months ended ~~June~~September 30, 2020.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Amendments to the 2016 Revolving Credit Agreement

On May 7, 2020, in connection with consummating the 2020 BrandCo Refinancing Transactions, ~~the Company~~Products Corporation entered into Amendment No. 4 to ~~Products Corporation’s~~its Asset-Based Revolving Credit Agreement, dated as of September 7, 2016, as amended (the “2016 Revolving Credit Facility”). Amendment No. 4, among other things, made certain amendments and provided for certain waivers relating to the 2020 BrandCo Refinancing Transactions under the 2016 Revolving Credit Facility. In exchange for such amendments and waivers, the interest rate margin applicable to loans under Tranche A of the 2016 Revolving Credit Facility increased by 0.75%. In connection with the amendments to the 2018 Tranche B of the 2016 Revolving Credit Facility (which was fully repaid on its May 17, 2020 extended maturity date), ~~the Company~~Products Corporation incurred approximately $1.1 million in lender's fees that upon its full repayment were entirely expensed within “Miscellaneous, net” on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss as of ~~June~~September 30, ~~2020.~~2020. See “Recent Developments” and Note 19, “Subsequent Events,” regarding, among other things, Amendment No. 5 to the 2016 Revolving Credit Facility.

Previously, on April 17, 2020 (the “FILO Closing Date”), ~~the Company~~Products Corporation entered into Amendment No. 3 to the 2016 Revolving Credit Facility (“Amendment No. 3”), pursuant to which, the maturity date applicable to $36.3 million of loans under the $41.5 million senior secured first in, last out 2018 Tranche B under the 2016 Revolving Credit Facility (the ~~“FILO~~“2018 FILO Tranche”) was extended from April 17, 2020 to May 17, 2020 (the “Extended Maturity Date”). ~~The Company~~Products Corporation repaid the remaining approximately $5.2 million of the 2018 FILO Tranche loans as of the FILO Closing Date. In addition, Amendment No. 3 increased the applicable interest margin for the 2018 FILO Tranche by 0.75%, subject to a LIBOR floor of 0.75%. TheProducts Corporation fully repaid the 2018 FILO Tranche ~~was fully repaid~~ on the Extended Maturity Date.

Covenants

Products Corporation was in compliance with all applicable covenants under the 2020 BrandCo Credit Agreement, 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the ~~Amended 2019 Senior~~2020 Restated Line of Credit ~~Agreement,~~Facility, as well as with all applicable covenants under its Senior Notes Indentures, in each case as of ~~June~~September 30, 2020. At ~~June~~September 30, 2020, the aggregate principal amounts outstanding and availability under Products Corporation’s various revolving credit facilities were as follows:


		Commitment		Borrowing Base		Aggregate principal amount outstanding at June 30, 2020		Availability at June 30, 2020 ^(a)			Commitment		Borrowing Base		Aggregate principal amount outstanding at September 30, 2020		Availability at September 30, 2020 (a)
Amended 2016 Revolving Credit Facility	Amended 2016 Revolving Credit Facility	$	400.0	$	307.9	$	249.5	$	50.7	Amended 2016 Revolving Credit Facility	$	400.0	$	345.9	$	291.9	$	52.6

Amended 2019 Senior Line of Credit Facility		$	30.0	N/A		$	—	$	30.0
2020 Restated Line of Credit Facility										2020 Restated Line of Credit Facility	$	30.0	N/A		$	0	$	30.0

^(a) Availability as of ~~June~~September 30, 2020 is based upon the borrowing base then in effect under the Amended 2016 Revolving Credit Facility of ~~$307.9~~$345.9 million, less ~~$7.7~~$1.4 million of outstanding undrawn letters of credit and ~~$249.5~~$291.9 million then drawn. As Products Corporation’s consolidated fixed charge coverage ratio was greater than 1.0 to 1.0 as of ~~June~~September 30, 2020, all of the ~~$50.7~~$52.6 million of availability under the

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

Amended 2016 Revolving Credit Facility was available as of such date. The 2018 Tranche B under the Amended 2016 Revolving Credit Facility was fully repaid in May 2020.

The Company’s foreign subsidiaries held ~~$62.1~~$93.7 million out of the Company's total ~~$338.5~~$268.3 million in cash and cash equivalents as of ~~June~~September 30, 2020. While the cash held by the Company’s foreign subsidiaries is primarily used to fund their operations, the Company regularly assesses its global cash needs and the available sources of cash to fund these needs, which regularly includes repatriating foreign-held cash to settle historical intercompany loans and other intercompany payables. The Company believes that it has and will have sufficient liquidity to meet its cash needs for at least the next 12 months based upon the cash generated by its operations, cash on hand (which as of ~~June~~September 30, 2020 included approximately ~~$276.4~~$175.0 million of proceeds remaining from the 2020 BrandCo Refinancing Transactions), availability under the Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility, as well as other permissible borrowings, along with the option to further settle historical intercompany loans and payables with certain foreign subsidiaries. The Company also expects to generate additional liquidity from cost reductions resulting from the implementation of the Revlon 2020 Restructuring Program, which was initiated during the first quarter of 2020, the 2018 Optimization Program and cost reductions generated from other cost control initiatives, including, without limitation, new interim measures to reduce costs in response to COVID-19 (such as: (i) switching to a reduced work week and reducing executive and employee compensation in the range of 20% to 40%; (ii) furloughing approximately 40% of the Company’s U.S.-based employees and those in certain other locations; (iii) suspending the Company’s 2020 merit base salary increases, discretionary profit sharing contributions and matching contributions to the Company’s 401(k) plan; (iv) reducing Board and committee compensation by 50% and eliminating Board and committee meeting fees; and (v) suspending or terminating services and payments under consulting agreements with certain directors), as well as funds provided by selling certain assets (such as the Natural Honey and Floid brands that were sold in December 2019) in connection with the Company's ongoing Strategic Review. For information regarding certain risks related to the Company’s indebtedness, see Item 1A. “Risk Factors” in the Company's 2019 Form ~~10-K.~~10-K, as supplemented by certain risk factors included

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

in the Company’s Quarterly Reports on Form 10-Q and in certain Current Reports on Form 8-K, in each case as filed with the SEC during 2020.

8. FAIR VALUE MEASUREMENTS

Assets and liabilities are required to be categorized into three levels of fair value based upon the assumptions used to value the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3, if applicable, generally would require significant management judgment. The three levels for categorizing the fair value measurement of assets and liabilities are as follows:

•Level 1: Fair valuing the asset or liability using observable inputs, such as quoted prices in active markets for identical assets or liabilities;

•Level 2: Fair valuing the asset or liability using inputs other than quoted prices that are observable for the applicable asset or liability, either directly or indirectly, such as quoted prices for similar (as opposed to identical) assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and

•Level 3: Fair valuing the asset or liability using unobservable inputs that reflect the Company’s own assumptions regarding the applicable asset or liability.

As of both ~~June~~September 30, 2020 and December 31, 2019, the Company did 0t have any financial assets and liabilities that were required to be measured at fair value.

As of ~~June~~September 30, 2020, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


		June 30, 2020																			September 30, 2020
		Fair Value																	Fair Value
		Level 1		Level 2		Level 3		Total		Carrying Value			Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:	Liabilities:											Liabilities:
Long-term debt, including current portion^(a)	Long-term debt, including current portion^(a)	$	—	$	2,250.2	$	—	$	2,250.2	$	3,624.1	Long-term debt, including current portion(a)	$	0	$	2,068.4	$	0	$	2,068.4	$	3,631.0

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

As of December 31, 2019, the fair value and carrying value of the Company’s long-term debt, including the current portion of long-term debt, are categorized in the table below:


		December 31, 2019																			December 31, 2019
		Fair Value																	Fair Value
		Level 1		Level 2		Level 3		Total		Carrying Value			Level 1		Level 2		Level 3		Total		Carrying Value
Liabilities:	Liabilities:											Liabilities:
Long-term debt, including current portion^(a)	Long-term debt, including current portion^(a)	$	—	$	2,522.2	$	—	$	2,522.2	$	3,194.2	Long-term debt, including current portion(a)	$	0	$	2,522.2	$	0	$	2,522.2	$	3,194.2

^(a)The fair value of the Company's long-term debt, including the current portion of long-term debt, is based on quoted market prices for similar issuances and maturities.

The carrying amounts of the Company's cash and cash equivalents, trade receivables, notes receivable, accounts payable and short-term borrowings approximate their respective fair values.

9. FINANCIAL INSTRUMENTS

Letters of Credit

Products Corporation maintains standby and trade letters of credit for various corporate purposes under which Products Corporation is obligated, of which ~~$7.7~~$1.4 million and $11.4 million (including amounts available under credit agreements in effect at that time) were maintained as of ~~June~~September 30, 2020 and December 31, 2019, respectively. Included in these amounts are approximately ~~$5.3~~$0.1 million and $8.3 million in standby letters of credit that primarily support Products Corporation’s workers compensation, general liability and automobile insurance programs, in each case as outstanding as of ~~June~~September 30, 2020 and December 31, 2019, respectively. The estimated liability under such programs is accrued by Products Corporation.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

10. PENSION AND POST-RETIREMENT BENEFITS

Net Periodic Benefit Cost

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the three months ended ~~June~~September 30, 2020 and 2019, respectively, were as follows:


		Pension Plans						Other Post-Retirement Benefit Plans							Pension Plans				Other Post-Retirement Benefit Plans
		Three Months Ended June 30,															Three Months Ended September 30,
		2020		2019		2020		2019			2020		2019		2020		2019
Net periodic benefit costs:	Net periodic benefit costs:									Net periodic benefit costs:
Service cost	Service cost	$	0.4	$	0.5	$	—	$	—	Service cost	$	0.5	$	0.4	$	0	$	0
Interest cost	Interest cost	3.7		5.0		0.1		0.1		Interest cost	3.8		5.1		0.1		0.1
Expected return on plan assets	Expected return on plan assets	(5.6)		(6.0)		—		—		Expected return on plan assets	(5.7)		(6.0)		0		0
Amortization of actuarial loss	Amortization of actuarial loss	2.9		2.6		0.1		—		Amortization of actuarial loss	2.7		2.5		0.1		0.1

Total net periodic benefit costs prior to allocation	Total net periodic benefit costs prior to allocation	$	1.4	$	2.1	$	0.2	$	0.1	Total net periodic benefit costs prior to allocation	$	1.3	$	2.0	$	0.2	$	0.2
Portion allocated to Revlon Holdings	Portion allocated to Revlon Holdings	(0.1)		(0.1)		—		—		Portion allocated to Revlon Holdings	0		0		0		0
Total net periodic benefit costs	Total net periodic benefit costs	$	1.3	$	2.0	$	0.2	$	0.1	Total net periodic benefit costs	$	1.3	$	2.0	$	0.2	$	0.2

In the three months ended ~~June~~September 30, 2020, the Company recognized net periodic benefit cost of $1.5 million, compared to net periodic benefit cost of ~~$2.1~~$2.2 million in the three months ended ~~June~~September 30, 2019, primarily due to lower interest costs partially offset by lower expected return on plan assets and higher amortization of actuarial loss.

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

The components of net periodic benefit costs for the Company's pension and the other post-retirement benefit plans for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively, were as follows:


		Pension Plans						Other Post-Retirement Benefit Plans							Pension Plans				Other Post-Retirement Benefit Plans
		Six Months Ended June 30,															Nine Months Ended September 30,
		2020		2019		2020		2019			2020		2019		2020		2019
Net periodic benefit costs:	Net periodic benefit costs:									Net periodic benefit costs:
Service cost	Service cost	$	0.8	$	1.0	$	—	$	—	Service cost	$	1.3	$	1.4	$	0	$	0
Interest cost	Interest cost	7.4		9.9		0.2		0.2		Interest cost	11.2		15.0		0.3		0.3
Expected return on plan assets	Expected return on plan assets	(11.4)		(12.0)		—		—		Expected return on plan assets	(17.1)		(18.0)		0		0
Amortization of actuarial loss	Amortization of actuarial loss	5.6		5.0		0.2		0.1		Amortization of actuarial loss	8.3		7.5		0.3		0.2

Total net periodic benefit costs prior to allocation	Total net periodic benefit costs prior to allocation	$	2.4	$	3.9	$	0.4	$	0.3	Total net periodic benefit costs prior to allocation	$	3.7	$	5.9	$	0.6	$	0.5
Portion allocated to Revlon Holdings	Portion allocated to Revlon Holdings	(0.1)		(0.1)		—		—		Portion allocated to Revlon Holdings	(0.1)		(0.1)		0		0
Total net periodic benefit costs	Total net periodic benefit costs	$	2.3	$	3.8	$	0.4	$	0.3	Total net periodic benefit costs	$	3.6	$	5.8	$	0.6	$	0.5

In the ~~six~~nine months ended ~~June~~September 30, 2020, the Company recognized net periodic benefit cost of ~~$2.7~~$4.2 million, compared to net periodic benefit cost of ~~$4.1~~$6.3 million in the ~~six~~nine months ended ~~June~~September 30, 2019, primarily due to lower interest costs partially offset by lower expected return on plan assets and higher amortization of actuarial loss.

Net periodic benefit costs are reflected in the Company's Unaudited Consolidated Financial Statements as follows for the periods presented:


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended September 30,				Nine Months Ended September 30,
		2020		2019		2020		2019			2020		2019		2020		2019
Net periodic benefit costs:	Net periodic benefit costs:									Net periodic benefit costs:

Selling, general and administrative expense	Selling, general and administrative expense	$	0.4	$	0.4	$	0.8	$	0.9	Selling, general and administrative expense	$	0.5	$	0.5	$	1.3	$	1.4
Miscellaneous, net	Miscellaneous, net	1.1		1.7		1.9		3.2		Miscellaneous, net	1.0		1.7		2.9		4.9
Total net periodic benefit costs	Total net periodic benefit costs	$	1.5	$	2.1	$	2.7	$	4.1	Total net periodic benefit costs	$	1.5	$	2.2	$	4.2	$	6.3

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

The Company expects that it will have net periodic benefit cost of approximately ~~$5.5~~$5.6 million for its pension and other post-retirement benefit plans for all of 2020, compared with net periodic benefit cost of $7.2 million in 2019.

Contributions:

The Company’s intent is to fund at least the minimum contributions required to meet applicable federal employee benefit laws and local laws, or to directly pay benefit payments where appropriate. During the three months ended ~~June~~September 30, 2020, $1.8 million and ~~$0.1~~$0.2 million were contributed to the Company’s pension plans and other post-retirement benefit plans, respectively. During the ~~six~~nine months ended ~~June~~September 30, 2020, ~~$5.2~~$7.0 million and ~~$0.3~~$0.5 million were contributed to the Company’s pension plans and other post-retirement benefit plans, respectively. During 2020, the Company expects to contribute approximately $19 million in the aggregate to its pension and other post-retirement benefit plans.

As a result of the CARES Act passed by the U.S. Congress in March 2020 to address the economic environment resulting from COVID-19, and in accordance with the Limited Relief for Pension Funding and Retirement Plan Distributions provision of such act, the Company expects to defer approximately ~~$9.4~~$9.3 million of contributions that were otherwise scheduled to be paid to its 2 qualified pension plans at different earlier dates during 2020. The first quarterly contributions for the 2 qualified plans were originally due by April 15, 2020. The Company had already made $1.6 million in contributions to its qualified pension plans during the first quarter of 2020, prior to adopting the aforementioned provision of the CARES Act. The deferral is in effect only for 2020 and under the CARES relief provisions the Company will be required to pay the contributions by no later than January 1, 2021, including interest at the plans’ 2020 effective interest rate ("EIR") from the original due date to the actual payment date.

Relevant aspects of the qualified defined benefit pension plans, non-qualified pension plans and other post-retirement benefit plans sponsored by Products Corporation are disclosed in Note 12, "Pension and Post-Retirement Benefits," to the Consolidated Financial Statements in the Company's 2019 Form 10-K.

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

11. STOCK COMPENSATION PLAN

Revlon maintains the Fourth Amended and Restated Revlon, Inc. Stock Plan (as amended, the "Stock Plan"), which provides for awards of stock options, stock appreciation rights, restricted or unrestricted stock and restricted stock units ("RSUs") to eligible employees and directors of Revlon and its affiliates, including Products Corporation. An aggregate of 6,565,000 shares were reserved for issuance as Awards under the Stock Plan, of which there remained approximately ~~1.1~~1.2 million shares available for grant as of ~~June~~September 30, 2020. In July 2014, the Stock Plan was amended to renew the Stock Plan for a 7-year renewal term expiring on April 14, 2021. In September 2019 the Stock Plan was amended in connection with the 2019 TIP, described below, to: (1) allow the Compensation Committee to delegate to Revlon’s Chief Executive Officer the authority to grant RSUs to the Company’s employees, other than its officers who are subject to Section 16 of the Securities Exchange Act of 1934, as amended (i.e., the Company’s Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer & Controller); (2) allow for accelerated vesting of equity awards upon a termination without cause; (3) change the minimum vesting period for specified equity awards from 3 years to 2 years; and (4) to increase by 250,000 shares the number of shares of Revlon common stock that are not subject to the Stock Plan’s minimum vesting requirements.

Revlon 2019 Transaction Incentive Program

In August 2019, it was disclosed that MacAndrews & Forbes and Revlon determined to explore strategic transactions involving Revlon and third parties (the "Strategic Review"). In light of this, the Compensation Committee of Revlon’s Board of Directors approved a Revlon 2019 Transaction Incentive Program (the “2019 TIP”) that enables the Company to award cash-based and RSU-based retention grants and transaction bonus awards, as well as providing for the accelerated vesting of time-based RSUs and restricted shares following a termination without cause or due to death or disability.

Each Tier 1 participant’s 2019 TIP award is payable two-thirds in cash and one-third in RSUs vesting in 50% tranches on each of December 31, 2020 and December 31, 2021, while Tier 2 awards are payable 100% in cash in one lump-sum on December 31, 2020, in each case subject to certain earlier vesting for a change of control or termination of employment without cause, as described below. As of September 5, 2019, the Company approved a total of 206,812 time-based RSUs under Tier 1 of the 2019 TIP, which are scheduled to vest in equivalent amounts on each of December 31, 2020 and December 31, 2021, subject to continued employment (the “2019 TIP RSUs”). As of ~~June~~September 30, 2020, a total of ~~153,739~~148,168 time-based RSUs under Tier 1 of the 2019 TIP had been granted and are outstanding. The Company’s President and Chief Executive Officer declined an award under the retention program and will receive a transaction bonus only if the Company completes a transaction.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

The 2019 TIP RSUs vest in full upon an involuntary termination, other than if due to cause; provided that if a change of control occurs or a brand or business segment is sold and (i) the impacted grantee accepts an offer of employment from the buyer, then: (A) if the buyer assumes the 2019 TIP RSUs, the grantee will continue to vest in the assumed awards (with the grantee having the continued right to accelerated vesting upon an involuntary termination, other than if due to cause); and (B) if the buyer does not assume the 2019 TIP RSUs, the grantee’s 2019 TIP RSUs will vest upon closing the change of control; and (ii) the impacted grantee declines an offer of employment from the buyer for substantially comparable total compensation and benefits, the grantee will forfeit their unvested 2019 TIP RSUs (collectively, the “Special Vesting Rules”).

The 2019 TIP also provides for the following cash-based awards payable to certain employees, subject to continued employment through the respective vesting dates: (i) Tier 1 - $6.8 million payable in 2 equal installments as of December 31, 2020 and December 31, 2021; and (ii) Tier 2 - $2.5 million payable in 1 installment as of December 31, 2020. Such cash-based awards follow the Special Vesting Rules following a termination without cause or due to death or disability. During 2019 and through ~~June~~September 30, 2020, the Company granted ~~$4.9~~$4.7 million and ~~$2.4~~$2.3 million cash-based awards, net of forfeitures, under Tier 1 and Tier 2 of the 2019 TIP, respectively, which are being amortized over the period from the grant dates to December 31, 2021 and December 31, 2020, respectively. The total amount amortized for these cash-based awards since the program's inception and through ~~June~~September 30, 2020 is approximately ~~$3.8~~$4.8 million, of which ~~$1.1~~$1.0 million and ~~$2.6~~$3.5 million were recorded during the three and ~~six~~nine months ended ~~June~~September 30, 2020, respectively, within "Acquisition, integration and divestiture costs" in the Company's Unaudited Consolidated Statements of Operations and Comprehensive Loss.

Long-Term Incentive Program

The Company's LTIP RSUs consist of time-based RSUs and performance-based RSUs. Time-based RSUs are generally scheduled to vest ratably over a 3-year service period, while performance-based RSUs are scheduled to vest based on the achievement of certain Company performance metrics and cliff-vest at the completion of a 3-year performance period.

The fair value of the LTIP and TIP RSUs is determined based on the NYSE closing share price on the grant date.

In connection with the announcement of the 2019 TIP, in August 2019 the Company also approved applying the Special Vesting Rules to outstanding, pre-existing LTIP RSUs, except that accelerated vesting in the case of termination of employment

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

without cause will apply only to any tranche of outstanding, pre-existing LTIP RSUs scheduled to vest in the 12-month period following termination, with any future tranches being forfeited. Prior to the approval of these Special Vesting Rules, while the outstanding, pre-existing LTIP RSUs would generally have accelerated vesting upon a change of control, they did not feature accelerated vesting for termination and, in such cases, they were entirely forfeited upon termination.

During the first quarter of 2020, the Company granted approximately 1.3 million time-based and performance-based RSU awards under the Stock Plan (the "2020 LTIP RSUs"). During the second and third quarter of 2020, there were 0 grants under the 2020 LTIP RSUs. See the roll-forward table in the following sections of this Note 11 for activity related to the ~~six~~nine months ended ~~June~~September 30, 2020.

Acceleration of Vesting

Under the aforementioned provisions for acceleration of vesting, as of ~~June~~September 30, 2020 and since the time these provisions became effective in September 2019, ~~30,781~~36,452 LTIP RSUs and ~~22,798~~27,356 2019 TIP Tier 1 RSUs were vested on an accelerated basis due to involuntary terminations, resulting in accelerated amortization of approximately ~~$1.0~~$1.2 million. In addition, for the three and ~~six~~nine months ended ~~June~~September 30, 2020 and under the same accelerated vesting provisions, the Company also recorded approximately ~~$0.1~~$0.2 million and ~~$0.8~~$1.0 million of accelerated amortization in connection with the cash portion of the 2019 TIP Tier 1 and Tier 2 awards that were vested on an accelerated basis due to involuntary terminations. See the roll-forward table in the following sections of this Note 11 for activity related to the ~~six~~nine months ended ~~June~~September 30, 2020.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

During the ~~six~~nine months ended ~~June~~September 30, 2020, the activity related to time-based and performance-based RSUs previously granted to eligible employees and the grant date fair value per share related to these RSUs were as follows under the LTIP and 2019 TIP programs, respectively:


		Time-Based LTIP			Performance-Based LTIP				Time-Based LTIP		Performance-Based LTIP
		RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU	RSUs (000's)		Weighted-Average Grant Date Fair Value per RSU		RSUs (000's)	Weighted-Average Grant Date Fair Value per RSU	RSUs (000's)		Weighted-Average Grant Date Fair Value per RSU
Outstanding as of December 31, 2019	Outstanding as of December 31, 2019						Outstanding as of December 31, 2019
2019 TIP RSUs ^(b)	2019 TIP RSUs ^(b)	200.6	16.44	n/a		—	2019 TIP RSUs (b)	200.6	16.44	n/a		—
LTIP RSUs:	LTIP RSUs:						LTIP RSUs:
2019	2019	425.6	22.55	425.6		22.55	2019	425.6	22.55	425.6		22.55
2018	2018	241.9	19.00	364.7		19.00	2018	241.9	19.00	364.7		19.00
2017 ^(a)	2017 ^(a)	54.0	19.70	110.9		19.70	2017 (a)	54.0	19.70	110.9		19.70
Total LTIP RSUs	Total LTIP RSUs	721.5		901.2			Total LTIP RSUs	721.5		901.2
Total LTIP and TIP RSUs Outstanding as of December 31, 2019	Total LTIP and TIP RSUs Outstanding as of December 31, 2019	922.1		901.2			Total LTIP and TIP RSUs Outstanding as of December 31, 2019	922.1		901.2
Granted	Granted						Granted
2019 TIP RSUs Granted ^(b)	2019 TIP RSUs Granted ^(b)	11.7	10.24	n/a		—	2019 TIP RSUs Granted (b)	11.7	10.24	n/a		—
LTIP RSUs:	LTIP RSUs:						LTIP RSUs:
2020	2020	648.4	14.96	648.4		14.96	2020	626.6	14.96	626.7		14.96
2019	2019	—	—	—		—	2019	0	0	0		0
2018	2018	—	—	—		—	2018	0	0	0		0
2017 ^(a)	2017 ^(a)	—	—	—		—	2017 (a)	0	0	0		0
Total LTIP RSUs Granted	Total LTIP RSUs Granted	648.4		648.4			Total LTIP RSUs Granted	626.6		626.7
Vested	Vested						Vested
2019 TIP RSUs Vested ^(b)(c)	2019 TIP RSUs Vested ^(b)(c)	(22.8)	16.44	n/a		—	2019 TIP RSUs Vested (b)(c)	(27.3)	16.44	—		—
LTIP RSUs:	LTIP RSUs:						LTIP RSUs:
2019^(c)	2019^(c)	(131.0)	22.55	—		—	2019 (c)	(133.9)	22.55	0		0
2018^(c)	2018^(c)	(105.6)	19.31	—		—	2018 (c)	(108.5)	19.32	0		0
2017 ^(a)(c)	2017 ^(a)(c)	(53.4)	19.70	(14.2)		19.70	2017 (a)(c)	(53.4)	19.70	(14.2)		19.70
Total LTIP RSUs Vested	Total LTIP RSUs Vested	(290.0)		(14.2)			Total LTIP RSUs Vested	(295.8)		(14.2)
Forfeited/Canceled	Forfeited/Canceled						Forfeited/Canceled
2019 TIP RSUs Forfeited/Canceled ^(b)	2019 TIP RSUs Forfeited/Canceled ^(b)	(35.8)	16.44	n/a		—	2019 TIP RSUs Forfeited/Canceled (b)	(36.8)	16.44	n/a		—
LTIP RSUs:	LTIP RSUs:						LTIP RSUs:
2019	2019	(79.8)	22.55	(102.5)		22.55	2019	(83.3)	22.55	(112.1)		22.55
2018	2018	(49.0)	17.56	(101.4)		17.87	2018	(49.0)	17.56	(110.0)		17.97
2017 ^(a)	2017 ^(a)	(0.6)	19.70	(96.7)		19.70	2017 (a)	(0.6)	19.70	(96.7)		19.70
Total LTIP RSUs Forfeited/Canceled	Total LTIP RSUs Forfeited/Canceled	(129.4)		(300.6)			Total LTIP RSUs Forfeited/Canceled	(132.9)		(318.8)
Outstanding as of June 30, 2020
Outstanding as of September 30, 2020							Outstanding as of September 30, 2020
2019 TIP RSUs	2019 TIP RSUs	153.7	15.97	n/a		—	2019 TIP RSUs	148.2	15.95	n/a		—
LTIP RSUs:	LTIP RSUs:						LTIP RSUs:
2020	2020	648.4	14.96	648.4		14.96	2020	626.6	14.96	626.7		14.96
2019	2019	214.8	22.55	323.1		22.55	2019	208.4	22.55	313.5		22.55
2018	2018	87.3	19.44	263.3		19.44	2018	84.4	19.43	254.7		19.45
2017 ^(a)	2017 ^(a)	—	—	—		—	2017 (a)	0	0	0		0
Total LTIP RSUs	Total LTIP RSUs	950.5		1,234.8			Total LTIP RSUs	919.4		1,194.9
Total LTIP and TIP RSUs Outstanding as of June 30, 2020		1,104.2		1,234.8
Total LTIP and TIP RSUs Outstanding as of September 30, 2020							Total LTIP and TIP RSUs Outstanding as of September 30, 2020	1,067.6		1,194.9

^(a)The 2017 time-based and performance-based LTIP RSUs were recognized over a 2-year service and performance period (i.e., 2018 and 2019).

^(b) The 2019 TIP provides for RSU awards that are only time-based.

^(c) Includes acceleration of vesting upon involuntary terminations for the ~~six~~nine months ended ~~June~~September 30, 2020 of ~~25,321~~30,992 RSUs under the 2019 ~~2018~~ and ~~2017~~2018 LTIPs and of ~~22,798~~27,356 RSUs under the 2019 TIP Tier I awards.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Time-Based LTIP and TIP RSUs

The Company recognized $2.1 million and ~~$3.8~~$5.9 million of net compensation expense related to the time-based LTIP and TIP RSUs for the three and ~~six~~nine months ended ~~June~~September 30, 2020, respectively. As of ~~June~~September 30, 2020, the Company had ~~$15.5~~$12.8 million of total deferred compensation expense related to non-vested, time-based LTIP and TIP RSUs. The cost is recognized over the vesting period of the awards, as described above.

Performance-based LTIP RSUs

The Company recognized ~~$1.5~~$2.5 million and ~~$1.2~~$1.3 million of net ~~adjustments to~~ compensation expense related to the performance-based LTIP RSUs for the three and ~~six~~nine months ended ~~June~~September 30, 2020, respectively. The amount of net compensation expense recognized during the nine months ended September 30, 2020 was affected by adjustments to the awards' expected achievement rates made primarily as a result of the ongoing adverse impact of COVID-19 on the Company's results of operations. As of ~~June~~September 30, 2020, the Company had ~~$21.9~~$18.9 million of total deferred compensation expense related to non-vested, performance-based LTIP RSUs. The cost is recognized over the service period of the awards, as described above.

12. INCOME TAXES

The Company's provision for income taxes represents federal, foreign, state and local income taxes. The Company’s tax provision changes quarterly based on various factors including, but not limited to, the geographical level and mix of earnings; enacted tax legislation; foreign, state and local income taxes; tax audit settlements; and the interaction of various global tax strategies.

For the three and ~~six~~nine months ended ~~June~~September 30, 2020, the Company concluded that the use of the cut-off tax rate method was more appropriate than the annual effective tax rate method, because the annual effective tax rate method would not be reliable due to its sensitivity to minimal changes in forecasted annual pre-tax earnings.

The Company recorded a provision for income taxes of $1.9 million (Products Corporation - provision for income taxes of $2.3 million) for the three months ended September 30, 2020 and a benefit from income taxes of ~~$9.9~~$2.1 million (Products Corporation - benefit from income taxes of ~~$9.6~~$1.8 million) for the three months ended ~~June 30, 2020 and a benefit from income taxes of $1.2 million (Products Corporation - benefit from income taxes of $0.9 million) for the three months ended June~~September 30, 2019, respectively. The ~~$8.7~~$4.0 million ~~increase~~decrease (Products Corporation - ~~$8.7~~$4.1 million) in the benefit from income taxes in the three months ended ~~June~~September 30, 2020, compared to the three months ended ~~June~~September 30, 2019, was primarily due to: (i) the ~~increased loss from continuing operations before income taxes on which the tax benefit is recognized; (ii) the~~ mix and level of earnings; ~~and (iii) a reduction~~(ii) an increase in the U.S. tax on the Company's foreign ~~earnings,~~earnings; and (iii) increased tax expense from return to provision adjustments, partially offset primarily by an increase in tax ~~expense related to uncertain tax positions and by~~benefit from the net change in valuation allowances ~~recorded~~ related to ~~increased net~~the recognition of previously unrecognized tax losses in ~~certain state jurisdictions.~~Canada.

The Company recorded a benefit from income taxes of ~~$47.1~~$45.2 million (Products Corporation - benefit from income taxes of ~~$46.5~~$44.2 million) for the ~~six~~nine months ended ~~June~~September 30, 2020 and a benefit from income taxes of ~~$1.1~~$3.2 million (Products Corporation - benefit from income taxes of ~~$0.6~~$2.4 million) for the ~~six~~nine months ended ~~June~~September 30, 2019, respectively. The ~~$46.0~~$42.0 million increase (Products Corporation - ~~$45.9~~$41.8 million) in the benefit from income taxes in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the ~~six~~nine months ended ~~June~~September 30, 2019, was primarily due to: (i) the increased loss from continuing operations before income taxes on which the tax benefit is recognized; (ii) the mix and level of earnings; and (iii) a reduction in the U.S. tax on the Company's foreign earnings, net of the impact of non-deductible impairment charges, partially offset by the net change in valuation allowances recorded related to the limitation on the deductibility of interest.

The Company's effective tax rate for the three ~~and six~~ months ended ~~June~~September 30, 2020 was lower than the federal statutory rate of 21% primarily due the mix and level of earnings and the change in valuation allowance related to the limitation on the deductibility of interest. The Company's effective tax rate for the nine months ended September 30, 2020 was lower than the federal statutory rate of 21% primarily due to the impact of non-deductible impairment charges and the valuation allowance related to the limitation on the deductibility of interest, partially offset by the impact of the "Coronavirus Aid, Relief and Economic Security Act" (the "CARES Act"), signed into law on March 27, 2020 by President Trump, which resulted in a partial release of a valuation allowance on the Company's 2019 federal tax attributes associated with the limitation on the deductibility of interest.

The Company's effective tax rate for the three and six months ended June 30, 2019 was lower than the federal statutory rate of 21%, primarily due to the valuation allowance related to the limitation on the deductibility of interest and the U.S. tax on the Company's foreign earnings.

The CARES Act, among other things, includes provisions providing for refundable payroll tax credits, the deferral of employer social security tax payments, acceleration of alternative minimum tax credit refunds and the increase of the net interest deduction limitation from 30% to 50%. The Company continues to examine the impact that the CARES Act may have on its results of operations, financial condition and/or financial statement disclosures.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

The Company's effective tax rate for the three months and nine months ended September 30, 2019 was lower than the federal statutory rate of 21%, primarily due to the valuation allowance related to the limitation on the deductibility of interest and the U.S. tax on the Company's foreign earnings.

The Company expects that its tax provision and effective tax rate in any individual quarter and year-to-date period will vary and may not be indicative of the Company's tax provision and effective tax rate for the full year.

In assessing the recoverability of its deferred tax assets, the Company continually evaluates ~~the~~all available positive and negative evidence to assess the amount of deferred tax assets for which it is more likely than not to realize a benefit. For any deferred tax asset in excess of the amount for which it is more likely than not that the Company will realize a benefit, the Company establishes a valuation allowance. A valuation allowance is a non-cash charge, and it in no way limits the Company's ability to utilize its deferred tax assets, including its ability to utilize tax loss and credit carryforward amounts.

As of ~~June~~September 30, 2020, the Company concluded that, based on its evaluation of objectively verifiable evidence, it does not require a valuation allowance on its federal deferred tax assets, other than those associated with the limitation on the deductibility of interest. The Company does have a valuation allowance on deferred tax assets associated with its activity in certain U.S. states and foreign jurisdictions. These conclusions regarding the establishment of valuation allowances on the Company's deferred tax assets as of the end of the ~~second~~third quarter of 2020 are consistent with the Company's conclusions on such matters as compared to prior quarters. The key assumptions used to determine positive and negative evidence included the Company’s cumulative taxable loss for the past three years, future reversals of existing taxable temporary differences, the Company's cost reduction initiatives and other efficiency efforts, as well as certain assumptions regarding COVID-19's expected impact on the Company. Potential negative evidence, including, among other things, any further worsening of the economies in the jurisdictions in which the Company operates and any future reduced profitability in such jurisdictions could result in additional valuation allowances which would reduce the Company's future deferred tax assets. In such event, the Company's tax expense would likely materially increase in the period the valuation allowance is recognized and adversely impact the Company's results of operations and statement of financial condition in such period. The Company will continue to monitor the circumstances that would require it to establish an additional valuation allowance on its deferred tax assets. Accordingly, depending on future evidence that may become available, the Company's assessments regarding its valuation allowance position may change.

For further information, see Note 14, "Income Taxes," to the Consolidated Financial Statements in the Company's 2019 Form 10-K and Item 1A. “Risk Factors-Uncertainties in the interpretation and application of the U.S. income tax provisions could have a material impact on the Company's financial condition, results of operations and/or cash flows” in the Company's 2019 Form 10-K.

13. ACCUMULATED OTHER COMPREHENSIVE LOSS

A roll-forward of the Company's accumulated other comprehensive loss as of ~~June~~September 30, 2020 is as follows:


		Foreign Currency Translation		Actuarial (Loss) Gain on Post-retirement Benefits		Other		Accumulated Other Comprehensive Loss			Foreign Currency Translation		Actuarial (Loss) Gain on Post-retirement Benefits		Other		Accumulated Other Comprehensive Loss

Balance at January 1, 2020	Balance at January 1, 2020	$	(27.3)	$	(219.8)	$	(0.3)	$	(247.4)	Balance at January 1, 2020	$	(27.3)	$	(219.8)	$	(0.3)	$	(247.4)
Foreign currency translation adjustment	Foreign currency translation adjustment	5.1		—		—		5.1		Foreign currency translation adjustment	7.3		—		—		7.3
Amortization of pension related costs, net of tax of $1.2 million^(a)		—		6.5		—		6.5
Amortization of pension related costs, net of tax of $0.7 million(a)										Amortization of pension related costs, net of tax of $0.7 million(a)	—		9.3		—		9.3

Other comprehensive (loss) gain	Other comprehensive (loss) gain	$	5.1	$	6.5	$	—	$	11.6	Other comprehensive (loss) gain	$	7.3	$	9.3	$	0	$	16.6
Balance at June 30, 2020		$	(22.2)	$	(213.3)	$	(0.3)	$	(235.8)
Balance at September 30, 2020										Balance at September 30, 2020	$	(20.0)	$	(210.5)	$	(0.3)	$	(230.8)

^(a)Amounts represent the change in accumulated other comprehensive loss as a result of the amortization of actuarial losses (gains) arising during each year related to the Company’s pension and other post-retirement plans. See Note 10, "Pension and Post-retirement Benefits," for further information on the Company’s pension and other post-retirement plans.

For the three and ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, the Company did not have any activity related to financial instruments.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

14. SEGMENT DATA AND RELATED INFORMATION

Operating Segments

Operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the Company's "Chief Executive Officer") in deciding how to allocate resources and in assessing the Company's performance. As a result of the similarities in the procurement,

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

manufacturing and distribution processes for the Company’s products, much of the information provided in the Unaudited Consolidated Financial Statements and provided in the segment table below is similar to, or the same as, that reviewed on a regular basis by the Company's Chief Executive Officer.

As of ~~June~~September 30, 2020, the Company’s operations are organized into the following reportable segments:

•Revlon - The Revlon segment is comprised of the Company's flagship Revlon brands. Revlon segment products are primarily marketed, distributed and sold in the mass retail channel, large volume retailers, chain drug and food stores, chemist shops, hypermarkets, general merchandise stores, e-commerce sites, television shopping, department stores, professional hair and nail salons, one-stop shopping beauty retailers and specialty cosmetic stores in the U.S. and internationally under brands such as Revlon in color cosmetics; Revlon ColorSilk and Revlon Professional in hair color; and Revlon in beauty tools.

•Elizabeth Arden - The Elizabeth Arden segment is comprised of the Company's Elizabeth Arden branded products. The Elizabeth Arden segment markets, distributes and sells fragrances, skin care and color cosmetics primarily to prestige retailers, department and specialty stores, perfumeries, boutiques, e-commerce sites, the mass retail channel, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and elizabetharden.com e-commerce website, in the U.S. and internationally, under brands such as Elizabeth Arden Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference and Skin Illuminating in the Elizabeth Arden skin care brands; and Elizabeth Arden White Tea, Elizabeth Arden Red Door, Elizabeth Arden 5th Avenue and Elizabeth Arden Green Tea in Elizabeth Arden fragrances.

•Portfolio - The Company’s Portfolio segment markets, distributes and sells a comprehensive line of premium, specialty and mass products primarily to the mass retail channel, hair and nail salons and professional salon distributors in the U.S. and internationally and large volume retailers, specialty and department stores under brands such as Almay and SinfulColors in color cosmetics; American Crew in men's grooming products (which are also sold direct-to-consumer on its americancrew.com website); CND in nail polishes, gel nail color and nail enhancements; Cutex nail care products; and Mitchum in anti-perspirant deodorants. The Portfolio segment also includes a multi-cultural hair care line consisting of Creme of Nature hair care products, which are sold in both professional salons and in large volume retailers and other retailers, primarily in the U.S.; and a hair color line under the Llongueras brand (licensed from a third party) that is sold in the mass retail channel, large volume retailers and other retailers, primarily in Spain.

•Fragrances - The Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances as well as the distribution of prestige fragrance brands owned by third parties. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers, specialty stores, e-commerce sites, the mass retail channel, travel retailers and other international retailers. The owned and licensed fragrances include brands such as: (i) Juicy Couture (which are also sold direct-to-consumer on its juicycouturebeauty.com website), John Varvatos and AllSaints in prestige fragrances; (ii) Britney Spears, Elizabeth Taylor, Christina Aguilera, Jennifer Aniston and Mariah Carey in celebrity fragrances; and (iii) Curve, Giorgio Beverly Hills, Ed Hardy, Charlie, Lucky Brand, ‹PS› (logo of former Paul Sebastian brand), Alfred Sung, Halston, Geoffrey Beene and White Diamonds in mass fragrances.

The Company's management evaluates segment profit for each of the Company's reportable segments. The Company allocates corporate expenses to each reportable segment to arrive at segment profit, and these expenses are included in the internal measure of segment operating performance. The Company defines segment profit as income from continuing operations before interest, taxes, depreciation, amortization, stock-based compensation expense, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt and miscellaneous expenses. Segment profit also excludes the impact of certain items that are not directly attributable to the reportable segments' underlying operating performance. Such items are shown below in the table reconciling segment profit to consolidated income from continuing operations before income taxes. The Company does not have any material inter-segment sales.

The accounting policies for each of the reportable segments are the same as those described in Note 1, "Description of Business and Summary of Significant Accounting Policies." The Company's assets and liabilities are managed centrally and

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

are reported internally in the same manner as the Unaudited Consolidated Financial Statements; thus, no additional information regarding assets and liabilities of the Company’s reportable segments is produced for the Company's Chief Executive Officer or included in these Unaudited Consolidated Financial Statements.

The following table is a comparative summary of the Company’s net sales and segment profit for Revlon and Products Corporation by reportable segment for the periods presented.

Revlon, Inc.




	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Segment Net Sales:
Revlon	$	166.0	$	217.3	$	482.8	$	716.1
Elizabeth Arden	106.3		123.2		282.4		352.0
Portfolio	99.6		118.2		298.1		354.1
Fragrances	105.2		138.1		214.4		298.0
Total	$	477.1	$	596.8	$	1,277.7	$	1,720.2

Segment Profit:
Revlon	$	13.5	$	7.3	$	41.4	$	58.5
Elizabeth Arden	3.4		12.5		18.4		17.1
Portfolio	12.2		14.4		33.9		25.0
Fragrances	25.4		34.2		34.6		53.6
Total	$	54.5	$	68.4	$	128.3	$	154.2

Reconciliation:
Total Segment Profit	$	54.5	$	68.4	$	128.3	$	154.2
Less:

Depreciation and amortization	35.1		38.9		108.3		124.6
Non-cash stock compensation expense	5.1		3.9		8.6		7.7
Non-Operating items:
Restructuring and related charges	4.5		5.4		61.2		27.4
Acquisition, integration and divestiture costs	0.9		0.1		4.2		0.7
Gain on divested assets	(1.1)		0		(0.5)		0
Financial control remediation and sustainability actions and related charges	0.7		3.4		8.5		9.8
Excessive coupon redemptions	0		0		4.2		0
COVID-19 charges	9.7		0		35.1		0


Capital structure and related charges	9.3		0		9.3		0
Impairment charges	0		0		144.1		0



Operating (loss) income	(9.7)		16.7		(254.7)		(16.0)
Less:
Interest Expense	68.7		50.2		178.0		145.7

Amortization of debt issuance costs	7.8		3.7		17.8		10.4

Gain on early extinguishment of debt	(31.2)		0		(43.1)		0
Foreign currency (gains) losses, net	(9.8)		7.6		9.1		9.0
Miscellaneous, net	(2.6)		1.7		13.9		7.6
Loss from continuing operations before income taxes	$	(42.6)	$	(46.5)	$	(430.4)	$	(188.7)

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

~~Revlon, Inc.~~

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Segment Net Sales:
Revlon $ 135.0 $ 251.5 $ 316.8 $ 498.8
Elizabeth Arden 80.9 117.4 176.1 228.8
Portfolio 88.5 118.7 198.5 235.9
Fragrances 43.2 82.6 109.2 159.9
Total $ 347.6 $ 570.2 $ 800.6 $ 1,123.4
Segment Profit:
Revlon $ 12.3 $ 25.6 $ 27.9 $ 51.2
Elizabeth Arden 10.8 2.7 15.0 4.6
Portfolio 14.5 6.1 21.7 10.6
Fragrances 7.8 12.6 9.2 19.4
Total $ 45.4 $ 47.0 $ 73.8 $ 85.8
Reconciliation:
Total Segment Profit $ 45.4 $ 47.0 $ 73.8 $ 85.8
Less:
Depreciation and amortization 36.4 38.7 73.2 85.7
Non-cash stock compensation expense 1.1 3.4 3.5 3.8
Non-Operating items:
Restructuring and related charges 22.3 9.9 56.7 22.0
Acquisition, integration and divestiture costs 1.2 — 3.3 0.6
(Gain) loss on divested assets (0.2) — 0.6 —
Financial control remediation and sustainability actions and related charges 5.7 4.4 7.8 6.4
Excessive coupon redemptions — — 4.2 —
COVID-19 charges 17.9 — 25.4 —
Impairment charges 19.8 — 144.1 —
Operating loss (58.8) (9.4) (245.0) (32.7)
Less:
Interest Expense 60.9 47.8 109.3 95.5
Amortization of debt issuance costs 6.0 3.5 10.0 6.7
(Gain) loss on early extinguishment of debt, net (11.9) — (11.9) —
Foreign currency losses, net 2.3 1.2 18.9 1.4
Miscellaneous, net 20.6 4.6 16.5 5.9
Loss from continuing operations before income taxes $ (136.7) $ (66.5) $ (387.8) $ (142.2)

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

Products Corporation


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended September 30,				Nine Months Ended September 30,
		2019		2018		2020		2019			2020		2019		2020		2019
Segment Net Sales:	Segment Net Sales:									Segment Net Sales:
Revlon	Revlon	$	135.0	$	251.5	$	316.8	$	498.8	Revlon	$	166.0	$	217.3	$	482.8	$	716.1
Elizabeth Arden	Elizabeth Arden	80.9		117.4		176.1		228.8		Elizabeth Arden	106.3		123.2		282.4		352.0
Portfolio	Portfolio	88.5		118.7		198.5		235.9		Portfolio	99.6		118.2		298.1		354.1
Fragrances	Fragrances	43.2		82.6		109.2		159.9		Fragrances	105.2		138.1		214.4		298.0
Total	Total	$	347.6	$	570.2	$	800.6	$	1,123.4	Total	$	477.1	$	596.8	$	1,277.7	$	1,720.2

Segment Profit:	Segment Profit:									Segment Profit:
Revlon	Revlon	$	13.0	$	26.3	$	29.4	$	52.7	Revlon	$	14.2	$	7.9	$	43.6	$	60.6
Elizabeth Arden	Elizabeth Arden	11.3		3.0		15.9		5.2		Elizabeth Arden	3.8		13.0		19.7		18.2
Portfolio	Portfolio	15.0		6.4		22.7		11.3		Portfolio	12.6		14.7		35.3		26.0
Fragrances	Fragrances	8.0		12.8		9.7		19.9		Fragrances	25.9		34.6		35.6		54.5
Total	Total	$	47.3	$	48.5	$	77.7	$	89.1	Total	$	56.5	$	70.2	$	134.2	$	159.3

Reconciliation:	Reconciliation:									Reconciliation:
Total Segment Profit	Total Segment Profit	$	47.3	$	48.5	$	77.7	$	89.1	Total Segment Profit	$	56.5	$	70.2	$	134.2	$	159.3
Less:	Less:									Less:

Depreciation and amortization	Depreciation and amortization	36.4		38.7		73.2		85.7		Depreciation and amortization	35.1		38.9		108.3		124.6
Non-cash stock compensation expense	Non-cash stock compensation expense	1.1		3.4		3.5		3.8		Non-cash stock compensation expense	5.1		3.9		8.6		7.7
Non-Operating items:	Non-Operating items:									Non-Operating items:
Restructuring and related charges	Restructuring and related charges	22.3		9.9		56.7		22.0		Restructuring and related charges	4.5		5.4		61.2		27.4
Acquisition, integration and divestiture costs	Acquisition, integration and divestiture costs	1.2		—		3.3		0.6		Acquisition, integration and divestiture costs	0.9		0.1		4.2		0.7
(Gain) loss on divested assets		(0.2)		—		0.6		—
Gain on divested assets										Gain on divested assets	(1.1)		0		(0.5)		0
Financial control remediation and sustainability actions and related charges	Financial control remediation and sustainability actions and related charges	5.7		4.4		7.8		6.4		Financial control remediation and sustainability actions and related charges	0.7		3.4		8.5		9.8

Excessive coupon redemptions	Excessive coupon redemptions	—		—		4.2		—		Excessive coupon redemptions	0		0		4.2		0
COVID-19 charges	COVID-19 charges	17.9		—		25.4		—		COVID-19 charges	9.7		0		35.1		0
Capital structure and related charges										Capital structure and related charges	9.3		0		9.3		0
Impairment charge	Impairment charge	19.8		—		144.1		—		Impairment charge	0		0		144.1		0

Operating income (loss)		(56.9)		(7.9)		(241.1)		(29.4)
Operating (loss) income										Operating (loss) income	(7.7)		18.5		(248.8)		(10.9)
Less:	Less:									Less:
Interest Expense	Interest Expense	60.9		47.8		109.3		95.5		Interest Expense	68.7		50.2		178.0		145.7

Amortization of debt issuance costs	Amortization of debt issuance costs	6.0		3.5		10.0		6.7		Amortization of debt issuance costs	7.8		3.7		17.8		10.4

(Gain) loss on early extinguishment of debt, net		(11.9)		—		(11.9)		—
Foreign currency losses, net		2.3		1.2		18.9		1.4
Gain on early extinguishment of debt										Gain on early extinguishment of debt	(31.2)		0		(43.1)		0
Foreign currency (gains) losses, net										Foreign currency (gains) losses, net	(9.8)		7.6		9.1		9.0
Miscellaneous, net	Miscellaneous, net	20.6		4.6		16.5		5.9		Miscellaneous, net	(2.6)		1.7		13.9		7.6
Loss from continuing operations before income taxes	Loss from continuing operations before income taxes	$	(134.8)	$	(65.0)	$	(383.9)	$	(138.9)	Loss from continuing operations before income taxes	$	(40.6)	$	(44.7)	$	(424.5)	$	(183.6)

As of ~~June~~September 30, 2020, the Company had operations established in approximately 25 countries outside of the U.S. and its products are sold throughout the world. Generally, net sales by geographic area are presented by attributing revenues from external customers on the basis of where the products are sold.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

The following tables present the Company's segment net sales by geography and total net sales by classes of similar products for the periods presented:

Three Months Ended June 30, 2020 Six Months Ended June 30, 2020
Revlon Elizabeth Arden Portfolio Fragrances Total Revlon Elizabeth Arden Portfolio Fragrances Total
Geographic Area⁽¹⁾:
Net Sales
   North America $ 80.1 $ 15.0 $ 52.1 $ 29.7 $ 176.9 $ 179.2 $ 36.4 $ 122.9 $ 71.9 $ 410.4
   EMEA* 26.5 13.7 30.2 9.3 79.7 63.8 39.6 60.8 25.6 189.8
   Asia 6.8 49.1 0.7 2.0 58.6 21.5 92.2 1.2 5.4 120.3
   Latin America* 10.0 0.2 3.4 0.3 13.9 24.0 1.0 8.3 1.1 34.4
   Pacific* 11.6 2.9 2.1 1.9 18.5 28.3 6.9 5.3 5.2 45.7
$ 135.0 $ 80.9 $ 88.5 $ 43.2 $ 347.6 $ 316.8 $ 176.1 $ 198.5 $ 109.2 $ 800.6


	Three Months Ended September 30, 2020										Nine Months Ended September 30, 2020
	Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio		Fragrances		Total
Geographic Area(1):
Net Sales
North America	$	86.4	$	30.5	$	59.9	$	79.2	$	256.0	$	265.6	$	66.9	$	182.8	$	151.1	$	666.4
EMEA*	41.4		25.3		32.8		18.8		118.3		105.2		64.9		93.6		44.4		308.1
Asia	12.1		43.3		0.4		2.7		58.5		33.6		135.5		1.6		8.1		178.8
Latin America*	11.3		2.5		3.3		1.5		18.6		35.3		3.5		11.6		2.6		53.0
Pacific*	14.8		4.7		3.2		3.0		25.7		43.1		11.6		8.5		8.2		71.4
	$	166.0	$	106.3	$	99.6	$	105.2	$	477.1	$	482.8	$	282.4	$	298.1	$	214.4	$	1,277.7


		Three Months Ended June 30, 2019																			Six Months Ended June 30, 2019																					Three Months Ended September 30, 2019					Nine Months Ended September 30, 2019
			Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio		Fragrances			Total				Revlon		Elizabeth Arden		Portfolio		Fragrances		Total		Revlon		Elizabeth Arden		Portfolio			Fragrances		Total
Geographic Area⁽¹⁾:	Geographic Area⁽¹⁾:																								Geographic Area(1):
Net Sales	Net Sales																							Net Sales
North America	North America		$	134.7	$	26.2	$	73.0	$	52.6	$	286.5	267.9		54.4		143.1		99.8			$	565.2	North America		$	100.0	$	29.5	$	71.4	$	98.6	$	299.5	367.9		83.9		214.5			198.4		$	864.7
EMEA*	EMEA*		51.5		30.6		34.8		21.9		138.8		105.2		58.5		72.6		42.1			278.4		EMEA*		48.1		37.3		38.4		26.8		150.6		153.3		95.8		111.0			68.9		429.0
Asia	Asia		24.4		53.9		1.4		4.1		83.8		48.3		101.6		2.2		8.8			160.9		Asia		30.1		46.5		1.0		4.0		81.6		78.4		148.1		3.2			12.8		242.5
Latin America*	Latin America*		21.7		2.2		6.5		1.8		32.2		37.4		5.0		11.7		4.0			58.1		Latin America*		18.8		2.2		4.5		3.1		28.6		56.2		7.2		16.2			7.1		86.7
Pacific*	Pacific*		19.2		4.5		3.0		2.2		28.9		40.0		9.3		6.3		5.2			60.8		Pacific*		20.3		7.7		2.9		5.6		36.5		60.3		17.0		9.2			10.8		97.3
			$	251.5	$	117.4	$	118.7	$	82.6	$	570.2	$	498.8	$	228.8	$	235.9	$	159.9		$	1,123.4			$	217.3	$	123.2	$	118.2	$	138.1	$	596.8	$	716.1	$	352.0	$	354.1		$	298.0	$	1,720.2

(1) During the first quarter of 2020, the Company changed the presentation of its Travel Retail business, which previously was included in its EMEA Region, as it is currently presented within each geographic area in accordance with the location of the retail customer. Travel Retail net sales represented approximately ~~1.8%~~2.0% and ~~5.3%~~4.6% of the Company's total net sales for the ~~second~~third quarter of 2020 and 2019, respectively, and ~~2.3%~~2.2% and ~~5.0%~~4.9% of the Company's total net sales for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively. Prior year amounts have been updated to reflect the current year presentation.

* The EMEA region includes Europe, the Middle East and Africa; the Latin America region includes Mexico, Central America and South America; and the Pacific region includes Australia and New Zealand.


		Three Months Ended June 30,											Six Months Ended June 30,											Three Months Ended September 30,				Nine Months Ended September 30,
		2020					2019				2020			2019							2020			2019			2020	2019
Classes of similar products:	Classes of similar products:													Classes of similar products:
Net sales:	Net sales:													Net sales:
Color cosmetics	Color cosmetics	$	70.6	20%	$	193.5	34%	$	200.6	25%	$	396.3	35%	Color cosmetics	$	104.7	22%	$	173.6	29%	$	305.3	24%	$	569.9	33%
Fragrance	Fragrance	64.0		18%	117.1		21%	158.9		20%	227.4		20%	Fragrance	141.6		30%	183.7		31%	300.5		24%	411.1		24%
Hair care	Hair care	105.4		30%	129.8		23%	222.1		28%	258.5		23%	Hair care	115.9		24%	120.5		20%	338.0		26%	379.0		22%
Beauty care	Beauty care	45.4		13%	48.0		8%	91.5		11%	89.1		8%	Beauty care	50.4		11%	43.6		7%	141.9		11%	132.7		8%
Skin care	Skin care	62.2		19%	81.8		14%	127.5		16%	152.1		14%	Skin care	64.5		13%	75.4		13%	192.0		15%	227.5		13%
		$	347.6		$	570.2		$	800.6		$	1,123.4			$	477.1		$	596.8		$	1,277.7		$	1,720.2

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

The following table presents the Company's long-lived assets by geographic area as of ~~June~~September 30, 2020 and December 31, 2019:


		June 30, 2020							December 31, 2019							September 30, 2020					December 31, 2019
Long-lived assets, net:	Long-lived assets, net:									Long-lived assets, net:
United States	United States	$	1,224.8	82%	$	1,414.0			83%	United States	$	1,208.1			82%	$	1,414.0			83%
International	International	262.4		18%	280.1				17%	International	259.3				18%	280.1				17%
		$	1,487.2				$	1,694.1					$	1,467.4				$	1,694.1

15. REVLON, INC. BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE

Shares used in calculating Revlon's basic loss per share are computed using the weighted-average number of Revlon's shares of Class A Common Stock outstanding during each period. Shares used in diluted loss per share include the dilutive effect of unvested restricted stock, LTIP RSUs and TIP RSUs under the Company’s Stock Plan using the treasury stock method. For the respective periods ended ~~June~~September 30, 2020 and 2019, Revlon's diluted loss per share equals basic loss per share, as the assumed vesting of restricted stock, LTIP RSUs and TIP RSUs would have an anti-dilutive effect. As of ~~June~~September 30, 2020 and 2019, there were 0 outstanding stock options under the Company's Stock Plan. See Note 11, "Stock Compensation Plan," for information on the LTIP and TIP RSUs.

Following are the components of Revlon's basic and diluted loss per common share for the periods presented:


		Three months ended June 30,						Six months ended June 30,							Three months ended September 30,				Nine months ended September 30,
		2020		2019		2020		2019			2020		2019		2020		2019
Numerator:	Numerator:									Numerator:
Loss from continuing operations, net of taxes	Loss from continuing operations, net of taxes	$	(126.8)	$	(65.3)	$	(340.7)	$	(141.1)	Loss from continuing operations, net of taxes	$	(44.5)	$	(44.4)	$	(385.2)	$	(185.5)
Income from discontinued operations, net of taxes		—		1.6		—		2.3
(Loss) income from discontinued operations, net of taxes										(Loss) income from discontinued operations, net of taxes	0		(0.3)		0		2.0
Net loss	Net loss	$	(126.8)	$	(63.7)	$	(340.7)	$	(138.8)	Net loss	$	(44.5)	$	(44.7)	$	(385.2)	$	(183.5)
Denominator:	Denominator:									Denominator:
Weighted-average common shares outstanding – Basic	Weighted-average common shares outstanding – Basic	53,471,004		53,126,700		53,319,228		53,020,633		Weighted-average common shares outstanding – Basic	53,476,354		53,129,004		53,371,986		53,057,154
Effect of dilutive restricted stock and RSUs	Effect of dilutive restricted stock and RSUs	—		—		—		—		Effect of dilutive restricted stock and RSUs	0		0		0		0
Weighted-average common shares outstanding – Diluted	Weighted-average common shares outstanding – Diluted	53,471,004		53,126,700		53,319,228		53,020,633		Weighted-average common shares outstanding – Diluted	53,476,354		53,129,004		53,371,986		53,057,154
Basic and Diluted (loss) earnings per common share:	Basic and Diluted (loss) earnings per common share:									Basic and Diluted (loss) earnings per common share:
Continuing operations	Continuing operations	$	(2.37)	$	(1.23)	$	(6.39)	$	(2.66)	Continuing operations	$	(0.83)	$	(0.84)	$	(7.22)	$	(3.50)
Discontinued operations	Discontinued operations	—		0.03		—		0.04		Discontinued operations	0		0		0		0.04
Net loss per common share	Net loss per common share	$	(2.37)	$	(1.20)	$	(6.39)	$	(2.62)	Net loss per common share	$	(0.83)	$	(0.84)	$	(7.22)	$	(3.46)

Unvested restricted stock and RSUs under the Stock Plan^(a)	Unvested restricted stock and RSUs under the Stock Plan^(a)	—		304,608		56,058		445,525		Unvested restricted stock and RSUs under the Stock Plan(a)	0		314,478		0		406,854

^(a)These are outstanding common stock equivalents that were not included in the computation of Revlon's diluted earnings per common share because their inclusion would have had an anti-dilutive effect.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

16. CONTINGENCIES

On August 12, 2020, UMB Bank, National Association (“UMB”), purporting to act as successor agent under the Term Credit Agreement, dated as of September 7, 2016 (as amended as of May 7, 2020 and as otherwise amended, restated, supplemented or otherwise modified from time to time, the “2016 Credit Agreement”), filed a lawsuit, titled UMB Bank, National Association v. Revlon, Inc. et al., against Revlon, Inc., Products Corporation, several of Products Corporation’s subsidiaries, and several of Products Corporation’s contractual counterparties, including Citibank, Jefferies Finance LLC, Jefferies LLC, and Ares Corporate Opportunities Fund V, in the U.S. District Court for the Southern District of New York (the “Complaint”). The Complaint alleged various claims, stemming from alleged breaches of the 2016 Credit Agreement. The Company believes that this lawsuit was without merit. On November 6, 2020, having failed to serve the lawsuit on any defendant or make any effort to pursue the case, UMB Bank dismissed the case without prejudice to its right to refile it at a later date.

The Company is also involved in various routine legal proceedings incidental to the ordinary course of its business. The Company believes that the outcome of all pending legal proceedings in the aggregate is not reasonably likely to have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows. However, in light of the uncertainties involved in legal proceedings generally, the ultimate outcome of a particular matter could be material to the Company’s operating results for a particular period depending on, among other things, the size of the loss or the nature of the liability imposed and the level of the Company’s income for that particular period.

~~Table of Contents~~

~~COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS~~

~~(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)~~

17. RELATED PARTY TRANSACTIONS

Reimbursement Agreements

Revlon, Products Corporation and MacAndrews & Forbes have entered into reimbursement agreements (the "Reimbursement Agreements") pursuant to which: (i) MacAndrews & Forbes is obligated to provide (directly or through its affiliates) certain professional and administrative services, including, without limitation, employees, to the Company, and to purchase services from third-party providers, such as insurance, legal, accounting and air transportation services, on behalf of the Company, to the extent requested by Products Corporation; and (ii) Products Corporation is obligated to provide certain professional and administrative services, including, without limitation, employees, to MacAndrews & Forbes and to purchase services from third-party providers, such as insurance, legal and accounting services, on behalf of MacAndrews & Forbes, to the extent requested by MacAndrews & Forbes, provided that in each case the performance of such services does not cause an unreasonable burden to MacAndrews & Forbes or Products Corporation, as the case may be.

The Company reimburses MacAndrews & Forbes for the allocable costs of the services that MacAndrews & Forbes purchases for or provides to the Company and for the reasonable out-of-pocket expenses that MacAndrews & Forbes incurs in connection with the provision of such services. MacAndrews & Forbes reimburses Products Corporation for the allocable costs of the services that Products Corporation purchases for or provides to MacAndrews & Forbes and for the reasonable out-of-pocket expenses incurred by Products Corporation in connection with the purchase or provision of such services. Each of the Company, on the one hand, and MacAndrews & Forbes, on the other, has agreed to indemnify the other party for losses arising out of the services provided by it under the Reimbursement Agreements, other than losses resulting from its willful misconduct or gross negligence.

The Reimbursement Agreements may be terminated by either party on 90 days' notice. The Company does not intend to request services under the Reimbursement Agreements unless their costs would be at least as favorable to the Company as could be obtained from unaffiliated third parties.

The Company participates in MacAndrews & Forbes' directors and officers liability insurance program (the "D&O Insurance Program"), as well as its other insurance coverages, such as property damage, business interruption, liability and other coverages, which cover the Company, as well as MacAndrews & Forbes and its subsidiaries. The limits of coverage for certain of the policies are available on an aggregate basis for losses to any or all of the participating companies and their respective directors and officers. The Company reimburses MacAndrews & Forbes from time-to-time for their allocable portion of the premiums for such coverage or the Company pays the insurers directly, which premiums the Company believes are more favorable than the premiums that the Company would pay were it to secure stand-alone coverage. Any amounts paid by the Company directly to MacAndrews & Forbes in respect of premiums are included in the amounts paid under the Reimbursement Agreements. To ensure the availability of directors and officers liability insurance coverage through January 2023, the Company and MacAndrews & Forbes agreed to collectively make payments under MacAndrews & Forbes’ D&O Insurance Program. In furtherance of such arrangement, on July 28, 2020, the Company made a payment of approximately $3.86 million to MacAndrews & Forbes under the Reimbursement Agreements. The Company expects to make a further payment of approximately $1.4 million in July 2021 in respect of its participation in the D&O Insurance Program.

The net activity related to services purchased under the Reimbursement Agreements during the six months ended June 30, 2020 and 2019 was $0.3 million income and $0.3 million expense, respectively. As of June 30, 2020 and December 31, 2019, a payable balance of $16,000 and $0.2 million, respectively, to MacAndrews & Forbes were included in the Company's Unaudited Consolidated Balance Sheet for transactions subject to the Reimbursement Agreements.

~~Amended 2019 Senior Line of Credit Facility~~

~~See Note 9, "Debt," in the Company's 2019 Form 10-K regarding the Amended 2019 Senior Line of Credit Agreement between Products Corporation and MacAndrews & Forbes Group, LLC.~~

~~Other~~

During the six months ended June 30, 2020 and 2019, the Company engaged several companies in which MacAndrews & Forbes had a controlling interest to provide the Company with various ordinary course business services. These services included processing approximately $14.2 million and $11.0 million of coupon redemptions for the Company's retail customers for the six months ended June 30, 2020 and 2019, respectively, for which the Company incurred fees of approximately $0.4 million and $0.2 million for the six months ended June 30, 2020 and 2019, respectively, and other similar advertising, coupon redemption and raw material supply services, for which the Company had net payables aggregating to approximately $0.3 million and $0.4 million for the six months ended June 30, 2020 and 2019, respectively. As of June 30, 2020 and December 31, 2019, a payable balance of approximately $4.3 million and $5.5 million, respectively, were included in the Company's

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

The net activity related to services purchased under the Reimbursement Agreements during the nine months ended September 30, 2020 and 2019 was $0.6 million income and $0.3 million expense, respectively. As of September 30, 2020 and December 31, 2019, a receivable balance of $0.3 million from, and a payable balance of $0.2 million to, MacAndrews & Forbes, respectively, were included in the Company's Unaudited Consolidated Balance Sheet for transactions subject to the Reimbursement Agreements.

2020 Restated Line of Credit Facility

See Note 7, "Debt," in this Form 10-Q regarding the 2020 Restated Line of Credit Facility between Products Corporation and MacAndrews & Forbes Group, LLC.

Other

During the nine months ended September 30, 2020 and 2019, the Company engaged several companies in which MacAndrews & Forbes had a controlling interest to provide the Company with various ordinary course business services. These services included processing approximately $28.2 million and $19.8 million of coupon redemptions for the Company's retail customers for the nine months ended September 30, 2020 and 2019, respectively, for which the Company incurred fees of approximately $0.8 million and $0.5 million for the nine months ended September 30, 2020 and 2019, respectively, and other similar advertising, coupon redemption and raw material supply services, for which the Company had net payables aggregating to approximately $0.4 million and $0.5 million for the nine months ended September 30, 2020 and 2019, respectively. As of September 30, 2020 and December 31, 2019, a payable balance of approximately $1.7 million and $5.5 million, respectively, were included in the Company's Consolidated Balance Sheet for the aforementioned coupon redemption services. The Company believes that its engagement of each of these affiliates was on arm's length terms, taking into account each firm's expertise in its respective field, and that the fees paid or received were at least as favorable as those available from unaffiliated parties.

In April 2020, in connection with the organizational measures taken by the Company in response to COVID-19, the Company and Ms. Debbie Perelman, the ~~Company��s~~Company’s President and Chief Executive Officer and a member of Revlon’s and Products Corporation’s Boards of Directors, agreed in writing that, effective on or about April 11, 2020, Ms. Perelman’s base salary would be reduced by 40% to $675,000, less all applicable withholdings and deductions, during the span of COVID-19. The Chairman of the Compensation Committee has the authority to reinstate Ms. Perelman’s base salary in effect immediately prior to such amendment at any time he deems appropriate, in his sole discretion, exercised reasonably. In July 2020, the Chairman of the Compensation Committee, acting pursuant to his delegated authority, partially reinstated Ms. Perelman’s base salary to the same 25% reduction ~~as is currently~~ applicable to the other members of the Company’s Executive Leadership Team. In late September 2020, the Company's CEO adjusted the initial COVID-driven 25% reduction in the base salary for members of its Executive Leadership Team to a 20% reduction. Also in connection with such COVID-19 measures, in March 2020, the Company agreed in writing with each of Ms. Mitra Hormozi and Mr. E. Scott Beattie that, effective April 1, 2020, their provision of advisory services to the Company was suspended, and payment of their consulting fees was also suspended. In connection with Ms. Hormozi’s resignation from the Board in July 2020, the Company and Ms. Hormozi terminated her Consulting Agreement, dated as of November 7, 2019, as amended, which Consulting Agreement had previously been suspended as part of the organizational cost-reduction measures taken by the Company in response to the ongoing COVID-19 pandemic. The Company’s CEO may reinstate Mr. Beattie’s advisory services and payment of his consulting fees at the appropriate time, in her sole discretion, exercised reasonably. See Note 19, "Subsequent Events."

As previously disclosed in the Company’s 2019 Form 10-K, prior to this suspension of services and payments, in March 2020, the Company and Mr. Beattie entered into an Amended and Restated Consulting Agreement (the “2020 Consulting Agreement”), pursuant to which he was scheduled to serve as Senior Advisor to the Company’s CEO for an additional year, subject to automatic 1-year renewals, unless either party elects not to renew, and subject to certain standard termination rights, in consideration for which, the Company would pay Mr. Beattie a fee of $250,000 per year, supplemental to the Board’s compensation program for non-employee directors. The foregoing description of the 2020 Consulting Agreement is qualified in its entirety by reference to the full text of such agreement, a copy of which was filed with the SEC on March 12, 2020 together with the Company’s 2019 Form 10-K.

MacAndrews & Forbes tendered approximately $15.5 million of 5.75% Senior Notes into the Exchange Offer and, in exchange, received the Mixed Consideration as described herein, in accordance with the terms and conditions of the Exchange Offer.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

18. PRODUCTS CORPORATION AND SUBSIDIARIES GUARANTOR FINANCIAL INFORMATION

Products Corporation's 5.75% Senior Notes and 6.25% Senior Notes are fully and unconditionally guaranteed on a senior basis by certain of Products Corporation’s direct and indirect wholly-owned domestic subsidiaries (the "5.75% Senior Notes Guarantors" and the "6.25% Senior Notes Guarantors," respectively, and together the "Guarantor Subsidiaries").

The following Condensed Consolidating Financial Statements present the financial information as of ~~June~~September 30, 2020 and December 31, 2019, and for each of the three and ~~six~~nine months ~~June~~September 30, 2020 and 2019 for (i) Products Corporation on a stand-alone basis; (ii) the Guarantor Subsidiaries on a stand-alone basis; (iii) the subsidiaries of Products Corporation that do not guarantee Products Corporation's 5.75% Senior Notes and 6.25% Senior Notes (the "Non-Guarantor Subsidiaries") on a stand-alone basis; and (iv) Products Corporation, the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries on a consolidated basis. The Condensed Consolidating Financial Statements are presented on the equity method, under which the investments in subsidiaries are recorded at cost and adjusted to the applicable share of the subsidiary's cumulative results of operations, capital contributions, distributions and other equity changes. The principal elimination entries eliminate investments in subsidiaries and intercompany balances and transactions.


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets	Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets																					Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of June 30, 2020
As of September 30, 2020												As of September 30, 2020
		Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated			Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS	ASSETS											ASSETS
Cash and cash equivalents	Cash and cash equivalents	$	271.9	$	5.9	$	60.7	$	—	$	338.5	Cash and cash equivalents	$	167.8	$	8.8	$	91.7	$	0	$	268.3
Trade receivables, less allowances for doubtful accounts	Trade receivables, less allowances for doubtful accounts	73.5		59.4		155.4		—		288.3		Trade receivables, less allowances for doubtful accounts	54.6		107.7		178.5		0		340.8
Inventories		145.9		175.9		189.4		—		511.2
Inventories, net												Inventories, net	141.0		180.9		203.6		0		525.5
Prepaid expenses and other	Prepaid expenses and other	224.8		38.1		44.9		—		307.8		Prepaid expenses and other	215.0		31.2		59.4		0		305.6
Intercompany receivables	Intercompany receivables	3,173.6		3,134.9		508.9		(6,817.4)		—		Intercompany receivables	3,375.6		3,296.1		464.4		(7,136.1)		0
Investment in subsidiaries	Investment in subsidiaries	1,574.2		14.8		—		(1,589.0)		—		Investment in subsidiaries	1,581.4		(0.1)		0		(1,581.3)		0
Property, plant and equipment, net	Property, plant and equipment, net	189.0		73.8		102.7		—		365.5		Property, plant and equipment, net	184.4		70.5		100.9		0		355.8
Deferred income taxes	Deferred income taxes	235.6		(53.6)		29.1		—		211.1		Deferred income taxes	243.5		(70.6)		39.0		0		211.9
Goodwill	Goodwill	48.9		264.0		249.8		—		562.7		Goodwill	48.9		264.0		250.3		0		563.2
Intangible assets, net	Intangible assets, net	(20.9)		333.8		128.7		—		441.6		Intangible assets, net	10.8		192.1		233.0		0		435.9
Other assets	Other assets	72.0		13.6		31.8		—		117.4		Other assets	69.0		13.4		30.1		0		112.5
Total assets	Total assets	$	5,988.5	$	4,060.6	$	1,501.4	$	(8,406.4)	$	3,144.1	Total assets	$	6,092.0	$	4,094.0	$	1,650.9	$	(8,717.4)	$	3,119.5
LIABILITIES AND STOCKHOLDER’S DEFICIENCY	LIABILITIES AND STOCKHOLDER’S DEFICIENCY																					LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	Short-term borrowings	$	—	$	—	$	2.6	$	—	$	2.6	Short-term borrowings	$	0	$	0	$	2.0	$	0	$	2.0
Current portion of long-term debt	Current portion of long-term debt	648.2		—		0.1		—		648.3		Current portion of long-term debt	649.0		0		55.5		0		704.5
Accounts payable	Accounts payable	107.6		47.6		69.4		—		224.6		Accounts payable	75.1		62.2		82.6		0		219.9
Accrued expenses and other	Accrued expenses and other	257.7		(35.0)		158.9		—		381.6		Accrued expenses and other	243.5		(48.2)		195.5		0		390.8
Intercompany payables	Intercompany payables	3,317.2		2,954.4		545.7		(6,817.3)		—		Intercompany payables	3,496.2		3,013.9		625.9		(7,136.0)		0
Long-term debt	Long-term debt	2,922.8		—		53.0		—		2,975.8		Long-term debt	2,926.2		0		0.3		0		2,926.5
Other long-term liabilities	Other long-term liabilities	173.1		111.4		38.4		—		322.9		Other long-term liabilities	172.9		109.3		38.1		0		320.3
Total liabilities	Total liabilities	7,426.6		3,078.4		868.1		(6,817.3)		4,555.8		Total liabilities	7,562.9		3,137.2		999.9		(7,136.0)		4,564.0
Stockholder’s (deficiency) equity	Stockholder’s (deficiency) equity	(1,438.1)		982.2		633.3		(1,589.1)		(1,411.7)		Stockholder’s (deficiency) equity	(1,470.9)		956.8		651.0		(1,581.4)		(1,444.5)
Total liabilities and stockholder’s (deficiency) equity	Total liabilities and stockholder’s (deficiency) equity	$	5,988.5	$	4,060.6	$	1,501.4	$	(8,406.4)	$	3,144.1	Total liabilities and stockholder’s (deficiency) equity	$	6,092.0	$	4,094.0	$	1,650.9	$	(8,717.4)	$	3,119.5

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)


Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets	Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets																					Products Corporation and Subsidiaries Condensed Consolidating Balance Sheets
As of December 31, 2019	As of December 31, 2019																					As of December 31, 2019
		Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated			Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated

ASSETS	ASSETS											ASSETS
Cash and cash equivalents	Cash and cash equivalents	$	0.8	$	6.4	$	97.1	$	—	$	104.3	Cash and cash equivalents	$	0.8	$	6.4	$	97.1	$	0	$	104.3
Trade receivables, less allowances for doubtful accounts	Trade receivables, less allowances for doubtful accounts	95.5		92.3		235.6		—		423.4		Trade receivables, less allowances for doubtful accounts	95.5		92.3		235.6		0		423.4
Inventories		131.0		151.5		165.9		—		448.4
Inventories, net												Inventories, net	131.0		151.5		165.9		0		448.4
Prepaid expenses and other	Prepaid expenses and other	219.7		26.4		46.5		—		292.6		Prepaid expenses and other	219.7		26.4		46.5		0		292.6
Intercompany receivables	Intercompany receivables	2,857.7		2,854.6		452.7		(6,165.0)		—		Intercompany receivables	2,857.7		2,854.6		452.7		(6,165.0)		0
Investment in subsidiaries	Investment in subsidiaries	1,598.3		30.7		—		(1,629.0)		—		Investment in subsidiaries	1,598.3		30.7		0		(1,629.0)		0
Property, plant and equipment, net	Property, plant and equipment, net	208.7		89.5		110.4		—		408.6		Property, plant and equipment, net	208.7		89.5		110.4		0		408.6
Deferred income taxes	Deferred income taxes	165.0		(37.8)		30.9		—		158.1		Deferred income taxes	165.0		(37.8)		30.9		0		158.1
Goodwill	Goodwill	159.9		264.0		249.8		—		673.7		Goodwill	159.9		264.0		249.8		0		673.7
Intangible assets, net	Intangible assets, net	13.0		346.9		130.8		—		490.7		Intangible assets, net	13.0		346.9		130.8		0		490.7
Other assets	Other assets	67.8		16.2		37.1		—		121.1		Other assets	67.8		16.2		37.1		0		121.1
Total assets	Total assets	$	5,517.4	$	3,840.7	$	1,556.8	$	(7,794.0)	$	3,120.9	Total assets	$	5,517.4	$	3,840.7	$	1,556.8	$	(7,794.0)	$	3,120.9
LIABILITIES AND STOCKHOLDER’S DEFICIENCY	LIABILITIES AND STOCKHOLDER’S DEFICIENCY																					LIABILITIES AND STOCKHOLDER’S DEFICIENCY
Short-term borrowings	Short-term borrowings	$	—	$	—	$	2.2	$	—	$	2.2	Short-term borrowings	$	0	$	0	$	2.2	$	0	$	2.2
Current portion of long-term debt	Current portion of long-term debt	287.9		—		0.1		—		288.0		Current portion of long-term debt	287.9		0		0.1		0		288.0
Accounts payable	Accounts payable	108.4		39.9		103.5		—		251.8		Accounts payable	108.4		39.9		103.5		0		251.8
Accrued expenses and other	Accrued expenses and other	124.1		70.0		224.1		—		418.2		Accrued expenses and other	124.1		70.0		224.1		0		418.2
Intercompany payables	Intercompany payables	3,030.3		2,668.7		466.0		(6,165.0)		—		Intercompany payables	3,030.3		2,668.7		466.0		(6,165.0)		0
Long-term debt	Long-term debt	2,822.2		—		84.0		—		2,906.2		Long-term debt	2,822.2		0		84.0		0		2,906.2
Other long-term liabilities	Other long-term liabilities	220.4		118.2		5.3		—		343.9		Other long-term liabilities	220.4		118.2		5.3		0		343.9
Total liabilities	Total liabilities	6,593.3		2,896.8		885.2		(6,165.0)		4,210.3		Total liabilities	6,593.3		2,896.8		885.2		(6,165.0)		4,210.3
Stockholder’s (deficiency) equity	Stockholder’s (deficiency) equity	(1,075.9)		943.9		671.6		(1,629.0)		(1,089.4)		Stockholder’s (deficiency) equity	(1,075.9)		943.9		671.6		(1,629.0)		(1,089.4)
Total liabilities and stockholder’s deficiency		$	5,517.4	$	3,840.7	$	1,556.8	$	(7,794.0)	$	3,120.9
Total liabilities and stockholder’s (deficiency) equity												Total liabilities and stockholder’s (deficiency) equity	$	5,517.4	$	3,840.7	$	1,556.8	$	(7,794.0)	$	3,120.9

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)


Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income	Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income																					Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended June 30, 2020
Three Months Ended September 30, 2020												Three Months Ended September 30, 2020
		Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated			Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	Net Sales	$	93.8	$	78.2	$	175.6	$	—	$	347.6	Net Sales	$	95.7	$	148.9	$	232.4	$	0.1	$	477.1
Cost of sales	Cost of sales	54.4		43.5		70.7		—		168.6		Cost of sales	45.6		92.6		96.0		0.1		234.3
Gross profit	Gross profit	39.4		34.7		104.9		—		179.0		Gross profit	50.1		56.3		136.4		0		242.8
Selling, general and administrative expenses	Selling, general and administrative expenses	58.8		45.2		90.4		—		194.4		Selling, general and administrative expenses	84.4		47.7		119.3		0		251.4
Acquisition and integration costs	Acquisition and integration costs	2.0		(0.5)		(0.3)		—		1.2		Acquisition and integration costs	0.8		0		0.1		0		0.9
Restructuring charges and other, net	Restructuring charges and other, net	17.1		3.0		0.6		—		20.7		Restructuring charges and other, net	(8.4)		2.7		5.0		0		(0.7)
Impairment charges	Impairment charges	19.8		—		—		—		19.8		Impairment charges	(23.4)		22.0		1.4		0		0
Gain on divested assets	Gain on divested assets	(0.2)		—		—		—		(0.2)		Gain on divested assets	(1.1)		0		0		0		(1.1)
Operating (loss) income	Operating (loss) income	(58.1)		(13.0)		14.2		—		(56.9)		Operating (loss) income	(2.2)		(16.1)		10.6		0		(7.7)
Other (income) expense:	Other (income) expense:											Other (income) expense:
Intercompany interest, net	Intercompany interest, net	(0.3)		0.6		(0.3)		—		—		Intercompany interest, net	(0.5)		0.7		(0.2)		0		0
Interest expense	Interest expense	59.2		—		1.7		—		60.9		Interest expense	67.3		0		1.4		0		68.7
Amortization of debt issuance costs	Amortization of debt issuance costs	6.0		—		—		—		6.0		Amortization of debt issuance costs	7.8		0		0		0		7.8
(Gain) loss on early extinguishment of debt, net		(11.9)		—		—		—		(11.9)
Gain on early extinguishment of debt												Gain on early extinguishment of debt	(31.2)		0		0		0		(31.2)
Foreign currency losses (gains), net	Foreign currency losses (gains), net	6.2		0.5		(4.4)		—		2.3		Foreign currency losses (gains), net	1.0		(0.7)		(10.1)		0		(9.8)
Miscellaneous, net	Miscellaneous, net	24.9		(6.9)		2.6		—		20.6		Miscellaneous, net	(1.8)		(55.4)		54.6		0		(2.6)
Other expense (income), net	Other expense (income), net	84.1		(5.8)		(0.4)		—		77.9		Other expense (income), net	42.6		(55.4)		45.7		0		32.9
(Loss) income from continuing operations before income taxes	(Loss) income from continuing operations before income taxes	(142.2)		(7.2)		14.6		—		(134.8)		(Loss) income from continuing operations before income taxes	(44.8)		39.3		(35.1)		0		(40.6)
(Benefit from) provision for income taxes	(Benefit from) provision for income taxes	(35.8)		21.6		4.6		—		(9.6)		(Benefit from) provision for income taxes	(6.3)		17.8		(9.2)		0		2.3
(Loss) income from continuing operations, net of taxes	(Loss) income from continuing operations, net of taxes	(106.4)		(28.8)		10.0		—		(125.2)		(Loss) income from continuing operations, net of taxes	(38.5)		21.5		(25.9)		0		(42.9)

Equity in income (loss) of subsidiaries	Equity in income (loss) of subsidiaries	4.7		(6.9)		—		2.2		—		Equity in income (loss) of subsidiaries	30.0		(10.0)		0		(20.0)		0
Net (loss) income	Net (loss) income	$	(101.7)	$	(35.7)	$	10.0	$	2.2	$	(125.2)	Net (loss) income	$	(8.5)	$	11.5	$	(25.9)	$	(20.0)	$	(42.9)
Other comprehensive income (loss)	Other comprehensive income (loss)	14.3		7.9		11.2		(19.1)		14.3		Other comprehensive income (loss)	5.0		(7.1)		1.6		5.5		5.0
Total comprehensive (loss) income	Total comprehensive (loss) income	$	(87.4)	$	(27.8)	$	21.2	$	(16.9)	$	(110.9)	Total comprehensive (loss) income	$	(3.5)	$	4.4	$	(24.3)	$	(14.5)	$	(37.9)

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)


Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income	Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income																					Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Three Months Ended June 30, 2019
Three Months Ended September 30, 2019												Three Months Ended September 30, 2019
		Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated			Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	Net Sales	$	155.5	$	124.8	$	290.3	$	(0.4)	$	570.2	Net Sales	$	118.4	$	174.8	$	303.9	$	(0.3)	$	596.8
Cost of sales	Cost of sales	72.2		64.1		108.0		(0.4)		243.9		Cost of sales	64.9		88.1		116.3		(0.3)		269.0
Gross profit	Gross profit	83.3		60.7		182.3		—		326.3		Gross profit	53.5		86.7		187.6		0		327.8
Selling, general and administrative expenses	Selling, general and administrative expenses	109.3		81.5		140.2		—		331.0		Selling, general and administrative expenses	90.5		82.1		133.7		0		306.3

Acquisition and integration costs												Acquisition and integration costs	0.1		0		0		0		0.1
Restructuring charges and other, net	Restructuring charges and other, net	0.8		0.8		1.6		—		3.2		Restructuring charges and other, net	1.0		0.5		1.4		0		2.9
Operating (loss) income	Operating (loss) income	(26.8)		(21.6)		40.5		—		(7.9)		Operating (loss) income	(38.1)		4.1		52.5		0		18.5
Other (income) expense:	Other (income) expense:											Other (income) expense:
Intercompany interest, net	Intercompany interest, net	(1.1)		0.7		0.4		—		—		Intercompany interest, net	(1.1)		0.6		0.5		0		0
Interest expense	Interest expense	46.1		—		1.7		—		47.8		Interest expense	48.5		0		1.7		0		50.2
Amortization of debt issuance costs	Amortization of debt issuance costs	3.5		—		—		—		3.5		Amortization of debt issuance costs	3.7		0		0		0		3.7

Foreign currency losses, net		1.8		0.3		(0.9)		—		1.2
Foreign currency losses (gains), net												Foreign currency losses (gains), net	0.9		(0.1)		6.8		0		7.6
Miscellaneous, net	Miscellaneous, net	(10.1)		(12.7)		27.4		—		4.6		Miscellaneous, net	(8.4)		(10.0)		20.1		0		1.7
Other expense (income), net	Other expense (income), net	40.2		(11.7)		28.6		—		57.1		Other expense (income), net	43.6		(9.5)		29.1		0		63.2
(Loss) income from continuing operations before income taxes	(Loss) income from continuing operations before income taxes	(67.0)		(9.9)		11.9		—		(65.0)		(Loss) income from continuing operations before income taxes	(81.7)		13.6		23.4		0		(44.7)
(Benefit from) provision for income taxes	(Benefit from) provision for income taxes	(3.6)		(0.1)		2.8		—		(0.9)		(Benefit from) provision for income taxes	(31.4)		18.9		10.7		0		(1.8)
Loss (income) from continuing operations, net of taxes	Loss (income) from continuing operations, net of taxes	(63.4)		(9.8)		9.1		—		(64.1)		Loss (income) from continuing operations, net of taxes	(50.3)		(5.3)		12.7		0		(42.9)
Income from discontinued operations, net of taxes	Income from discontinued operations, net of taxes	—		—		1.6		—		1.6		Income from discontinued operations, net of taxes	0		0		(0.3)		0		(0.3)
Equity in income (loss) of subsidiaries	Equity in income (loss) of subsidiaries	1.1		6.3		—		(7.4)		—		Equity in income (loss) of subsidiaries	30.8		0.1		0		(30.9)		0
Net (loss) income	Net (loss) income	$	(62.3)	$	(3.5)	$	10.7	$	(7.4)	$	(62.5)	Net (loss) income	$	(19.5)	$	(5.2)	$	12.4	$	(30.9)	$	(43.2)
Other comprehensive income (loss)	Other comprehensive income (loss)	5.3		(1.1)		(0.5)		1.6		5.3		Other comprehensive income (loss)	0.5		3.9		(1.9)		(2.0)		0.5
Total comprehensive (loss) income	Total comprehensive (loss) income	$	(57.0)	$	(4.6)	$	10.2	$	(5.8)	$	(57.2)	Total comprehensive (loss) income	$	(19.0)	$	(1.3)	$	10.5	$	(32.9)	$	(42.7)

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)


Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income	Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income																					Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Six Months Ended June 30, 2020
Nine Months Ended September 30, 2020												Nine Months Ended September 30, 2020
		Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated			Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	Net Sales	$	210.2	$	190.7	$	399.8	$	(0.1)	$	800.6	Net Sales	$	305.9	$	339.6	$	632.2	$	0	$	1,277.7
Cost of sales	Cost of sales	112.9		97.9		155.7		(0.1)		366.4		Cost of sales	158.5		190.5		251.7		0		600.7
Gross profit	Gross profit	97.3		92.8		244.1		—		434.2		Gross profit	147.4		149.1		380.5		0		677.0
Selling, general and administrative expenses	Selling, general and administrative expenses	163.2		116.1		202.5		—		481.8		Selling, general and administrative expenses	247.6		163.8		321.8		0		733.2
Acquisition, integration and divestiture costs	Acquisition, integration and divestiture costs	3.2		—		0.1		—		3.3		Acquisition, integration and divestiture costs	4.0		0		0.2		0		4.2
Restructuring charges and other, net	Restructuring charges and other, net	40.7		4.3		0.5		—		45.5		Restructuring charges and other, net	32.3		7.0		5.5		0		44.8
Impairment charges	Impairment charges	144.1		—		—		—		144.1		Impairment charges	120.7		22.0		1.4		0		144.1
Loss on divested assets		0.6		—		—		—		0.6
Gain on divested assets												Gain on divested assets	(0.5)		0		0		0		(0.5)
Operating (loss) income	Operating (loss) income	(254.5)		(27.6)		41.0		—		(241.1)		Operating (loss) income	(256.7)		(43.7)		51.6		0		(248.8)
Other (income) expense:	Other (income) expense:											Other (income) expense:
Intercompany interest, net	Intercompany interest, net	(3.0)		1.1		1.9		—		—		Intercompany interest, net	(3.5)		1.8		1.7		0		0
Interest expense	Interest expense	105.7		—		3.6		—		109.3		Interest expense	173.0		0		5.0		0		178.0
Amortization of debt issuance costs	Amortization of debt issuance costs	10.0		—		—		—		10.0		Amortization of debt issuance costs	17.8		0		0		0		17.8
(Gain) loss on early extinguishment of debt, net		(11.9)		—		—		—		(11.9)
Gain on early extinguishment of debt												Gain on early extinguishment of debt	(43.1)		0		0		0		(43.1)
Foreign currency losses, net	Foreign currency losses, net	0.6		2.4		15.9		—		18.9		Foreign currency losses, net	1.6		1.7		5.8		0		9.1
Miscellaneous, net	Miscellaneous, net	0.9		(16.1)		31.7		—		16.5		Miscellaneous, net	(0.9)		(71.5)		86.3		0		13.9
Other expense (income), net	Other expense (income), net	102.3		(12.6)		53.1		—		142.8		Other expense (income), net	144.9		(68.0)		98.8		0		175.7
Loss from continuing operations before income taxes	Loss from continuing operations before income taxes	(356.8)		(15.0)		(12.1)		—		(383.9)		Loss from continuing operations before income taxes	(401.6)		24.3		(47.2)		0		(424.5)
Benefit from for income taxes	Benefit from for income taxes	(52.1)		1.4		4.2		—		(46.5)		Benefit from for income taxes	(58.4)		19.2		(5.0)		0		(44.2)
Loss from continuing operations, net of taxes	Loss from continuing operations, net of taxes	(304.7)		(16.4)		(16.3)		—		(337.4)		Loss from continuing operations, net of taxes	(343.2)		5.1		(42.2)		0		(380.3)

Equity in (loss) income of subsidiaries	Equity in (loss) income of subsidiaries	(29.3)		(26.9)		—		56.2		—		Equity in (loss) income of subsidiaries	0.7		(36.9)		0		36.2		0
Net (loss) income	Net (loss) income	$	(334.0)	$	(43.3)	$	(16.3)	$	56.2	$	(337.4)	Net (loss) income	$	(342.5)	$	(31.8)	$	(42.2)	$	36.2	$	(380.3)
Other comprehensive (loss) income	Other comprehensive (loss) income	11.6		14.4		2.4		(16.8)		11.6		Other comprehensive (loss) income	16.6		7.3		4.0		(11.3)		16.6
Total comprehensive (loss) income	Total comprehensive (loss) income	$	(322.4)	$	(28.9)	$	(13.9)	$	39.4	$	(325.8)	Total comprehensive (loss) income	$	(325.9)	$	(24.5)	$	(38.2)	$	24.9	$	(363.7)

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)


Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income	Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income																					Products Corporation and Subsidiaries Condensed Consolidating Statement of Operations and Comprehensive (Loss) Income
Six Months Ended June 30, 2019
Nine Months Ended September 30, 2019												Nine Months Ended September 30, 2019
		Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated			Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
Net Sales	Net Sales	$	311.0	$	254.1	$	561.5	$	(3.2)	$	1,123.4	Net Sales	$	429.4	$	428.9	$	865.4	$	(3.5)	$	1,720.2
Cost of sales	Cost of sales	140.2		129.2		215.5		(3.2)		481.7		Cost of sales	205.1		217.3		331.8		(3.5)		750.7
Gross profit	Gross profit	170.8		124.9		346.0		—		641.7		Gross profit	224.3		211.6		533.6		0		969.5
Selling, general and administrative expenses	Selling, general and administrative expenses	239.0		156.6		266.2		—		661.8		Selling, general and administrative expenses	329.5		238.7		399.9		0		968.1
Acquisition, integration and divestiture costs	Acquisition, integration and divestiture costs	0.5		0.1		—		—		0.6		Acquisition, integration and divestiture costs	0.6		0.1		0		0		0.7
Restructuring charges and other, net	Restructuring charges and other, net	2.4		2.9		3.4		—		8.7		Restructuring charges and other, net	3.4		3.4		4.8		0		11.6

Operating (loss) income	Operating (loss) income	(71.1)		(34.7)		76.4		—		(29.4)		Operating (loss) income	(109.2)		(30.6)		128.9		0		(10.9)
Other (income) expenses:	Other (income) expenses:											Other (income) expenses:
Intercompany interest, net	Intercompany interest, net	(2.4)		1.4		1.0		—		—		Intercompany interest, net	(3.5)		2.0		1.5		0		0
Interest expense	Interest expense	92.0		—		3.5		—		95.5		Interest expense	140.5		0		5.2		0		145.7
Amortization of debt issuance costs	Amortization of debt issuance costs	6.7		—		—		—		6.7		Amortization of debt issuance costs	10.4		0		0		0		10.4

Foreign currency losses, net	Foreign currency losses, net	0.3		0.3		0.8		—		1.4		Foreign currency losses, net	1.2		0.2		7.6		0		9.0
Miscellaneous, net	Miscellaneous, net	(18.0)		(26.2)		50.1		—		5.9		Miscellaneous, net	(26.4)		(36.2)		70.2		0		7.6
Other expense (income), net	Other expense (income), net	78.6		(24.5)		55.4		—		109.5		Other expense (income), net	122.2		(34.0)		84.5		0		172.7
(Loss) income from continuing operations before income taxes	(Loss) income from continuing operations before income taxes	(149.7)		(10.2)		21.0		—		(138.9)		(Loss) income from continuing operations before income taxes	(231.4)		3.4		44.4		0		(183.6)
(Benefit from) provision for income taxes	(Benefit from) provision for income taxes	(5.4)		0.4		4.4		—		(0.6)		(Benefit from) provision for income taxes	(36.8)		19.3		15.1		0		(2.4)
(Loss) income from continuing operations, net of taxes	(Loss) income from continuing operations, net of taxes	(144.3)		(10.6)		16.6		—		(138.3)		(Loss) income from continuing operations, net of taxes	(194.6)		(15.9)		29.3		0		(181.2)
Income from discontinued operations, net of taxes	Income from discontinued operations, net of taxes	—		—		2.3		—		2.3		Income from discontinued operations, net of taxes	0		0		2.0		0		2.0
Equity in income (loss) of subsidiaries	Equity in income (loss) of subsidiaries	8.5		11.7		—		(20.2)		—		Equity in income (loss) of subsidiaries	39.3		11.8		0		(51.1)		0
Net (loss) income	Net (loss) income	$	(135.8)	$	1.1	$	18.9	$	(20.2)	$	(136.0)	Net (loss) income	$	(155.3)	$	(4.1)	$	31.3	$	(51.1)	$	(179.2)
Other comprehensive income (loss)	Other comprehensive income (loss)	6.2		(1.2)		0.1		1.1		6.2		Other comprehensive income (loss)	6.7		2.7		(1.8)		(0.9)		6.7
Total comprehensive (loss) income	Total comprehensive (loss) income	$	(129.6)	$	(0.1)	$	19.0	$	(19.1)	$	(129.8)	Total comprehensive (loss) income	$	(148.6)	$	(1.4)	$	29.5	$	(52.0)	$	(172.5)

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows	Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows																					Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Six Months Ended June 30, 2020
Nine Months Ended September 30, 2020												Nine Months Ended September 30, 2020
		Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated			Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:	CASH FLOWS FROM OPERATING ACTIVITIES:											CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	Net cash (used in) provided by operating activities	$	(148.3)	$	14.6	$	(30.5)	$	—	$	(164.2)	Net cash (used in) provided by operating activities	$	(260.0)	$	6.6	$	(3.5)	$	0	$	(256.9)
CASH FLOWS FROM INVESTING ACTIVITIES:	CASH FLOWS FROM INVESTING ACTIVITIES:											CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash (used in) provided by investing activities		(2.7)		—		—		—		(2.7)
Net cash used in investing activities												Net cash used in investing activities	(6.0)		(0.5)		(0.9)		0		(7.4)

CASH FLOWS FROM FINANCING ACTIVITIES:	CASH FLOWS FROM FINANCING ACTIVITIES:											CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	Net decrease in short-term borrowings and overdraft	(1.3)		(6.2)		0.5		—		(7.0)		Net decrease in short-term borrowings and overdraft	2.5		(3.8)		0.6		0		(0.7)
Borrowings under the 2020 BrandCo Facilities	Borrowings under the 2020 BrandCo Facilities	880.0		—		—		—		880.0		Borrowings under the 2020 BrandCo Facilities	880.0		0		0		0		880.0
Repurchases of the 5.75% Senior Notes	Repurchases of the 5.75% Senior Notes	(99.6)		—		—		—		(99.6)		Repurchases of the 5.75% Senior Notes	(114.1)		0		0		0		(114.1)
Net borrowings under the Amended 2016 Revolving Credit Facility	Net borrowings under the Amended 2016 Revolving Credit Facility	(22.9)		—		—		—		(22.9)		Net borrowings under the Amended 2016 Revolving Credit Facility	19.5		0		0		0		19.5

Repayment of the 2019 Term Loan Facility		(200.0)		—		—		—		(200.0)
Net borrowings under the 2019 Term Loan Facility (a)												Net borrowings under the 2019 Term Loan Facility (a)	(200.0)		0		0		0		(200.0)
Repayments under the 2018 Foreign Asset-Based Term Loan	Repayments under the 2018 Foreign Asset-Based Term Loan	(31.4)				—		—		(31.4)		Repayments under the 2018 Foreign Asset-Based Term Loan	(31.4)		0		0		0		(31.4)
Repayments under the 2016 Term Loan Facility	Repayments under the 2016 Term Loan Facility	(6.9)		—		—		—		(6.9)		Repayments under the 2016 Term Loan Facility	(9.2)		0		0		0		(9.2)
Payment of financing costs	Payment of financing costs	(101.2)		—		—		—		(101.2)		Payment of financing costs	(109.4)		0		1.1		0		(108.3)
Tax withholdings related to net share settlements of restricted stock and RSUs	Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		—		—		—		(1.6)		Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		0		0		0		(1.6)
Other financing activities	Other financing activities	(1.0)		—		—		—		(1.0)		Other financing activities	(0.1)		(0.1)		(0.1)		0		(0.3)
Net cash provided by (used in) financing activities	Net cash provided by (used in) financing activities	414.1		(6.2)		0.5		—		408.4		Net cash provided by (used in) financing activities	436.2		(3.9)		1.6		0		433.9
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	—		(9.0)		6.9		—		(2.1)		Effect of exchange rate changes on cash, cash equivalents and restricted cash	0.4		2.0		(2.8)		0		(0.4)
Net increase (decrease) in cash, cash equivalents and restricted cash	Net increase (decrease) in cash, cash equivalents and restricted cash	263.1		(0.6)		(23.1)		—		239.4		Net increase (decrease) in cash, cash equivalents and restricted cash	170.6		4.2		(5.6)		0		169.2
Cash, cash equivalents and restricted cash at beginning of period	Cash, cash equivalents and restricted cash at beginning of period	$	1.0	$	6.4	$	97.2	$	—	$	104.5	Cash, cash equivalents and restricted cash at beginning of period	$	1.0	$	6.4	$	97.2	$	0	$	104.5
Cash, cash equivalents and restricted cash at end of period	Cash, cash equivalents and restricted cash at end of period	$	264.1	$	5.8	$	74.1	$	—	$	343.9	Cash, cash equivalents and restricted cash at end of period	$	171.6	$	10.6	$	91.6	$	0	$	273.7

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)


Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows	Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows																					Products Corporation and Subsidiaries Condensed Consolidating Statements of Cash Flows
Six Months Ended June 30, 2019
Nine Months Ended September 30, 2019												Nine Months Ended September 30, 2019
		Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated			Products Corporation		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations		Consolidated
CASH FLOWS FROM OPERATING ACTIVITIES:	CASH FLOWS FROM OPERATING ACTIVITIES:											CASH FLOWS FROM OPERATING ACTIVITIES:
Net cash (used in) provided by operating activities	Net cash (used in) provided by operating activities	$	(36.8)	$	4.8	$	(9.2)	$	—	$	(41.2)	Net cash (used in) provided by operating activities	$	(169.1)	$	5.6	$	(3.3)	$	0	$	(166.8)
CASH FLOWS FROM INVESTING ACTIVITIES:	CASH FLOWS FROM INVESTING ACTIVITIES:											CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities	Net cash used in investing activities	(6.3)		(1.2)		(4.7)		—		(12.2)		Net cash used in investing activities	(10.9)		(2.0)		(7.1)		0		(20.0)
CASH FLOWS FROM FINANCING ACTIVITIES:	CASH FLOWS FROM FINANCING ACTIVITIES:											CASH FLOWS FROM FINANCING ACTIVITIES:
Net decrease in short-term borrowings and overdraft	Net decrease in short-term borrowings and overdraft	(9.7)		(6.6)		(2.5)		—		(18.8)		Net decrease in short-term borrowings and overdraft	(11.5)		(7.2)		(3.7)		0		(22.4)
Net borrowings under the Amended 2016 Revolving Credit Facility												Net borrowings under the Amended 2016 Revolving Credit Facility	13.4		0		0		0		13.4
Net borrowings under the 2019 Term Loan Facility (a)												Net borrowings under the 2019 Term Loan Facility (a)	200.0		0		0		0		200.0
Repayments under the 2016 Term Loan Facility	Repayments under the 2016 Term Loan Facility	(9.0)		—		—		—		(9.0)		Repayments under the 2016 Term Loan Facility	(13.5)		0		0		0		(13.5)

Net borrowings under the Amended 2016 Revolving Credit Facility		59.9		—		—		—		59.9

Payments of financing costs	Payments of financing costs	(0.8)		—		(0.6)		—		(1.4)		Payments of financing costs	(12.2)		0		(1.2)		0		(13.4)
Tax withholdings related to net share settlements of restricted stock and RSUs	Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		—		—		—		(1.6)		Tax withholdings related to net share settlements of restricted stock and RSUs	(1.6)		0		0		0		(1.6)
Other financing activities	Other financing activities	(0.4)		—		(0.1)		—		(0.5)		Other financing activities	(0.6)		(0.1)		(0.2)		0		(0.9)
Net cash provided by financing activities		38.4		(6.6)		(3.2)		—		28.6
Net cash provided by (used in) financing activities												Net cash provided by (used in) financing activities	174.0		(7.3)		(5.1)		0		161.6
Effect of exchange rate changes on cash, cash equivalents and restricted cash	Effect of exchange rate changes on cash, cash equivalents and restricted cash	—		0.1		0.4		—		0.5		Effect of exchange rate changes on cash, cash equivalents and restricted cash	0		0.4		(1.8)		0		(1.4)
Net decrease in cash, cash equivalents and restricted cash	Net decrease in cash, cash equivalents and restricted cash	(4.7)		(2.9)		(16.7)		—		(24.3)		Net decrease in cash, cash equivalents and restricted cash	(6.0)		(3.3)		(17.3)		0		(26.6)
Cash, cash equivalents and restricted cash at beginning of period	Cash, cash equivalents and restricted cash at beginning of period	$	7.2	$	6.6	$	73.7	$	—	87.5		Cash, cash equivalents and restricted cash at beginning of period	$	7.2	$	6.6	$	73.7	$	0	87.5
Cash, cash equivalents and restricted cash at end of period	Cash, cash equivalents and restricted cash at end of period	$	2.5	$	3.7	$	57.0	$	—	$	63.2	Cash, cash equivalents and restricted cash at end of period	$	1.2	$	3.3	$	56.4	$	0	$	60.9

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

19. SUBSEQUENT EVENTS

5.75% Senior Notes Exchange Offer

On ~~July 27,~~October 23, 2020, Products Corporation ~~commenced an offer~~amended its previously-announced Exchange Offer to exchange ~~(the “Exchange Offer”)~~ any and all of ~~its $387.2 million~~the then-outstanding $342,785,000 in aggregate principal amount of ~~outstanding~~ its Existing 5.75% Senior Notes, ~~due 2021 (the “Existing Notes”) for a combination of~~ ~~5.75%~~ ~~Senior Notes due February 15, 2024 (the “New Notes”) and an Early Tender/Consent Fee, payable in cash, upon the terms and conditions set forth~~as described in the ~~confidential~~amended and restated Offering Memorandum and Consent Solicitation Statement (the “Offering Memorandum”), dated ~~July 27,~~October 23, 2020, which Exchange Offer closed on November 13, 2020. ~~The New Notes will be senior unsecured notes with terms substantially the same as those of the Existing Notes, with certain adjustments specified in the Offering Memorandum.~~ Concurrently with the Exchange Offer, ~~the Company is soliciting~~Products Corporation solicited consents (the “Consent Solicitation”) to eliminate substantially all of the restrictive covenants and certain events of default ~~with respect to~~provisions from the ~~Existing Notes.~~indenture governing the 5.75% Senior Notes (the “5.75% Senior Notes Indenture”).

~~Unless earlier terminated or extended, the Exchange Offer will expire at 11:59 p.m. E.D.T. on August 21, 2020.~~ For each $1,000 principal amount of ~~Existing~~5.75% Senior Notes validly tendered, holders received either, at their option, (i) $275 in cash (plus a $50 early tender/consent fee payable if such 5.75% Senior Notes are tendered at or before 11:59 p.m. New York City time, on November 10, 2020 (the "Expiration Time"), for an aggregate of $325 in cash, or (ii) a combination of (1) $200 in cash (plus a $50 early tender/consent fee payable if such 5.75% Senior Notes are tendered at or before the Expiration Time), for an aggregate of $250 in cash, plus, (2) (A) the Per $1,000 Pro Rata Share of $50 million aggregate principal amount of new 2020 ABL FILO Term Loans and (B) the Per $1,000 Pro Rata Share of $75 million aggregate principal amount of the New BrandCo Second-Lien Term Loans, if the holder is: (a)(i) a qualified institutional buyer as defined in Rule 144A under the Securities Act; (ii) an institutional accredited investor within the meaning of Rule 501(a)(1), (a)(2), (a)(3) or (a)(7) of the Securities Act; or (iii) a person that is not a “U.S. person” within the meaning of Regulation S under the Securities Act, (b) not a natural person and (c) not a “Disqualified Institution” (as defined under the Amended 2016 Revolving Credit Facility and related security documents and intercreditor agreements or the 2020 BrandCo Term Loan Facility and related security documents and intercreditor agreements).

On November 13, 2020, the Company announced that the Exchange Offer was successfully consummated and that Products Corporation had accepted $236 million in aggregate principal amount of 5.75% Senior Notes tendered ~~into~~in the Exchange Offer. Products Corporation used cash on hand to redeem, effective as of November 13, 2020, the remaining $106.8 million in aggregate principal amount of 5.75% Senior Notes pursuant to the terms of the 5.75% Senior Notes Indenture. Following the consummation of the Exchange Offer and the satisfaction and discharge of the remaining 5.75% Senior Notes, 0 5.75% Senior Notes remained outstanding. Accrued and unpaid interest on the 5.75% Senior Notes that were tendered in the Exchange Offer was paid to, but not including, the settlement date of the Exchange Offer.

The 2020 ABL FILO Term Loans are new “Tranche B” term loans in the aggregate principal amount of $50 million, ranking junior in right of payment to the “Tranche A” revolving loans under the Amended 2016 Revolving Credit Agreement and equal in right of payment with all existing and future unsubordinated indebtedness of Products Corporation and the guarantors under the Amended 2016 Revolving Credit Agreement (such new Tranche B term loans, the “2020 ABL FILO Term Loans”). The 2020 ABL FILO Term Loans will mature six months after the maturity date of the Tranche A Loans (and any extension thereof in part or in whole). The 2020 ABL FILO Term Loans bear interest at a rate of LIBOR (subject to a 1.75% floor) plus 8.50% per annum, accruing from the settlement date of the Exchange Offer. The borrowing base for the 2020 ABL FILO Term Loans consists of an advance rate of 100% of eligible collateral with a customary push down reserve, with collateral consisting of: (i) a first-priority lien on accounts receivable, inventory, cash, negotiable instruments, chattel paper, investment property (other than capital stock), equipment and real property of Products Corporation and the subsidiary guarantors, subject to customary exceptions (the “Priority Collateral”); and (ii) a second-priority lien on substantially all tangible and intangible personal property of Products Corporation and the subsidiary guarantors, subject to customary exclusions (other than the Priority Collateral).

The New BrandCo Second Lien Term Loans are “Term B-2 Loans” in the aggregate principal amount of $75 million (ranking junior to the Term B-1 Loans and senior to the Term B-3 Loans with respect to liens on certain specified collateral) under the 2020 BrandCo Term Loan Facility (such Term B-2 Loans, the “New BrandCo Second-Lien Term Loans”). See Note 7, “Debt,” and Note 19, “Subsequent Events,” regarding the 2020 BrandCo Refinancing Transactions for further details and amounts outstanding under the 2020 BrandCo Credit Agreement).

In conjunction with the Exchange Offer, Products Corporation conducted the Consent Solicitation ~~prior~~to effectuate amendments to the ~~early tender deadline~~5.75% Senior Notes Indenture, which eliminated substantially all of ~~5:00 p.m. E.D.T. on August 7,~~the restrictive covenants and certain events of default provisions from the 5.75% Senior Notes Indenture.

Table of Contents

COMBINED NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(except where otherwise noted, all tabular amounts in millions, except share and per share amounts)

Amendment No. 1 to BrandCo Credit Agreement

On November 13, 2020, ~~holders~~Products Corporation entered into that certain Amendment No. 1 (the “BrandCo Amendment”) to the 2020 BrandCo Credit Agreement in connection with the Exchange Offer in order to, among other things, provide for the incurrence of ~~Existing Notes will receive $750~~$75 million in aggregate principal amount of New ~~Notes~~BrandCo Second-Lien Term Loans. The New BrandCo Second Lien Term Loans are a separate tranche of “Term B-2 Loans” (ranking junior to the Term B-1 Loans and ~~$50~~senior to the Term B-3 Loans with respect to liens on certain specified collateral) under the BrandCo Credit Agreement. Except as to the use of ~~cash as an early tender/consent fee. Holders who tender their Existing Notes after~~proceeds, the ~~early tender deadline will receive only $750 principal amount~~terms of the New BrandCo Second-Lien Term Loans are substantially consistent with the other Term B-2 Loans. In connection with the BrandCo Amendment, Products Corporation paid certain fees to the lenders in-kind in the form of New ~~Notes for each $1,000 principal amount of Existing Notes tendered.~~BrandCo Second-Lien Term Loans in accordance with the BrandCo TSA.

Amendment to Credit Facilities; New Tranche B ABL FILO Term Loan Facility

On October 23, 2020 (the “5th Amendment Effective Date”), Products Corporation entered into Amendment No. 5 (the “5th Amendment”) to the Amended 2016 Revolving Credit Agreement.

The ~~Exchange Offer~~5th Amendment amended and ~~Consent Solicitation are subject~~restated the Amended 2016 Revolving Credit Agreement to ~~the following conditions precedent: (i) the valid tender without valid withdrawal~~add a new Tranche B consisting of ~~not less than 95% of the~~$50 million aggregate ~~outstanding~~ principal amount of ~~Existing Notes (and~~“first-in, last-out” Tranche B term loans (such new Tranche B, the ~~provision~~“2020 ABL FILO Term Loan Facility” and the loans incurred thereunder, the “2020 ABL FILO Term Loans”). The 5th Amendment also required Products Corporation to maintain "Excess Availability" (as defined in the 5th Amendment) of ~~the related Consents for such tendered Existing Notes); (ii) the receipt of all necessary consents~~at least $85 million from the ~~lenders under~~5th Amendment Effective Date until the ~~Company’s term and revolving credit agreements required in order to consummate~~transactions contemplated by the Exchange Offer were consummated (such date, the “Exchange Offer Effective Date”). As a result, on October 23, 2020, Products Corporation repaid $35 million of Tranche A loans under the Amended 2016 Revolving Credit Agreement.

On the Exchange Offer Effective Date, Products Corporation’s As-Adjusted Liquidity was required to be at least $175 million (which condition was satisfied) and ~~Consent Solicitation; (iii) the receipt of requisite consents~~Products Corporation cannot hold more than $100 million in cash or Cash Equivalents (as defined in the ~~Consent Solicitation;~~5th Amendment). Furthermore, the 5th Amendment provides that a $30 million reserve will be automatically and ~~(iv) various other~~immediately established against the Tranche A Borrowing Base (as defined in the 5th Amendment) if the results of ongoing appraisals and field exams are not delivered to the administrative agent prior to the occurrence of certain specified defaults.

Products Corporation will pay customary ~~conditions precedent.The conditions precedent are~~fees to Alter Domus (US) LLC as the administrative agent for the ~~sole benefit~~2020 ABL FILO Term Loan Facility. Except as to maturity date, interest, borrowing base and differences due to their nature as term loans, the terms of the ~~Company~~2020 ABL FILO Term Loans are otherwise substantially consistent with the Tranche A Revolving Loans.

COVID-19-Related Compensation Actions

In November 2020, the Compensation Committee of Revlon’s Board of Directors ratified the following changes to the previously-disclosed COVID-19-related compensation arrangements for certain members of management and ~~may be amended or waived,~~the Board: (i) the determination by Mr. Alan Bernikow, in ~~whole or in part, at any time, in the sole and absolute discretion~~his role as Chairman of the ~~Company, subject~~Compensation Committee, to ~~applicable law.~~reinstate Ms. Perelman’s annual base salary back to its pre-pandemic level of $1,125,000 per annum, pursuant to the Board’s delegation of such authority to Mr. Bernikow at the time such reductions were implemented in April 2020; and (ii) the determinations by Ms. Perelman, in her role as the Company’s President and Chief Executive Officer, to reinstate (A) the annual retainer fees for non-employee Board members, Audit Committee members and the chairmen of the Audit Committee and the Compensation Committee to their pre-pandemic levels (i.e., $115,000 per annum for Revlon Board members, $25,000 per annum for Products Corporation’s Board members, $10,000 per annum for Audit Committee members and $10,000 per annum for the chairman of each of the Audit Committee and Compensation Committee) and (B) the annual base salaries for certain members of the Company’s Executive Leadership Team back to their respective pre-pandemic levels, pursuant to the Board’s delegation of such authority to Ms. Perelman at the time such reductions were implemented in April 2020.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Item 2. Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations

RECENT DEVELOPMENTS

Liquidity and Ability to Continue as a Going Concern

As previously disclosed, on October 23, 2020, Products Corporation commenced an amended exchange offer (as amended, the “Exchange Offer”) to exchange any and all of its outstanding 5.75% Senior Notes due 2021 (the “5.75% Senior Notes”), which closed on November 13, 2020. In the Exchange Offer, for each $1,000 principal amount of 5.75% Senior Notes validly tendered, holders received either, at their option, (i) $275 in cash (plus a $50 early tender/consent fee payable if such 5.75% Senior Notes were tendered at or before 11:59 p.m. New York City time on November 10, 2020 (the “Expiration Time”)), for an aggregate of $325 in cash (the “Cash Consideration”), or (ii) a combination of (1) $200 in cash (plus a $50 early tender/consent fee payable if such 5.75% Senior Notes were tendered at or before the Expiration Time), for an aggregate of $250 in cash, plus, (2) (A) the Per $1,000 Pro Rata Share (as hereinafter defined) of $50 million aggregate principal amount of new 2020 ABL FILO Term Loans (as hereinafter defined) and (B) the Per $1,000 Pro Rata Share of $75 million aggregate principal amount of the New BrandCo Second-Lien Term Loans (the “Mixed Consideration” and such loans, together with the 2020 ABL FILO Term Loans, the “New Loans”), if the holder is: (a)(i) a qualified institutional buyer as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”); (ii) an institutional accredited investor within the meaning of Rule 501(a)(1), (a)(2), (a)(3) or (a)(7) of the Securities Act; or (iii) a person that is not a “U.S. person” within the meaning of Regulation S under the Securities Act, (b) not a natural person and (c) not a “Disqualified Institution” (as defined under the Amended 2016 Revolving Credit Facility and related security documents and intercreditor agreements or the 2020 BrandCo Term Loan Facility and related security documents and intercreditor agreements) (an “Eligible Holder”). The “Per $1,000 Pro Rata Share” is (1) $1,000, divided by (2) the aggregate principal amount of 5.75% Senior Notes tendered for Mixed Consideration by all Eligible Holders and accepted for payment by Products Corporation.

For more information, please see the risk factors discussed in Part II, Item 1A. “Risk Factors” of this Quarterly Report on Form 10-Q.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

5.75% Senior Notes Exchange Offer

On October 23, 2020, Products Corporation amended its previously-announced Exchange Offer to exchange any and all of the then-outstanding $342,785,000 in aggregate principal amount of its Existing 5.75% Senior Notes, as described in the amended and restated Offering Memorandum and Consent Solicitation Statement (the “Offering Memorandum”), dated October 23, 2020, which Exchange Offer closed on November 13, 2020. Concurrently with the Exchange Offer, Products Corporation solicited consents to eliminate substantially all of the restrictive covenants and certain events of default provisions from the indenture governing the 5.75% Senior Notes (the “5.75% Senior Notes Indenture”).

For each $1,000 principal amount of 5.75% Senior Notes validly tendered, holders received either, at their option, (i) $275 in cash (plus a $50 early tender/consent fee payable if such 5.75% Senior Notes are tendered at or before 11:59 p.m. New York City time, on November 10, 2020 (the "Expiration Time"), for an aggregate of $325 in cash, or (ii) a combination of (1) $200 in cash (plus a $50 early tender/consent fee payable if such 5.75% Senior Notes are tendered at or before the Expiration Time), for an aggregate of $250 in cash, plus, (2) (A) the Per $1,000 Pro Rata Share of $50 million aggregate principal amount of new 2020 ABL FILO Term Loans and (B) the Per $1,000 Pro Rata Share of $75 million aggregate principal amount of the New BrandCo Second-Lien Term Loans, if the holder is an Eligible Holder.

On November 13, 2020, the Company announced that the Exchange Offer was successfully consummated and that Products Corporation had accepted $236 million in aggregate principal amount of 5.75% Senior Notes tendered in the Exchange Offer. Products Corporation used cash on hand to redeem, effective as of November 13, 2020, the remaining $106.8 million in aggregate principal amount of 5.75% Senior Notes pursuant to the terms of the 5.75% Senior Notes Indenture. Following the consummation of the Exchange Offer and the satisfaction and discharge of the remaining 5.75% Senior Notes, no 5.75% Senior Notes remained outstanding. Accrued and unpaid interest on the 5.75% Senior Notes that were tendered in the Exchange Offer was paid to, but not including, the settlement date of the Exchange Offer.

In conjunction with the Exchange Offer, Products Corporation conducted the Consent Solicitation to effectuate amendments to the 5.75% Senior Notes Indenture, which eliminated substantially all of the restrictive covenants and certain events of default provisions from the 5.75% Senior Notes Indenture.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Amendment No. 1 to BrandCo Credit Agreement

Amendment to Credit Facilities; New Tranche B ABL FILO Term Loan Facility

On October 23, 2020 (the “5th Amendment Effective Date”), Products Corporation entered into Amendment No. 5 (the “5th Amendment”) to the Amended 2016 Revolving Credit Agreement.

The 5th Amendment amended and restated the Amended 2016 Revolving Credit Agreement to add a new Tranche B consisting of $50 million aggregate principal amount of “first-in, last-out” Tranche B term loans (such new Tranche B, the “2020 ABL FILO Term Loan Facility” and the loans incurred thereunder, the “2020 ABL FILO Term Loans”). The 5th Amendment also required Products Corporation to maintain "Excess Availability" (as defined in the 5th Amendment) of at least $85 million from the 5th Amendment Effective Date until the transactions contemplated by the Exchange Offer were consummated (such date, the “Exchange Offer Effective Date”). As a result, on October 23, 2020, Products Corporation repaid $35 million of Tranche A loans under the Amended 2016 Revolving Credit Agreement.

On the Exchange Offer Effective Date, Products Corporation’s As-Adjusted Liquidity was required to be at least $175 million (which condition was satisfied) and Products Corporation cannot hold more than $100 million in cash or Cash Equivalents (as defined in the 5th Amendment). Furthermore, the 5th Amendment provides that a $30 million reserve will be automatically and immediately established against the Tranche A Borrowing Base (as defined in the 5th Amendment) if the results of ongoing appraisals and field exams are not delivered to the administrative agent prior to the occurrence of certain specified defaults.

Products Corporation will pay customary fees to Alter Domus (US) LLC as the administrative agent for the 2020 ABL FILO Term Loan Facility. Except as to maturity date, interest, borrowing base and differences due to their nature as term loans, the terms of the 2020 ABL FILO Term Loans are otherwise substantially consistent with the Tranche A Revolving Loans.

COVID-19-Related Compensation Actions

In November 2020, the Compensation Committee of Revlon’s Board of Directors ratified the following changes to the previously-disclosed COVID-19-related compensation arrangements for certain members of management and the Board: (i) the determination by Mr. Alan Bernikow, in his role as Chairman of the Compensation Committee, to reinstate Ms. Perelman’s annual base salary back to its pre-pandemic level of $1,125,000 per annum, pursuant to the Board’s delegation of such authority to Mr. Bernikow at the time such reductions were implemented in April 2020; and (ii) the determinations by Ms. Perelman, in her role as the Company’s President and Chief Executive Officer, to reinstate (A) the annual retainer fees for non-employee Board members, Audit Committee members and the chairmen of the Audit Committee and the Compensation Committee to their pre-pandemic levels (i.e., $115,000 per annum for Revlon Board members, $25,000 per annum for Products Corporation’s Board members, $10,000 per annum for Audit Committee members and $10,000 per annum for the chairman of each of the Audit Committee and Compensation Committee) and (B) the annual base salaries for certain members of the Company’s Executive Leadership Team back to their respective pre-pandemic levels, pursuant to the Board’s delegation of such authority to Ms. Perelman at the time such reductions were implemented in April 2020.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Overview

Overview of the Business

Revlon, Inc. ("Revlon" and together with its subsidiaries, the "Company") conducts its business exclusively through its direct wholly-owned operating subsidiary, Revlon Consumer Products Corporation ("Products Corporation"), and its subsidiaries. Revlon is an indirect majority-owned subsidiary of MacAndrews & Forbes Incorporated (together with certain of its affiliates other than the Company, "MacAndrews & Forbes"), a corporation beneficially owned by Ronald O. Perelman.

The Company operates in four brand-centric reporting segments that are aligned with its organizational structure based on four global brand teams: Revlon; Elizabeth Arden; Portfolio; and Fragrances. The Company manufactures, markets and sells an extensive array of beauty and personal care products worldwide, including color cosmetics; fragrances; skin care; hair color, hair care and hair treatments; beauty tools; men's grooming products; anti-perspirant deodorants; and other beauty care products.

Business Strategy

The Company remains focused on its 3 key strategic pillars to drive its future success and growth. First, strengthening its iconic brands through innovation and relevant product portfolios; second, building its capabilities to better communicate and connect with its consumers through media channels where they spend the most time; and third, ensuring availability of its products where consumers shop, both in-store and increasingly online. The Company also continues to deliver against the objectives of the Revlon 2020 Restructuring Program, which includes rightsizing our organization with the objectives of driving improved profitability, cash flow and liquidity. The Company is also managing the business to conserve cash and liquidity, as well as focusing on stabilizing the business, growing e-commerce and preparing the foundation for achieving future growth.

Strategic Review

In August 2019, it was disclosed that MacAndrews & Forbes and the Company determined to explore strategic transactions involving the Company and third parties. This review is ongoing and remains focused on exploring potential options for the Company's portfolio and regional brands (the “Strategic Review”).

COVID-19 Impact on the Company’s Business

While the Company continues to execute its business strategy, the ongoing and prolonged COVID-19 pandemic has adversely impacted net sales in all major commercial regions around the globe that are important to the Company's business. COVID-19’s adverse impact on the global economy has contributed to significant and extended quarantines, stay-at-home orders and other social distancing measures; closures and bankruptcies of retailers, beauty salons, spas, offices and manufacturing facilities; increased levels of unemployment; travel and transportation restrictions leading to declines in consumer traffic in key shopping and tourist areas around the globe; and import and export restrictions. These adverse economic conditions have resulted in the general slowdown of the global economy, in turn contributing to a significant decline in net sales within each of the Company’s reporting segments and ~~regions.~~regions. As the Company currently expects that the COVID-19 pandemic, including the impact of the pandemic’s “second wave,” will continue to impact its business going forward, the Company will continue to closely monitor the associated impacts and take appropriate actions in an effort to mitigate COVID-19’s negative effects on the Company’s operations and financial results.

The ongoing and prolonged COVID-19 pandemic has continued to adversely impact the Company’s business in Q3 2020, as social-distancing restrictions and related actions designed to curb the spread of the virus have remained in place or have been reinstated as the COVID-19 pandemic spikes across the globe. These restrictions could continue for the foreseeable future, as global economies face a “second-wave” of the pandemic as re-opening plans are implemented.

The ongoing and prolonged COVID-19 pandemic contributed an estimated ~~$214~~$119 million ($~~217~~119 million "XFX," as hereinafter defined), to the Company's ~~$222.6~~$119.7 million decline in net sales for the three months ended ~~June~~September 30, 2020, compared to the prior year quarter, and an estimated ~~$268~~$387 million ($~~272~~392 million XFX) to the Company's ~~$322.8~~$442.5 million decline in net sales for the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. ~~These declines were partially offset by~~During the three months ended September 30, 2020, the Company experienced increased net sales of ~~Revlon~~Revlon-branded beauty tools, Revlon hair color products and certain Elizabeth Arden skincare ~~and fragrances~~products in certain markets, as well as ~~continued strong~~ growth in the Company's e-commerce net sales.

~~For the second quarter of 2020, Revlon segment net sales declined~~ ~~$116.5 million~~ (~~$113.5 million~~ ~~XFX) versus the prior year quarter, with COVID-19 contributing an estimated $115 million ($116 million XFX) to such decline. This net sales decline was partially offset by increased net sales of~~ ~~Revlon-branded~~ ~~beauty tools and~~ ~~Revlon~~ hair color products in North America. COVID-19 had a similar negative impact on the Company's other reporting segments over such period, with COVID-19 contributing (i) an estimated $34 million ($35 million XFX) to a ~~$36.5 million~~ (~~$34.7 million~~ ~~XFX) decline in the Elizabeth Arden segment, (ii) an estimated $30 million ($31 million XFX) to a~~ ~~$30.2 million~~ (~~$27.9 million~~ ~~XFX) decline in the Portfolio segment and (iii) an estimated $34 million ($35 million XFX) to a~~ ~~$39.4 million~~ ~~($38.5 million XFX) decline in the Fragrances segment. Within the Company's Portfolio Segment, during the second quarter of 2020 both the~~ ~~Cutex~~ ~~and~~ ~~Creme of Natur~~e

5258

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~brands~~For the third quarter of 2020, Revlon segment net sales declined $51.3 million ($51.9 million XFX) versus the prior year quarter, with the ongoing and prolonged COVID-19 pandemic contributing an estimated $50 million ($50 million XFX) to such decline. During the third quarter of 2020, the Revlon segment experienced ~~double digit~~ increased net sales of Revlon-branded beauty tools and hair color products in North America. COVID-19 had a similar negative impact on the Company's other reporting segments over such period, with COVID-19 contributing: (i) an estimated $25 million ($25 million XFX) to a $32.9 million ($33.1 million XFX) decline in the Fragrances segment; (ii) an estimated $24 million ($25 million XFX) to a $16.9 million ($18.4 million XFX) decline in the Elizabeth Arden segment; and (iii) an estimated $19 million ($19 million XFX) to a $18.6 million ($19.1 million XFX) decline in the Portfolio segment. Within the Company's Portfolio segment, during the third quarter of 2020 the Creme of Nature brand continued to deliver net sales growth versus the ~~second~~third quarter of 2019, driven by increased demand due to a shift in consumer buying preferences.

On a regional basis, the ongoing and prolonged COVID-19 pandemic had a similar negative impact on the Company's North America and International regions during the ~~second~~third quarter of 2020. Of a ~~$109.6~~$43.5 million ($~~109.1~~43.2 million XFX) decline in the Company's net sales in its North America region during the ~~second~~third quarter of 2020 compared to the ~~second~~third quarter of 2019, COVID-19 contributed an estimated ~~$104~~$47 million ($~~104~~47 million XFX) to such decline. Similarly, of a ~~$113.0~~$76.2 million ($~~105.5~~79.3 million XFX) decline in the Company's net sales in its International region over such period, COVID-19 contributed an estimated ~~$110~~$72 million ($~~113~~72 million XFX) to such decline. ~~This net sales decline was partially offset by~~ During the third quarter of 2020, on a regional basis, the Company also experienced increased net sales of Revlon-branded beauty tools, Revlon hair color products and certain Elizabeth Arden skincare products, predominantly in China, as well as growth in ~~Cutex~~certain local and ~~CND~~ ~~nail care products~~regional brands in various markets.

For the ~~six~~nine months ended ~~June~~September 30, 2020, Revlon segment net sales declined $~~182.0~~233.3 million ($~~175.5~~227.4 million XFX) versus the prior year period, with the ongoing and prolonged COVID-19 pandemic contributing an estimated ~~$135~~$174 million ($~~137~~176 million XFX) to such decline. ~~This net sales decline was partially offset by~~ During the nine months ended September 30, 2020, the Revlon segment experienced increased net sales of Revlon-branded beauty tools and Revlon hair color products in North America. COVID-19 had a similar negative impact on the Company's other reporting segments over such period, with COVID-19 contributing: (i) an estimated ~~$56~~$93 million ($5795 million XFX) to a $~~52.7~~69.6 million ($~~48.4~~66.8 million XFX) decline in the Elizabeth Arden segment, partially offset by higher net sales of Ceramide skin care ~~products internationally;~~products; (ii) an estimated ~~$37~~$65 million ($3765 million XFX) to a $~~37.4~~83.6 million ($~~33.1~~82.0 million XFX) decline in the Fragrances segment; and (iii) an estimated $56 million ($56 million XFX) to a $56.0 million ($52.2 million XFX) decline in the Portfolio ~~segment; and (iii) an estimated $40 million ($41 million XFX) to a~~ ~~$50.7 million~~ (~~$48.9 million~~ ~~XFX) decline in the Fragrances~~ segment.

On a regional basis, the ongoing and prolonged COVID-19 pandemic had a similar negative impact on the Company's North America and International regions during the ~~six~~nine months ended ~~June~~September 30, 2020. Of a ~~$154.8~~$198.3 million ($~~154.2~~197.3 million XFX) decline in the Company’s net sales in its North America region during the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period, COVID-19 contributed an estimated ~~$116~~$162 million ($~~116~~163 million XFX) to such decline. Similarly, of a ~~$168.0~~$244.2 million ($~~151.8~~231.1 million XFX) decline in the Company’s net sales in its International region over such period, COVID-19 contributed an estimated ~~$152~~$225 million ($~~156~~229 million XFX) to such decline. ~~This net sales decline was partially offset by~~ During the nine months ended September 30, 2020, on a regional basis, the Company also experienced increased net sales of Revlon-branded beauty tools, Revlon hair color products and certain Elizabeth Arden skincare products, predominantly in China, as well as growth in Cutex nail care products, ~~as well as~~ ~~Creme of Nature~~ ~~products~~ ~~among~~and certain local and regional brands, in certain markets.

In April 2020, the Company took several cost reduction measures designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on ~~the Company’s~~its net sales, including, without limitation: (i) reducing brand support, as a result of the abrupt decline in retail store traffic; (ii) continuing to monitor the Company’s sales and order flow and periodically scaling down operations and cancelling promotional programs; and (iii) closely managing cash flow and liquidity and prioritizing cash to minimize COVID-19’s impact on the Company’s production capabilities. In April 2020, the Company also implemented various organizational interim measures designed to reduce costs in response to COVID-19, including, without limitation: (i) switching to a reduced work week in the U.S. and in the Company's international locations and reducing executive and employee compensation in the range of 20% to 40%; (ii) furloughing approximately 40% of the Company’s U.S.-based office-based employees and 30% factory-based employees, as well as employees in a majority of the Company's other locations; (iii) suspending the Company’s 2020 merit base salary increases, discretionary profit sharing contributions and matching contributions to the Company’s 401(k) plan; (iv) reducing Board and committee compensation by 50% and eliminating Board and committee meeting fees; and (v) suspending or terminating services and payments under consulting agreements with certain directors. ~~With~~During the third quarter of 2020, the Company started to gradually roll back some of these measures especially with regards to some of the employees previously furloughed and/or on a reduced work week. With most of these measures still in place, including the Revlon 2020 Restructuring Program, the Company achieved cost reductions of approximately ~~$105~~$78 million and ~~$153~~$231 million during the three and ~~six~~nine months ended ~~June~~September 30, 2020, respectively, that have substantially offset the impact of the decline in the Company's net sales over such period. However, with the ongoing and prolonged COVID-19

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

pandemic, these mitigation actions may not prove to be effective in insulating the Company from any further damaging economic ~~impact of this~~impacts from the pandemic.

For additional information regarding the Company's business, see "Part 1, Item 1 - Business" in the Company's 2019 Form 10-K. Certain capitalized terms used in this Form 10-Q are defined throughout this Item 2.

Overview of Net Sales and Earnings Results

Consolidated net sales in the ~~second~~third quarter of 2020 were ~~$347.6~~$477.1 million, a ~~$222.6~~$119.7 million decrease, or ~~39.0%~~20.1%, compared to ~~$570.2~~$596.8 million in the ~~second~~third quarter of 2019. Excluding the ~~$8.0~~$2.8 million ~~unfavorable~~favorable impact of foreign currency fluctuations (referred to herein as "FX," "XFX" or on an "XFX basis"), consolidated net sales decreased by ~~$214.6~~$122.5 million, or ~~37.6%~~20.5%, during the ~~second~~third quarter of 2020. The ongoing and prolonged COVID-19 pandemic contributed an estimated ~~$214~~$119 million ($~~217~~119 million XFX), to the Company's $~~222.6~~$119.7 million decline in net sales in the three months ended ~~June~~September 30, 2020, compared to the three months ended ~~June~~September 30, 2019. The XFX net sales decrease of ~~$214.6~~$122.5 million in the ~~second~~third quarter of 2020 was due to: a ~~$113.5~~$51.9 million, or ~~45.1%~~23.9%, decrease in

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

Revlon segment net sales; a ~~$38.5~~$33.1 million, or ~~46.6%~~24.0%, decrease in Fragrances segment net sales; a ~~$34.7~~$19.1 million, or ~~29.6%~~16.2%, decrease in Portfolio segment net sales; and a $18.4 million, or 14.9%, decrease in Elizabeth Arden segment net ~~sales; and a $27.9 million, or 23.5%, decrease in Portfolio segment net~~ sales.

Consolidated net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 were ~~$800.6~~$1,277.7 million, a ~~$322.8~~$442.5 million decrease, or ~~28.7%~~25.7%, compared to ~~$1,123.4~~$1,720.2 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$16.9~~$14.1 million unfavorable FX impact, consolidated net sales decreased by ~~$305.9~~$428.4 million, or ~~27.2%~~24.9%, during the ~~six~~nine months ended ~~June~~September 30, 2020. The ongoing and prolonged COVID-19 pandemic contributed an estimated ~~$268~~$387 million ($~~272~~392 million XFX), to the Company's ~~$322.8~~$442.5 million decline in net sales in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The XFX net sales decrease of ~~$305.9~~$428.4 million in the ~~six~~nine months ended ~~June~~September 30, 2020 was due to: a ~~$175.5~~$227.4 million, or ~~35.2%~~31.8%, decrease in Revlon segment net sales; a ~~$48.9~~$82.0 million, or ~~30.6%~~27.5%, decrease in Fragrances segment net sales; a ~~$48.4~~$66.8 million, or ~~21.2%~~19.0%, decrease in Elizabeth Arden segment net sales; and a ~~$33.1~~$52.2 million, or ~~14.0%~~14.7%, decrease in Portfolio segment net sales.

Consolidated loss from continuing operations, net of taxes, in the ~~second~~third quarter of 2020 was ~~$126.8~~$44.5 million, compared to ~~$65.3~~$44.4 million in the ~~second~~third quarter of 2019. The ~~$61.5~~$0.1 million increase in consolidated loss from continuing operations, net of taxes, in the second quarter of 2020 was primarily due to:

•$~~147.3~~85.0 million of lower gross profit, primarily due to the lower net sales in the ~~second~~third quarter of 2020, primarily as a result of the effects of COVID-19, compared the ~~second~~third quarter of 2019;

•a ~~$19.8 million increase in non-cash impairment charges recorded for the second quarter of 2020, primarily attributable to the effects of COVID-19~~, ~~compared to having had no impairment charges for the second quarter of 2019. This increase is attributable to non-cash impairment charges of~~ ~~$11.2 million~~ recorded on the Company's goodwill and to $8.6 million of non-cash impairment charges recorded on certain of the Company's indefinite-lived intangible assets following the Company's interim impairment assessments for the second quarter of 2020;

•a $17.5 million increase in restructuring charges, primarily related to higher expenditures under the Revlon 2020 Restructuring Program in the second quarter of 2020, compared to the expenditures incurred primarily under the 2018 Optimization Program in the second quarter of 2019;

•a $16.0 million net increase in other miscellaneous expenses, net, in the second quarter of 2020 compared to the second quarter of 2019, primarily due to financing fees expensed in connection with the 2020 Refinancing Transactions (as hereinafter defined);

•~~a $13.1~~$18.5 million increase in interest expense in the ~~second~~third quarter of 2020, compared to the ~~second~~third quarter of 2019, primarily due to higher weighted average ~~borrowings~~interest rates and higher weighted average ~~interest rates~~borrowings driven primarily by the 2020 BrandCo Term Loan Facility ~~and the 2019 Term Loan Facility (the latter of which was fully repaid in May 2020 using proceeds from the 2020 BrandCo Term Loan Facility)~~;

•a ~~$2.5~~$4.1 million increase in amortization of debt issuance costs in the ~~second~~third quarter of 2020, compared to the ~~second~~third quarter of 2019, primarily due to the additional debt issuance costs recorded and amortized in connection with the 2020 BrandCo Refinancing Transactions;

•a $4.0 million decrease in the benefit from income taxes in the third quarter of 2020 compared to the third quarter of 2019, primarily due to: (i) the mix and level of earnings; (ii) an increase in the U.S. tax on the Company's foreign earnings; and (iii) increased tax expense from return to provision adjustments, partially offset primarily by an increase in tax benefit from the net change in valuation allowances related to the recognition of previously unrecognized tax losses in Canada;

•$~~1.2~~0.8 million of higher acquisition, integration and divestiture costs in the ~~second~~third quarter of 2020, compared to the ~~second~~third quarter of 2019, relating to the amortization of the cash-based awards under Tier 1 and Tier 2 of the Revlon 2019 Transaction Incentive Program (the "2019 TIP"; see Note 11, "Stock Compensation Plan," to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q for additional details on the 2019 TIP); ~~and~~

•~~$1.1 million~~of unfavorable variance in foreign currency, resulting from $2.3 million in foreign currency losses during the second quarter of 2020, compared to $1.2 million in foreign currency losses during the second quarter of 2019;

with the foregoing partially offset by:

•$~~136.2~~54.7 million of lower SG&A expenses in the ~~second~~third quarter of 2020 compared to the ~~second~~third quarter of 2019, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as from the Revlon 2020 Restructuring Program;

•~~an $11.9 million increase in net gain on the early extinguishment of debt in the second quarter of 2020, compared to having had no gain in the second quarter of 2019,~~ ~~recorded upon the repurchase and cancellation of approximately $112.8 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes during the second quarter of 2020; and~~

5460

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

•a ~~$8.7~~$31.2 million increase in gain on the ~~benefit from income taxes~~early extinguishment of debt in the ~~second~~third quarter of 2020, compared to having had no gain in the third quarter of 2019, recorded upon the repurchase and cancellation of approximately $44.4 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes during the third quarter of 2020; and

•$17.4 millionof favorable variance in foreign currency, resulting from $9.8 million in foreign currency gains during the third quarter of 2020, compared to $7.6 million in foreign currency losses during the third quarter of 2019;

•a $4.3 million net decrease in other miscellaneous expenses, net, in the third quarter of 2020 compared to the ~~second~~third quarter of 2019, primarily due ~~to: (i)~~to the ~~increased loss from continuing operations before income taxes on which the tax benefit is recognized; (ii) the mix and level of earnings; and (iii) a reduction~~subsequent true-up in the ~~U.S. tax on~~third quarter of 2020 of financing fees previously expensed in 2020 in connection with the ~~Company's foreign earnings, offset by an increase~~2020 BrandCo Refinancing Transactions; and

•a $3.6 million decrease in ~~tax expense related~~restructuring charges, primarily due to ~~uncertain tax positions~~the subsequent true-up in the third quarter of 2020 of restructuring charges previously accrued in 2020 under the Revlon 2020 Restructuring Program, compared to the expenditures incurred primarily under the 2018 Optimization Program in the third quarter of 2019; and ~~by the net change in valuation allowances recorded related to increased net losses in certain state jurisdictions.~~

Consolidated loss from continuing operations, net of taxes, in the ~~six~~nine months ended ~~June~~September 30, 2020 was ~~$340.7~~$385.2 million, compared to consolidated loss from continuing operations, net of taxes, of ~~$141.1~~$185.5 million in the ~~six~~nine months ended ~~June~~September 30, 2019. The ~~$199.6~~$199.7 million increase in consolidated loss from continuing operations, net of taxes, in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to ~~six~~nine months ended ~~June~~September 30, 2019, was primarily due to:

•$~~207.5~~292.5 million of lower gross profit, primarily due to the COVID-19 related lower net sales in the ~~six~~nine months ended ~~June~~September 30, 2020;

•a $144.1 million increase in non-cash impairment charges recorded for the ~~six~~nine months ended ~~June~~September 30, 2020, primarily attributable to the effects of the ongoing and prolonged COVID-19 pandemic, compared to having had no impairment charges for the ~~six~~nine months ended ~~June~~September 30, 2019. This increase is attributable to non-cash impairment charges of $111.0 million recorded on the Company's goodwill and to $33.1 million of non-cash impairment charges recorded on certain of the Company's indefinite-lived intangible assets following the Company's interim impairment assessments during the first and second quarters of 2020~~all of which are primarily attributable to the effects of COVID-19;~~;

•a ~~$36.8~~$33.2 million increase in restructuring charges, primarily related to higher expenditures under the Revlon 2020 Restructuring Program in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the expenditures incurred primarily under the 2018 Optimization Program in the ~~six~~nine months ended ~~June 30, 2019;~~

•$17.5 million of unfavorable variance in foreign currency, resulting from $18.9 million in foreign currency losses during the six months ended June 30, 2020, compared to $1.4 million in foreign currency losses during the six months ended JuneSeptember 30, 2019;

•a ~~$13.8~~$32.3 million increase in interest expense in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period, ~~primarily due to~~ higher weighted average borrowings and higher weighted average interest rates driven primarily by the 2020 BrandCo Term Loan Facility and the 2019 Term Loan Facility (the latter of which was fully repaid in May 2020 using proceeds from the 2020 BrandCo Term Loan Facility);

•a $10.6 million net increase in other miscellaneous expenses, net, in the six months ended June 30, 2020 compared to the prior year period, primarily due to financing fees expensed in connection with the 2020 Refinancing Transactions;

•a ~~$3.3~~7.4 million increase in amortization of debt issuance costs in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period, primarily due to the additional debt issuance costs recorded and amortized in connection with the 2020 BrandCo Refinancing Transactions;

•a $6.3 million net increase in other miscellaneous expenses, net, in the nine months ended September 30, 2020, compared to the prior year period, primarily due to financing fees expensed in connection with the 2020 BrandCo Refinancing Transactions; and

•$~~2.7~~3.5 million of higher acquisition, integration and divestiture costs in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period, including $0.7 million in professional fees incurred in connection with the exploration of strategic transactions involving the Company and third parties pursuant to the Strategic Review and approximately ~~$2.6~~$3.5 million relating to the amortization of the cash-based awards under Tier 1 and Tier 2 of the Revlon 2019 TIP (see Note 11, "Stock Compensation Plan," to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q for additional details on the 2019 TIP);

with the foregoing partially offset by:

•$~~179.4~~234.1 million of lower SG&A expenses in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as from the Revlon 2020 Restructuring Program;

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

•a ~~$46.0~~$43.1 million increase in gain on the early extinguishment of debt in the nine months ended September 30, 2020, compared to having had no gain in the prior year period, primarily due to $31.2 million recorded during the third quarter of 2020 and $11.9 million recorded during the second quarter of 2020 upon the repurchase and subsequent cancellation of approximately $157.2 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes; and

•a $42.0 million increase in the benefit from income taxes in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period, primarily due to: (i) the increased loss from continuing operations before income taxes on which the tax benefit is recognized; (ii) the mix and level of earnings; and (iii) a reduction in the U.S. tax on the Company's foreign earnings, net of the impact of non-deductible impairment charges, partially offset by the net change in valuation allowances recorded related to the limitation on the deductibility of ~~interest; and~~

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

interest.

•~~a $11.9 million increase in net gain on the early extinguishment of debt in the six months ended June 30, 2020, compared to having had no gain in the prior year period,~~ ~~recorded during the second quarter of 2020 upon the repurchase and cancellation of approximately $112.8 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes.~~

Recent Debt Transactions

5.75% Senior Notes Exchange Offer

See “Recent Developments” for important information regarding the Company’s debt-related transactions occurring after September 30, 2020. On ~~July 27,~~September 29, 2020, Products Corporation commenced ~~an offer~~the Exchange Offer to exchange ~~(the “Exchange Offer”)~~ any and all of ~~its $387.2~~the then-outstanding 5.75% Senior Notes (the “Existing 5.75% Senior Notes”). As described in "Recent Developments," the Exchange Offer was amended on October 23, 2020 and on November 13, 2020, the Company announced that the Exchange Offer was successfully consummated and that Products Corporation had accepted $236 million in aggregate principal amount of ~~outstanding~~ 5.75% Senior Notes ~~due 2021 (the “Existing Notes”) for a combination~~tendered in the Exchange Offer. Products Corporation used cash on hand to redeem, effective as of November 13, 2020, the remaining $106.8 million in aggregate principal amount of 5.75% Senior Notes ~~due February 15, 2024 (the “New Notes”) and an Early Tender/Consent Fee, payable in cash, upon~~pursuant to the terms of the 5.75% Senior Notes Indenture. Following the consummation of the Exchange Offer and ~~conditions set forth~~the satisfaction and discharge of the remaining 5.75% Senior Notes, no 5.75% Senior Notes remained outstanding as of the closing on November 13, 2020.

Amendments to the 2020 BrandCo Term Loan Facility

Prior to consummating the Exchange Offer, on September 28, 2020, Products Corporation and certain lenders under the 2020 BrandCo Term Loan Facility, representing more than a majority in aggregate principal amount of loans thereunder (the “Supporting BrandCo Lenders”), entered into a Transaction Support Agreement (the “BrandCo TSA”) under which the ~~confidential Offering Memorandum~~Supporting BrandCo Lenders agreed to take certain actions to facilitate the Exchange Offer and Consent Solicitation, ~~Statement (the “Offering Memorandum”) dated July 27, 2020. The~~including, among other things:

•Relinquishing certain rights of such Supporting BrandCo Lenders to “roll-up” loans held by such Supporting BrandCo Lenders under the 2016 Term Loan Facility into New ~~Notes will be senior unsecured notes with terms substantially~~BrandCo Second-Lien Term Loans under the ~~same as those of~~ 2020 BrandCo Term Loan Facility (the ~~Existing Notes, with certain adjustments specified in the Offering Memorandum. Concurrently with the Exchange Offer, the Company is soliciting consents (the “Consent Solicitation”~~“Roll-up Rights”) ~~to eliminate substantially all of the restrictive covenants and certain events of default with respect to the Existing Notes.~~;

•

~~Unless earlier terminated or extended, the Exchange Offer will expire at 11:59 p.m. E.D.T. on August 21, 2020. For each $1,000 principal amount of~~Tendering any Existing 5.75% Senior Notes ~~tendered~~held by such Supporting BrandCo Lenders into the Exchange Offer and Consent ~~Solicitation prior~~Solicitation;

•Consenting to amendments to the ~~early tender deadline~~2020 BrandCo Term Loan Facility to permit the exchange of 5:00 p.m. E.D.T. on August 7, 2020, holders of Existing Notes will receive $750 principal amount of New Notes and $50 of cash as an early tender/consent fee. Holders who tender their Existing Notes after the early tender deadline will receive only $750 principal amount of NewExisting 5.75% Senior Notes for ~~each $1,000 principal amount~~the New BrandCo Second-Lien Term Loans under the 2020 BrandCo Term Loan Facility as contemplated by the Offering Memorandum and the payment of ~~Existing Notes tendered.~~

the BrandCo Support and Consent Consideration;

~~The~~•Consenting to other amendments to the 2020 BrandCo Term Loan Facility and the Amended 2016 Revolving Credit Facility to permit the Exchange Offer and Consent Solicitation ~~are subject~~ to be completed as contemplated by the ~~following conditions precedent: (i)~~Offering Memorandum; and

•Supporting and cooperating with Products Corporation to consummate the ~~valid tender without valid withdrawal of not less than 95% of~~transactions contemplated by the ~~aggregate outstanding principal amount of Existing Notes (and~~BrandCo TSA and the provision of the related Consents for such tendered Existing Notes); (ii) the receipt of all necessary consents from the lenders under the Company’s term and revolving credit agreements required in order to consummateOffering Memorandum, including the Exchange Offer and Consent ~~Solicitation; (iii)~~Solicitation.

In connection with such amendments, Products Corporation agreed to provide the ~~receipt~~following consideration (collectively, the “BrandCo Support and Consent Consideration”) upon the successful consummation of ~~requisite consents~~the Exchange Offer:

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

•to all lenders under the 2020 BrandCo Term Loan Facility (including the Supporting BrandCo Lenders), an amendment fee that was payable pro rata based on principal amount of loans consenting, consisting of, at Products Corporation's option, either (x) an aggregate of $2.5 million of cash or (y) $5.0 million aggregate principal amount of New BrandCo Second-Lien Term Loans. Pursuant to the BrandCo Amendment, Products Corporation elected to pay this fee in-kind in the ~~Consent Solicitation; and (iv) various~~form of $5.0 million aggregate principal amount of New BrandCo Second-Lien Term Loans.

On November 13, 2020, Products Corporation entered into that certain Amendment No. 1 (the “BrandCo Amendment”) to the 2020 BrandCo Credit Agreement in connection with the Exchange Offer in order to, among other ~~customary conditions precedent.The conditions precedent are~~things, provide for the ~~sole benefit~~incurrence of $75 million in aggregate principal amount of New BrandCo Second-Lien Term Loans. The New BrandCo Second Lien Term Loans are a separate tranche of “Term B-2 Loans” (ranking junior to the Term B-1 Loans and senior to the Term B-3 Loans with respect to liens on certain specified collateral) under the BrandCo Credit Agreement. Except as to the use of proceeds, the terms of the New BrandCo Second-Lien Term Loans are substantially consistent with the other Term B-2 Loans. In connection with the BrandCo Amendment, Products Corporation paid certain fees to the lenders in-kind in the form of New BrandCo Second-Lien Term Loans in accordance with the BrandCo TSA.

MacAndrews & Forbes 2020 Restated Line of Credit Facility

In light of the upcoming maturity on July 9, 2021 of the 2018 Foreign Asset-Based Term Facility and the upcoming expiration on December 31, 2020 of the Amended 2019 Senior Line of Credit Facility, the Company sought to refinance or extend both the 2018 Foreign Asset-Based Term Facility and the Amended 2019 Senior Line of Credit Facility. Products Corporation sought to do so in order to reinforce its liquidity position to be better able to address the current business and economic environment and prepare for any further potential disruptions to its business and operations as may be ~~amended~~brought on by the ongoing COVID-19 pandemic or ~~waived, in whole or in part, at any time, in the sole~~other events.

As a result, and ~~absolute discretion~~anticipating a future refinancing of the ~~Company,~~2018 Foreign Asset-Based Term Facility (a “Future Refinanced European ABL Facility”), on September 28, 2020, Products Corporation and M&F entered into the Second Amended and Restated 2019 Senior Unsecured Line of Credit Facility (the “2020 Restated Line of Credit Facility”), which amended and restated the Amended 2019 Senior Line of Credit Facility and will provide Products Corporation with up to a $30 million tranche of a new facility of the 2018 Foreign Asset-Based Term Facility (the “New European ABL FILO Facility”) that would be secured on a “last-out” basis by the same collateral as the 2018 Foreign Asset-Based Term Facility or, if no Future Refinanced European ABL Facility is obtained, a stand-alone $30 million credit facility secured by the same collateral as the 2018 Foreign Asset-Based Term Facility when that facility is terminated, in each case, subject to a borrowing base. Upon the earlier of (x) the incurrence of a New European ABL FILO Facility and (y) December 31, 2020, the 2020 Restated Line of Credit Facility will terminate, such that M&F’s maximum committed amount under the 2020 Restated Line of Credit Facility will never exceed $30.0 million. As of September 30, 2020, there were no borrowings outstanding under the 2020 Restated Line of Credit Facility.

Consummation of 2020 BrandCo Refinancing Transactions

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

loan facility in an aggregate principal amount of $950 million (the “Roll-up BrandCo Facility”); and (iii) a senior secured term loan facility in an aggregate principal amount outstanding on the BrandCo 2020 Facilities Closing Date of $3 million (the “Junior Roll-up BrandCo Facility”). Additionally, on May 28, 2020, Products Corporation borrowed from the 2020 Facilities Lenders an additional $65 million of term loans under the 2020 BrandCo Facility to repay in full the 2020 Incremental Facility ~~(as defined below)~~ under the 2016 Term Loan Facility, as a result of which the 2020 BrandCo Facility at June 30, 2020 had an aggregate principal amount outstanding of $910.6 million (including paid-in-kind closing fees of $29.1 million and paid-in-kind interest of $1.5 million that ~~have been~~were capitalized). Additionally, during the three months ended June 30, 2020 and the three months ended September 30, 2020, certain lenders under the 2016 Term Loan Facility due June 2023, representing ~~$809.8~~$846.0 million in aggregate principal outstanding, rolled-up to the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility due June 2025, as a result of which the Roll-up BrandCo

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

Facility and the Junior Roll-up BrandCo Facility at ~~June~~September 30, 2020 ~~have~~had an aggregate principal amount outstanding of ~~$809.8~~$846.0 million. The Company determined that the roll-up of such 2016 Term Loan Facility lenders into the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility represented a debt modification under U.S. GAAP, as the cash flow effect between the amount that Products Corporation owed to the participating lenders under the old debt instrument (i.e., the 2016 Term Loan Facility) and the amount that Products Corporation owed to such lenders after the consummation of the roll-up into the new debt instrument (i.e., the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility) on a present value basis was less than 10% and, thus, the debt instruments were not considered to be substantially different within the meaning of ASC 470, Debt, under U.S. GAAP.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

Facilities also restrict distributions and other payments from the BrandCos based on certain minimum thresholds of net sales with respect to the Specified Brand Assets. The 2020 BrandCo Facilities also contain certain customary representations, warranties and events of default, including a cross default provision making it an event of default under the 2020 BrandCo Credit Agreement if there is an event of default under Products Corporation’s existing 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement or the indentures governing each of Products Corporation’s 5.75% Senior Notes ~~Indentures. The~~due 2021 and its 6.25% Senior Notes due 2024 (the “Senior Notes Indentures”). The lenders under the 2020 BrandCo Credit Agreement may declare all outstanding loans under the 2020 BrandCo Facilities to be due and payable immediately upon an event of default. Under such circumstances, the lenders under the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, and the holders under the Senior Notes Indentures may also declare all outstanding amounts under such instruments to be due and payable immediately as a result of similar cross default or cross acceleration provisions, subject to certain exceptions and limitations described in the relevant instruments.

2016 Term Loan Facility Extension Amendment: Term loan lenders under the 2016 Term Loan Facility were offered the opportunity to participate at par in the 2020 BrandCo Facilities based on their holdings of term loans under the 2016 Term Loan Facility. Lenders participating in the 2020 BrandCo Facilities, as well as other consenting lenders representing, in the aggregate, a majority of the loans and commitments under the 2016 Term Loan Facility, consented to an amendment to the 2016 Term Loan Facility (the “Extension Amendment”) that, among other things, made certain modifications to the covenants thereof and extended the maturity date of their term loans (“Extended Term Loans”) to June 30, 2025, subject to (i) the same September 7, 2023 springing maturity date of the non-extended term loans under the 2016 Term Loan Facility if, on such date, $75 million or more in aggregate principal amount of the non-extended term loans under the 2016 Term Loan Facility remains outstanding, and (ii) a springing maturity of 91 days prior to the August 1, 2024 maturity date of the 6.25% Senior Notes if, on such date, $100 million or more in aggregate principal amount of the 6.25% Senior Notes remains outstanding. The Extension Amendment became effective on the BrandCo 2020 Facilities Closing Date. As of ~~June~~September 30, 2020, approximately ~~$30.8~~$30.7 million in aggregate principal amount of Extended Term Loans were outstanding after giving effect to the 2020 BrandCo Refinancing Transactions. The Extended Term Loans bear interest at a rate of LIBOR (with a LIBOR floor of 0.75%) plus 3.50% per annum, payable not less than quarterly in arrears in cash, consistent with the interest rate applicable to the non-extended term loans. Approximately $17.0million of accrued interest outstanding on the 2016 Term Loan Facility was paid on the BrandCo 2020 Facilities Closing Date. The aggregate principal amount of non-extended term loans under the 2016 Term Loan Facility as of ~~June~~September 30, 2020 was ~~$894.0~~approximately $855.6 million.

Repurchases of 5.75% Senior Notes due 2021

On May 7, 2020, ~~the Company~~Products Corporation used a portion of the proceeds from the 2020 BrandCo Facility to repurchase and subsequently cancel $50 million in aggregate principal face amount of its 5.75% Senior Notes. Products Corporation also paid approximately $0.7 million of accrued interest outstanding on the 5.75% Senior Notes on May 7, 2020. After the BrandCo 2020 Facilities Closing Date, ~~the Company~~Products Corporation repurchased and subsequently canceled in July 2020 a further $62.8 million in aggregate principal face amount of its 5.75% Senior Notes. Furthermore, during the three months ended September 30, 2020, Products Corporation repurchased and subsequently canceled an additional $44.4 million in aggregate principal face amount of its 5.75% Senior Notes. Accordingly, as of ~~June~~September 30, 2020, ~~the Company~~Products Corporation had repurchased and subsequently cancelled a total of approximately ~~$112.8~~$157.2 million in aggregate principal face amount of its 5.75% Senior Notes, resulting in a ~~net~~

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

gain on extinguishment of debt of approximately ~~$11.9~~$31.2 million and $43.1 million for the three and nine months ended September 30, 2020, respectively, which ~~was~~were recorded within ~~"(Gain) loss~~"Gain on early extinguishment of ~~debt, net"~~debt" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and ~~six~~nine months ended ~~June~~September 30, ~~202~~0.

2020. See “Recent Developments” with respect to the 5.75% Senior Notes Exchange Offer.

Prepayment of the 2019 Term Loan Facility due 2023

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

different within the meaning of ASC 470, Debt, under U.S. GAAP. Accordingly, the $33.5 million of prepayment premiums, as well as the $10.3 million in other lenders' fees were capitalized as part of the aforementioned ~~$116.7~~$119.3 million of total new debt issuance costs for the 2020 BrandCo Term Loan Facility, while the aforementioned $0.3 million of legal fees and $2.0 million in other third party fees were expensed as incurred in the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the ~~three and six~~nine months ended ~~June~~September 30, 2020.

Amendment to the 2018 Foreign Asset-Based Term Facility

•increasing the interest rate on the loan from EURIBOR (with a floor 0.50%) plus a margin of 6.50% to EURIBOR (with a floor 0.50%) plus a margin of 7.00%;

•requiring a mandatory prepayment of €5.0 million; and

•clarifying certain terms and waiving certain provisions in connection with the 2020 BrandCo Refinancing Transactions.

Incremental Revolving Credit Facility under the 2016 Term Loan Agreement

~~Amendments to 2016 Revolving Credit Agreement~~

On May 7, 2020, in connection with consummating the 2020 Refinancing Transactions, the Company entered into Amendment No. 4 to Products Corporation’s Asset-Based Revolving Credit Agreement, dated as of September 7, 2016, as amended (the “2016 Revolving Credit Facility”). Amendment No. 4, among other things, made certain amendments and provided for certain waivers relating to the 2020 Refinancing Transactions under the 2016 Revolving Credit Facility. In exchange for such amendments and waivers, the interest rate margin applicable to loans under Tranche A of the 2016 Revolving Credit Facility increased by 0.75%. In connection with the amendments to Tranche B of the 2016 Revolving Credit Facility (which was fully repaid on its May 17, 2020 extended maturity date), the Company incurred approximately $1.1 million in lender's fees that upon its full repayment were entirely expensed within “Miscellaneous, net” on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss as of June 30, 2020.

Previously, on April 17, 2020 (the “FILO Closing Date”), the Company entered into Amendment No. 3 to the 2016 Revolving Credit Facility (“Amendment No. 3”), pursuant to which, the maturity date applicable to $36.3 million of loans

5966

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Amendments to the 2016 Revolving Credit Agreement

See “Recent Developments” regarding the 5th Amendment to the Amended 2016 Revolving Credit Facility. On May 7, 2020, in connection with consummating the 2020 BrandCo Refinancing Transactions, Products Corporation entered into Amendment No. 4 to its Asset-Based Revolving Credit Agreement, dated as of September 7, 2016, as amended (the “2016 Revolving Credit Facility”). Amendment No. 4, among other things, made certain amendments and provided for certain waivers relating to the 2020 BrandCo Refinancing Transactions under the 2016 Revolving Credit Facility. In exchange for such amendments and waivers, the interest rate margin applicable to loans under Tranche A of the 2016 Revolving Credit Facility increased by 0.75%. In connection with the amendments to the 2018 Tranche B of the 2016 Revolving Credit Facility (which was fully repaid on its May 17, 2020 extended maturity date), Products Corporation incurred approximately $1.1 million in lender's fees that upon its full repayment were entirely expensed within “Miscellaneous, net” on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss as of September 30, 2020. See “Recent Developments” and Note 19, “Subsequent Events,” regarding, among other things, Amendment No. 5 to the 2016 Revolving Credit Facility.

Previously, on April 17, 2020 (the “FILO Closing Date”), Products Corporation entered into Amendment No. 3 to the 2016 Revolving Credit Facility (“Amendment No. 3”), pursuant to which, the maturity date applicable to $36.3 million of loans under the $41.5 million senior secured first in, last out 2018 Tranche B under the 2016 Revolving Credit Facility (the ~~“FILO~~“2018 FILO Tranche”) was extended from April 17, 2020 to May 17, 2020 (the “Extended Maturity Date”). ~~The Company~~Products Corporation repaid the remaining approximately $5.2 million of the 2018 FILO Tranche loans as of the FILO Closing Date. In addition, Amendment No. 3 increased the applicable interest margin for the 2018 FILO Tranche by 0.75%, subject to a LIBOR floor of 0.75%. TheProducts Corporation fully repaid the 2018 FILO Tranche ~~was fully repaid~~ on the Extended Maturity Date.

Operating Segments

The Company operates in four reporting segments: Revlon; Elizabeth Arden; Portfolio; and Fragrances:

•Elizabeth Arden - The Elizabeth Arden segment is comprised of the Company's Elizabeth Arden branded products. The Elizabeth Arden segment markets, distributes and sells fragrances, skin care and color cosmetics primarily to prestige retailers, department and specialty stores, perfumeries, boutiques, e-commerce sites, the mass retail channel, travel retailers and distributors, as well as direct sales to consumers via its Elizabeth Arden branded retail stores and elizabetharden.com e-commerce business under brands such as Elizabeth Arden Ceramide, Prevage, Eight Hour, SUPERSTART, Visible Difference and Skin Illuminating in the Elizabeth Arden skin care brands; and Elizabeth Arden White Tea, Elizabeth Arden Red Door, Elizabeth Arden 5th Avenue and Elizabeth Arden Green Tea in Elizabeth Arden fragrances.

•Portfolio - The Company’s Portfolio segment markets, distributes and sells a comprehensive line of premium, specialty and mass products primarily to the mass retail channel, hair and nail salons and professional salon distributors in the U.S. and internationally and large volume retailers, specialty and department stores under brands such as Almay and SinfulColors in color cosmetics; American Crew in men's grooming products (which are also sold direct-to-consumer on its americancrew.com website); CND in nail polishes, gel nail color and nail enhancements; Cutex in nail care products; and Mitchum in anti-perspirant deodorants. The Portfolio segment also includes a multi-cultural hair care line consisting of Creme of Nature hair care products, which are sold in both professional salons and in large volume retailers and other retailers, primarily in the U.S.; and a hair color line under the Llongueras brand (licensed from a third party) that is sold in the mass retail channel, large volume retailers and other retailers, primarily in Spain.

•Fragrances - The Fragrances segment includes the development, marketing and distribution of certain owned and licensed fragrances, as well as the distribution of prestige fragrance brands owned by third parties. These products are typically sold to retailers in the U.S. and internationally, including prestige retailers, specialty stores, ~~e-commerce~~e-

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

commerce sites, the mass retail channel, travel retailers and other international retailers. The owned and licensed fragrances include brands such as: (i) Juicy Couture (which are also sold direct-to-consumer on its juicycouturebeauty.com website), John Varvatos and AllSaints in prestige fragrances; (ii) Britney Spears, Elizabeth Taylor, Christina Aguilera, Jennifer Aniston and Mariah Carey in celebrity fragrances; and (iii) Curve, Giorgio Beverly Hills, Ed Hardy, Charlie, Lucky Brand, ‹PS› (logo of former Paul Sebastian brand), Alfred Sung, Halston, Geoffrey Beene and White Diamonds in mass fragrances.

6068

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Results of Operations — Revlon, Inc.

Consolidated Net Sales:

~~Second~~Third quarter results:

~~Year-to-date-results:~~Year-to-date results:

See "Segment Results" below for further information on net sales by segment.

Segment Results:

The Company's management evaluates segment profit for each of the Company's reportable segments. The Company allocates corporate expenses to each reportable segment to arrive at segment profit, as these expenses are included in the internal measure of segment operating performance. The Company defines segment profit as income from continuing operations before interest, taxes, depreciation, amortization, stock-based compensation expense, gains/losses on foreign currency fluctuations, gains/losses on the early extinguishment of debt and miscellaneous expenses. Segment profit also excludes the impact of certain items that are not directly attributable to the segments' underlying operating performance. The Company does not have any material inter-segment sales. For a reconciliation of segment profit to loss from continuing operations before income taxes, see Note 14, "Segment Data and Related Information," to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q.

6169

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

The following tables provide a comparative summary of the Company's segment results for the periods presented.


		Net Sales																						Segment Profit																								Net Sales						Segment Profit
		Three Months Ended June 30,						Change						XFX Change ^(a)						Three Months Ended June 30,								Change						XFX Change ^(a)						Three Months Ended September 30,				Change				XFX Change (a)				Three Months Ended September 30,	Change	XFX Change (a)
		2020		2019		$		%		$		%		2020		2019		$		%		$		%			2020		2019		$		%			$		%		2020		2019		$		%		$		%
Revlon	Revlon	$	135.0	$	251.5	$	(116.5)	(46.3)	%	$	(113.5)	(45.1)	%	$	12.3	$	25.6	$	(13.3)	(52.0)	%	$	(13.4)	(52.3)	%	Revlon	$	166.0	$	217.3	$	(51.3)	(23.6)		%	$	(51.9)	(23.9)	%	$	13.5	$	7.3	$	6.2	84.9	%	$	5.9	80.8	%
Elizabeth Arden	Elizabeth Arden	80.9		117.4		(36.5)		(31.1)	%	(34.7)		(29.6)	%	10.8		2.7		8.1		N.M.		8.3		N.M.		Elizabeth Arden	106.3		123.2		(16.9)		(13.7)		%	(18.4)		(14.9)	%	3.4		12.5		(9.1)		(72.8)	%	(9.5)		(76.0)	%
Portfolio	Portfolio	88.5		118.7		(30.2)		(25.4)	%	(27.9)		(23.5)	%	14.5		6.1		8.4		137.7	%	8.4		137.7	%	Portfolio	99.6		118.2		(18.6)		(15.7)		%	(19.1)		(16.2)	%	12.2		14.4		(2.2)		(15.3)	%	(2.5)		(17.4)	%
Fragrances	Fragrances	43.2		82.6		(39.4)		(47.7)	%	(38.5)		(46.6)	%	7.8		12.6		(4.8)		(38.1)	%	(4.7)		(37.3)	%	Fragrances	105.2		138.1		(32.9)		(23.8)		%	(33.1)		(24.0)	%	25.4		34.2		(8.8)		(25.7)	%	(9.1)		(26.6)	%
Total	Total	$	347.6	$	570.2	$	(222.6)	(39.0)	%	$	(214.6)	(37.6)	%	$	45.4	$	47.0	$	(1.6)	(3.4)	%	$	(1.4)	(3.0)	%	Total	$	477.1	$	596.8	$	(119.7)	(20.1)		%	$	(122.5)	(20.5)	%	$	54.5	$	68.4	$	(13.9)	(20.3)	%	$	(15.2)	(22.2)	%


		Net Sales																						Segment Profit																								Net Sales						Segment Profit
		Six Months Ended June 30,						Change						XFX Change ^(a)						Six Months Ended June 30,								Change						XFX Change ^(a)						Nine Months Ended September 30,				Change				XFX Change (a)				Nine Months Ended September 30,	Change	XFX Change (a)
		2020		2019		$		%		$		%		2020		2019		$		%		$		%			2020		2019		$		%			$		%		2020		2019		$		%		$		%
Revlon	Revlon	$	316.8	$	498.8	$	(182.0)	(36.5)	%	$	(175.5)	(35.2)	%	$	27.9	$	51.2	$	(23.3)	(45.5)	%	$	(22.7)	(44.3)	%	Revlon	$	482.8	$	716.1	$	(233.3)	(32.6)		%	$	(227.4)	(31.8)	%	$	41.4	$	58.5	$	(17.1)	(29.2)	%	$	(16.8)	(28.7)	%
Elizabeth Arden	Elizabeth Arden	176.1		228.8		(52.7)		(23.0)	%	(48.4)		(21.2)	%	15.0		4.6		10.4		226.1	%	11.1		241.3	%	Elizabeth Arden	282.4		352.0		(69.6)		(19.8)		%	(66.8)		(19.0)	%	18.4		17.1		1.3		7.6	%	1.6		9.4	%
Portfolio	Portfolio	198.5		235.9		(37.4)		(15.9)	%	(33.1)		(14.0)	%	21.7		10.6		11.1		104.7	%	11.3		106.6	%	Portfolio	298.1		354.1		(56.0)		(15.8)		%	(52.2)		(14.7)	%	33.9		25.0		8.9		35.6	%	8.8		35.2	%
Fragrances	Fragrances	109.2		159.9		(50.7)		(31.7)	%	(48.9)		(30.6)	%	9.2		19.4		(10.2)		(52.6)	%	(10.0)		(51.5)	%	Fragrances	214.4		298.0		(83.6)		(28.1)		%	(82.0)		(27.5)	%	34.6		53.6		(19.0)		(35.4)	%	(19.1)		(35.6)	%
Total	Total	$	800.6	$	1,123.4	$	(322.8)	(28.7)	%	$	(305.9)	(27.2)	%	$	73.8	$	85.8	$	(12.0)	(14.0)	%	$	(10.3)	(12.0)	%	Total	$	1,277.7	$	1,720.2	$	(442.5)	(25.7)		%	$	(428.4)	(24.9)	%	$	128.3	$	154.2	$	(25.9)	(16.8)	%	$	(25.5)	(16.5)	%

^(a) XFX excludes the impact of foreign currency fluctuations.

~~N.M. - Not meaningful~~

Revlon Segment

~~Second~~Third quarter results:

Revlon segment net sales in the ~~second~~third quarter of 2020 were ~~$135.0~~$166.0 million, a ~~$116.5~~$51.3 million, or ~~46.3%~~23.6%, decrease, compared to ~~$251.5~~$217.3 million in the ~~second~~third quarter of 2019. Excluding the ~~$3.0~~$0.6 million ~~unfavorable~~favorable FX impact, total Revlon segment net sales in the ~~second~~third quarter of 2020 decreased by ~~$113.5~~$51.9 million, or ~~45.1%~~23.9%, compared to the ~~second~~third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $~~115~~50 million ($~~116~~50 million XFX) to the Revlon segment's decrease in net sales in the ~~second~~third quarter of 2020, compared to the prior year quarter. The Revlon segment XFX decrease in net sales of ~~$113.5~~$51.9 million in the ~~second~~third quarter of 2020 was driven primarily by lower net sales of Revlon color cosmetics, as well as lower ~~international~~ net sales of Revlon-branded professional hair-care products in International regions and lower net sales of Revlon ColorSilk hair color products in North America, due, primarily, to the continuing effects of COVID-19 on the mass retail channels and on salon activity, respectively. This decrease was partially offset by higher net sales of Revlon-branded beauty tools and hair color products in North America.

Revlon segment profit in the ~~second~~third quarter of 2020 was ~~$12.3~~$13.5 million, a ~~$13.3~~$6.2 million, or ~~52.0%~~84.9%, ~~decrease,~~increase, compared to ~~$25.6~~$7.3 million in the ~~second~~third quarter of 2019. Excluding the ~~$0.1~~$0.3 million favorable FX impact, Revlon segment profit in the ~~second~~third quarter of 2020 ~~decreased~~increased by ~~$13.4~~$5.9 million, or ~~52.3%~~80.8%, compared to the ~~second~~third quarter of 2019. This ~~decrease~~increase was driven primarily by the Revlon segment's ~~lower net sales, primarily due to COVID-19 as described above, and lower gross profit margin, partially offset primarily by~~ lower brand support and other SG&A expenses, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as the Revlon 2020 Restructuring ~~Program.~~Program, partially offset by the segment's lower net sales, primarily due to COVID-19 as described above, and lower gross profit margin.

Year-to-date results:

Revlon segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 were ~~$316.8~~$482.8 million, a ~~$182.0~~$233.3 million, or ~~36.5%~~32.6%, decrease, compared to ~~$498.8~~$716.1 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$6.5~~$5.9 million unfavorable FX impact, total Revlon segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$175.5~~$227.4 million, or ~~35.2%~~31.8%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed ~~an estimated~~ ~~$135 million ($137 million XFX) to the Revlon segment's decrease in net sales in the six months ended June 30, 2020, compared to the prior year period.~~ ~~The Revlon~~

6270

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

an estimated $174 million ($176 million XFX) to the Revlon segment's decrease in net sales in the nine months endedSeptember 30, 2020, compared to the prior year period. The Revlon segment's XFX decrease in net sales of ~~$175.5~~$227.4 million in the ~~six~~nine months ended ~~June~~September 30, 2020 was driven primarily by lower net sales of Revlon color cosmetics, ~~as well as~~ lower ~~international~~ net sales of Revlon-branded professional hair-care products ~~and~~in International regions, as well as lower net sales of Revlon ColorSilk hair color, ~~products,~~ due, primarily, to the continuing effects of COVID-19 on the mass retail channels and on salons activity, respectively, partially offset by increased net sales of ~~Revlon-branded~~Revlon-branded beauty tools and Revlon hair color products in North America.

Revlon segment profit in the ~~six~~nine months ended ~~June~~September 30, 2020 was ~~$27.9~~$41.4 million, a ~~$23.3~~$17.1 million, or ~~45.5%~~29.2%, decrease, compared to ~~$51.2~~$58.5 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$0.6~~$0.3 million unfavorable FX impact, Revlon segment profit in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$22.7~~$16.8 million, or ~~44.3%~~28.7%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. This decrease was driven primarily by the Revlon segment's lower net sales, primarily due to COVID-19 as described above, and lower gross profit margin, partially offset primarily by the segment's lower brand support and other SG&A expenses, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as the Revlon 2020 Restructuring Program.

Elizabeth Arden Segment

~~Second~~Third quarter results:

Elizabeth Arden segment net sales in the ~~second~~third quarter of 2020 were ~~$80.9~~$106.3 million, a ~~$36.5~~$16.9 million, or ~~31.1%~~13.7%, decrease, compared to ~~$117.4~~$123.2 million in the ~~second~~third quarter of 2019. Excluding the ~~$1.8~~$1.5 million ~~unfavorable~~favorable FX impact, Elizabeth Arden segment net sales in the ~~second~~third quarter of 2020 decreased by ~~$34.7~~$18.4 million, or ~~29.6%~~14.9%, compared to the ~~second~~third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $3424 million ($3525 million XFX) to the Elizabeth Arden segment’s decrease in net sales in the ~~second~~third quarter of 2020, compared to the prior year quarter. The Elizabeth Arden segment XFX decrease in net sales of ~~$34.7~~$18.4 million in the ~~second~~third quarter of 2020 was driven primarily by lower net sales of certain Elizabeth Arden~~Arden-branded~~-branded skin care products and color cosmetics in International regions, as well as ~~color cosmetics, and~~ lower net sales of Elizabeth Arden-branded fragrances, due, primarily, to the continuing effects of COVID-19 on foot traffic at department stores and other retail outlets, partially offset by higher net sales of Ceramide skin care ~~products.~~products in North America.

Elizabeth Arden segment profit in the ~~second~~third quarter of 2020 was ~~$10.8~~$3.4 million, ~~an $8.1~~a $9.1 million ~~increase,~~decrease, compared to ~~$2.7~~$12.5 million in the ~~second~~third quarter of 2019. Excluding the ~~$0.2~~$0.4 million ~~unfavorable~~favorable FX impact, Elizabeth Arden segment profit in the ~~second~~third quarter of 2020 ~~increased~~decreased by ~~$8.3~~$9.5 million, compared to the ~~second~~third quarter of 2019. This ~~increase~~decrease was driven primarily by the Elizabeth Arden segment's ~~higher~~lower net sales, primarily due to COVID-19 as described above, and lower gross profit margin, ~~and~~partially offset primarily by the segment's lower ~~SG&A and~~ brand support and other SG&A expenses, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as the Revlon 2020 Restructuring ~~Program, partially offset by the segment's lower net sales described above.~~Program.

Year-to-date results:

Elizabeth Arden segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 were ~~$176.1~~$282.4 million, a ~~$52.7~~$69.6 million, or ~~23.0%~~19.8%, decrease, compared to ~~$228.8~~$352.0 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$4.3~~$2.8 million unfavorable FX impact, Elizabeth Arden segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$48.4~~$66.8 million, or ~~21.2%~~19.0%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $5693 million ($5795 million XFX) to the Elizabeth Arden segment’s decrease in net sales in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The Elizabeth Arden segment XFX decrease in net sales of ~~$48.4~~$66.8 million in the ~~six~~nine months ended ~~June~~September 30, 2020 was driven primarily by lower net sales of certain Elizabeth Arden-branded skin care products, as well as color cosmetics, and lower net sales of Elizabeth Arden-branded fragrances, due, primarily, to the continuing effects of COVID-19 on foot traffic at department stores and other retail outlets, partially offset by higher net sales of Ceramide skin care ~~products internationally.~~products.

Elizabeth Arden segment profit in the ~~six~~nine months ended ~~June~~September 30, 2020 was ~~$15.0~~$18.4 million, a ~~$10.4~~$1.3 million, or ~~226.1%~~7.6%, increase, compared to ~~$4.6~~$17.1 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$0.7~~$0.3 million unfavorable FX impact, Elizabeth Arden segment profit in the ~~six~~nine months ended ~~June~~September 30, 2020 increased by ~~$11.1~~$1.6 million, or ~~241.3%~~9.4%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. This increase was driven primarily by the Elizabeth Arden segment's higher gross profit margin and lower other SG&A and brand support expenses, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of COVID-19 on the Company's operations, as well as the Revlon 2020 Restructuring Program, partia~~lly offset by the segment's lower net sales described above.~~

6371

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

lower other SG&A and brand support expenses and slightly higher gross profit margin, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as the Revlon 2020 Restructuring Program, partially offset by the segment's lower net sales, primarily due to COVID-19 as described above.

Portfolio Segment

~~Second~~Third quarter results:

Portfolio segment net sales in the ~~second~~third quarter of 2020 were ~~$88.5~~$99.6 million, a ~~$30.2~~$18.6 million, or ~~25.4%~~15.7%, decrease, compared to ~~$118.7~~$118.2 million in the ~~second~~third quarter of 2019. Excluding the ~~$2.3~~$0.5 million ~~unfavorable~~favorable FX impact, total Portfolio segment net sales in the ~~second~~third quarter of 2020 decreased by ~~$27.9~~$19.1 million, or ~~23.5%~~16.2%, compared to the ~~second~~third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $3019 million ($3119 million XFX) to the Portfolio segment’s decrease in net sales in the ~~second~~third quarter of 2020, compared to the prior year quarter. The Portfolio segment XFX decrease in net sales of ~~$27.9~~$19.1 million in the ~~second~~third quarter of 2020 was driven primarily by lower net sales of Almay color cosmetics, CND nail products and American Crew men's grooming products, ~~CND~~ ~~nail products and~~ ~~Mitchum~~ ~~anti-perspirant deodorants,~~ primarily in North America, as well as lower net sales of certain local and regional brands, driven, primarily, by the continuing effect of COVID-19 on the mass retail channel and on salons. This decrease was partially offset by higher net sales of ~~Cutex~~ ~~nail care products, primarily~~ in North America ~~and~~ of Creme of Nature products and ~~among~~Mitchum anti-perspirant deodorants. ~~local and regional brands.~~

Portfolio segment profit in the ~~second~~third quarter of 2020 was ~~$14.5~~$12.2 million, a ~~$8.4~~$2.2 million ~~increase~~decrease, compared to ~~$6.1~~$14.4 million in the ~~second~~third quarter of 2019. ~~This increase~~ Excluding the $0.3 million favorable FX impact, Portfolio segment profit in the three months ended September 30, 2020 decreased by $2.5 million, or 17.4%, compared to the three months ended September 30, 2019. This decrease was driven primarily by the Portfolio segment's lower ~~SG&A~~net sales, primarily due to the ongoing and prolonged COVID-19 pandemic, as described above, and lower gross profit margin, partially offset by the segment's lower brand support and other SG&A expenses, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as the Revlon 2020 Restructuring ~~Program, partially offset by the segment's lower net sales,~~ ~~primarily due to COVID-19~~ ~~as described above and lower gross profit margin.~~Program.

Year-to-date results:

Portfolio segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 were ~~$198.5~~$298.1 million, a ~~$37.4~~$56.0 million, or ~~15.9%~~15.8%, decrease, compared to ~~$235.9~~$354.1 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$4.3~~$3.8 million unfavorable FX impact, total Portfolio segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$33.1~~$52.2 million, or ~~14.0%~~14.7%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $3756 million ($3756 million XFX) to the Portfolio segment’s decrease in net sales in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The Portfolio segment XFX decrease in net sales of ~~$33.1~~$52.2 million in the ~~six~~nine months ended ~~June~~September 30, 2020 was driven primarily by lower net sales of Almay color cosmetics, American Crew men's grooming products, CND nail products, primarily in North America, as well as certain local and regional skin care products brands, driven, primarily, by the continuing effects of COVID-19 on the mass retail channel and salons. This decrease was partially offset primarily by higher net sales of Creme of Nature products and of Cutex nail care products, primarily in North America.

Portfolio segment profit in the ~~six~~nine months ended ~~June~~September 30, 2020 was ~~$21.7~~$33.9 million, a ~~$11.1~~$8.9 million, or ~~104.7%~~35.6%, increase compared to ~~$10.6~~$25.0 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$0.2~~$0.1 million ~~unfavorable~~favorable FX impact, Portfolio segment profit in the ~~six~~nine months ended ~~June~~September 30, 2020 increased by ~~$11.3~~$8.8 million, or ~~106.6%~~35.2%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. This increase was driven primarily by the Portfolio segment's ~~slightly higher gross profit margin and~~ lower SG&A and brand support expenses, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as the Revlon 2020 Restructuring Program, partially offset by the segment's lower net sales, primarily due to COVID-19, as described ~~above.~~above, and slightly lower gross profit margin.

Fragrances Segment

~~Second~~Third quarter results:

Fragrances segment net sales in the second quarter of 2020 were $43.2 million, a $39.4 million, or 47.7%, decrease, compared to $82.6 million in the second quarter of 2019. Excluding the $0.9 million unfavorable FX impact, total Fragrances segment net sales in th~~e second quarter of 2020 decreased by $38.5 million, or 46.6%, compared to the second quarter of 2019. COVID-19 contributed an estimated $34 million ($35 million XFX) to the~~ ~~Fragrances segment’s~~ ~~decrease in net sales in the second quarter of 2020, compared to the prior year quarter. The Fragrances segment XFX decrease in net sales of $38.5 million~~ ~~in the second quarter of 2020~~ ~~was driven primarily by continuing impacts from COVID-19 especially in the prestige channel due to temporary door closures.~~

Fragrances segment profit in the second quarter of 2020 was $7.8 million, a $4.8 million, or 38.1%, decrease, compared to $12.6 million in the second quarter of 2019. Excluding the $0.1 million unfavorable FX impact, Fragrances segment profit in the second quarter of 2020 decreased by $4.7 million, or 37.3%, compared to the second quarter of 2019. This decrease was driven primarily by the Fragrances segment's lower net sales, ~~primarily due to COVID-19~~ ~~as described above, partially offset by~~

6472

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~higher~~Fragrances segment net sales in the third quarter of 2020 were $105.2 million, a $32.9 million, or 23.8%, decrease, compared to $138.1 million in the third quarter of 2019. Excluding the $0.2 million favorable FX impact, total Fragrances segment net sales in the third quarter of 2020 decreased by $33.1 million, or 24.0%, compared to the third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $25 million ($25 million XFX) to the Fragrances segment’s decrease in net sales in the third quarter of 2020, compared to the prior year quarter. The Fragrances segment XFX decrease in net sales of $33.1 million in the third quarter of 2020 was driven primarily by continuing impacts from COVID-19, especially in the prestige channel, resulting in decreased foot traffic.

Fragrances segment profit in the third quarter of 2020 was $25.4 million, a $8.8 million, or 25.7%, decrease, compared to $34.2 million in the third quarter of 2019. Excluding the $0.3 million favorable FX impact, Fragrances segment profit in the third quarter of 2020 decreased by $9.1 million, or 26.6%, compared to the third quarter of 2019. This decrease was driven primarily by the Fragrances segment's lower net sales, primarily due to the ongoing and prolonged COVID-19 pandemic, as described above, and lower gross profit margin, partially offset by the segment's lower brand support and other SG&A expenses, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as the Revlon 2020 Restructuring Program.

Year-to-date results:

Fragrances segment net sales in the nine months ended September 30, 2020 were $214.4 million, a $83.6 million, or 28.1%, decrease, compared to $298.0 million in the nine months ended September 30, 2019. Excluding the $1.6 million unfavorable FX impact, total Fragrances segment net sales in the nine months ended September 30, 2020 decreased by $82.0 million, or 27.5%, compared to the nine months ended September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $65 million ($65 million XFX) to the Fragrances segment’sdecrease in net sales in the nine months ended September 30, 2020, compared to the prior year period. The Fragrances segment XFX decrease in net sales of $82.0 million in the nine months ended September 30, 2020 was driven primarily by continuing impacts from COVID-19, especially in the prestige channel, resulting in decreased foot traffic and temporary door closures.

Fragrances segment profit in the nine months ended September 30, 2020 was $34.6 million, a $19.0 million, or 35.4%, decrease, compared to $53.6 million in the nine months ended September 30, 2019. Excluding the $0.1 million favorable FX impact, Fragrances segment profit in the nine months ended September 30, 2020 decreased by $19.1 million, or 35.6%, compared to the nine months ended September 30, 2019. This decrease was driven primarily by the Fragrances segment's lower net sales, primarily due to the ongoing and prolonged COVID-19 pandemic, as described above, and slightly lower gross profit margin, partially offset primarily by lower other SG&A and brand support expenses, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 ~~on the Company's operations, as well as the Revlon 2020 Restructuring Program.~~

~~Year-to-date results:~~

Fragrances segment net sales in the six months ended June 30, 2020 were $109.2 million, a $50.7 million, or 31.7%, decrease, compared to $159.9 million in the six months ended June 30, 2019. Excluding the $1.8 million unfavorable FX impact, total Fragrances segment net sales in the six months ended June 30, 2020 decreased by $48.9 million, or 30.6%, compared to the six months ended June 30, 2019. COVID-19 contributed an estimated ~~$40 million ($41 million XFX) to the~~ ~~Fragrances segment’sdecrease in net sales in the six months ended June 30, 2020, compared to the prior year period.~~ ~~The Fragrances segment XFX decrease in net sales of $48.9 million in the six months ended June 30, 2020 was driven primarily by continuing impacts from COVID-19~~ ~~especially in the prestige channel due to temporary door closures~~.

Fragrances segment profit in the six months ended June 30, 2020 was $9.2 million, a $10.2 million, or 52.6%, decrease, compared to $19.4 million in the six months ended June 30, 2019. Excluding the $0.2 million unfavorable FX impact, Fragrances segment profit in the six months ended June 30, 2020 decreased by $10.0 million, or 51.5%, compared to the six months ended June 30, 2019. This decrease was driven primarily by the Fragrances segment's lower net sales, primarily due to COVID-19 as described above, partially offset by higher gross profit mar~~gin and lower SG&A and brand support expenses, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of COVID-19~~pandemic on the Company's operations, as well as the Revlon 2020 Restructuring Program.

6573

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Geographic Results:

The following tables provide a comparative summary of the Company's North America and International net sales for the periods presented:


		Three Months Ended June 30,						Change								XFX Change ^(a)					Three Months Ended September 30,				Change		XFX Change (a)
		2020		2019		$		%		$		%			2020		2019		$		%		$		%
Revlon	Revlon													Revlon
North America	North America	$	80.1	$	134.7	$	(54.6)	(40.5)	%	$	(54.3)	(40.3)	%	North America	$	86.4	$	100.0	$	(13.6)	(13.6)	%	$	(13.7)	(13.7)	%
International	International	54.9		116.8		(61.9)		(53.0)	%	(59.2)		(50.7)	%	International	79.6		117.3		(37.7)		(32.1)	%	(38.2)		(32.6)	%
Elizabeth Arden	Elizabeth Arden													Elizabeth Arden
North America	North America	$	15.0	$	26.2	$	(11.2)	(42.7)	%	$	(11.2)	(42.7)	%	North America	$	30.5	$	29.5	$	1.0	3.4	%	$	1.1	3.7	%
International	International	65.9		91.2		(25.3)		(27.7)	%	(23.5)		(25.8)	%	International	75.8		93.7		(17.9)		(19.1)	%	(19.5)		(20.8)	%
Portfolio	Portfolio													Portfolio
North America	North America	$	52.1	$	73.0	$	(20.9)	(28.6)	%	$	(20.7)	(28.4)	%	North America	$	59.9	$	71.4	$	(11.5)	(16.1)	%	$	(11.3)	(15.8)	%
International	International	36.4		45.7		(9.3)		(20.4)	%	(7.2)		(15.8)	%	International	39.7		46.8		(7.1)		(15.2)	%	(7.8)		(16.7)	%
Fragrance	Fragrance													Fragrance
North America	North America	$	29.7	$	52.6	$	(22.9)	(43.5)	%	$	(22.9)	(43.5)	%	North America	$	79.2	$	98.6	$	(19.4)	(19.7)	%	$	(19.3)	(19.6)	%
International	International	13.5		30.0		(16.5)		(55.0)	%	(15.6)		(52.0)	%	International	26.0		39.5		(13.5)		(34.2)	%	(13.8)		(34.9)	%
Total Net Sales	Total Net Sales	$	347.6	$	570.2	$	(222.6)	(39.0)	%	$	(214.6)	(37.6)	%	Total Net Sales	$	477.1	$	596.8	$	(119.7)	(20.1)	%	$	(122.5)	(20.5)	%

		Six Months Ended June 30,						Change								XFX Change ^(a)					Nine Months Ended September 30,				Change		XFX Change (a)
		2020		2019		$		%		$		%			2020		2019		$		%		$		%
Revlon	Revlon													Revlon
North America	North America	$	179.2	$	267.9	$	(88.7)	(33.1)	%	$	(88.3)	(33.0)	%	North America	$	265.6	$	367.9	$	(102.3)	(27.8)	%	$	(102.0)	(27.7)	%
International	International	137.6		230.9		(93.3)		(40.4)	%	(87.2)		(37.8)	%	International	217.2		348.2		(131.0)		(37.6)	%	(125.4)		(36.0)	%
Elizabeth Arden	Elizabeth Arden													Elizabeth Arden
North America	North America	$	36.4	$	54.4	$	(18.0)	(33.1)	%	$	(17.8)	(32.7)	%	North America	$	66.9	$	83.9	$	(17.0)	(20.3)	%	$	(16.7)	(19.9)	%
International	International	139.7		174.4		(34.7)		(19.9)	%	(30.6)		(17.5)	%	International	215.5		268.1		(52.6)		(19.6)	%	(50.1)		(18.7)	%
Portfolio	Portfolio													Portfolio
North America	North America	$	122.9	$	143.1	$	(20.2)	(14.1)	%	$	(20.1)	(14.0)	%	North America	$	182.8	$	214.5	$	(31.7)	(14.8)	%	$	(31.4)	(14.6)	%
International	International	75.6		92.8		(17.2)		(18.5)	%	(13.0)		(14.0)	%	International	115.3		139.6		(24.3)		(17.4)	%	(20.8)		(14.9)	%
Fragrances	Fragrances													Fragrances
North America	North America	$	71.9	$	99.8	$	(27.9)	(28.0)	%	$	(27.9)	(28.0)	%	North America	$	151.1	$	198.4	$	(47.3)	(23.8)	%	$	(47.2)	(23.8)	%
International	International	37.3		60.1		(22.8)		(37.9)	%	(21.0)		(34.9)	%	International	63.3		99.6		(36.3)		(36.4)	%	(34.8)		(34.9)	%
Total Net Sales	Total Net Sales	$	800.6	$	1,123.4	$	(322.8)	(28.7)	%	$	(305.9)	(27.2)	%	Total Net Sales	$	1,277.7	$	1,720.2	$	(442.5)	(25.7)	%	$	(428.4)	(24.9)	%

^(a) XFX excludes the impact of foreign currency fluctuations.

Revlon Segment

~~Second~~Third quarter results:

North America

In North America, Revlon segment net sales in the ~~second~~third quarter of 2020 decreased by ~~$54.6~~$13.6 million, or ~~40.5%~~13.6%, to ~~$80.1~~$86.4 million, compared to ~~$134.7~~$100.0 million in the ~~second~~third quarter of 2019. Excluding the ~~$0.3~~$0.1 million ~~unfavorable~~favorable FX impact, Revlon segment net sales in North America in the ~~second~~third quarter of 2020 decreased by ~~$54.3~~$13.7 million, or ~~40.3%~~13.7%, compared to the ~~second~~third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $5015 million ($5015 million XFX) to the Revlon segment’s decrease in net sales in North America in the ~~second~~third quarter of 2020, compared to the prior year quarter. The Revlon segment's ~~$54.3~~$13.7 million XFX decrease in North America net sales in the ~~second~~third quarter of 2020 was primarily due to the Revlon segment's lower net sales of Revlon color cosmetics and of RevlonColorSilk hair color products, due, primarily, to

6674

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~lower net sales of~~ ~~Revlon~~ ~~color cosmetics, due, primarily, to~~ the continuing effects of COVID-19 on the mass retail channel, partially offset by higher net sales of Revlon-branded beauty tools and hair-care products.

International

Internationally, Revlon segment net sales in the ~~second~~third quarter of 2020 decreased by ~~$61.9~~$37.7 million, or ~~53.0%~~32.1%, to ~~$54.9~~$79.6 million, compared to ~~$116.8~~$117.3 million in the ~~second~~third quarter of 2019. Excluding the ~~$2.7~~$0.5 million ~~unfavorable~~favorable FX impact, Revlon segment International net sales in the ~~second~~third quarter of 2020 decreased by ~~$59.2~~$38.2 million, or ~~50.7%~~32.6%, compared to the ~~second~~third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $6535 million ($6735 million XFX) to the Revlon segment’s decrease in International net sales in the ~~second~~third quarter of 2020, compared to the prior year quarter. The Revlon segment's ~~$59.2~~$38.2 million XFX decrease in International net sales in the ~~second~~third quarter of 2020 was driven primarily by the Revlon segment's lower net sales of Revlon color cosmetics, as well as lower net sales of Revlon-branded professional hair-care ~~professional~~ products ~~and~~ ~~Revlon ColorSilk~~ ~~hair color products, within the Company's EMEA, Asia, Latin America and Pacific regions,~~ due, primarily, to the continuing effects of COVID-19 on the mass retail channel and ~~salons,~~salons. This decrease was partially offset by higher net sales of ~~continued strong~~Revlon ColorSilk hair color products, primarily within the Company's Latin America region, and growth in e-commerce net sales.

Year-to-date results:

North America

In North America, Revlon segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$88.7~~$102.3 million, or ~~33.1%~~27.8%, to ~~$179.2~~$265.6 million, compared to ~~$267.9~~$367.9 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$0.4~~$0.3 million unfavorable FX impact, Revlon segment net sales in North America in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$88.3~~$102.0 million, or ~~33.0%~~27.7%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $5267 million ($5267 million XFX) to the Revlon segment’s decrease in net sales in North America in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The Revlon segment's ~~$88.3~~$102.0 million XFX decrease in North America net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 was primarily due to the Revlon segment's lower net sales of Revlon color cosmetics, as well as Revlon ColorSilk hair color products, due, primarily, to the continuing effects of COVID-19 on the mass retail channel, partially offset by higher net sales of Revlon-branded beauty tools and hair care products.

International

Internationally, Revlon segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$93.3~~$131.0 million, or ~~40.4%~~37.6%, to ~~$137.6~~$217.2 million, compared to ~~$230.9~~$348.2 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$6.1~~$5.6 million unfavorable FX impact, Revlon segment International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$87.2~~$125.4 million, or ~~37.8%~~36.0%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $83107 million ($85109 million XFX) to the Revlon segment’s decrease in International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The Revlon segment's ~~$87.2~~$125.4 million XFX decrease in International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 was driven primarily by the Revlon segment's lower net sales of Revlon color cosmetics, as well as lower net sales of Revlon-branded hair-care professional products and Revlon ColorSilk hair color products, within the Company's EMEA, Asia, Latin America and Pacific regions, due, primarily, to the continuing effects of COVID-19 on the mass retail channel and salons.

Elizabeth Arden Segment

~~Second~~Third quarter results:

North America

In North America, Elizabeth Arden segment net sales in the ~~second~~third quarter of 2020 ~~decreased~~increased by ~~$11.2~~$1.0 million, or ~~42.7%~~3.4%, to ~~$15.0~~$30.5 million, compared to ~~$26.2~~$29.5 million in the ~~second~~third quarter of 2019. Excluding the $0.1 million unfavorable FX impact, Elizabeth Arden net sales in North America in the third quarter of 2020 increased by $1.1 million, or 3.7%, compared to the third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $111 million ($111 million XFX) to the Elizabeth Arden segment’s variance~~decrease~~ in net sales in North America in the ~~second~~third quarter of 2020, compared to the prior year quarter. The Elizabeth Arden segment's ~~$11.2~~$1.1 million ~~decrease~~XFX increase in North America net sales in the ~~second~~third quarter of 2020 was driven primarily by the Elizabeth Arden segment's ~~lower net sales of certain~~ ~~Elizabeth Arden-branded skin care and color cosmetics products, as well as~~ ~~Elizabeth Arden-branded fragrances, due, primarily, to the continuing effects of COVID-19 on foot traffic at department stores and other retail outlets, partially offset by~~ higher net sales of Ceramide skin care ~~products.~~

products, partially offset by lower net

6775

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~International~~

Internationally, Elizabeth Arden segment net sales in the second quarter of 2020 decreased by $25.3 million, or 27.7%, to $65.9 million, compared to $91.2 million in the second quarter of 2019. Excluding the $1.8 million unfavorable FX impact, Elizabeth Arden segment International net sales in the second quarter of 2020 decreased by $23.5 million, or 25.8%, compared to the second quarter of 2019. COVID-19 contributed an estimated ~~$23 million ($24 million XFX) to the~~ ~~Elizabeth Arden segment’sdecrease in the International net sales in the second quarter of 2020, compared to the prior year quarter.~~ ~~The Elizabeth Arden segment's $23.5 million XFX decrease in International net sales in the second quarter of 2020 was driven primarily by lower net~~ sales of certain ~~Elizabeth Arden-branded skin care products and color cosmetics products, as well as~~ ~~Elizabeth Arden~~-branded fragrances, primarily within the Company's EMEA and, to a lesser extent, Asia regions, due, primarily, to the continuing effects of COVID-19 on foot traffic at department stores and on travel retail outlets. This decrease was partially offset by higher net sales of ~~Elizabeth Arden-branded~~ ~~Ceramide~~ ~~skin care products and~~ ~~Green Tea~~ ~~fragrances within the Company's Asia region.~~

~~Year-to-date results:~~

~~North America~~

In North America, Elizabeth Arden segment net sales in the six months ended June 30, 2020 decreased by $18.0 million, or 33.1%, to $36.4 million, compared to $54.4 million in the six months ended June 30, 2019. Excluding the $0.2 million unfavorable FX impact, Elizabeth Arden segment net sales in North America in the six months ended June 30, 2020 decreased by $17.8 million, or 32.7%, compared to the six months ended June 30, 2019. COVID-19 contributed an estimated ~~$15 million ($15 million XFX) to the~~ ~~Elizabeth Arden segment’s~~ ~~decrease in net sales in North America in the six months ended June 30, 2020, compared to the prior year period.~~ ~~The Elizabeth Arden segment's $17.8 million XFX decrease in North America net sales in the six months ended June 30, 2020 was driven primarily by the Elizabeth Arden segment's lower net sales of~~other Elizabeth Arden-branded skin care and ~~color cosmetics~~fragrances products, ~~as well as~~ ~~Elizabeth Arden-branded fragrances,~~ due, primarily, to the continuing effects of COVID-19 on foot traffic at department stores and other retail outlets.

International

Internationally, Elizabeth Arden segment net sales in the ~~six~~third quarter of 2020 decreased by $17.9 million, or 19.1%, to $75.8 million, compared to $93.7 million in the third quarter of 2019. Excluding the $1.6 million favorable FX impact, Elizabeth Arden segment International net sales in the third quarter of 2020 decreased by $19.5 million, or 20.8%, compared to the third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $23 million ($24 million XFX) to the Elizabeth Arden segment’sdecrease in the International net sales in the third quarter of 2020, compared to the prior year quarter. The Elizabeth Arden segment's $19.5 million XFX decrease in International net sales in the third quarter 2020 was driven primarily by lower net sales of Elizabeth Arden-branded skin care products and color cosmetics products, as well as certain Elizabeth Arden-branded fragrances, primarily within the Company's EMEA and, to a lesser extent, Asia and Pacific regions, due, primarily, to the continuing effects of COVID-19 on foot traffic at department stores and on travel retail outlets.

Year-to-date results:

North America

In North America, Elizabeth Arden segment net sales in the nine months ended ~~June~~September 30, 2020 decreased by ~~$34.7~~$17.0 million, or 20.3%, to $66.9 million, compared to $83.9 million in the nine months ended September 30, 2019. Excluding the $0.3 million unfavorable FX impact, Elizabeth Arden segment net sales in North America in the nine months ended September 30, 2020 decreased by $16.7 million, or 19.9%, compared to ~~$139.7~~the nine months ended September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $16 million ($16 million XFX) to the Elizabeth Arden segment’s decrease in net sales in North America in the nine months ended September 30, 2020, compared to the prior year period. The Elizabeth Arden segment's $16.7 million XFX decrease in North America net sales in the nine months ended September 30, 2020 was driven primarily by the Elizabeth Arden segment's lower net sales of certain Elizabeth Arden-branded skin care products, as well as Elizabeth Arden-branded color cosmetics products and fragrances, due, primarily, to the continuing effects of COVID-19 on foot traffic at department stores and other retail outlets. This decrease was partially offset by higher net sales of Ceramide skin care products, as well as growth in e-commerce net sales.

International

Internationally, Elizabeth Arden segment net sales in the nine months ended September 30, 2020 decreased by $52.6 million, or 19.6%, to $215.5 million, compared to ~~$174.4~~$268.1 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$4.1~~$2.5 million unfavorable FX impact, Elizabeth Arden segment International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$30.6~~$50.1 million, or ~~17.5%~~18.7%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $4176 million ($4279 million XFX) to the Elizabeth Arden segment’s decrease in International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The Elizabeth Arden segment's ~~$30.6~~$50.1 million XFX decrease in International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 was driven primarily by lower net sales of certain Elizabeth Arden-branded skin care products, ~~and color cosmetics products,~~ as well as lower net sales of Elizabeth Arden-branded fragrances and color cosmetics, primarily within the Company's EMEA and, to a lesser extent, Asia, Pacific and Latin America ~~and Pacific~~ regions, due, primarily, to the continuing effects of COVID-19 on foot traffic at department stores and on travel retail outlets. This decrease was partially offset by higher net sales of Ceramide skin care products within the Company's Asia region, as well as ~~continued strong~~ growth in e-commerce net sales.

Portfolio Segment

~~Second~~Third quarter results:

North America

In North America, Portfolio segment net sales in the ~~second~~third quarter of 2020 decreased by ~~$20.9~~$11.5 million, or ~~28.6%~~16.1%, to ~~$52.1~~$59.9 million, compared to ~~$73.0~~$71.4 million in the ~~second~~third quarter of 2019. Excluding the ~~0.2~~$0.2 million unfavorable FX impact, Portfolio segment North America net sales in the ~~second~~third quarter of 2020 decreased by ~~$20.7~~$11.3 million, or ~~28.4%~~15.8%, compared to the ~~second~~third quarter ~~second~~third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $2114 million ($~~21 million XFX) to the~~ ~~Portfolio segment’sdecrease in net sales in North America in the second quarter of 2020, compared to the prior year quarter.~~ ~~The Portfolio segment's $20.7 million XFX decrease in North America net sales in the second quarter of 2020 was driven primarily by the Portfolio segment's lower net sales of~~ ~~Almay~~ ~~color cosmetics,~~ ~~CND~~ ~~nail products,~~ ~~American Crew~~ ~~men's grooming products and~~ ~~Mitchum~~ ~~anti-perspirant deodorants, driven, primarily, by the continuing effects of COVID-19 on the mass retail channel~~14

6876

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

million XFX) to the Portfolio segment’sdecrease in net sales in North America in the third quarter of 2020, compared to the prior year quarter. The Portfolio segment's $11.3 million XFX decrease in North America net sales in the third quarter of 2020 was driven primarily by the Portfolio segment's lower net sales of Almay color cosmetics, CND nail products, American Crew men's grooming products, driven, primarily, by the continuing effects of COVID-19 on the mass retail channel and on salons. This decrease was partially offset primarily by higher net sales of ~~Cutex~~ ~~nail products and~~ ~~SinfulColors~~ ~~cosmetics, as well as~~ Creme of Nature products, as well as ~~among~~Mitchum anti-perspirant deodorants and ~~local and regional brands~~Cutex. nail products.

International

Internationally, Portfolio segment net sales in the ~~second~~third quarter of 2020 decreased by ~~$9.3~~$7.1 million, or ~~20.4%~~15.2%, to ~~$36.4~~$39.7 million, compared to ~~$45.7~~$46.8 million in the ~~second~~third quarter of 2019. Excluding the ~~$2.1~~$0.7 million ~~unfavorable~~favorable FX impact, Portfolio segment International net sales decreased by ~~$7.2~~$7.8 million, or ~~15.8%~~16.7%, in the ~~second~~third quarter of 2020, compared to the ~~second~~third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $95 million ($105 million XFX) to the Portfolio segment’s decrease in International net sales in the ~~second~~third quarter of 2020, compared to the prior year quarter. The Portfolio segment's ~~$7.2~~$7.8 million XFX decrease in International net sales in the ~~second~~third quarter of 2020 was driven primarily by ~~the Portfolio segment's~~ lower net sales of local and regional brands, CND nail products, American Crew men's grooming products~~Mitchum~~ ~~anti-perspirant deodorants~~ and Almay color cosmetics, primarily in the Company's EMEA region, driven, primarily, by the continuing effects of COVID-19 on salons and the mass retail ~~channel, partially offset by~~ ~~continued strong growth in e-commerce net sales~~.channel.

Year-to-date results:

North America

In North America, Portfolio segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$20.2~~$31.7 million, or ~~14.1%~~14.8%, to ~~$122.9~~$182.8 million, as compared to ~~$143.1~~$214.5 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$0.1~~$0.3 million unfavorable FX impact, Portfolio segment net sales in North America in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$20.1~~$31.4 million, or ~~14.0%~~14.6%, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $2439 million ($2539 million XFX) to the Portfolio segment’s decrease in net sales in North America in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The Portfolio segment's ~~$20.1~~$31.4 million XFX decrease in North America net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 was driven primarily by the Portfolio segment's lower net sales of Almay color cosmetics, CND nail products and American Crew men's grooming products, due, primarily, to the continuing effects of COVID-19 on the mass retail channel and on salons. This decrease was partially offset primarily by higher net sales of Creme of Nature and certain other local and regional products brands, ~~and~~ Cutex nail products and Mitchum anti-perspirant deodorants, as well as ~~continued strong~~ growth in e-commerce net sales.

International

Internationally, Portfolio segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$17.2~~$24.3 million, or ~~18.5%~~17.4%, to ~~$75.6~~$115.3 million, compared to ~~$92.8~~$139.6 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$4.2~~$3.5 million unfavorable FX impact, Portfolio segment International net sales decreased by ~~$13.0~~$20.8 million, or ~~14.0%~~14.9%, in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $1217 million ($1317 million XFX) to the Portfolio segment’s decrease in International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The Portfolio segment's ~~$13.0~~$20.8 million XFX decrease in International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 was driven primarily by the Portfolio segment's lower net sales of ~~American Crew~~ ~~men's grooming products,~~ certain local and regional skin care products brands,American Crew men's grooming products, CND nail products and Almay color cosmetics, primarily in the Company's EMEA region, due, primarily, to the continuing effect of COVID-19 on the mass retail channel and on salons.

Fragrances Segment

~~Second~~Third quarter results:

North America

In North America, Fragrances segment net sales in the ~~second~~third quarter of 2020 decreased by ~~$22.9~~$19.4 million, or ~~43.5%~~19.7%, to ~~$29.7~~$79.2 million, as compared to ~~$52.6~~$98.6 million in the ~~second~~third quarter of 2019. ~~COVID-19 contributed an estimated~~ ~~$22~~Excluding the $0.1 million ~~($22 million XFX) to the~~ unfavorable FX impact, Fragrances ~~segment’s~~ ~~decrease in~~segment net sales in North America decreased by $19.3 million, or 19.6%, in the ~~second~~third quarter of 2020, compared to the ~~prior year quarter.~~ ~~The Fragrances segment's $22.9 million decrease in North America net sales in the second~~third quarter of ~~2020 wa~~2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated ~~s driven primarily by lower net sales due to the continuing impacts from COVID-19 especially in the prestige channel due to temporary door closures.~~

$16 million ($16 million

6977

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

XFX) to the Fragrances segment’s decrease in net sales in North America in the third quarter of 2020, compared to the prior year quarter. The Fragrances segment's $19.3 million XFX decrease in North America net sales in the third quarter of 2020 was driven primarily by lower net sales due to the continuing impacts from COVID-19, especially in the prestige channel, resulting in decreased foot traffic.

International

Internationally, Fragrances segment net sales in the ~~second~~third quarter of 2020 decreased by ~~$16.5~~$13.5 million, or ~~55.0%~~34.2%, to ~~$13.5~~$26.0 million, compared to ~~$30.0~~$39.5 million in the ~~second~~third quarter of 2019. Excluding the ~~$0.9~~$0.3 million ~~unfavorable~~favorable FX impact, Fragrances segment International net sales decreased by ~~$15.6~~$13.8 million, or ~~52.0%~~34.9%, in the ~~second~~third quarter of 2020, compared to the ~~second~~third quarter of 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $139 million ($139 million XFX) to the Fragrances segment’s decrease in International net sales in the ~~second~~third quarter of 2020, compared to the prior year quarter. The Fragrances segment's ~~$15.6~~$13.8 million XFX decrease in International net sales during the ~~second~~third quarter of 2020 was due to lower net sales of certain licensed fragrances primarily in the Company's EMEA region and also, to a lesser extent, in the Company's ~~Asia~~Pacific, Latin America and ~~Latin America~~Asia regions, due to the continuing impacts from COVID-19 ~~and retail~~ ~~door closures~~, resulting in decreased foot traffic.

Year-to-date results:

North America

In North America, Fragrances segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$27.9~~$47.3 million, or ~~28.0%~~23.8%, to ~~$71.9~~$151.1 million, as compared to ~~$99.8~~$198.4 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the $0.1 million unfavorable FX impact, Fragrances segment net sales in North America decreased by $47.2 million, or 23.8%, in the nine months ended September 30, 2020, compared to the nine months ended September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated ~~$24~~$40 million ($2440 million XFX) to the Fragrances segment’s decrease in net sales in North America in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The Fragrances segment's ~~$27.9~~$47.2 million XFX decrease in North America net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 was driven primarily by the continuing impacts from COVID-19, especially in the prestige channel, ~~due to~~resulting in decreased foot traffic and temporary door ~~closures~~.closures.

International

Internationally, Fragrances segment net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~$22.8~~$36.3 million, or ~~37.9%~~36.4%, to ~~$37.3~~$63.3 million, compared to ~~$60.1~~$99.6 million in the ~~six~~nine months ended ~~June~~September 30, 2019. Excluding the ~~$1.8~~$1.5 million unfavorable FX impact, Fragrances segment International net sales decreased by ~~$21.0~~$34.8 million, or 34.9%, in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The ongoing and prolonged COVID-19 pandemic contributed an estimated $1624 million ($1725 million XFX) to the Fragrances segment’s decrease in International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the prior year period. The Fragrances segment's ~~$21.0~~$34.8 million XFX decrease in International net sales in the ~~six~~nine months ended ~~June~~September 30, 2020 was driven primarily by lower net sales in the Company's EMEA region and also, to a lesser extent, in the Company's Asia, ~~and~~ Latin America and Pacific regions, due to the continuing impacts from COVID-19, resulting in decreased foot traffic and ~~retail~~temporary door closures.

Gross profit:

The table below shows the Company's gross profit and gross margin for the periods presented:


		Three Months Ended June 30,												Six Months Ended June 30,													Three Months Ended September 30,									Nine Months Ended September 30,
		2020			2019			Change			2020			2019			Change				2020			2019			Change			2020			2019			Change
Gross profit	Gross profit	$	179.0		$	326.3		$	(147.3)		$	434.2		$	641.7		$	(207.5)		Gross profit	$	242.8		$	327.8		$	(85.0)		$	677.0		$	969.5		$	(292.5)
Percentage of net sales	Percentage of net sales	51.5		%	57.2		%	(5.7)		%	54.2		%	57.1		%	(2.9)		%	Percentage of net sales	50.9		%	54.9		%	(4.0)		%	53.0		%	56.4		%	(3.4)		%

~~Second~~Third quarter results:

Gross profit decreased by ~~$147.3~~$85.0 million in the ~~second~~third quarter of 2020, as compared to the ~~second~~third quarter of 2019. Unfavorable sales volume, primarily driven by the ~~ongoing~~ effects of the ongoing and prolonged COVID-19 pandemic, decreased gross profit in the ~~second~~third quarter of 2020 by approximately ~~$127~~$66 million, compared to the ~~second~~third quarter of 2019, with no impact on gross margin. Gross profit as a percentage of net sales (i.e., gross margin) in the ~~second~~third quarter of 2020 decreased by ~~5.7%~~4.0% compared to the ~~second~~

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

third quarter of 2019. The decrease in gross margin in the ~~second~~third quarter of 2020, as compared to the ~~second~~third quarter of 2019, was ~~primarily driven~~impacted by the negative effect of product mix, mainly attributable to the ~~ongoing~~ effects of the ongoing and prolonged COVID-19 ~~and~~pandemic, higher manufacturing costs resulting, in part, from the ongoing and prolonged COVID-19 pandemic, as well as unfavorable impacts of tariffs, partially offset by the impact of cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of COVID-19 on the Company's operations, as well as the Revlon 2020 Restructuring Program.

Year-to-date results:

Gross profit decreased by ~~$207.5~~$292.5 million in the ~~six~~nine months ended ~~June~~September 30, 2020, as compared to the ~~second~~third quarter of 2019. Unfavorable sales volume, primarily driven by the ~~ongoing~~ effects of the ongoing and prolonged COVID-19 pandemic, decreased gross profit in the ~~six~~nine months ended ~~June~~September 30, 2020 by approximately ~~$184~~$249 million, compared to the ~~six~~nine months ended ~~June~~September 30, 2019, with no impact

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

on gross margin. Gross profit as a percentage of net sales (i.e., gross margin) in the ~~six~~nine months ended ~~June~~September 30, 2020 decreased by ~~2.9~~3.4 percentage points, as compared to the ~~six~~nine months ended ~~June~~September 30, 2019. The decrease in gross margin in the ~~six~~nine months ended ~~June~~September 30, 2020, as compared to the ~~six~~nine months ended ~~June~~September 30, 2019, was ~~primarily driven~~impacted by the negative effect of product mix, mainly attributable to the ongoing effects of the ongoing and prolonged COVID-19 pandemic, higher manufacturing costs resulting, in part, from the ongoing and ~~higher sales allowances,~~prolonged COVID-19 pandemic, as well as unfavorable impacts of FX and tariffs, partially offset by the impact of cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of COVID-19 on the Company's operations, as well as the Revlon 2020 Restructuring Program.

SG&A expenses:

The table below shows the Company's SG&A expenses for the periods presented:

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 Change 2020 2019 Change
SG&A expenses $ 196.3 $ 332.5 $ (136.2) $ 485.7 $ 665.1 $ (179.4)


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		Change		2020		2019		Change
SG&A expenses	$	253.4	$	308.1	$	(54.7)	$	739.1	$	973.2	$	(234.1)

~~Second~~Third quarter results:

SG&A expenses decreased by ~~$136.2~~$54.7 million in the ~~second~~third quarter of 2020, compared to the ~~second~~third quarter of 2019, driven primarily by:

•a net decrease of approximately $36 million in brand support expenses, resulting from the Company's ongoing cost reduction initiatives in response to the ongoing and prolonged COVID-19 pandemic and decreased media spend to align with the lower net sales, primarily in North America and in the EMEA regions, primarily within the Revlon segment and, to a lesser extent, within the Portfolio, Elizabeth Arden and Fragrances segments;

•lower distribution expenses of approximately $8 million, driven primarily by the net sales decline;

•lower general and administrative expenses of approximately ~~$65~~$7 million, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as the Revlon 2020 Restructuring Program;

•a net decrease of approximately $53 million in brand support expenses, resulting from the Company's ongoing cost reduction initiatives in response to COVID-19, decreased media spend to align with the lower net sales, primarily in North America within the Revlon segment and, to a lesser extent, within the Elizabeth Arden, Portfolio and Fragrances segments, partially offset by an increase in brand support to support sales growth in Asia;

•~~lower distribution expenses of approximately $12 million, driven primarily by the net sales decline;~~ and

•~~favorable~~unfavorable FX impact of approximately $4$2 million.

~~Year-to-date results:~~

~~SG&A expenses decreased by $179.4 million in the six months ended June 30, 2020, compared to the six months ended June 30, 2019, driven primarily by:~~

•~~lower general and administrative expenses of approximately $75 million,~~ primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of COVID-19 on the Company's operations, as well as the Revlon 2020 Restructuring Program;

•a net decrease of approximately $75 million in brand support expenses, resulting from the Company's ongoing cost reduction initiatives in response to COVID-19, decreased media spend to align with the lower net sales primarily in North America within the Revlon segment and, to a lesser extent, within the Elizabeth Arden, Portfolio and Fragrances segments, partially offset by an increase in brand support to support sales growth in Asia;

•~~lower distribution expenses of approximately $17 million, driven primarily by the net sales decline; and~~

•~~favorable FX impact of approximately $8 million.~~

~~Acquisition, integration and divestiture costs:~~

~~The table below shows the Company's acquisition, integration and divestiture costs for the periods presented:~~

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 Change 2020 2019 Change
Integration Costs $ — $ — $ — $ — $ 0.6 $ (0.6)
Divestiture Costs 1.2 — 1.2 3.3 — 3.3
Total acquisition, integration and divestiture costs $ 1.2 $ — $ 1.2 $ 3.3 $ 0.6 $ 2.7

7179

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~Second~~Year-to-date results:

SG&A expenses decreased by $234.1 million in the nine months ended September 30, 2020, compared to the nine months ended September 30, 2019, driven primarily by:

•a net decrease of approximately $111 million in brand support expenses, resulting from the Company's ongoing cost reduction initiatives in response to the ongoing and prolonged COVID-19 pandemic and decreased media spend to align with the lower net sales primarily in North America and in the EMEA regions, primarily within the Revlon segment and, to a lesser extent, within the Elizabeth Arden, Portfolio and Fragrances segments, partially offset by an increase in brand support to support sales growth in Asia;

•lower general and administrative expenses of approximately $82 million, primarily driven by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of the ongoing and prolonged COVID-19 pandemic on the Company's operations, as well as the Revlon 2020 Restructuring Program;

•lower distribution expenses of approximately $24 million, driven primarily by the net sales decline; and

•favorable FX impact of approximately $6 million.

Acquisition, integration and divestiture costs:

The table below shows the Company's acquisition, integration and divestiture costs for the periods presented:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		Change		2020		2019		Change

Integration Costs	$	—	$	0.1	$	(0.1)	$	—	$	0.7	$	(0.7)
Divestiture Costs	0.9		—		0.9		4.2		—		4.2
Total acquisition, integration and divestiture costs	$	0.9	$	0.1	$	0.8	$	4.2	$	0.7	$	3.5

Third quarter results:

The Company incurred ~~$1.2~~$0.9 million of divestiture costs in the ~~second~~third quarter of 2020 relating to the amortization of the cash-based awards under Tier 1 and Tier 2 of the Revlon 2019 TIP (see Note 11, "Stock Compensation Plan," to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q for additional details on the 2019 TIP).

Year-to-date results:

The Company incurred ~~$3.3~~$4.2 million of divestiture costs in the ~~six~~nine months ended ~~June~~September 30, 2020 including $0.7 million in professional fees incurred in connection with the exploration of strategic transactions involving the Company and third parties pursuant to the Strategic Review and approximately ~~$2.6~~$3.5 million relating to the amortization of the cash-based awards under Tier 1 and Tier 2 of the Revlon 2019 TIP (See Note 11, "Stock Compensation Plan," to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q for additional details on the 2019 TIP).

The Company incurred ~~$0.6~~$0.7 million of integration costs in the ~~six~~nine months ended ~~June~~September 30, 2019, related primarily to the Company's integration of Elizabeth Arden's operations into the Company's business, including professional fees and employee-related costs.

Restructuring charges and other, net:

The table below shows the Company's restructuring charges and other, net for the periods presented:

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 Change 2020 2019 Change
Restructuring charges and other, net $ 20.7 $ 3.2 $ 17.5 $ 45.5 $ 8.7 $ 36.8


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		Change		2020		2019		Change
Restructuring charges and other, net	$	(0.7)	$	2.9	$	(3.6)	$	44.8	$	11.6	$	33.2

Restructuring charges and other, net, decreased $3.6 million during the three months ended September 30, 2020, compared to the three months ended September 30, 2019, primarily due to the subsequent true-up in the third quarter of 2020 of

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

restructuring charges previously accrued in 2020 under the Revlon 2020 Restructuring Program, compared to the expenditures incurred primarily under the 2018 Optimization Program in the third quarter of 2019.

Restructuring charges and other, net, increased ~~$17.5 million and $36.8~~$33.2 million during the ~~three and six~~nine months ended ~~June~~September 30, 2020, ~~respectively,~~ compared to the ~~three and six~~nine months ended ~~June~~September 30, 2019, primarily due to higher charges in connection with the Revlon 2020 Restructuring ~~Program.~~ Program, compared to the expenditures incurred primarily under the 2018 Optimization Program in the third quarter of 2019.

Further information on the Company's restructuring charges in relation to its restructuring initiatives follows.

Revlon 2020 Restructuring Program

Building upon its previously-announced 2018 Optimization Program, in March 2020 the Company announced that it is implementing a worldwide organizational restructuring (the “Revlon 2020 Restructuring Program”) designed to reduce the Company’s SG&A expenses, as well as cost of goods sold, improve the Company’s gross profit and Adjusted EBITDA and maximize productivity, cash flow and liquidity. The Revlon 2020 Restructuring Program includes rightsizing the organization and operating with more efficient workflows and processes. The leaner organizational structure is also expected to improve communication flow and cross-functional collaboration, leveraging the more efficient business processes.

In March 2020, the Company began informing certain employees that were affected by the Revlon 2020 Restructuring Program. While certain aspects of the Revlon 2020 Restructuring Program may be subject to consultations with employees, works councils, unions and/or governmental authorities, the Company currently expects to substantially complete the employee-related actions by the end of 2020 and the other consolidation and outsourcing actions during 2021 and 2022.

In connection with implementing the Revlon 2020 Restructuring Program, the Company expects to recognize during 2020 approximately $60 million to $70 million of total pre-tax restructuring and related charges (the “2020 Restructuring Charges”), consisting primarily of employee-related costs, such as severance, retention and other contractual termination benefits. In addition, the Company expects restructuring charges in the range of $75 million to $85 million to be charged and paid during 2021 and 2022. The Company expects that substantially all of these restructuring charges will be paid in cash, with approximately $55 million to $65 million of the total charges expected to be paid in 2020, approximately $40 million to $45 million expected to be paid in 2021, with the balance expected to be paid in 2022. During the ~~second~~third quarter of 2020, the Company recorded ~~$22.7~~$4.1 million of net restructuring and related charges under the 2020 Restructuring Program consisting of: (i) ~~$21.0 million of severance and other personnel costs; and (ii) $1.7~~$5.1 million of lease and other restructuring-related charges that

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

were recorded within SG~~&A.~~&A; and (ii) $1.0 million true up of previously accrued severance and other personnel costs. Since commencing the Revlon 2020 Restructuring Program and through ~~June~~September 30, 2020, the Company recorded ~~$57.1~~$61.2 million of restructuring and related charges under the 2020 Restructuring Program consisting of: (i) ~~$46.6~~$45.6 million of severance and other personnel costs; and (ii) ~~$10.5~~$15.6 million of lease and other restructuring-related charges that were recorded within SG&A. Of these charges, approximately ~~$9.3~~$21.5 million were paid through ~~June~~September 30, 2020.

As a result of the Revlon 2020 Restructuring Program, the Company expects to deliver in the range of $200 million to $230 million of annualized cost reductions by the end of 2022, with approximately 50% of these annualized cost reductions to be realized from the headcount reductions occurring in 2020. During 2020, the Company expects to realize approximately $105 million to $115 million of in-year cost reductions, of which approximately ~~$38~~$22 million and ~~$65~~$87 million had been achieved during the three and ~~six~~nine months ~~June~~September 30, 2020, respectively.

2018 Optimization Program

During 2018, the Company announced its 2018 Optimization Program designed to streamline the Company’s operations, reporting structures and business processes, with the objective of maximizing productivity and improving profitability, cash flows and liquidity. During the ~~second~~third quarter of 2020, the Company recorded ~~a reversal of previously accrued~~restructuring charges related to severance and personnel benefits of ~~$0.3~~$0.1 million under the 2018 Optimization Program. During the ~~six~~nine months ended ~~June~~September 30, 2020, the Company recorded, under the 2018 Optimization Program, ~~$0.7~~$0.6 million due to the reversal of previously accrued severance, personnel benefits and other restructuring costs, offset by $0.7 million of other restructuring-related charges that were recorded within SG&A and cost of sales. The Company recognized approximately ~~$39.5~~$39.6 million of cumulative total pre-tax restructuring

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

and related charges under the 2018 Optimization Program since its inception in November 2018, consisting of employee-related costs, such as severance, pension and other termination costs, as well as other related charges within SG&A and cost of sales and approximately $6.5 million of additional capital expenditures. As of ~~June~~September 30, 2020, restructuring and related charges to be paid in cash are approximately $32 million of the total charges, of which ~~$29.8~~$30.3 million were already paid through ~~June~~September 30, 2020, with any residual balance expected to be paid during the remainder of 2020.

During the three and ~~six~~nine months ended ~~June~~September 30, 2019, the Company recorded ~~$3.2~~$2.9 million and ~~$8.7~~$11.6 million, respectively, of restructuring charges primarily related to the 2018 Optimization Program.

For further information on the Revlon 2020 Restructuring Program, the 2018 Optimization Program and on the Company's other restructuring initiatives, see Note 2, "Restructuring Charges," to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q.

Impairment Charges:

The table below shows the Company's impairment charges for the periods presented:

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 Change 2020 2019 Change
Impairment charges $ 19.8 $ — $ 19.8 $ 144.1 $ — $ 144.1


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		Change		2020		2019		Change
Impairment charges	$	—	$	—	$	—	$	144.1	$	—	$	144.1

During the first ~~quarter~~and second quarters of 2020, as a result of COVID-19’s impact on the Company’s operations, the Company determined that indicators of potential impairment existed requiring the Company to perform interim impairment analyses. These indicators included a deterioration in the general economic conditions, developments in equity and credit markets, deterioration in some of the economic channels in which the Company's operates (especially in the mass retail channel), the recent trading values of the Company's capital stock and the corresponding decline in the Company’s market capitalization and the revision of the Company's ~~internal forecasts~~expected future cash flows as a result of COVID-19. Based on the first ~~quarter~~and second quarters of 2020 interim impairment analyses, the Company recorded $124.3 million and $19.8 million of total non-cash impairment charges for the first and second quarter of ~~2020.~~2020, respectively.

~~Primarily as a result~~As of September 30, 2020, due to the continued worldwide effects of the ongoing and prolonged COVID-19 ~~still affecting multiple countries around the world,~~pandemic, the Company ~~considered~~re-assessed whether ~~newer and/or additional~~further indicators of impairment ~~existed~~arose during the ~~second~~third quarter of 2020 that ~~would warrant another interim~~might result in additional goodwill impairment charges. Based upon such assessment, the Company determined that it was more likely than not that the fair value of ~~goodwill for impairment purposes. The Company concluded that additional indicators~~each of ~~impairment existed~~its reporting units exceeded their respective carrying amounts as of ~~June~~September 30, ~~2020, primarily in connection with further revisions to~~2020. Consequently, no impairment changes were recognized during the ~~Company's expected future cash flows as a result of COVID-19.~~ ~~Based on the second quarter of 2020 interim impairment analyses, the Company recorded $19.8 million of total non-cash impairment charges for the second quarter of~~three months ended September 30, 2020.

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

For further information on these non-cash impairment charges, see Note 5, “Goodwill and Intangible Assets, Net,” to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q.

Interest expense:

The table below shows the Company's interest expense for the periods presented:

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 Change 2020 2019 Change
Interest expense $ 60.9 $ 47.8 $ 13.1 $ 109.3 $ 95.5 $ 13.8


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		Change		2020		2019		Change
Interest expense	$	68.7	$	50.2	$	18.5	$	178.0	$	145.7	$	32.3

The ~~$13.1~~$18.5 million increase in interest expense in the ~~second~~third quarter of 2020, as compared to the ~~second~~third quarter of 2019, was primarily due to higher weighted average interest rates and higher weighted average borrowings driven primarily by the 2020 BrandCo Term Loan Facility.

The $32.3 million increase in interest expense during the nine months endedSeptember 30, 2020, as compared to the nine months endedSeptember 30, 2019, was primarily due to higher weighted average borrowings and higher weighted average

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

interest rates driven primarily by the 2020 BrandCo Term Loan Facility and the 2019 Term Loan Facility (the latter of which was fully repaid in May 2020 using proceeds from the 2020 BrandCo Term Loan Facility).

Gain on early extinguishment of debt:


	Three Months Ended September 30,					Nine Months Ended September 30,
	2020	2019		Change		2020		2019		Change
Gain on early extinguishment of debt	(31.2)	$	—	$	(31.2)	$	(43.1)	$	—	$	(43.1)

~~The $13.8 million increase in interest expense during th~~e ~~six months endedJune 30, 2020, as compared to the six months ended~~ ~~June 30, 2019~~, was primarily due to higher weighted average borrowings and higher weighted average interest rates driven primarily by the 2020 BrandCo Term Loan Facility and the 2019 Term Loan Facility (the latter of which was fully repaid in May 2020 using proceeds from the 2020 BrandCo Term Loan Facility).

~~(Gain) loss~~Gain on early extinguishment of debt ~~net:~~

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 Change 2020 2019 Change
(Gain) loss on early extinguishment of debt, net $ (11.9) $ — $ (11.9) $ (11.9) $ — $ (11.9)

~~(Gain) loss on early extinguishment of debt, net~~ for the three and ~~six~~nine months ended ~~June~~September 30, 2020 includes ~~net~~ debt extinguishment gains of $31.2 million recorded during the third quarter of 2020 and $11.9 million recorded during the second quarter of 2020 upon the repurchase and subsequent cancellation of approximately ~~$112.8~~$157.2 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes occurring in the third and second ~~quarter~~quarters of 2020.

For information on the terms and conditions of these debt instruments, see "Recent Developments," as well as Note 7, ~~“Debt”~~“Debt,” and Note 19, “Subsequent Events,” to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q and Note 9, "Debt," in the Audited Consolidated Financial Statements in the Company's 2019 Form 10-K. Also, please refer to "Financial Condition, Liquidity and Capital Resources - Long-Term Debt Instruments" in Item 2 of this Form 10-Q for further information.

Foreign currency losses, net:

The table below shows the Company's foreign currency losses, net for the periods presented:

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 Change 2020 2019 Change
Foreign currency losses, net $ 2.3 $ 1.2 $ 1.1 $ 18.9 $ 1.4 $ 17.5


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		Change		2020		2019		Change
Foreign currency (gains) losses, net	$	(9.8)	$	7.6	$	(17.4)	$	9.1	$	9.0	$	0.1

The ~~$1.1~~$17.4 million increase in foreign currency ~~losses,~~gains, net, during the ~~second~~third quarter of 2020, compared to the ~~second~~third quarter of 2019, was primarily driven by the net ~~unfavorable~~favorable impact of foreign currency fluctuations on certain U.S. Dollar denominated intercompany payables and foreign currency denominated receivables compared to the prior year's quarter.

The ~~$17.5~~$0.1 million increase in foreign currency losses, net, during the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the ~~six~~nine months ended ~~June~~September 30, 2019, was primarily driven by the net unfavorable impact of foreign currency fluctuations on certain U.S. Dollar denominated intercompany payables and foreign currency denominated receivables compared to the prior year's period.

Provision for (benefit from) income taxes:

The table below shows the Company's provision for (benefit from) income taxes for the periods presented:


	Three Months Ended September 30,						Nine Months Ended September 30,
	2020		2019		Change		2020		2019		Change
Provision for (benefit from) income taxes	$	1.9	$	(2.1)	$	4.0	$	(45.2)	$	(3.2)	$	(42.0)

The Company recorded a provision for income taxes of $1.9 million for the third quarter of 2020, compared to a benefit from income taxes of $2.1 million for the third quarter of 2019. The $4.0 million decrease in the benefit from income taxes for the third quarter of 2020, compared to the same quarter in 2019, was primarily due to: (i) the mix and level of earnings; (ii) an increase in the U.S. tax on the Company's foreign earnings; and (iii) increased tax expense from return to provision adjustments, partially offset primarily by an increase in tax benefit from the net change in valuation allowances related to the recognition of previously unrecognized tax losses in Canada.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

~~Benefit from income taxes:~~

~~The table below shows the Company's (benefit from) provision for income taxes for the periods presented:~~

Three Months Ended June 30, Six Months Ended June 30,
2020 2019 Change 2020 2019 Change
Benefit from income taxes $ (9.9) $ (1.2) $ (8.7) $ (47.1) $ (1.1) $ (46.0)

The Company recorded a benefit from income taxes of ~~$9.9~~$45.2 million for the ~~second quarter of~~nine months ended September 30, 2020, compared to a benefit from income taxes of ~~$1.2~~$3.2 million for the ~~second quarter of~~nine months ended September 30, 2019. The ~~$8.7~~$42.0 million increase in the benefit from income taxes for the second quarter of 2020, compared to the same quarter in 2019, was primarily due to: (i) the increased loss from continuing operations before income taxes on which the tax benefit is recognized; (ii) the mix and level of earnings; and (iii) a reduction in the U.S. tax on the Company's foreign earnings, offset by an increase in tax expense related to uncertain tax positions and by the net change in valuation allowances recorded related to increased net losses in certain state jurisdictions.

~~The Company recorded a benefit from income taxes of $47.1 million for the six~~nine months ended June 30, 2020, compared to a benefit from income taxes of $1.1 million for the six months ended June 30, 2019. The $46.0 million increase in the benefit from income taxes for the six months ended JuneSeptember 30, 2020, compared to same period in 2019, was primarily due to: (i) the increased loss from continuing operations before income taxes on which the tax benefit is recognized; (ii) the mix and level of earnings; and (iii) a reduction in the U.S. tax on the Company's foreign earnings, net of the impact of non-deductible impairment charges, partially offset by the net change in valuation allowances recorded related to the limitation on the deductibility of interest.

~~The~~ CARES Act, among other things, includes provisions providing for refundable payroll tax credits, the deferral of employer social security tax payments, acceleration of alternative minimum tax credit refunds and the increase of the net interest deduction limitation from 30% to 50%. The Company continues to examine the impact that the CARES Act may have on its results of operations, financial condition and/or financial statement disclosures.

~~Table of Contents~~

~~REVLON, INC AND SUBSIDIARIES~~

~~COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION~~

~~AND RESULTS OF OPERATIONS~~

~~(all tabular amounts in millions, except share and per share amounts)~~

For further information, see Note 12, "Income Taxes," to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q, as well as Note 14, "Income Taxes," to the Consolidated Financial Statements in the Company's 2019 Form 10-K and Item 1A. “Risk Factors-Uncertainties in the interpretation and application of the U.S. income tax provisions could have a material impact on the Company's financial condition, results of operations and/or cash flows” in the Company's 2019 Form 10-K.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Results of Operations — Products Corporation

Products Corporation's Unaudited Consolidated Statements of Operations and Comprehensive Loss are essentially identical to Revlon, Inc.'s Unaudited Consolidated Statements of Operations and Comprehensive Loss, except for the following:


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended September 30,				Nine Months Ended September 30,
		2020		2019		2020		2019			2020		2019		2020		2019
Net loss - Revlon, Inc.	Net loss - Revlon, Inc.	$	(126.8)	$	(63.7)	$	(340.7)	$	(138.8)	Net loss - Revlon, Inc.	$	(44.5)	$	(44.7)	$	(385.2)	$	(183.5)
Selling, general and administrative expenses - public company costs	Selling, general and administrative expenses - public company costs	1.9		1.5		3.9		3.3		Selling, general and administrative expenses - public company costs	2.0		1.8		5.9		5.1
Provision for income taxes	Provision for income taxes	(0.3)		(0.3)		(0.6)		(0.5)		Provision for income taxes	(0.4)		(0.3)		(1.0)		(0.8)
Net loss - Products Corporation	Net loss - Products Corporation	$	(125.2)	$	(62.5)	$	(337.4)	$	(136.0)	Net loss - Products Corporation	$	(42.9)	$	(43.2)	$	(380.3)	$	(179.2)

Refer to Revlon’s “Management Discussion and Analysis of Financial Condition and Results of Operations” herein.

Financial Condition, Liquidity and Capital Resources

At ~~June~~September 30, 2020, the Company had a liquidity position of ~~$415.7~~$340.4 million, consisting of: (i) ~~$338.5~~$268.3 million of unrestricted cash and cash equivalents (with approximately ~~$62.1~~$93.7 million held outside the U.S.); (ii) ~~$50.7~~$52.6 million in available borrowing capacity under Products Corporation's Amended 2016 Revolving Credit Facility (which had ~~$249.5~~$291.9 million drawn at such date); (iii) $30 million in available borrowing capacity under the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility, which had no borrowings at such date; and less (iv) approximately ~~$3.5~~$10.5 million of outstanding checks. Under the Amended 2016 Revolving Credit Facility, as Products Corporation’s consolidated fixed charge coverage ratio ("FCCR") was greater than 1.0 to 1.0 as of ~~June~~September 30, 2020, all of the approximately ~~$50.7 million of availability under the Amended 2016 Revolving Credit Facility was available as of such date.~~

~~At July 31, 2020, the Company estimates that it had a liquidity position of $392 million, consisting of: (i) $318 million of unrestricted cash and cash equivalents (with approximately $62 million held outside the U.S.); (ii) $51 million~~ in available borrowing capacity under Products Corporation's Amended 2016 Revolving Credit Facility (which had $259 million drawn at such date); (iii) $30 million in available borrowing capacity under the Amended 2019 Senior Line of Credit Facility, which had no borrowings at such date; and less (iv) approximately $7 million of outstanding checks. Under the Amended 2016 Revolving Credit Facility, as Products Corporation’s FCCR was greater than 1.0 to 1.0 as of June 30, 2020, all of the approximately $51$52.6 million of availability under the Amended 2016 Revolving Credit Facility was available as of such date.

See “Recent Developments,” as well as Note 7, "Debt," and Note 19, “Subsequent Events,” to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q and Note 9, "Debt," to the Company's Audited Consolidated Financial Statements in the Company’s 2019 Form 10-K for detailed information on the terms and conditions of the Company’s various debt instruments.

5.75% Senior Notes Exchange Offer

See “Recent Developments” for important information regarding the Company’s debt-related transactions occurring after September 30, 2020. On September 29, 2020, Products Corporation commenced the Exchange Offer to exchange any and all of the then-outstanding 5.75% Senior Notes. As described in "Recent Developments," the Exchange Offer was amended on October 23, 2020 and on November 13, 2020, the Company announced that the Exchange Offer was successfully consummated and that Products Corporation had accepted $236 million in aggregate principal amount of 5.75% Senior Notes tendered in the Exchange Offer. Products Corporation used cash on hand to redeem, effective as of November 13, 2020, the remaining $106.8 million in aggregate principal amount of 5.75% Senior Notes pursuant to the terms of the 5.75% Senior Notes Indenture. Following the consummation of the Exchange Offer and the satisfaction and discharge of the remaining 5.75% Senior Notes, no 5.75% Senior Notes remained outstanding as of the closing on November 13, 2020.

Amendments to the 2020 BrandCo Term Loan Facility

•Tendering any Existing 5.75% Senior Notes held by such Supporting BrandCo Lenders into the Exchange Offer and Consent Solicitation;

MacAndrews & Forbes 2020 Restated Line of Credit Facility

Credit Facility will terminate, such that M&F’s maximum committed amount under the 2020 Restated Line of Credit Facility will never exceed $30.0 million. As of September 30, 2020, there were no borrowings outstanding under the 2020 Restated Line of Credit Facility.

Consummation of 2020 BrandCo Refinancing Transactions

loan facilities (the “2020 BrandCo Facilities” and, collectively, the "2020 BrandCo Term Loan Facility" and, together with the use of proceeds thereof and the Extension Amendment, ~~(as defined below),~~ the “2020 BrandCo Refinancing Transactions”).

aggregate principal amount outstanding of ~~$809.8~~$846.0 million, with a remaining capacity for the roll-up of loans under the 2016 Term Loan Facility of ~~$143.2~~$107.0 million. See “Amendments to the 2020 BrandCo Term Loan Facility” regarding the Supporting BrandCo Lenders relinquishing certain Roll-up Rights and Products Corporation’s issuance of the BrandCo Support and Consent Consideration.

license and royalty arrangements on arm’s length terms with the relevant BrandCos to provide for the continued use of the Specified Brand Assets by Products Corporation and its subsidiaries during the term of the 2020 BrandCo Facilities.

2016 Term Loan Facility Extension Amendment: Term loan lenders under the 2016 Term Loan Facility were offered the opportunity to participate at par in the 2020 BrandCo Facilities based on their holdings of term loans under the 2016 Term Loan Facility. Lenders participating in the 2020 BrandCo Facilities, as well as other consenting lenders representing, in the aggregate, a majority of the loans and commitments under the 2016 Term Loan Facility, consented to an amendment to the 2016 Term Loan Facility (the “Extension Amendment”) that, among other things, made certain modifications to the covenants thereof and extended the maturity date of their term loans (“Extended Term Loans”) to June 30, 2025, subject to (i) the same September 7, 2023 springing maturity date of the non-extended term loans under the 2016 Term Loan Facility if, on such date, $75 million or more in aggregate principal amount of the non-extended term loans under the 2016 Term Loan Facility remains outstanding, and (ii) a springing maturity of 91 days prior to the August 1, 2024 maturity date of the 6.25% Senior Notes if, on such date, $100 million or more in aggregate principal amount of the 6.25% Senior Notes remains outstanding. The Extension Amendment became effective on the BrandCo 2020 Facilities Closing Date. As of ~~June~~September 30, 2020, approximately ~~$30.8~~$30.7 million in aggregate principal amount of Extended Term Loans were outstanding after giving effect to the 2020 BrandCo Refinancing Transactions. The Extended Term Loans bear interest at a rate of LIBOR (with a LIBOR floor of 0.75%) plus 3.50% per annum, payable not less than quarterly in arrears in cash, consistent with the interest rate applicable to the non-extended term loans. Approximately $17.0 million of accrued interest outstanding on the 2016 Term Loan Facility was paid on the BrandCo 2020 Facilities Closing Date. The aggregate principal amount of non-extended term loans under the 2016 Term Loan Facility as of ~~June~~September 30, 2020 was ~~$894.0~~approximately $855.6 million.

Repurchases of 5.75% Senior Notes due 2021

On May 7, 2020, ~~the Company~~Products Corporation used a portion of the proceeds from the 2020 BrandCo Facility to repurchase and subsequently cancel $50 million in aggregate principal face amount of its 5.75% Senior Notes. Products Corporation also paid approximately$0.7 million of accrued interest outstanding on the 5.75% Senior Notes on May 7, 2020. After the BrandCo 2020 Facilities Closing Date, ~~the Company~~Products Corporation repurchased and subsequently canceled in July 2020 a further $62.8 million in aggregate principal face amount of its 5.75% Senior Notes. Furthermore, during the three months ended September 30, 2020, Products Corporation repurchased and subsequently canceled an additional $44.4 million in aggregate principal face amount of its 5.75% Senior Notes. Accordingly, as of ~~June~~September 30, 2020, ~~the Company~~Products Corporation had repurchased and subsequently cancelled a total of approximately ~~$112.8~~$157.2 million in aggregate principal face amount of its 5.75% Senior Notes, resulting in a ~~net~~ gain on extinguishment of debt of approximately ~~$11.9~~$31.2 million and $43.1 million for the three and nine months ended September 30, 2020, respectively, which ~~was~~were recorded within ~~"(Gain) loss~~"Gain on

early extinguishment of ~~debt, net"~~debt" on the Company's Unaudited Consolidated Statement of Operations and Comprehensive Loss for the three and ~~six~~nine months ended ~~June~~September 30, 2020. See “Recent Debt Transactions—Exchange Offer” in this Item 7. "Combined Management's Discussion and Analysis of Financial Condition and Results of Operations" for more information regarding Products Corporation's5.75% Senior Notes and the related Exchange ~~Offer that the Company commenced in July 2020 with respect to the 5.75% Senior Notes.~~Offer.

Prepayment of the 2019 Term Loan Facility due 2023

Amendment to the 2018 Foreign Asset-Based Term Facility

•increasing the interest rate on the loan from EURIBOR (with a floor 0.50%) plus a margin of 6.50% to EURIBOR (with a floor 0.50%) plus a margin of 7.00%;

•requiring a mandatory prepayment of €5.0 million; and

•clarifying certain terms and waiving certain provisions in connection with the 2020 BrandCo Refinancing Transactions.

Incremental Revolving Credit Facility under the 2016 Term Loan Agreement

~~Amendments to 2016 Revolving Credit Agreement~~

Changes in Cash Flows

As of ~~June~~September 30, 2020, the Company had cash, cash equivalents and restricted cash of ~~$343.9~~$273.7 million (which as of ~~June~~September 30, 2020 included approximately ~~$276.4~~$175.0 million of proceeds remaining from the 2020 BrandCo Refinancing Transactions), compared with $104.5 million at December 31, 2019. The following table summarizes the Company’s cash flows from operating, investing and financing activities for the periods presented:


		Six Months Ended June 30,							Nine Months Ended September 30,
		2020		2019			2020		2019
Net cash used in operating activities	Net cash used in operating activities	$	(164.2)	$	(41.2)	Net cash used in operating activities	$	(256.9)	$	(166.8)
Net cash used in investing activities	Net cash used in investing activities	(2.7)		(12.2)		Net cash used in investing activities	(7.4)		(20.0)
Net cash provided by financing activities	Net cash provided by financing activities	408.4		28.6		Net cash provided by financing activities	433.9		161.6
Effect of exchange rate changes on cash and cash equivalents	Effect of exchange rate changes on cash and cash equivalents	(2.1)		0.5		Effect of exchange rate changes on cash and cash equivalents	(0.4)		(1.4)
Net increase (decrease) in cash, cash equivalents and restricted cash	Net increase (decrease) in cash, cash equivalents and restricted cash	239.4		(24.3)		Net increase (decrease) in cash, cash equivalents and restricted cash	169.2		(26.6)
Cash, cash equivalents and restricted cash at beginning of period	Cash, cash equivalents and restricted cash at beginning of period	104.5		87.5		Cash, cash equivalents and restricted cash at beginning of period	104.5		87.5
Cash, cash equivalents and restricted cash at end of period	Cash, cash equivalents and restricted cash at end of period	$	343.9	$	63.2	Cash, cash equivalents and restricted cash at end of period	$	273.7	$	60.9

Operating Activities

Net cash used in operating activities was ~~$164.2~~$256.9 million and ~~$41.2~~$166.8 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively. The increase in cash used in operating activities for the ~~six~~nine months ended ~~June~~September 30, 2020, compared to the ~~six~~nine months ended ~~June~~September 30, 2019, was primarily driven by lower net sales, primarily due to the COVID-19 impacts described above, ~~and unfavorable working capital changes,~~ partially offset by cost reductions achieved through the Company's initiatives designed to mitigate the adverse impact of COVID-19 on the Company's operations, including the Revlon 2020 Restructuring Program.

Investing Activities

Net cash used in investing activities was ~~$2.7~~$7.4 million for the ~~six~~nine months ended ~~June~~September 30, 2020, compared to ~~$12.2~~$20.0 million of net cash used in investing activities for the ~~six~~nine months ended ~~June~~September 30, 2019. The decrease in cash used in investing activities was related to lower capital expenditures in the ~~six~~nine months ended ~~June~~September 30, 2020 compared to the prior year period.

Financing Activities

Net cash provided by financing activities was ~~$408.4~~$433.9 million and ~~$28.6~~$161.6 million for the ~~six~~nine months ended ~~June~~September 30, 2020 and 2019, respectively.

Net cash provided by financing activities for the ~~six~~nine months ended ~~June~~September 30, 2020 primarily included:

•$880.0 of borrowings under the 2020 BrandCo Term Loan Facility; and

•$19.5 million net borrowings under the Amended 2016 Revolving Credit Agreement;

with the foregoing partially offset by:

•$200.0 million used to fully repay the 2019 Term Loan Facility;

•$~~101.2~~114.1 million used to repurchase approximately $157.2 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes;

•$108.3 million used to pay financing costs incurred in connection with the 2020 BrandCo Refinancing Transactions;

•~~$99.6 million used to repurchase~~ ~~approximately $112.8 million in aggregate principal face amount of Products Corporation's 5.75% Senior Notes;~~

•$31.4 million used to partially repay the 2018 Foreign Asset-Based Term Loan;

•$~~22.9~~19.5 million used to partially repay the Amended 2016 Revolving Credit Agreement;

•$~~6.9~~9.2 million used to partially repay the 2016 Term Loan Facility; and

•$~~7.0~~0.7 million of decreases in short-term borrowings and ~~overdraft;~~overdraft.

Net cash provided by financing activities for the ~~six~~nine months ended ~~June~~September 30, 2019 primarily included:

•$59.9 million of borrowings under the Amended 2016 Revolving Credit Facility; and

with the foregoing partially offset by:

•$9.0 million of repayments under the 2016 Term Loan Facility;

•$18.8 million of decreases in short-term borrowings and overdraft; and

•$1.4 million of payment of financing costs incurred in connection with the Amendment No. 2 to the Amended 2016 Revolving Credit Facility.

Long-Term Debt Instruments

For detailed information on the terms and conditions of Products Corporation’s various outstanding debt instruments, including, without limitation, the 2020 BrandCo Facilities, 2016 Term Loan Facility, Amended 2016 Revolving Credit Facility, 2019 Term Loan Facility (which was fully repaid as part of consummating the 2020 BrandCo Refinancing Transactions), 2018 Foreign Asset-Based Term Facility, ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility, 5.75% Senior Notes and 6.25% Senior Notes, see the aforementioned discussion in this Form 10-Q under “Financial Condition, Liquidity and Capital Resources - Consummation of 2020 BrandCo Refinancing Transactions” and Note 9, "Debt," to the Consolidated Financial Statements in Revlon's 2019 Form 10-K, as well as "Management's Discussion and Analysis of Financial Condition and Results of Operations - Financial Condition, Liquidity and Capital Resources," in Revlon's 2019 Form 10-K. For information regarding certain risks related to the Company’s indebtedness, see Item 1A. “Risk Factors” in the Company's 2019 Form 10-K, as updated by Part II, Item 1A. “Risk Factors” in ~~this~~the Company’s Form ~~10-Q~~10-Qs filed with the SEC during 2020..

Covenants

Products Corporation was in compliance with all applicable covenants under the 2020 BrandCo Credit Agreement, 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the ~~Amended 2019 Senior~~2020 Restated Line of Credit ~~Agreement,~~Facility, as well as with all applicable covenants under its Senior Notes Indentures, in each case as of ~~June~~September 30, 2020. As of ~~June~~September 30, 2020, the aggregate principal amounts outstanding and availability under Products Corporation’s various revolving credit facilities were as follows:


		Commitment		Borrowing Base		Aggregate principal amount outstanding at June 30, 2020		Availability at June 30, 2020 (a)			Commitment		Borrowing Base		Aggregate principal amount outstanding at September 30, 2020		Availability at September 30, 2020 (a)
Amended 2016 Revolving Credit Facility	Amended 2016 Revolving Credit Facility	$	400.0	$	307.9	$	249.5	$	50.7	Amended 2016 Revolving Credit Facility	$	400.0	$	345.9	$	291.9	$	52.6

Amended 2019 Senior Line of Credit Facility		$	30.0	N/A		$	—	$	30.0
2020 Restated Line of Credit Facility										2020 Restated Line of Credit Facility	$	30.0	N/A		$	—	$	30.0

Sources and Uses

The Company’s principal sources of funds are expected to be operating revenues, cash on hand (which as of ~~June~~September 30, 2020 included approximately ~~$276.4~~$175.0 million of proceeds remaining from the 2020 BrandCo Refinancing Transactions) and funds that may be available from time to time for borrowing under the Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and other permissible borrowings. The 2016 Credit Agreements, the Senior Notes Indentures and the 2018 Foreign Asset-Based Term Agreement contain certain provisions that by their terms limit Products Corporation's and its subsidiaries’ ability to, among other things, incur additional debt, subject to certain exceptions.

The Company’s principal uses of funds are expected to be the payment of operating expenses, including payments in connection with the purchase of permanent wall displays; capital expenditure requirements; debt service payments and costs; cash tax payments; pension and other post-retirement benefit plan contributions; payments in connection with the Company’s

restructuring programs, such as the 2018 Optimization Program and the Revlon 2020 Restructuring Program; severance not otherwise included in the Company’s restructuring programs; business and/or brand acquisitions (including, without limitation, through licensing transactions), if any; additional debt and/or equity repurchases, if any; costs related to litigation; and payments in connection with discontinuing non-core business lines and/or exiting and/or entering certain territories and/or channels of trade. For information regarding certain risks related to the Company’s indebtedness and cash flows, see Item 1A. “Risk Factors” in the Company's ~~2019~~2019 Form 10-K,, as updated by Part II, Item 1A. “Risk Factors” in ~~this~~the Company’s Form ~~10-Q~~.10-Qs filed with the SEC during 2020.

The Company’s cash contributions to its pension and post-retirement benefit plans in the ~~six~~nine months ended ~~June~~September 30, 2020 were ~~$5.5~~$7.5 million. The Company expects that cash contributions to its pension and post-retirement benefit plans will be approximately $19 million in the aggregate for 2020. The Company’s cash taxes paid in the ~~six~~nine months ended ~~June~~September 30, 2020 were ~~$8.0~~$12.6 million. The Company expects to pay net cash taxes totaling approximately $5$10 million to ~~$10~~$15 million in the aggregate during 2020. For a further discussion, see Note 10, "Pension and Post-Retirement Benefits," and Note 12, "Income Taxes," to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q.

The Company’s purchases of permanent wall displays and capital expenditures in the ~~six~~nine months ended ~~June~~September 30, 2020 were ~~$12.7~~$16.5 million and ~~$2.7~~$7.4 million, respectively. The Company expects that purchases of permanent wall displays will total approximately $35 million to $45 million in the aggregate during 2020 and expects that capital expenditures will total approximately $10 million to $20 million in the aggregate during 2020.

The Company has undertaken, and continues to assess, refine and implement, a number of programs to efficiently manage its working capital, including, among other things, initiatives intended to optimize inventory levels over time; centralized procurement to secure discounts and efficiencies; prudent management of trade receivables and accounts payable; and controls on general and administrative spending. In the ordinary course of business, the Company’s source or use of cash from operating activities may vary on a quarterly basis as a result of a number of factors, including the timing of working capital flows. For certain of the Company’s other recent cost reduction initiatives, see “COVID-19 Impact on the Company’s Business” under the Overview section of this "Management Discussion and Analysis of Financial Condition and Results of Operations".

Continuing to execute the Company’s business initiatives could include taking advantage of additional opportunities to reposition, repackage or reformulate one or more brands or product lines, launching additional new products, acquiring businesses or brands (including, without limitation, through licensing transactions), divesting or discontinuing non-core business lines (which may include exiting certain territories), further refining the Company’s approach to retail merchandising and/or taking further actions to optimize its manufacturing, sourcing and organizational size and structure. Any of these actions, the intended purpose of which would be to create value through improving the Company's financial performance, could result in the Company making investments and/or recognizing charges related to executing against such opportunities. Any such activities may be funded with operating revenues, cash on hand, ~~(which as of June 30, 2020 included approximately $276.4 million of proceeds remaining from the 2020 Refinancing Transactions),~~ funds that may be available from time to time under the Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility, other permissible borrowings and/or other permitted additional sources of capital, which actions could increase the Company’s total debt.

The Company may also, from time-to-time, seek to retire or purchase its outstanding debt obligations and/or equity in open market purchases, block trades, privately negotiated purchase transactions or otherwise and may seek to refinance some or all of its indebtedness based upon market ~~conditions, including pursuant to the Exchange Offer.~~conditions. Any such retirement or purchase of debt and/or equity may be funded with operating cash flows of the business or other sources and will depend upon prevailing market conditions, liquidity requirements, contractual restrictions and other factors, and the amounts involved may be material. (See “Financial Condition, Liquidity and Capital Resources - Consummation of 2020 BrandCo Refinancing Transactions” regarding the Company’s repurchase of certain 5.75% Senior Notes during the second ~~quarter~~and third quarters of 2020).

The Company expects that operating revenues, cash on hand (which as of ~~June~~September 30, 2020 included approximately ~~$276.4~~$175.0 million of proceeds remaining from the 2020 BrandCo Refinancing Transactions) and funds that may be available from time-to-time for borrowing under the Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and other permissible borrowings will be sufficient to enable the Company to pay its operating expenses for 2020, including payments in connection with the purchase of permanent wall displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company’s restructuring programs, such as the 2018 Optimization Program and the Revlon 2020 Restructuring Program, severance not otherwise included in the Company’s restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade. The Company also expects to generate additional liquidity from cost reductions resulting from the implementation of the Revlon 2020 Restructuring Program and the

2018 Optimization Program, and cost reductions generated from other cost control initiatives, including, without limitation, the Company’s interim measures to reduce costs in response to the COVID-19 pandemic (such as: (i) switching to a reduced work week and reducing executive and employee compensation in the range of 20% to 40%; (ii) furloughing approximately 40% of the Company’s U.S.-based employees and those in certain other locations; (iii) suspending the Company’s 2020 merit base salary increases, discretionary profit sharing contributions and matching contributions to the Company’s 401(k) plan; (iv) reducing Board and committee compensation by 50% and eliminating Board and committee meeting fees; and (v) suspending or terminating services and payments under consulting agreements with certain directors), as well as funds provided by selling certain assets (such as the Natural Honey and Floid brands that were sold in December 2019) in connection with the Company's ongoing Strategic Review.

There can be no assurance that available funds will be sufficient to meet the Company’s cash requirements on a consolidated basis, as, among other things, the Company’s liquidity can be impacted by a number of factors, including its level of sales, costs and expenditures, as well as accounts receivable and inventory, which serve as the principal variables impacting the amount of liquidity available under Products Corporation’s Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility. For example, subject to certain exceptions, loans under the 2018 Foreign Asset-Based Term Facility must be prepaid to the extent that outstanding loans exceed the borrowing base, consisting of accounts receivable and inventory. For information regarding certain risks related to the Company’s indebtedness and cash flows, see Item 1A. “Risk Factors” in the Company's 2019 Form ~~10-K~~10,-K, as updated by Part II, Item 1A. “Risk Factors” in ~~this~~the Company’s Form ~~10-Q~~.10-Qs filed with the SEC during 2020.

If the Company’s anticipated level of revenues is not achieved because of, among other things, decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments, whether attributable to the COVID-19 pandemic or otherwise; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company’s products as a result of increased competitive activities by the Company’s competitors and/or decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise; changes in consumer purchasing habits, including with respect to retailer preferences and/or sales channels, such as due to any further consumption declines that the

Company has experienced; inventory management by the Company's customers; space reconfigurations or reductions in display space by the Company's customers; retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers; or less than anticipated results from the Company’s existing or new products or from its advertising, promotional, pricing and/or marketing plans; or if the Company’s expenses, including, without limitation, for the purchase of permanent displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company’s restructuring programs (such as the 2018 Optimization Program and the Revlon 2020 Restructuring Program), severance not otherwise included in the Company’s restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, additional debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade, advertising, promotional and marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise, exceed the anticipated level of expenses, the Company’s current sources of funds may be insufficient to meet the Company’s cash requirements.

Any such developments, if significant, could reduce the Company’s revenues and operating income and could adversely affect Products Corporation’s ability to comply with certain financial and/or other covenants under the 2020 BrandCo Credit Agreement, 2016 Credit Agreements, the 6.25% Senior Notes ~~Indentures~~indenture and/or the 2018 Foreign Asset-Based Term Agreement and in such event the Company could be required to take measures, including, among other things, reducing discretionary spending. For further discussion of certain risks associated with the Company's business and indebtedness, see Item 1A. "Risk Factors" in the Company's 2019 Form 10-K, as updated by Part II, Item 1A. “Risk Factors” in ~~this~~the Company’s Form ~~10-Q.~~10-Qs filed with the SEC during 2020.

Off-Balance Sheet Transactions

The Company does not maintain any off-balance sheet transactions, arrangements, obligations or other relationships with unconsolidated entities or others that are reasonably likely to have a material current or future effect on the Company's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Table of Contents

REVLON, INC AND SUBSIDIARIES

COMBINED MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

(all tabular amounts in millions, except share and per share amounts)

Discussion of Critical Accounting Policies

For a discussion of the Company's critical accounting policies, see the Company's 2019 Form 10-K.

Recently Issued Accounting Pronouncements

See discussion of recent accounting pronouncements in Note 1, "Description of Business and Summary of Significant Accounting Policies," to the Unaudited Consolidated Financial Statements in this Form 10-Q.

7686

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not applicable as a smaller reporting company.

7787

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures. The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company's reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to management, including the Company's Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In March 2020, the Company announced the Revlon 2020 Restructuring Program and in April 2020 the Company took several financial measures, such as implementing a reduced work week and furloughing a significant number of employees, designed to mitigate the adverse financial impacts of COVID-19 (the “COVID-19 Organizational Actions”). In response, the Company implemented mitigating actions to address the potential for any impact from these measures on the Company’s disclosure controls and procedures and its internal control over financial reporting, such as transferring responsibilities for the eliminated positions and furloughed employees and enhancing employee training and internal controls monitoring. The Company's management, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company's disclosure controls and procedures as of the end of the fiscal period covered by this Form 10-Q. Based upon such evaluation, the Company's Chief Executive Officer and Chief Financial Officer have concluded that the Company's disclosure controls and procedures were effective as of ~~June~~September 30, 2020.

(b) Changes in Internal Control Over Financial Reporting ("ICFR"). There have not been any changes in the Company’s internal control over financial reporting during the quarter ended ~~June~~September 30, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. As described in Item 4(a) above, the Revlon 2020 Restructuring Program and the Company’s COVID-19 Organizational Actions did not materially affect, nor are they reasonably likely to materially affect, the Company's ICFR for the quarter ended ~~June~~September 30, 2020.

7888

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Forward-Looking Statements

This Quarterly Report on Form 10-Q for the period ended ~~June~~September 30, 2020, as well as the Company's other public documents and statements, may contain forward-looking statements that involve risks and uncertainties, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the beliefs, expectations, estimates, projections, assumptions, forecasts, plans, anticipations, targets, outlooks, initiatives, visions, objectives, strategies, opportunities, drivers, focus and intents of the Company's management. While the Company believes that its estimates and assumptions are reasonable, the Company cautions that it is very difficult to predict the impact of known and unknown factors, and, of course, it is impossible for the Company to anticipate all factors that could affect its results. The Company's actual results may differ materially from those discussed in such forward-looking statements. Such statements include, without limitation, the Company's expectations, plans and estimates (whether qualitative or quantitative) as to:

(i)the Company's future financial performance and/or sales growth;

(ii)the effect on sales of decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments, whether due to COVID-19 or otherwise; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company's products as a result of increased competitive activities by the Company's competitors and/or decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise, changes in consumer purchasing habits, including with respect to retailer preferences and/or among sales channels, such as due to the continuing consumption declines in core beauty categories in the mass retail channel in North America; inventory management by the Company's customers; inventory de-stocking by certain retail customers; space reconfigurations or reductions in display space by the Company's customers; retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers; less than anticipated results from the Company's existing or new products or from its advertising, promotional, pricing and/or marketing plans; or if the Company's expenses, including, without limitation, for the purchase of permanent displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company's restructuring programs (such as the 2018 Optimization Program and the Revlon 2020 Restructuring Program), severance not otherwise included in the Company's restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, additional debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade, advertising, promotional and marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise, exceed the anticipated level of expenses;

(iii)the Company's belief that continuing to execute its business initiatives could include taking advantage of additional opportunities to reposition, repackage or reformulate one or more brands or product lines, launching additional new products, acquiring businesses or brands (including through licensing transactions, if any), divesting or discontinuing non-core business lines (which may include exiting certain territories), further refining its approach to retail merchandising and/or taking further actions to optimize its manufacturing, sourcing and organizational size and structure, any of which, the intended purpose would be to create value through improving the Company's financial performance, could result in the Company making investments and/or recognizing charges related to executing against such opportunities, which activities may be funded with operating revenues, cash on hand which as of ~~June~~September 30, 2020 included approximately ~~$276.4~~$175.0 million of proceeds remaining from the 2020 BrandCo Refinancing Transactions, funds available under the Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility, other permissible borrowings and/or other permitted additional sources of capital, which actions could increase the Company's total debt;

(iv)the Company's plans to remain focused on its 3 key strategic pillars to drive its future success and growth, including (1) strengthening its iconic brands through innovation and relevant product portfolios; (2) building its capabilities to better communicate and connect with its consumers through media channels where they spend the most time; and (3) ensuring availability of its products where consumers shop, both in-store and increasingly online;

(v)the effect of restructuring activities, restructuring costs and charges, the timing of restructuring payments and the benefits from such activities, including, without limitation: (1) the Company’s plans to implement the Revlon 2020 Restructuring Program; including its expectation and belief that the Revlon 2020 Restructuring Program will reduce the Company’s selling, general and administrative expenses, as well as cost of goods sold, improve the

Company’s gross profit and Adjusted EBITDA and maximize productivity, cash flow and liquidity, as well as

rightsizing the organization and operating with more efficient workflows and processes and that the leaner organizational structure will improve communication flow and cross-functional collaboration, leveraging the more efficient business processes; (2) the Company’s expectation that the Revlon 2020 Restructuring Program will result in the elimination of approximately 1,000 positions worldwide including approximately 650 current employees and approximately 350 open positions; (3) the Company’s expectation that it will substantially complete the employee-related actions by the end of 2020 and the other consolidation and outsourcing actions during 2021 and 2022; (4) the Company’s expectations regarding the amount and timing of the 2020 Restructuring Charges and payments related to the Revlon 2020 Restructuring Program, including that: (a) it will recognize during 2020 approximately $60 million to $70 million of total pre-tax restructuring and related charges and in addition restructuring charges in the range of $75 million to $85 million to be charged and paid during 2021 and 2022; and (b) substantially all of the 2020 Restructuring Charges will be paid in cash, with approximately $55 million to $65 million of the total charges expected to be paid in 2020, approximately $40 million to $45 million expected to be paid in 2021, with the balance expected to be paid in 2022; and (5) the Company’s expectations that as a result of the Revlon 2020 Restructuring Program, the Company will deliver in the range of $200 million to $230 million of annualized cost reductions by the end of 2022, with approximately 50% of these annualized cost reductions to be realized from the headcount reductions occurring in 2020, including the Company’s expectations that during 2020, the Company will realize approximately $105 million to $115 million of in-year cost reductions;

(vi)the Company's expectation that operating revenues, cash on hand (which as of ~~June~~September 30, 2020 included approximately ~~$276.4~~$175.0 million of proceeds remaining from the 2020 BrandCo Refinancing Transactions) and funds that may be available from time to time for borrowing under Products Corporation's Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility, and other permissible borrowings will be sufficient to enable the Company to cover its operating expenses for 2020, including the cash requirements referred to in item (viii) below, and the Company's belief that (a) it has and will have sufficient liquidity to meet its cash needs for at least the next 12 months based upon the cash generated by its operations, cash on hand (which as of ~~June~~September 30, 2020 included approximately ~~$276.4~~$175.0 million of proceeds remaining from the 2020 BrandCo Refinancing Transactions), availability under the Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility, and other permissible borrowings, along with the option to further settle intercompany loans and payables with certain foreign subsidiaries, and that such cash resources will be further enhanced as the Company implements its 2018 Optimization Program and its Revlon 2020 Restructuring Program and cost reductions generated from other cost control initiatives, including, without limitation, the Company's interim measures to reduce costs in response to the COVID-19 pandemic (such as: (i) switching to a reduced work week and reducing executive and employee compensation in the range of 20% to 40%; (ii) furloughing approximately 40% of the Company’s U.S.-based employees and those in certain other locations; (iii) suspending the Company’s 2020 merit base salary increases, discretionary profit sharing contributions and matching contributions to the Company’s 401(k) plan; (iv) reducing Board and committee compensation by 50% and eliminating Board and committee meeting fees; and (v) suspending or terminating services and payments under consulting agreements with certain directors), as well as funds provided by selling certain assets (such as the Natural Honey and Floid brands that were sold in December 2019) in connection with the Company's ongoing Strategic Review, and (b) restrictions and/or taxes on repatriation of foreign earnings will not have a material effect on the Company's liquidity during such period;

(vii)the Company's expected principal sources of funds, including operating revenues, cash on hand (which as of ~~June~~September 30, 2020 included approximately ~~$276.4~~$175.0 million of proceeds remaining from the 2020 BrandCo Refinancing Transactions) and funds available for borrowing under Products Corporation's Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and other permissible borrowings, as well as the availability of funds from the Company taking certain measures, including, among other things, reducing discretionary spending and the Company's expectation to generate additional liquidity from cost reductions resulting from the implementation of the 2018 Optimization Program and the Revlon 2020 Restructuring Program and from other cost reduction initiatives, including, without limitation, the Company’s interim measures to reduce costs in response to the COVID-19 pandemic (such as: (i) switching to a reduced work week and reducing executive and employee compensation in the range of 20% to 40%; (ii) furloughing approximately 40% of the Company’s U.S.-based employees and those in certain other locations; (iii) suspending the Company’s 2020 merit base salary increases, discretionary profit sharing contributions and matching contributions to the Company’s 401(k) plan; (iv) reducing Board and committee compensation by 50% and eliminating Board and committee meeting fees; and (v) suspending or terminating services and payments under consulting agreements with certain directors), as well as funds provided by selling certain assets (such as the Natural Honey and Floid brands that were sold in December 2019) in connection with the Company's ongoing Strategic Review;

(viii)the Company's expected principal uses of funds, including amounts required for payment of operating expenses including in connection with the purchase of permanent wall displays; capital expenditure requirements; debt service payments and costs; cash tax payments; pension and other post-retirement benefit plan contributions;

payments in connection with the Company's restructuring programs, such as the 2018 Optimization Program and the Revlon 2020 Restructuring Program; severance not otherwise included in the Company's restructuring programs; business and/or brand acquisitions (including, without limitation, through licensing transactions), if any; debt and/or equity repurchases, if any; costs related to litigation; and payments in connection with discontinuing non-core business lines and/or exiting and/or entering certain territories and/or channels of trade (including, without limitation, that the Company may also, from time-to-time, seek to retire or purchase its outstanding debt obligations and/or equity in open market purchases, block trades, privately negotiated purchase transactions or otherwise and may seek to refinance some or all of its indebtedness based upon market conditions and that any such retirement or purchase of debt and/or equity may be funded with operating cash flows of the business or other sources and will depend upon prevailing market conditions, liquidity requirements, contractual restrictions and other factors, and the amounts involved may be material); and its estimates of the amount and timing of such operating and other expenses;

(ix)matters concerning the impact on the Company from changes in interest rates and foreign exchange rates;

(x)the Company's expectation to efficiently manage its working capital, including, among other things, initiatives intended to optimize inventory levels over time; centralized procurement to secure discounts and efficiencies; prudent management of trade receivables, accounts payable and controls on general and administrative spending; and the Company's belief that in the ordinary course of business, its source or use of cash from operating activities may vary on a quarterly basis as a result of a number of factors, including the timing of working capital flows;

(xi)the Company's expectations regarding its future net periodic benefit cost for its U.S. and international defined benefit plans;

(xii)the Company's expectation that its tax provision and effective tax rate in any individual quarter and year-to-date period will vary and may not be indicative of the Company's tax provision and effective tax rate for the full year and the Company's expectations regarding whether it will be required to establish additional valuation allowances on its deferred tax assets;

(xiii)the Company's belief that the UMB lawsuit is without merit and its plans to vigorously to contest it and that the outcome of all other pending legal proceedings in the aggregate is not reasonably likely to have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows, but that in light of the uncertainties involved in legal proceedings generally, the ultimate outcome of a particular matter could be material to the Company's operating results for a particular period depending on, among other things, the size of the loss or the nature of the liability imposed and the level of the Company's income for that particular period; and

(xiv)the Company's plans to explore certain strategic transactions pursuant to the Strategic ~~Review; and~~

~~(xv)the Company’s plans to consummate the Exchange Offer and refinance the 5.75% Senior Notes.~~Review.

Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language such as "estimates," "objectives," "visions," "projects," "forecasts," "focus," "drive towards," "plans," "targets," "strategies," "opportunities," "assumptions," "drivers," "believes," "intends," "outlooks," "initiatives," "expects," "scheduled to," "anticipates," "seeks," "may," "will" or "should" or the negative of those terms, or other variations of those terms or comparable language, or by discussions of strategies, targets, long-range plans, models or intentions. Forward-looking statements speak only as of the date they are made, and except for the Company's ongoing obligations under the U.S. federal securities laws, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Investors are advised, however, to consult any additional disclosures the Company made or may make in the Company's 2019 Form 10-K and in its Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in each case filed with the SEC in 2020 and 2019 (which, among other places, can be found on the SEC's website at http://www.sec.gov, as well as on the Company's corporate website at www.revloninc.com). Except as expressly set forth in this Form 10-Q, the information available from time-to-time on such websites shall not be deemed incorporated by reference into this Form 10-Q. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. (See also Item 1A. "Risk Factors" in this Form 10-Q for further discussion of risks associated with the Company's business). In addition to factors that may be described in the Company's filings with the SEC, including this filing, the following factors, among others, could cause the Company's actual results to differ materially from those expressed in any forward-looking statements made by the Company:

(i)unanticipated circumstances or results affecting the Company's financial performance and or sales growth, including: greater than anticipated levels of consumers choosing to purchase their beauty products through e-commerce and other social media channels and/or greater than anticipated declines in the brick-and-mortar retail channel, or either of those conditions occurring at a rate faster than anticipated; the Company's inability to address the pace and impact of the new commercial landscape, such as its inability to enhance its e-commerce and social media capabilities and/or increase its penetration of e-commerce and social media channels; the Company's inability to drive a successful long-term omni-channel strategy and significantly increase its e-commerce penetration; difficulties, delays and/or the Company's inability to (in whole or in part) develop and implement effective content to enhance its online retail position, improve its consumer engagement across social media platforms and/or transform its technology and data to support efficient management of its digital infrastructure; the Company incurring greater than anticipated levels of expenses and/or debt to facilitate the foregoing objectives, which could result in, among other things, less than anticipated revenues and/or profitability; decreased consumer spending in response to weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments, whether attributable to COVID-19 or otherwise; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company's products as a result of increased competitive activities by the Company's competitors; decreased performance by third-party suppliers, whether due to COVID-19, shortages of raw materials or otherwise; and/or supply disruptions at the Company's manufacturing facilities, whether attributable to COVID-19 or otherwise; changes in consumer preferences, such as reduced consumer demand for the Company's color cosmetics and other current products, including new product launches; changes in consumer purchasing habits, including with respect to retailer preferences and/or among sales channels, such as due to the continuing consumption declines in core beauty categories in the mass retail channel in North America, whether attributable to COVID-19 or otherwise; lower than expected customer acceptance or consumer acceptance of, or less than anticipated results from, the Company's existing or new products, whether attributable to COVID-19 or otherwise; higher than expected retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels, whether attributable to COVID-19 or otherwise; higher than expected purchases of permanent displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company's restructuring programs (such as the 2018 Optimization Program and the Revlon 2020 Restructuring Program), severance not otherwise included in the Company's restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade, advertising, promotional and marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise or lower than expected results from the Company's advertising, promotional, pricing and/or marketing plans, whether attributable to COVID-19 or otherwise; decreased sales of the Company’s existing or new products, whether attributable to COVID-19 or otherwise; actions by the Company's customers, such as greater than expected inventory management and/or de-stocking, and greater than anticipated space reconfigurations or reductions in display space and/or product discontinuances or a greater than expected impact from pricing, marketing, advertising and/or promotional strategies by the Company's customers, whether attributable to COVID-19 or otherwise; and changes in the competitive environment and actions by the Company's competitors, including, among other things, business combinations, technological breakthroughs, implementation of new pricing strategies, new product offerings, increased advertising, promotional and marketing spending and advertising, promotional and/or marketing successes by competitors;

(ii)in addition to the items discussed in (i) above, the effects of and changes in economic conditions (such as volatility in the financial markets, whether attributable to COVID-19 or otherwise, inflation, increasing interest rates, monetary conditions and foreign currency fluctuations, tariffs, foreign currency controls and/or government-mandated pricing controls, as well as in trade, monetary, fiscal and tax policies in international markets), political conditions (such as military actions and terrorist activities) and natural disasters, such as the devastating fires in Australia and the earthquakes in Puerto Rico;

(iii)unanticipated costs or difficulties or delays in completing projects associated with continuing to execute the Company's business initiatives or lower than expected revenues or the inability to create value through improving the Company's financial performance as a result of such initiatives, including lower than expected sales, or higher than expected costs, including as may arise from any additional repositioning, repackaging or reformulating of one or more brands or product lines, launching of new product lines, including higher than expected expenses, including for sales returns, for launching its new products, acquiring businesses or brands (including through licensing transactions, if any), divesting or discontinuing non-core business lines (which may include exiting certain territories or converting the Company's go-to-trade structure in certain countries to other business models), further refining its approach to retail merchandising and/or difficulties, delays or increased costs in connection with taking further actions to optimize the Company's manufacturing, sourcing, supply chain or organizational size and structure (including difficulties or delays in and/or the Company's inability to optimally implement the 2018 Optimization Program and/or the Revlon 2020 Restructuring Program and/or less than expected benefits from such programs and/or more than expected costs in implementing such programs, which could cause the Company not to realize the projected cost reductions), as well as the unavailability of cash generated by operations, cash on hand and/or funds under the Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and/or other permissible borrowings and/or from other permissible additional sources of capital to fund such potential activities, as well as the unavailability of funds due to potential mandatory repayment obligations under the 2018 Foreign Asset-Based Term Facility;

(iv)difficulties, delays in or less than expected results from the Company's efforts to execute on its 3 key strategic pillars to drive its future success and growth, including, without limitation: (1) less than effective new product development and innovation, less than expected acceptance of its new products and innovations by the Company's consumers and/or customers in one or more of its segments and/or less than expected levels of execution vis-à-vis its new product launches with its customers in one or more of its segments or regions, in each case whether attributable to COVID-19 or otherwise; (2) less than expected levels of advertising, promotional and/or marketing activities for its new product launches, less than expected acceptance of its advertising, promotional, pricing and/or marketing plans and/or brand communication by consumers and/or customers in one or more of its segments, less than expected investment in advertising, promotional and/or marketing activities or greater than expected competitive investment, in each case whether attributable to COVID-19 or otherwise; and/or (3) difficulties or disruptions impacting the Company's ability to ensure availability of its products where consumers shop, both in-store and increasingly online, including, without limitation, difficulties with, delays in or the inability to achieve the Company’s expected results, such as due to, among other things, the Company’s business experiencing greater than anticipated disruptions due to COVID-19 related uncertainty or other related factors making it more difficult to maintain relationships with employees, business partners or governmental entities and/or other unanticipated circumstances, trends or events affecting the Company’s financial performance, including decreased consumer spending in response to the COVID-19 pandemic and related conditions and restrictions, weaker than expected economic conditions due to the COVID-19 pandemic and its related restrictions and conditions continuing for periods longer than currently estimated or COVID-19 expanding into more territories than currently anticipated, or other weakness in the consumption of beauty-related products, lower than expected acceptance of the Company’s new products, adverse changes in foreign currency exchange rates, decreased sales of the Company’s products as a result of increased competitive activities by the Company’s competitors, the unavailability of one or more forms of additional credit in the current capital markets and/or decreased performance by third party suppliers;

(v)difficulties, delays or unanticipated costs or charges or less than expected cost reductions and other benefits resulting from the Company's restructuring activities, such as in connection with the 2018 Optimization Program and/or the Revlon 2020 Restructuring Program, higher than anticipated restructuring charges and/or payments and/or changes in the expected timing of such charges and/or payments; and/or less than expected additional sources of liquidity from such initiatives;

(vi)lower than expected operating revenues, cash on hand and/or funds available under the Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and/or other permissible borrowings or generated from cost reductions resulting from the implementation of the Revlon 2020 Restructuring Program and the 2018 Optimization Program and/or other cost control initiatives, including, without limitation, the Company’s interim measures to reduce costs in response to the COVID-19 pandemic (such as: (i) switching to a reduced work week and reducing executive and employee compensation in the range of 20% to 40%; (ii) furloughing approximately 40% of the Company’s U.S.-based employees and those in certain other locations; (iii) suspending the Company’s 2020 merit base salary increases, discretionary profit sharing contributions and matching contributions to the Company’s 401(k) plan; (iv) reducing Board and committee compensation by 50% and eliminating Board and committee meeting fees; and (v) suspending or terminating services and payments under consulting agreements with certain directors), and/or from selling certain assets (such as the Natural Honey and

Floid brands that were

sold in December 2019) in connection with the Company's ongoing Strategic Review; higher than anticipated operating expenses, such as referred to in clause (viii) below; and/or less than anticipated cash generated by the Company's operations or unanticipated restrictions or taxes on repatriation of foreign earnings;

(vii)the unavailability of funds under Products Corporation's Amended 2016 Revolving Credit Facility, the ~~Amended 2~~2020 Restated~~019 Senior~~ Line of Credit Facility and/or other permissible borrowings; the unavailability of funds under the 2018 Foreign Asset-Based Term Facility, such as due to reductions in the applicable borrowing base that could require certain mandatory prepayments; the unavailability of funds from difficulties, delays in or the Company's inability to take other measures, such as reducing discretionary spending and/or less than expected liquidity from cost reductions resulting from the implementation of the Revlon 2020 Restructuring Program and the 2018 Optimization Program and from other cost reduction initiatives, including, without limitation, the Company’s interim measures to reduce costs in response to the COVID-19 pandemic (such as: (i) switching to a reduced work week and reducing executive and employee compensation in the range of 20% to 40%; (ii) furloughing approximately 40% of the Company’s U.S.-based employees and those in certain other locations; (iii) suspending the Company’s 2020 merit base salary increases, discretionary profit sharing contributions and matching contributions to the Company’s 401(k) plan; (iv) reducing Board and committee compensation by 50% and eliminating Board and committee meeting fees; and (v) suspending or terminating services and payments under consulting agreements with certain directors), and/or from selling certain assets (such as the Natural Honey and Floid brands that were sold in December 2019) in connection with the Company's ongoing Strategic Review;

(viii)higher than expected operating expenses, such as higher than expected purchases of permanent displays, capital expenditures, debt service payments and costs, cash tax payments, pension and other post-retirement plan contributions, payments in connection with the Company's restructuring programs (such as the 2018 Optimization Program and/or the Revlon 2020 Restructuring Program), severance not otherwise included in the Company's restructuring programs, business and/or brand acquisitions (including, without limitation, through licensing transactions), if any, additional debt and/or equity repurchases, if any, costs related to litigation, discontinuing non-core business lines and/or entering and/or exiting certain territories and/or channels of trade, advertising, promotional and marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise;

(ix)unexpected significant impacts on the Company from changes in interest rates or foreign exchange rates;

(x)difficulties, delays or the inability of the Company to efficiently manage its cash and working capital;

(xi)lower than expected returns on pension plan assets and/or lower discount rates, which could result in higher than expected cash contributions, higher net periodic benefit costs and/or less than expected net periodic benefit income;

(xii)unexpected significant variances in the Company's tax provision, effective tax rate and/or unrecognized tax benefits, whether due to the enactment of the Tax Act or otherwise, such as due to the issuance of unfavorable guidance, interpretations, technical clarifications and/or technical corrections legislation by the U.S. Congress, the U.S. Treasury Department or the IRS, unexpected changes in foreign, state or local tax regimes in response to the Tax Act, and/or changes in estimates that may impact the calculation of the Company's tax provisions, as well as changes in circumstances that could adversely impact the Company's expectations regarding the establishment of additional valuation allowances on its deferred tax assets;

(xiii)unanticipated adverse effects on the Company's business, prospects, results of operations, financial condition and/or cash flows as a result of unexpected developments with respect to the Company's legal proceedings; and/or

(xiv)difficulties or delays that could affect the Company's ability to consummate one or more transactions pursuant to the Strategic Review, such as due to the Company's respective businesses experiencing disruptions due to transaction-related uncertainty ~~or other factors; and/or~~

~~(xv)~~difficulties or delays that could affect the Company's ability to consummate the Exchange Offer and/or refinance the 5.75% Senior Notes, such as due to the Company's respective businesses experiencing ongoing COVID-19 related disruptions or other factors.

Factors other than those listed above could also cause the Company's results to differ materially from expected results. This discussion is provided pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

7989

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Website Availability of Reports, Corporate Governance Information and Other Financial Information

The Company maintains a comprehensive corporate governance program, including Corporate Governance Guidelines for Revlon’s Board of Directors, Revlon’s Board Guidelines for Assessing Director Independence and charters for Revlon’s Audit Committee and Compensation Committee. Revlon maintains a corporate investor relations website, www.revloninc.com, where stockholders and other interested persons may review, without charge, among other things, Revlon's corporate governance materials and certain SEC filings (such as Revlon's annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements, annual reports, Section 16 reports reflecting certain changes in the stock ownership of Revlon’s directors and Section 16 officers, and certain other documents filed with the SEC), each of which are generally available on the same business day as the filing date with the SEC on the SEC’s website http://www.sec.gov. Products Corporation's SEC filings are also available on the SEC's website http://www.sec.gov. In addition, under the section of the website entitled, "Corporate Governance," Revlon posts printable copies of the latest versions of its Corporate Governance Guidelines, Board Guidelines for Assessing Director Independence and charters for Revlon's Audit Committee and Compensation Committee, as well as the Company's Code of Conduct and Business Ethics, which includes the Company's Code of Ethics for Senior Financial Officers, and the Audit Committee Pre-Approval Policy. From time-to-time, the Company may post on www.revloninc.com certain presentations that may include material information regarding its business, financial condition and/or results of operations. The business and financial materials and any other statement or disclosure on, or made available through, the websites referenced herein shall not be deemed incorporated by reference into this report.

8090

Table of Contents of Contents

REVLON, INC. AND SUBSIDIARIES

(all tabular amounts in millions, except share and per share amounts)

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Item 1A. Risk Factors

In addition to the other information in this report, when evaluating the Company’s business investors should consider carefully the following risk factors which have been updated since the Company’s 2019 Form 10-K. For definitions of certain capitalized terms used in this Form 10-Q referring to the Company's debt facilities, see Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations - Financial Condition, Liquidity and Capital Resources - Long-Term Debt Instruments" of this Form 10-Q and in the Company’s 2019 Form 10-K.

Revlon is a holding company with no business operations of its own and is dependent on its subsidiaries to pay certain expenses and dividends. In addition, shares of the capital stock of Products Corporation, Revlon's wholly-owned operating subsidiary, are pledged by Revlon to secure its obligations under the 2016 Credit Agreements and the 2020 BrandCo Credit Agreement.

Revlon is a holding company with no business operations of its own. Revlon's only material asset is all of the outstanding capital stock of Products Corporation, Revlon's wholly-owned operating subsidiary, through which Revlon conducts its business operations. As such, Revlon's net income has historically consisted predominantly of its equity in the net loss of Products Corporation, which for 2019 and 2018 was $151.2 million and $289.1 million, respectively (in each case excluding $7.9 million and $6.3 million, respectively, in expenses primarily related to Revlon being a public holding company). Revlon is dependent on the earnings and cash flow of, and dividends and distributions from, Products Corporation to pay Revlon’s expenses incidental to being a public holding company and to pay any cash dividend or distribution on its Class A Common Stock in each case that may be authorized by Revlon’s Board of Directors.

Products Corporation may not generate sufficient cash flow to pay dividends or distribute funds to Revlon because, for example, Products Corporation may not generate sufficient cash or net income; state laws may restrict or prohibit Products Corporation from issuing dividends or making distributions unless Products Corporation has sufficient surplus or net profits, which Products Corporation may not have; or because contractual restrictions, including negative covenants contained in Products Corporation’s various debt instruments, may prohibit or limit such dividends or distributions.

The terms of Products Corporation's 2016 Credit Agreements, the ~~indentures~~indenture governing Products Corporation's 6.25% Senior Notes due 2024 (the "6.25% Senior Notes Indenture" and the "6.25% Senior Notes," respectively) and 5.75% Senior Notes due 2021 (the "5.75% Senior Notes Indenture" and the "5.75% Senior Notes," respectively, and, together with the 6.25% Senior Notes Indenture, the "Senior Notes Indentures" and the "Senior Notes," respectively) and the 2020 BrandCo Credit Agreement (as hereinafter defined) generally restrict Products Corporation from paying dividends or making distributions to Revlon, except in limited circumstances. For example, Products Corporation is permitted to pay dividends and make distributions to Revlon to enable Revlon to, among other things, maintain its existence and its ownership of Products Corporation, such as paying professional fees (e.g., legal, accounting and insurance fees), regulatory fees (e.g., SEC filing fees and NYSE listing fees), pay certain taxes and other expenses related to being a public holding company and, subject to certain limitations, to pay dividends, if any, on Revlon’s outstanding securities or make distributions in certain circumstances to

Table of Contents

REVLON, INC. AND SUBSIDIARIES

finance Revlon’s purchase of shares of its Class A Common Stock issued in connection with the delivery of such shares to grantees under the Fourth Amended and Restated Revlon, Inc. Stock Plan, as amended. These limitations therefore restrict Revlon's ability to pay dividends on its Class A Common Stock.

All of the shares of Products Corporation’s capital stock held by Revlon are pledged to secure Revlon’s guarantee of Products Corporation's obligations under its 2016 Credit Agreements and the 2020 BrandCo Credit Agreement. A foreclosure upon the shares of Products Corporation's common stock would result in Revlon no longer holding its only material asset, would have a material adverse effect on the holders and price of Revlon’s Class A Common Stock and would be a change of

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

control under Products Corporation’s other debt instruments. (See also Item 1A. Risk Factors - "Shares of Revlon Class A Common Stock and Products Corporation's capital stock are pledged to secure various of Revlon's and/or other of the Company's affiliates’ obligations and foreclosure upon these shares or dispositions of shares could result in the acceleration of debt under Products Corporation's 2016 Senior Credit Facilities, 2018 Foreign Asset-Based Term Facility, 2020 BrandCo Facilities, ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and/or its 6.25% Senior Notes and could have other consequences.")

Products Corporation’s substantial indebtedness could adversely affect the Company’s operations and flexibility and Products Corporation’s ability to service its debt.

Products Corporation has a substantial amount of outstanding indebtedness. As of ~~June~~September 30, 2020 the Company’s total indebtedness was ~~$3,789.3~~$3,791.4 million (or ~~$3,626.7~~$3,633.0 million net of discounts and debt issuance costs), including: (i) ~~$1,720.4~~$1,761.3 million in aggregate principal amount of its 2020 BrandCo Term Loan Facility; (ii) $450 million in aggregate principal amount of its 6.25% Senior Notes; (iii) ~~$387.2~~$342.8 million in aggregate principal amount of its 5.75% Senior Notes; (iv) ~~$249.5~~$291.9 million of secured indebtedness under Tranche A of its Amended 2016 Revolving Credit Facility; (v) ~~$924.8~~$886.3 million in aggregate principal amount of secured indebtedness under its 2016 Term Loan Facility; (vi) ~~$54.5~~the Euro equivalent of $56.8 million in aggregate principal amount of secured indebtedness under its 2018 Foreign Asset-Based Term ~~Facility (as hereinafter defined);~~Facility; (vii) nil in aggregate principal amount of indebtedness under its ~~Amended 2019 Senior~~2020 Restated Line of Credit ~~Facility (as hereinafter defined);~~Facility; and (viii) ~~$2.6~~$2.0 million in aggregate principal amount of other indebtedness. ~~In addition, as of such date~~On November 13, 2020, Products Corporation ~~would have had~~successfully consummated the ~~ability to incur an additional $50.7 million of secured indebtedness under its Amended 2016 Revolving Credit Facility~~Exchange Offer and ~~$30~~accepted $236 million in aggregate principal amount of ~~indebtedness under its Amended 2019~~5.75% Senior ~~Line~~Notes tendered in the Exchange Offer. Products Corporation issued $50 million aggregate principal amount of ~~Credit Facility.~~ new ABL FILO Term Loans and $75 million aggregate principal amount of the New BrandCo Second-Lien Term Loans. Products Corporation used cash on hand to redeem, effective as of November 13, 2020, the remaining $106.8 million in aggregate principal amount of 5.75% Senior Notes pursuant to the terms of the 5.75% Senior Notes Indenture. Following the consummation of the Exchange Offer and the satisfaction and discharge of the remaining 5.75% Senior Notes, no 5.75% Senior Notes remained outstanding.

In addition, in May 2020 Products Corporation repaid in full the 2019 Term Loan Facility, incurred additional indebtedness under the 2020 BrandCo Term Loan Facility and exchanged a significant portion of indebtedness under the 2016 Term Loan Facility for indebtedness under the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility in connection with the 2020 BrandCo Refinancing Transactions ~~(each as hereinafter defined)~~ (see Note 7, "Debt" and Note 19, “Subsequent Events,” to the Company's Unaudited Consolidated Financial Statements in this Form 10-Q. See also, " ~~Recent~~"Recent Debt ~~Transactions~~ "Transactions" in Item 7. "Combined Management's Discussion and Analysis of Financial Condition and Results of Operations."). If the Company is unable to maintain or increase its profitability and cash flow and sustain such results in future periods, it could adversely affect the Company's operations and Products Corporation's ability to service its debt and/or comply with the financial and/or operating covenants under its various debt instruments. (See also Item 1A. Risk Factors - "Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply.")

The Company is subject to the risks normally associated with substantial indebtedness, including the risk that the Company’s profitability and cash flow will be insufficient to meet required payments of principal and interest under Products Corporation’s various debt instruments, and the risk that Products Corporation will be unable to refinance existing indebtedness when it becomes due or, if it is unable to comply with the financial or operating covenants under its various debt instruments, to obtain any necessary consents, waivers or amendments or that the terms of any such refinancing and/or consents, waivers or amendments will be less favorable than the current terms of such indebtedness. Products Corporation’s substantial indebtedness could also have the effect of:

•limiting the Company’s ability to fund (including by obtaining additional financing) the costs and expenses of executing the Company’s business initiatives, future working capital, capital expenditures, advertising, promotional and/or marketing expenses, new product development costs, purchases and reconfigurations of wall displays, acquisitions, and related integration costs, investments, restructuring programs and other general corporate purposes;

Table of Contents

REVLON, INC. AND SUBSIDIARIES

•requiring the Company to dedicate a substantial portion of its cash flow from operations to payments on Products Corporation’s indebtedness, thereby reducing the availability of the Company’s cash flow necessary for executing the Company’s business initiatives and for other general corporate purposes;

•placing the Company at a competitive disadvantage compared to its competitors that have less debt;

•exposing the Company to potential events of default (if not cured or waived) under the financial and operating covenants contained in Products Corporation’s various debt instruments;

•limiting the Company’s flexibility in responding to changes in its business and the industry in which it operates; and

•making the Company more vulnerable in the event of adverse economic conditions or a downturn in its business.

Although agreements governing Products Corporation’s indebtedness, including the 2016 Credit Agreements, the 6.25% Senior Notes ~~Indentures~~Indenture and the 2020 BrandCo Credit Agreement (as hereinafter defined), limit Products Corporation’s ability to borrow funds, under certain circumstances Products Corporation is allowed to borrow a significant amount of additional money, some of which, in certain circumstances and subject to certain limitations, could be secured indebtedness. To the extent that more debt, whether secured or unsecured, is added to the Company's current debt levels, the risks described above would increase further. See “Recent Debt Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

Even after the consummation of the Exchange Offer, Products Corporation’s ability to pay the principal amount of its indebtedness depends on many factors.

The ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility matures on December 31, ~~2020;~~2020 (provided that upon the ~~5.75% Senior Notes~~incurrence of a New European ABL FILO Facility under such facility, the New European ABL FILO Facility would mature ~~in February 2021;~~on (x) the maturity date of any such Future Refinanced European ABL Facility or (y) if there is no Future Refinanced European ABL Facility, July 9, 2022); the 2018 Foreign Asset-Based Term Facility matures in July 2021; Tranche A under the Amended 2016 Revolving Credit Facility matures no later than September 2021; the 2016 Term Loan Facility matures no later than September 2023; Tranche B under the Amended 2016 Revolving Credit Agreement matures no later than December 2023; the 6.25% Senior Notes mature in August 2024; and the 2020 BrandCo Facilities and the Extended Term Loans mature no later than June 2025. Also, while the 2016 Term Loan Facility is scheduled to mature no later than September 2023, its maturity would accelerate to the 91st day prior to the maturity of the 5.75% Senior Notes due February 15, 2021 if any 5.75% Senior Notes remain outstanding by such date, subject to certain minimum liquidity exceptions. Tranche A of the Amended 2016 Revolving Credit Facility has a springing maturity similar to the 2016 Term Loan Facility. The 2018 Foreign Asset-Based Term Facility has a springing maturity similar to the 2016 Term Loan Facility and Tranche A of the Amended 2016 Revolving Credit Facility, but the 2018 Foreign Asset-Based Term Facility does not have any liquidity-based exceptions. The 2020 BrandCo Facilities have a springing maturity that accelerates to the 91st day prior to the maturity of the 6.25% Senior Notes if an aggregate principal amount of the 6.25% Senior Notes in excess of ~~$100,000,000~~$100 million remains outstanding by such date. For a more complete description of the maturities of these debt instruments, including events that could accelerate their respective maturities, see "Recent Developments," as well as Note 7, “Debt,” and Note 19, “Subsequent Events,” to the Company's unaudited Consolidated Financial Statements in this Form 10-Q. See also, “Recent Debt Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Products Corporation currently anticipates that, in order to pay the principal amount of its outstanding indebtedness upon the occurrence of any event of default, or to repurchase any of the 6.25% Senior Notes if a change of control occurs, or in the event that Products Corporation’s cash flows from operations are insufficient to allow it to pay the principal amount of its indebtedness by their respective maturity dates, the Company will be required to refinance some or all of Products Corporation’s indebtedness, seek to sell assets or operations, seek to sell additional Revlon equity, seek to sell debt securities of Revlon or Products Corporation and/or seek additional capital contributions or loans from MacAndrews & Forbes or from the Company’s other affiliates and/or third parties. The Company may be unable to take any of these actions due to a variety of commercial or market factors or constraints in Products Corporation’s various debt instruments, including, for example, market conditions being unfavorable for an equity or debt issuance, additional capital contributions or loans not being available from affiliates and/or third parties, or that the transactions may not be permitted under the terms of Products Corporation’s various debt instruments then in effect, including restrictions on the incurrence of additional debt, incurrence of liens, asset dispositions and/or related party transactions included in such debt instruments. Such actions, if ever taken, may not enable the Company to satisfy its cash requirements if the actions do not result in sufficient cost reductions or generate a sufficient amount of additional capital, as the case may be.

None of the Company’s affiliates are required to make any capital contributions, loans or other payments to Products Corporation regarding its obligations on its indebtedness, other than the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility. Products Corporation may not be able to pay the principal amount of its indebtedness using any of the above actions because, under certain circumstances, the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the 2020 BrandCo Credit Agreement, the 6.25% Senior Notes ~~Indentures,~~Indenture, any of Products Corporation's other debt instruments and/or the debt instruments of Products Corporation’s subsidiaries then in effect may not permit the Company to take such actions. (See also Item 1A. Risk Factors - "Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply").

Table of Contents

REVLON, INC. AND SUBSIDIARIES

The future state of the credit markets, including any volatility and/or tightening of the credit markets and reduction in credit availability, could adversely impact the Company’s ability to refinance or replace, in whole or in part, Products Corporation’s outstanding indebtedness by their respective maturity dates, which could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.

Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply.

The agreements that govern Products Corporation's indebtedness, including the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the 2020 BrandCo Credit Agreement and Products Corporation's 6.25% Senior Notes ~~Indentures,~~Indenture, contain a number of significant restrictions and covenants that limit Products Corporation’s ability (subject in each case to certain exceptions) to, among other things:

•borrow money;

•use assets as security in other borrowings or transactions;

•pay dividends on stock or purchase stock;

•sell assets and use the proceeds from such sales;

•enter into certain transactions with affiliates;

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

•make certain investments;

•prepay, redeem or repurchase specified indebtedness; and

•permit restrictions on the payment of dividends to Products Corporation by its subsidiaries.

These covenants affect Products Corporation’s operating flexibility by, among other things, restricting its ability to incur indebtedness that could be used to fund the costs of executing the Company’s business initiatives and to grow the Company’s business, as well as to fund general corporate purposes.

Certain breaches under the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the 2020 BrandCo Credit Agreement, the ~~Amended 2019 Senior~~2020 Restated Line of Credit ~~Agreement~~Facility and/or the 6.25% Senior Notes ~~Indentures~~Indenture would permit the Company’s lenders to accelerate amounts outstanding thereunder. The acceleration of amounts outstanding under the 2016 Senior Credit Facilities, the 2018 Foreign Asset-Based Term Facility, the 2020 BrandCo Credit Agreement, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and/or the 6.25% Senior Notes would in certain circumstances constitute an event of default under the other instruments permitting amounts outstanding under such instruments to be accelerated. See “Recent Debt Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.” In addition, holders of the 6.25% Senior Notes may require Products Corporation to repurchase their notes in the event of a change of control under the applicable indenture and a change of control would be an event of default under the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement and the 2020 BrandCo Credit Agreement. Products Corporation may not have sufficient funds at the time of any such breach or change of control to repay, in full or in part, amounts outstanding under the 2016 Senior Credit Facilities, the 2020 BrandCo Credit Agreement, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility or the 2018 Asset-Based Term Facility or to repay, repurchase or redeem, in full or in part, the 6.25% Senior Notes.

Events beyond the Company’s control could impair the Company’s operating performance, which could affect Products Corporation’s ability to comply with the terms of Products Corporation’s debt instruments. Such events may include decreased consumer spending in response to the ongoing and prolonged COVID-19 pandemic or other weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company's products as a result of increased competitive activities by the Company’s competitors and/or decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise; changes in consumer purchasing habits, including with respect to retailer preferences and/or among sales channels, such as due to any further consumption declines that the Company has experienced; inventory management by the Company's customers; inventory de-stocking by certain retail customers; space reconfigurations or reductions in display space by the Company's customers; retail store closures in the brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers; less than anticipated results from the Company's existing or new products or from its advertising, promotional, pricing and/or marketing plans; or if the Company’s expenses, including, without limitation, those for pension expense under its benefit plans, restructuring programs and related severance expenses, acquisitions and related integration costs, capital expenditures, costs related to litigation, advertising, promotional and/or marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise, exceed the Company's anticipated level of expenses.

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Under such circumstances, Products Corporation may be unable to comply with the requirements of one or more of its various debt instruments, including any financial covenants in the 2016 Credit Agreements. If Products Corporation is unable to satisfy such requirements at any future time, Products Corporation would need to seek an amendment or waiver of such requirements. The respective lenders under the 2016 Credit Agreements may not consent to any amendment or waiver requests that Products Corporation may make in the future, and, if they do consent, they may only do so on terms that are unfavorable to Products Corporation and/or Revlon.

If Products Corporation is unable to obtain any such waiver or amendment, Products Corporation's inability to meet the requirements of the 2016 Credit Agreements would constitute an event of default under such agreements, which, under certain circumstances, would permit the bank lenders to accelerate the repayment of the 2016 Senior Credit Facilities, and, under certain circumstances, would constitute an event of default under the 2020 BrandCo Credit Agreement, the 2018 Foreign Asset-Based Term Agreement, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Agreement and the 6.25% Senior Notes ~~Indentures.~~Indenture. An event of default under the 6.25% Senior Notes ~~Indentures~~Indenture would permit the ~~respective~~6.25% Senior Notes Trustee or the Requisite Note Holders to accelerate payment of the principal and accrued, but unpaid, interest on the ~~respective~~6.25% Senior Notes. An event of default under the ~~Amended 2019 Senior~~2020 Restated Line of Credit Agreement, under certain circumstances, would permit the lenders to accelerate the repayment of such facility.

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

Products Corporation’s assets and/or cash flows and/or that of Products Corporation’s subsidiaries may not be sufficient to fully repay borrowings under its various debt instruments, either upon maturity or if accelerated upon an event of default or change of control, and if the Company is required to repay, repurchase and/or redeem, in whole or in part, amounts outstanding under its 2016 Senior Credit Facilities, the 2018 Foreign Asset-Based Term Facility, the 2020 BrandCo Credit Agreement, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and/or its 6.25% Senior Notes, it may be unable to refinance or restructure the payments on such debt. See “Recent Debt Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Further, if the Company is unable to repay, refinance or restructure its indebtedness under the 2016 Senior Credit Facilities, the 2018 Foreign Asset-Based Term Facility and/or the 2020 BrandCo Credit Agreement, the lenders could proceed against the collateral securing that indebtedness, subject to certain conditions and limitations as set forth in the related intercreditor agreements and collateral agreements. As described above, the consequences of complying with the foregoing restrictions, covenants and limitations under the Company’s various debt instruments could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.

Limits on Products Corporation's borrowing capacity under the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility may affect the Company's ability to finance its operations.

At ~~June~~September 30, 2020, Products Corporation had ~~$249.5~~$291.9 million in aggregate borrowings outstanding under the Amended 2016 Revolving Credit ~~Facility. As~~Facility and the Euro equivalent of ~~December 31, 2020, Products Corporation had $86.3~~$56.8 million ~~in borrowings outstanding under the 2018 Foreign Asset-Based Term Facility. After a partial repayment in May 2020, $54.5 million remained~~ outstanding under the 2018 Foreign Asset-Based Term Facility as of ~~June~~September 30, 2020. While the Amended 2016 Revolving Credit Facility provides for up to $400.0 million of commitments, the Company’s ability to borrow funds under such facility is limited by a borrowing base determined relative to the value, from time-to-time, of certain eligible assets.

While the 2018 Foreign Asset-Based Term Facility provides for a euro-denominated senior secured asset-based term loan facility in an original aggregate principal amount of €77 million, the full amount of which was funded on the closing of the facility in July 2018, the 2018 Foreign Asset-Based Term Agreement requires the maintenance of a borrowing base supporting the borrowing thereunder, based on the sum of: (i) 85% of eligible accounts receivable; and (ii) 90% of the net orderly liquidation value of eligible inventory, in each case with respect to certain of Products Corporation’s subsidiaries organized in Australia, Bermuda, Germany, Italy, Spain and Switzerland, subject to certain customary availability reserves.

Under the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility, if the value of the Company's eligible assets is not sufficient to support the full borrowing base under the respective facility, Products Corporation will not have complete access to the entire commitment available under such facilities, but rather would have access to a lesser amount as determined by the borrowing base.

The Borrowers must prepay loans under the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility to the extent that outstanding loans exceed its respective borrowing base ~~Under~~under the 2018 Foreign Asset-Based Term Facility, in lieu of a mandatory prepayment, the Loan Parties may deposit cash in an amount not to exceed 10% of the borrowing base into a designated U.S. bank account with the Agent that is subject to a control agreement (such cash, the "Qualified Cash"). If any such over-advance has not been cured within 60 days, the Qualified Cash may be applied, at the Agent’s option, to prepay the loans under the 2018 Foreign Asset-Based Term Facility. To the extent certain levels of

Table of Contents

REVLON, INC. AND SUBSIDIARIES

availability are obtained during a certain period of time, the Borrowers can withdraw the Qualified Cash from such bank account. In addition, the 2018 Foreign Asset-Based Term Facility is subject to mandatory prepayments from the net proceeds from the incurrence by the Loan Parties of debt not permitted thereunder.

As Products Corporation continues to manage its working capital (including its and its subsidiaries inventory and accounts receivable, which are significant components of the eligible assets comprising the borrowing base under the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility), this could reduce the borrowing base under the Amended 2016 Revolving Credit Facility and/or the 2018 Asset-Based Term Facility. Further, if Products Corporation borrows funds under the Amended 2016 Revolving Credit Facility, subsequent changes in the value or eligibility of the assets within the borrowing base could require Products Corporation to pay down amounts outstanding under such facility so that there is no amount outstanding in excess of the then-existing borrowing base. Likewise, subsequent changes in the value or eligibility of the assets within the borrowing base under the 2018 Foreign Asset-Based Term Facility could require Products Corporation to pay down amounts outstanding under such facility so that there is no amount outstanding in excess of the then-existing borrowing base, which, unlike the Amended 2016 Revolving Credit Facility, cannot be re-borrowed.

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

The Company’s ability to borrow under the Amended 2016 Revolving Credit Facility is also conditioned upon its compliance with other covenants in the agreements that govern the 2016 Senior Credit Facilities. Because of these limitations, the Company may not always be able to meet its cash requirements with funds borrowed under the Amended 2016 Revolving Credit Facility, which could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.

If one or more lenders under the Amended 2016 Revolving Credit Facility are unable to fulfill their commitment to advance funds to Products Corporation under such facility, it would impact the Company’s liquidity and, depending upon the amount involved and the Company’s liquidity requirements, it could have an adverse effect on the Company’s ability to fund its operations, which could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.

At ~~June~~September 30, 2020, the Company had a liquidity position of $~~415.7~~340.4 million, consisting of: (i) $~~338.5~~268.3 million of unrestricted cash and cash equivalents (with approximately ~~$62.1~~$93.7 million held outside the U.S.); (ii) $~~50.7~~52.6 million in available borrowing capacity under Products Corporation's Amended 2016 Revolving Credit Facility (which had $~~249.5~~291.9 million drawn at such date); (iii) $30 million in available borrowing capacity under the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility, which had no borrowings at such date; and less (iv) approximately $~~3.5~~10.5 million of outstanding checks. See “Recent Debt Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

A substantial portion of Products Corporation's indebtedness is subject to floating interest rates and the potential discontinuation or replacement of LIBOR could result in an increase to our interest expense.

A substantial portion of the Products Corporation's indebtedness is subject to floating interest rates, which makes the Company more vulnerable in the event of adverse economic conditions, increases in prevailing interest rates or a downturn in the Company’s business. As of ~~June~~September 30, 2020 ~~$2,949.2~~, $2,966.4 million of Products Corporation’s total indebtedness, or approximately ~~78%~~79% of its total indebtedness, was subject to floating interest rates.

In July 2017, the U.K.’s Financial Conduct Authority, which regulates LIBOR, announced that it intends to stop persuading or compelling banks to submit LIBOR rates after 2021. It is unclear whether or not LIBOR will cease to exist at that time (and if so, what reference rate will replace it) or if new methods of calculating LIBOR will be established such that it continues to exist after 2021. Certain of Products Corporation’s financing agreements, including its 2016 Term Loan Facility, the Amended 2016 Revolving Credit Facility and the 2020 BrandCo Facilities are made at variable rates that use LIBOR as a benchmark for establishing the applicable interest rate. While the 2016 Credit Agreements contain limited “fallback” provisions providing for comparable or successor rates in the event LIBOR is unavailable, these provisions may not adequately address the actual changes to LIBOR or its successor rates. For example, if future rates based upon the successor reference rate (or a new method of calculating LIBOR) are higher than LIBOR rates as currently determined, it may have a material adverse effect on our business, prospects, results of operations, financial condition and/or cash flows. On the other hand, if future rates based upon the successor reference rate (or a new method of calculating LIBOR) are lower than LIBOR rates as currently determined, the lenders under such credit agreements may seek amendments to increase the applicable interest rate margins or invoke their right to require the use of the alternate base rate in place of LIBOR, which could result in an increase to our interest expense as discussed below. By contrast, the 2020 BrandCo Credit Agreement contains provisions governing the selection and adjustment of replacement reference rates. More generally, a phase-out of LIBOR could cause market volatility or disruption and may

Table of Contents

REVLON, INC. AND SUBSIDIARIES

adversely affect our access to the capital markets and cost of funding, which would have a material adverse effect on our business, prospects, results of operations, financial condition and/or cash flows.

Similar considerations as the ones described above with respect to LIBOR as benchmark for establishing interest rates apply to EURIBOR. Our 2018 Foreign Asset-Based Term Facility is denominated in Euros and the interest rate thereunder is tied to EURIBOR. To the extent that EURIBOR becomes unavailable, the agreement contains fallback provisions ultimately providing for a rate determined by the administrative agent as the all-in-cost of funds for borrowings denominated in Euros with maturities comparable to the interest period applicable to the loans under the 2018 Foreign Asset-Based Term Facility.

As of ~~June~~September 30, 2020, the entire ~~$924.8~~$886.3 million in aggregate principal amount outstanding under the 2016 Term Loan Facility bore interest, at Product Corporation’s option, at a rate per annum of LIBOR (which has a floor of 0.75%) plus a margin of 3.5% or an alternate base rate plus a margin of 2.5%, payable quarterly, at a minimum. At ~~June~~September 30, 2020, LIBOR and the alternate base rate for the 2016 Term Loan Facility were 0.75% and 3.25%, respectively. As of ~~June~~September 30, 2020, ~~$249.5~~$291.9 million in aggregate principal amount outstanding under Tranche A of the Amended 2016 Revolving Credit Facility bore interest, at Products Corporation’s option, at a rate per annum equal to either: (i) the alternate base rate plus an applicable margin equal to 0.25%, 0.50% or 0.75%, depending on the average excess availability (based on the borrowing base as most

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

recently reported by Products Corporation to the administrative agent from time-to-time); or (ii) the Eurocurrency rate plus an applicable margin equal to 1.25%, 1.5% or 1.75%, depending on the average excess availability (based on the borrowing base as most recently reported by Products Corporation to the administrative agent from time-to-time). Under the Amended 2016 Revolving Credit Facility, the applicable margin increases as average excess availability thereunder decreases. Under the 2018 Foreign Asset-Based Term Facility, which had ~~$54.5~~the Euro equivalent of $56.8 million in aggregate principal amount outstanding as of ~~June~~September 30, 2020, interest accrues on borrowings at a rate per annum equal to the EURIBOR rate plus a 6.50% applicable margin. Interest accrues on the 2020 BrandCo Term Loan Facility ~~(as hereinafter defined)~~ at a rate per annum equal to (i) 2.00%, payable in kind, plus (ii) LIBOR (which has a floor of 1.50%) plus a margin of 10.5%. Interest accrues on the Roll-up BrandCo Facility and the Junior Roll-up BrandCo Facility ~~(each as hereinafter defined)~~ at a rate per annum of LIBOR (which has a floor of 0.75%) plus a margin of 3.5%. See “Recent Debt Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

If any of LIBOR (or its successor rate), the prime rate or the federal funds effective rate increases, Products Corporation’s debt service costs will increase to the extent that Products Corporation has elected such rates for its outstanding loans. Based on the amounts outstanding under the 2016 Senior Credit Facilities, the 2018 Foreign Asset-Based Term Facility, the 2020 BrandCo Facilities and other short-term borrowings (which, in the aggregate, are Products Corporation’s only debt currently subject to floating interest rates) as of ~~June~~September 30, 2020, a 1% increase in LIBOR (or an equivalent successor rate) would increase the Company’s annual interest expense by ~~$30.0~~$30.5 million. Based on the same amounts outstanding, a change from LIBOR to the alternate base rate in the case of the 2016 Credit Agreements would increase the Company’s annual interest expense by ~~$15.3~~$15.0 million. Increased debt service costs would adversely affect the Company’s cash flows and could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.

The Company's ability to service its debt and meet its cash requirements depends on many factors, including achieving anticipated levels of revenue and expenses. If such revenue or expense levels prove to be other than as anticipated, the Company may be unable to meet its cash requirements or Products Corporation may be unable to meet the requirements of the 2016 Credit Agreements, 2018 Foreign Asset-Based Term Loan Agreement, 2020 BrandCo Credit Agreement and/or ~~Amended 2019 Senior~~2020 Restated Line of Credit Agreement, which could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows.

The Company currently expects that operating revenues, cash on hand, and funds that may be available for borrowing under the Amended 2016 Revolving Credit Facility, the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and other permissible borrowings will be sufficient to enable the Company to cover its operating expenses for 2020, including: cash requirements for the payment of expenses in connection with executing the Company's business initiatives and its advertising, promotional, pricing and/or marketing plans; purchases of permanent wall displays; capital expenditure requirements; debt service payments and costs; cash tax payments; pension and other post-retirement plan contributions; payments in connection with the Company's restructuring programs (including, without limitation, the EA Integration Restructuring Program, the 2018 Optimization Program and the Revlon 2020 Restructuring Program); severance not otherwise included in the Company's restructuring programs; business and/or brand acquisitions (including, without limitation, through licensing transactions), if any; debt and/or equity repurchases, if any; costs related to litigation; and payments in connection with discontinuing non-core business lines and/or exiting and/or entering certain territories and/or channels of trade. See “Recent Debt Transactions” in Item 7. “Combined Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Table of Contents

REVLON, INC. AND SUBSIDIARIES

However, if the Company's anticipated level of revenue is not achieved because of, for example, decreased consumer spending in response to the ongoing and prolonged COVID-19 pandemic or other weak economic conditions or weakness in the consumption of beauty products in one or more of the Company's segments; adverse changes in tariffs, foreign currency exchange rates, foreign currency controls and/or government-mandated pricing controls; decreased sales of the Company's products as a result of increased competitive activities by the Company's competitors and/or decreased performance by third-party suppliers, whether due to shortages of raw materials or otherwise; changes in consumer purchasing habits, including with respect to retailer preferences and/or sales channels, such as due to the consumption declines in core beauty categories in the mass retail channel in North America; inventory management by the Company's customers; space reconfigurations or reductions in display space by the Company's customers; retail store closures in brick-and-mortar channels where the Company sells its products, as consumers continue to shift purchases to online and e-commerce channels; changes in pricing, marketing, advertising and/or promotional strategies by the Company's customers; less than anticipated results from the Company's existing or new products or from its advertising, promotional, pricing and/or marketing plans; or if the Company's expenses, including, without limitation, those for pension expense under its benefit plans, capital expenditures, restructuring and severance costs (including, without limitation, for the EA Integration Restructuring Program, the 2018 Optimization Program and the Revlon 2020 Restructuring Program), acquisition and integration costs, costs related to litigation, advertising, promotional or marketing activities or for sales returns related to any reduction of space by the Company's customers, product discontinuances or otherwise, exceed the anticipated

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

level of expenses, the Company's current sources of funds may be insufficient to meet its cash requirements. In addition, such developments, if significant, could reduce the Company's revenues and could have a material adverse effect on Products Corporation's ability to comply with the terms of the 2016 Credit Agreements, 2018 Foreign Asset-Based Term Loan Agreement, 2020 BrandCo Credit Agreement and/or ~~Amended 2019 Senior~~2020 Restated Line of Credit Agreement (See also Item 1A. Risk Factors - "Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply," which discusses, among other things, the consequences of noncompliance with Products Corporation's debt covenants).

If the Company's operating revenues, cash on hand and/or funds that may be available for borrowing are insufficient to cover the Company's expenses and/or are insufficient to enable Products Corporation to comply with the requirements of the 2016 Credit Agreements, 2018 Foreign Asset-Based Term Loan Agreement, 2020 BrandCo Credit Agreement and/or ~~Amended 2019 Senior~~2020 Restated Line of Credit Agreement, the Company could be required to adopt one or more of the alternatives listed below:

•delaying the implementation of or revising certain aspects of the Company's business initiatives;

•reducing or delaying purchases of wall displays and/or expenses related to the Company's advertising, promotional and/or marketing activities;

•reducing or delaying capital spending;

•implementing new restructuring programs;

•refinancing Products Corporation's indebtedness;

•selling assets or operations;

•seeking additional capital contributions and/or loans from MacAndrews & Forbes, the Company's other affiliates and/or third parties;

•selling additional Revlon equity or debt securities or Products Corporation's debt securities; and/or

•reducing other discretionary spending.

The Company may not be able to take any of these actions because of a variety of commercial or market factors or constraints in one or more of Products Corporation's various debt instruments, including, for example, market conditions being unfavorable for an equity or a debt issuance, additional capital contributions or loans not being available from affiliates and/or third parties, or that the transactions may not be permitted under the terms of one or more of Products Corporation's various debt instruments then in effect, such as due to restrictions on the incurrence of debt, incurrence of liens, asset dispositions and/or related party transactions. If the Company is required to take any of these actions, it could have a material adverse effect on its business, prospects, results of operations, financial condition and/or cash flows.

Such actions, if ever taken, may not enable the Company to satisfy its cash requirements or enable Products Corporation to comply with the terms of the 2016 Credit Agreements, 2018 Foreign Asset-Based Term Loan Agreement and/or 2020 BrandCo Credit Agreement if the actions do not result in sufficient cost reductions or generate a sufficient amount of additional capital, as the case may be. (See also Item 1A. Risk Factors - "Restrictions and covenants in Products Corporation’s various debt instruments limit its ability to take certain actions and impose consequences in the event of failure to comply," which discusses, among other things, the consequences of noncompliance with Products Corporation's debt covenants).

If the Company is unable to maintain sufficient cash balances, or otherwise obtain sufficient financing, for the repayment in full of its 5.75% Senior Notes due 2021, certain of its credit facilities will be subject to an Accelerated Maturity Event which could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows.

The 5.75% Senior Notes are due on February 15, 2021. If Products Corporation is unable to repay or refinance the 5.75% Senior Notes in full prior to November 16, 2020 (91 days before they are due) (the "Accelerated Maturity Date"), then, subject to (other than in the case of the 2018 Foreign Asset-Based Term Facility, as amended in May 2020) certain minimum liquidity-related exceptions, the 2016 Term Loan Facility, Tranche A of the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility will become due on the Accelerated Maturity Date (an "Accelerated Maturity Event"). As of June 30, 2020, the aggregate principal amount of indebtedness outstanding under the 5.75% Senior Notes, the 2016 Term Loan Facility, Tranche A of the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility was ~~$387.2 million~~, ~~$924.8 million~~, ~~$249.5 million~~ ~~and~~ ~~$54.5~~ ~~million, respectively.~~

On May 7, 2020, Products Corporation entered into the 2020 BrandCo Credit Agreement and consummated the other 2020 Refinancing Transactions (each as hereinafter defined). The proceeds of the $880.0 million aggregate principal amount 2020 BrandCo Term Loan Facility, after the repayment in full of the 2019 Term Loan Facility and the 2020 Incremental Facility (as hereinafter defined) and payment of related fees and expenses, are available for general corporate purposes, including to refinance the 5.75% Senior Notes. ~~See "Recent Debt Transactions" in Item 7. "Combined Management's Discussion and~~

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

~~Analysis of Financial Condition and Results of Operations."~~ If for any reason the Company fails to maintain sufficient cash balances to refinance the 5.75% Senior Notes from the proceeds of the 2020 BrandCo Term Loan Facility or otherwise, the Company will need to obtain sufficient alternative funding (whether from borrowed funds or from the proceeds of asset sales) or amend or obtain a waiver from the lenders under the 2016 Term Loan Facility, Tranche A of the Amended 2016 Revolving Credit Facility and the 2018 Foreign Asset-Based Term Facility. There can be no assurance that the Company will be able to obtain any such financing or amendment or waiver on favorable terms or at all. If an Accelerated Maturity Event were to occur, it could have a material adverse effect on the Company’s business, prospects, results of operations, financial condition and/or cash flows. For a discussion of factors affecting Products Corporation's ability to repay or refinance indebtedness by maturity and the consequences of its inability to do so, see Item 1A. Risk Factors – “Products Corporation’s ability to pay the principal amount of its indebtedness depends on many factors.”

Shares of Revlon Class A Common Stock and Products Corporation's capital stock are pledged to secure various of Revlon's and/or other of the Company's affiliates’ obligations and foreclosure upon these shares or dispositions of shares could result in the acceleration of debt under Products Corporation's 2016 Senior Credit Facilities, 2018 Foreign ~~Asset-Based~~Asset-

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Based Term Facility, 2020 BrandCo Facilities, ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility and/or its 6.25% Senior Notes and could have other consequences.

All of Products Corporation's shares of common stock are pledged to secure Revlon’s guarantee under the 2016 Senior Credit Facilities and the 2020 BrandCo Facilities. MacAndrews & Forbes has advised the Company that it has pledged shares of Revlon’s Class A Common Stock to secure certain obligations of MacAndrews & Forbes. Additional shares of Revlon and shares of common stock of intermediate holding companies between Revlon and MacAndrews & Forbes may from time-to-time be pledged to secure obligations of MacAndrews & Forbes. A default under any of these obligations that are secured by the pledged shares could cause a foreclosure with respect to such shares of Revlon's Class A Common Stock, Products Corporation's common stock or stock of intermediate holding companies between Revlon and MacAndrews & Forbes.

A foreclosure upon any such shares of common stock or dispositions of shares of Revlon’s Class A Common Stock, Products Corporation's common stock or stock of intermediate holding companies between Revlon and MacAndrews & Forbes that are beneficially owned by MacAndrews & Forbes could, in a sufficient amount, constitute a "change of control" under Products Corporation’s 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement, the 2020 BrandCo Credit Agreement and the 6.25% Senior Notes ~~Indentures.~~Indenture. A change of control constitutes an event of default under the 2016 Credit Agreements, the 2018 Foreign Asset-Based Term Agreement and the 2020 BrandCo Credit Agreement that would permit Products Corporation's and its subsidiaries' lenders to accelerate amounts outstanding under such facilities. In addition, holders of the 6.25% Senior Notes may require Products Corporation to repurchase their respective notes under those circumstances.

Products Corporation may not have sufficient funds at the time of any such change of control to repay in full or in part the borrowings under the 2016 Senior Credit Facilities, the 2018 Foreign Asset-Based Term Facility, the 2020 BrandCo Facilities and the ~~Amended 2019 Senior~~2020 Restated Line of Credit Facility (as a result of its cross-default provisions) and/or to repurchase or redeem some or all of the 6.25% Senior Notes. (See also Item 1A. Risk Factors - "The Company's ability to service its debt and meet its cash requirements depends on many factors, including achieving anticipated levels of revenue and expenses. If such revenue or expense levels prove to be other than as anticipated, the Company may be unable to meet its cash requirements or Products Corporation may be unable to meet the requirements of the 2016 Credit Agreements, 2018 Foreign Asset-Based Term Loan Agreement, 2020 BrandCo Credit Agreement and/or ~~Amended 2019 Senior~~2020 Restated Line of Credit Agreement, which could have a material adverse effect on the Company's business, prospects, results of operations, financial condition and/or cash flows."

The ongoing and prolonged COVID-19 pandemic has resulted in significantly decreased net sales for the Company and has had, and could continue to have, a significant adverse effect on the Company's business, results of operations, financial condition and/or cash flows.

The ongoing and prolonged COVID-19 pandemic has had, and continues to have, a significant adverse effect on the Company’s business around the globe, which could continue for the foreseeable future. After China began reporting on the spread of the COVID-19 coronavirus in early 2020, there have been ~~approximately 15~~over 45 million cases of the COVID-19 coronavirus globally and it has contributed to over ~~a half a~~1.1 million deaths worldwide, according to data from the World Health Organization. The COVID-19 pandemic has adversely impacted net sales in all major commercial regions that are important to the Company’s business. COVID-19’s adverse impact on the global economy has contributed to significant and extended quarantines, stay-at-home orders and other social distancing measures; closures and bankruptcies of retailers, beauty salons, spas, offices and manufacturing facilities; increased levels of unemployment; travel and transportation restrictions leading to declines in consumer traffic in key shopping and tourist areas around the globe; and import and export restrictions. These adverse economic conditions have resulted in the

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

general slowdown of the global economy, in turn contributing to a significant decline in net sales within each of the Company’s reporting segments and regions.

The ongoing and prolonged COVID-19 pandemic contributed an estimated ~~$214~~$119 million ($~~217~~119 million ~~XFX)~~"XFX," as hereinafter defined), to the Company's ~~$222.6~~$119.7 million decline in net sales for the three months ended ~~June~~September 30, 2020 three months ended September 30, 2020, compared to the prior year quarter, and an estimated ~~$268~~$387 million ~~($272~~($392 million XFX) to the Company's ~~$322.8~~$442.5 million decline in net sales for the ~~six~~nine months ended ~~June~~ September 30, 2020, compared to the prior year period.These declines were partially offset by increased net sales of Revlon beauty tools, Revlon hair color products and Elizabeth Arden skincare and fragrances in certain markets, as well as continued strong growth in the Company's e-commerce net sales.

Table of Contents

REVLON, INC. AND SUBSIDIARIES

The ongoing and prolonged COVID-19 pandemic has caused the Company and various of its key third party suppliers to temporarily close one or more of their manufacturing facilities. While these closures have not yet had ana material adverse impact on the Company’s ability to operate and fulfill orders, if the COVID-19 restrictions continue for a period longer than the period for the re-opening of retailers, such restrictions could lead to a shortage of raw materials, components and finished products, which in turn could cause the Company to be unable to ship products to retailers and consumers and continue to adversely impact the Company’s net sales. The continuation of any of the foregoing events or other unforeseen consequences of the COVID-19 pandemic would continue to significantly adversely affect the Company’s business, results of operations, financial condition and cash flows.

In addition to the other information in this report, investors should consider carefully the risk factors discussed in Part I, Item 1A. "Risk Factors" in the Company's 2019 Form 10-K.

Item 5. Other Information

~~Exchange Offer~~

~~On July 27, 2020, Products Corporation commenced an offer to exchange (the “Exchange Offer”) any and all of its $387.2~~MacAndrews & Forbes tendered approximately $15.5 million ~~aggregate principal amount of outstanding 5.75% Senior Notes due 2021 (the “Existing Notes”) for a combination~~ of 5.75% Senior Notes due February 15, 2024 (the “New Notes”) and an Early Tender/Consent Fee, payable in cash, upon the terms and conditions set forth in the confidential Offering Memorandum and Consent Solicitation Statement (the “Offering Memorandum”) dated July 27, 2020. The New Notes will be senior unsecured notes with terms substantially the same as those of the Existing Notes, with certain adjustments specified in the Offering Memorandum. Concurrently with the Exchange Offer, the Company is soliciting consents (the “Consent Solicitation”) to eliminate substantially all of the restrictive covenants and certain events of default with respect to the Existing Notes.

~~Unless earlier terminated or extended, the Exchange Offer will expire at 11:59 p.m. E.D.T. on August 21, 2020. For each $1,000 principal amount of Existing Notes tendered~~ into the Exchange Offer and, ~~Consent Solicitation prior to~~in exchange, received the ~~early tender deadline of 5:00 p.m. E.D.T. on August 7, 2020, holders of Existing Notes will receive $750 principal amount of New Notes~~Mixed Consideration as described herein, in accordance with the terms and $50 of cash as an early tender/consent fee. Holders who tender their Existing Notes after the early tender deadline will receive only $750 principal amount of New Notes for each $1,000 principal amount of Existing Notes tendered.

~~The Exchange Offer and Consent Solicitation are subject to the following~~ conditions ~~precedent: (i) the valid tender without valid withdrawal of not less than 95%~~ of the ~~aggregate outstanding principal amount of Existing Notes (and the provision of the related Consents for such tendered Existing Notes); (ii) the receipt of all necessary consents from the lenders~~

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~

~~under the Company’s term and revolving credit agreements required in order to consummate the~~ Exchange ~~Offer and Consent Solicitation; (iii) the receipt of requisite consents in the Consent Solicitation; and (iv) various other customary conditions precedent.~~The conditions precedent are for the sole benefit of the Company and may be amended or waived, in whole or in part, at any time, in the sole and absolute discretion of the Company, subject to applicable law.Offer.

91100

Table of Contents

REVLON, INC. AND SUBSIDIARIES

Item 6. Exhibits




















































4.			Instruments Defining the Rights of Security Holders, including Indentures.
~~4.1~~			Amendment No. 1, dated as of May 7, 2020, to the Term Credit Agreement, dated as of September 7, 2016 by and among Products Corporation, Revlon, certain lenders party thereto and Citibank, N.A., as administrative agent and collateral agent ~~(incorporated by reference to Exhibit 4.1 to Revlon's Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2020, filed with the SEC on August 6, 2020 (the "Revlon Q2 2020 Form 10-Q"))~~.
~~4.2~~			Amendment No. 4, dated as of May 7, 2020, to the Asset-Based Revolving Credit Agreement, dated as of September 7, 2016 (as amended), by and among Products Corporation, Revlon, certain lenders party thereto and Citibank, N.A., as administrative agent and collateral agent (incorporated by reference to Exhibit 4.2 to the Revlon Q2 2020 Form 10-Q).
~~4.3~~			BrandCo Credit Agreement, dated as of May 7, 2020, by and among Products Corporation, Revlon (solely for the purposes set forth therein), certain lenders party thereto and Jefferies Finance LLC ("Jefferies"), as administrative agent and each collateral agent ~~(incorporated by reference to Exhibit 4.~~3 ~~to the Revlon Q2 2020 Form 10-Q~~).
~~4.4~~			~~Term Loan Guarantee and Collateral Agreement, dated as of May 7, 2020, made by each of the signatories thereto in favor of Jefferies, as pari passu collateral agent(incorporated by reference to Exhibit 4.~~4 ~~to the Revlon Q2 2020 Form 10-Q~~).
~~4.5~~			~~Holdings Term Loan Guarantee and Pledge Agreement, dated as of May 7, 2020, made by Revlon in favor of Jefferies, as pari passu collateral agent(incorporated by reference to Exhibit 4.~~5 ~~to the Revlon Q2 2020 Form 10-Q~~).
~~4.6~~			First Lien BrandCo Stock Pledge Agreement, dated as of May 7, 2020, by and among Products Corporation, certain subsidiaries of Products Corporation party thereto from time to time, and Jefferies, as first lien collateral agent ~~(incorporated by reference to Exhibit 4.~~6 ~~to the Revlon Q2 2020 Form 10-Q)~~.
~~4.7~~			First Lien Pari Passu Intercreditor Agreement, dated as of May 7, 2020, by and among Revlon, Products Corporation, certain subsidiaries of Products Corporation party thereto from time to time, Jefferies, as administrative agent and collateral agent, and Citibank, N.A ~~(incorporated by reference to Exhibit 4.~~7 ~~to the Revlon Q2 2020 Form 10-Q)~~.
~~4.8~~			Second Lien BrandCo Stock Pledge Agreement, dated as of May 7, 2020, by and among Products Corporation, certain subsidiaries of Products Corporation party thereto from time to time, and Jefferies, as second lien collateral agent ~~(incorporated by reference to Exhibit 4.~~8 ~~to the Revlon Q2 2020 Form 10-Q)~~.
~~4.9~~			~~BrandCo First Lien Guarantee and Security Agreement, dated as of May 7, 2020, made by each of the signatories thereto in favor of Jefferies, as administrative agent and first lien collateral agent(incorporated by reference to Exhibit 4.~~9 ~~to the Revlon Q2 2020 Form 10-Q)~~.
~~4.10~~			Third Lien BrandCo Stock Pledge Agreement, dated as of May 7, 2020, by and among Products Corporation, certain subsidiaries of Products Corporation party thereto from time to time, and Jefferies, as third lien collateral agent ~~(incorporated by reference to Exhibit 4.~~10 ~~to the Revlon Q2 2020 Form 10-Q)~~.
~~4.11~~			~~BrandCo Second Lien Guarantee and Security Agreement, dated as of May 7, 2020, made by each of the signatories thereto in favor of Jefferies, as administrative agent and second lien collateral agent(incorporated by reference to Exhibit 4.~~11 ~~to the Revlon Q2 2020 Form 10-Q)~~.
~~4.12~~			~~BrandCo Third Lien Guarantee and Security Agreement, dated as of May 7, 2020, made by each of the signatories thereto in favor of Jefferies, as administrative agent and collateral agent(incorporated by reference to Exhibit 4.~~12 ~~to the Revlon Q2 2020 Form 10-Q)~~.
~~4.13~~			First Lien/Second Lien/Third Lien Intercreditor Agreement, dated as of May 7, 2020, by and among Revlon, Products Corporation, certain subsidiaries of Products Corporation party thereto from time to time, and Jefferies, as administrative agent and each collateral agent ~~(incorporated by reference to Exhibit 4.~~13 ~~to the Revlon Q2 2020 Form 10-Q)~~.
~~4.14~~			~~Amended and Restated Intellectual Property License Agreement, dated as of May 7, 2020, by and between Beautyge II, LLC and Products Corporation(incorporated by reference to Exhibit 4.~~1 ~~4 to the Revlon Q2 2020 Form 10-Q)~~.
~~4.15~~			Intellectual Property License Agreement, dated as of May 7, 2020, by and between BrandCo Elizabeth Arden 2020 LLC and Products Corporation (incorporated by reference to Exhibit 4.15 to the Revlon Q2 2020 Form 10-Q).
~~4.16~~			~~Intellectual Property License Agreement, dated as of May 7, 2020, by and between BrandCo Mitchum 2020 LLC and Products Corporation(incorporated by reference to Exhibit 4.~~16 ~~to the Revlon Q2 2020 Form 10-Q)~~.

~~Table of Contents~~

~~REVLON, INC. AND SUBSIDIARIES~~


~~4.17~~			~~Intellectual Property License Agreement, dated as of May 7, 2020, by and between BrandCo Multicultural Group 2020 LLC and Products Corporation(incorporated by reference to Exhibit 4.~~17 ~~to the Revlon Q2 2020 Form 10-Q)~~.
~~10.~~			~~Material Contracts.~~














~~10.1~~			~~Amendment, dated as of April 10, 2020, to the Amended and Restated Employment Agreement, dated as of November 16, 2018, by and among Revlon, Products Corporation and Debra Perelman~~ ~~(incorporated by reference to Exhibit 10.2 to Revlon, Inc.’s Quarterly Report on Form 10-Q filed with the SEC on May 11, 2020)~~.









































4.1			Second Amended and Restated Senior Unsecured Line of Credit Agreement, dated as of September 28, 2020, between Products Corporation, as borrower, and MacAndrews & Forbes Group, LLC, as lender (incorporated by reference to Exhibit 4.1 to Revlon's Quarterly Report on Form 10 -Q for the fiscal quarter ended September 30, 2020, filed with the SEC on November 13, 2020 (the "Revlon Q3 2020 Form 10-Q")).
10.			Material Contracts.
10.1			Transaction Support Agreement, dated as of September 28, 2020, by and among Products Corporation, Revlon and certain beneficial holders, or investment advisors or managers for the account of beneficial holders, of term loans under the BrandCo Credit Agreement, dated as of May 7, 2020, by and among Products Corporation, Revlon, certain lenders party thereto and Jefferies Finance LLC, as administrative agent and collateral agent (inc orporated by reference to Exhibit 10.1 to the Revlon Q3 2020 Form 10-Q).
*31.1			Certification of Debra Perelman, Chief Executive Officer, dated ~~August 6,~~November 13, 2020, pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act.
*31.2			Certification of Victoria Dolan, Chief Financial Officer, dated ~~August 6,~~November 13, 2020, pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act.
**32.1			Certification of Debra Perelman, Chief Executive Officer, dated ~~August 6,~~November 13, 2020, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
**32.2			Certification of Victoria Dolan, Chief Financial Officer, dated ~~August 6,~~November 13, 2020, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


*101.INS			Inline XBRL Instance Document
*101.SCH			Inline XBRL Taxonomy Extension Schema
*101.CAL			Inline XBRL Taxonomy Extension Calculation Linkbase
*101.DEF			Inline XBRL Taxonomy Extension Definition Linkbase
*101.LAB			Inline XBRL Taxonomy Extension Label Linkbase
*101.PRE			Inline XBRL Taxonomy Extension Presentation Linkbase
*104			Cover Page Interactive Data File, formatted in Inline XBRL and contained in Exhibit 101

*Filed herewith.

**Furnished herewith.

93101

S I G N A T U R E S

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, each Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: ~~August 6,~~November 13, 2020

Revlon, Inc.

(Registrant)

By: /s/ Debra Perelman

By: /s/ Victoria Dolan

By: /s/ Pamela Bucher

Debra Perelman

Victoria Dolan

Pamela Bucher

President, Chief Executive Officer &

Chief Financial Officer

Vice President,

Director

Chief Accounting Officer

& Controller

Revlon Consumer Products Corporation

(Registrant)

By: /s/ Debra Perelman

By: /s/ Victoria Dolan

By: /s/ Pamela Bucher

Debra Perelman

Victoria Dolan

Pamela Bucher

President, Chief Executive Officer &

Chief Financial Officer

Vice President,

Director

Chief Accounting Officer

& Controller

94102


	Six Months Ended
	June 30, 2020			June 30, 2019
Lease Cost:
Finance Lease Cost:
Amortization of ROU assets	$	0.2		$	0.1
Interest on lease liabilities	0.1			0.0
Operating Lease Cost	21.8			21.3
Total Lease Cost	$	22.1		$	21.4

Other Information:
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from finance leases	0.1			0.0
Operating cash flows from operating leases	19.2			21.0
Financing cash flows from finance leases	0.1			0.4

	June 30, 2020			December 31, 2019
ROU assets for finance leases	0.8			1.0
ROU assets for operating leases	88.4			91.4
Accumulated amortization on ROU assets for finance leases	0.5			0.3
Accumulated amortization on ROU assets for operating leases	29.7			23.2

Weighted-average remaining lease term - finance leases	2.4 years			2.8 years
Weighted-average remaining lease term - operating leases	5.8 years			6.2 years

Weighted-average discount rate - finance leases	15.0		%	15.6		%
Weighted-average discount rate - operating leases	15.7		%	15.8		%


	Operating Leases		Finance Leases
July 2020 through December 2020	$	18.0	$	0.3
2021	33.6		0.5
2022	26.4		0.3
2023	21.9		0.0
2024	16.5		—
Thereafter	47.8		—
Total undiscounted cash flows	$	164.2	$	1.1

Present value:
Short-term lease liability	$	19.3	$	0.4
Long-term lease liability	85.5		0.4
Total lease liability	$	104.8	$	0.8
Difference between undiscounted cash flows and discounted cash flows	$	59.4	$	0.3